Processing 00000000.tx.1: Early-onset Amyloid Deposition and Cognitive Deficits in Transgenic Mice Expressing a Double Mutant Form of Amyloid Precursor Protein 695* M. 

Phrase: "Early-onset Amyloid Deposition"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011560:Amyloid deposition [Pathologic Function]
   861   C1705760:Amyloid Deposition [Finding]
   812   C0333562:Deposition [Functional Concept]

Phrase: "and"

Phrase: "Cognitive Deficits in Transgenic Mice"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   806   C0679466:Cognitive deficits [Mental or Behavioral Dysfunction]
   760   C2987487:deficits [Qualitative Concept]
   726 E C0162429:Deficit, NOS [Disease or Syndrome]

Phrase: "Expressing"

Phrase: "a Double Mutant Form of Amyloid Precursor Protein 695"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0348078:Form [Qualitative Concept]
   742   C0376315:Form [Manufactured Object]
   742   C1522492:Form [Functional Concept]

Phrase: "* M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.2: Azhar Chishtia, Dun-Shen Yanga, Christopher Janusa, Amie L. 

Phrase: "Azhar Chishtia,"

Phrase: "Dun-Shen Yanga,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3331378:Yanga [Eukaryote]

Phrase: "Christopher Janusa,"

Phrase: "Amie L."
Processing 00000000.tx.3: Phinneyab, Patrick Hornea, Jacqueline Pearsona, Robert Stromea, Noah Zukera, James Loukidesa, Janet Frencha, Sherry Turnerc, Gianluca Lozzad, Mariagrazia Grillid, Suzanne Kunickief, Cline Morissettee, Julie Paquettee, Francine Gervaise, Catherine Bergeronagh, Paul E. 

Phrase: "Phinneyab,"

Phrase: "Patrick Hornea,"

Phrase: "Jacqueline Pearsona,"

Phrase: "Robert Stromea,"

Phrase: "Noah Zukera,"

Phrase: "James Loukidesa,"

Phrase: "Janet Frencha,"

Phrase: "Sherry Turnerc,"

Phrase: "Gianluca Lozzad,"

Phrase: "Mariagrazia Grillid,"

Phrase: "Suzanne Kunickief,"

Phrase: "Cline Morissettee,"

Phrase: "Julie Paquettee,"

Phrase: "Francine Gervaise,"

Phrase: "Catherine Bergeronagh,"

Phrase: "Paul E."
Processing 00000000.tx.4: Fraserai, George A. 

Phrase: "Fraserai,"

Phrase: "George A."
Processing 00000000.tx.5: Carlsonc, Peter St. 

Phrase: "Carlsonc,"

Phrase: "Peter St."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3272372:ST [Intellectual Product]
Processing 00000000.tx.6: George-Hyslopajh, and David Westawayagk From the aCentre for Research in Neurodegenerative Diseases, the gDepartment of Laboratory Medicine and Pathobiology, the iDepartment of Medical Biophysics, the jDepartment of Medicine (Division of Neurology), hUniversity Health Network, University of Toronto, Toronto, Ontario M5S 3H2, Canada, cMcLaughlin Research Institute, Great Falls, Montana 59405-4900,dSchering-Plough Research Institute, Milan, Italy, and eNeurochem Inc., Ville St.-Laurent, Montreal, Quebec H4S 2A1, Canada Received for publication, January 25,2001, and in revised form, March 9,2001  ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES We have created early-onset transgenic (Tg) models by exploiting the synergistic effects of familial Alzheimer's disease mutations on amyloid -peptide (A) biogenesis. 

Phrase: "George-Hyslopajh,"

Phrase: "and"

Phrase: "David Westawayagk From the aCentre"

Phrase: "for Research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035168:research [Research Activity]
  1000   C0242481:Research [Research Activity]

Phrase: "in Neurodegenerative Diseases,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0524851:Neurodegenerative Diseases [Disease or Syndrome]
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]

Phrase: "the gDepartment of Laboratory Medicine"

Phrase: "and"

Phrase: "Pathobiology,"

Phrase: "the iDepartment of Medical Biophysics,"

Phrase: "the jDepartment of Medicine"

Phrase: "(Division of Neurology"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   811   C0228059:division nervous system [Body System]
   790   C1293097:Division [Therapeutic or Preventive Procedure]
   790   C2919030:Division [Organization]
   790   C2919031:Division [Activity]

Phrase: ")"

Phrase: ","

Phrase: "hUniversity Health Network,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1513822:Network [Professional or Occupational Group]
   827   C1705739:Network [Manufactured Object]
   827   C1882071:Network [Conceptual Entity]

Phrase: "University of Toronto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Toronto,"

Phrase: "Ontario M5S 3H2,"

Phrase: "Canada,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]

Phrase: "cMcLaughlin Research Institute,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0035172:Research Institute [Organization]
   827   C0021622:institute [Organization]
   827   C0035168:research [Research Activity]
   827   C0242481:Research [Research Activity]
   827   C1272753:Institute [Idea or Concept]

Phrase: "Great Falls,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085639:Falls [Finding]
   827 E C0238715:Fall [Temporal Concept]

Phrase: "Montana 59405-4900,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0026506:Montana [Geographic Area]
   827   C1948075:Montana [Eukaryote]

Phrase: "dSchering-Plough Research Institute,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0035172:Research Institute [Organization]
   812   C0021622:institute [Organization]
   812   C0035168:research [Research Activity]
   812   C0242481:Research [Research Activity]
   812   C1272753:Institute [Idea or Concept]

Phrase: "Milan,"

Phrase: "Italy,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022277:Italy [Geographic Area]

Phrase: "and"

Phrase: "eNeurochem Inc.,"

Phrase: "Ville St.-Laurent,"

Phrase: "Montreal,"

Phrase: "Quebec H4S 2A1,"

Phrase: "Canada"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "January 25,"

Phrase: "2001,"

Phrase: "and in revised form,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1515981:And [Idea or Concept]
   770   C1522492:Form [Functional Concept]
   770   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "March 9,"

Phrase: "2001  ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "We"

Phrase: "have"

Phrase: "created"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1706214:Created [Activity]
   966 E C3244320:create [Functional Concept]

Phrase: "early-onset transgenic (Tg) models by exploiting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   773   C1519606:Transgenic Model [Experimental Model of Disease]
   753   C3161035:Models [Intellectual Product]

Phrase: "the synergistic effects of familial Alzheimer's disease mutations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   744   C1280500:effects [Qualitative Concept]
   744   C2986495:Synergistic [Qualitative Concept]
   711 E C2348382:Effect [Qualitative Concept]

Phrase: "on amyloid -peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(A) biogenesis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005495:Biogenesis [Natural Phenomenon or Process]
   861   C0220781:Biogenesis [Biologic Function]
Processing 00000000.tx.7: TgCRND8 mice encode a double mutant form of amyloid precursor protein 695(KM670/671NL+V717F) under the control of the PrP gene promoter. 

Phrase: "TgCRND8 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "encode"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "a double mutant form of amyloid precursor protein 695"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0348078:Form [Qualitative Concept]
   742   C0376315:Form [Manufactured Object]
   742   C1522492:Form [Functional Concept]

Phrase: "(KM670/671NL+V717F"

Phrase: ")"

Phrase: "under the control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "of the PrP gene promoter."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.8: Thioflavine S-positive A amyloid deposits are present at 3months, with dense-cored plaques and neuritic pathology evident from 5months of age. 

Phrase: "Thioflavine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0950261:thioflavine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "S-"

Phrase: "positive"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439178:% Positive [Quantitative Concept]
  1000   C1446409:Positive [Qualitative Concept]
  1000   C1514241:Positive [Finding]
  1000   C2825490:Positive [Qualitative Concept]

Phrase: "A amyloid deposits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2936349:Amyloid Deposits [Acquired Abnormality]
   861   C0333562:Deposits [Functional Concept]

Phrase: "are"

Phrase: "present at 3months,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0150312:Present [Quantitative Concept]
   790   C0449450:Present [Idea or Concept]

Phrase: "with dense-cored plaques"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   896   C1817256:dense plaque [Cell Component]
   827   C0333463:plaques [Acquired Abnormality]
   793 E C0011389:Plaque [Disease or Syndrome]
   793 E C0332461:Plaque [Finding]

Phrase: "and"

Phrase: "neuritic pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0030664:Pathology [Biomedical Occupation or Discipline]
   861   C0205469:pathology [Functional Concept]
   861   C0677042:pathology [Pathologic Function]
   789 E C1521733:Pathologic [Functional Concept]

Phrase: "evident from 5months of age."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   762   C0332120:Evidence of [Functional Concept]
Processing 00000000.tx.9: TgCRND8 mice exhibit 3,200-4,600 pmol of A42 per g brain at age 6months, with an excess of A42 over A40. 

Phrase: "TgCRND8 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "3,200-4,600 pmol of A42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0439192:pmol [Quantitative Concept]

Phrase: "per g brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "at age 6months,"

Phrase: "with an excess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979886:Excess [Qualitative Concept]

Phrase: "of A42"

Phrase: "over A40."
Processing 00000000.tx.10: High level production of the pathogenic A42 form of A peptide was associated with an early impairment in TgCRND8 mice in acquisition and learning reversal in the reference memory version of the Morris water maze, present by 3months of age. 

Phrase: "High level production of the pathogenic A42 form of A peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0033268:production [Occupational Activity]

Phrase: "was"

Phrase: "associated with an early impairment"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0684336:Impairment [Pathologic Function]
   760   C1279919:Early [Temporal Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in TgCRND8 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "in acquisition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706701:Acquisition [Activity]

Phrase: "and"

Phrase: "learning reversal in the reference memory version of the Morris water maze,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   751   C0035375:Reversal Learning [Research Activity]
   736   C0443290:Reversal [Functional Concept]

Phrase: "present by 3months of age."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
Processing 00000000.tx.11: Notably, learning impairment in young mice was offset by immunization against A42 (Janus, C., Pearson, J., McLaurin, J., Mathews, P.M., Jiang, Y., Schmidt, S.D., Chishti, M.A., Horne, P., Heslin, D., French, J., Mount, H.T.J., Nixon, R.A., Mercken, M., Bergeron, C., Fraser, P.E., St. George-Hyslop, P., and Westaway, D.(2000) Nature 408,979-982). 

Phrase: "Notably,"

Phrase: "learning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013621:learning [Educational Activity]
  1000   C0023185:Learning [Mental Process]

Phrase: "impairment in young mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0684336:Impairment [Pathologic Function]

Phrase: "was"

Phrase: "offset by immunization"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   790   C0042196:immunisation [Therapeutic or Preventive Procedure]
   790   C1711330:Offset [Quantitative Concept]
   790   C3244291:immunization [Functional Concept]

Phrase: "against A42"

Phrase: "(Janus,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0266700:Janus [Congenital Abnormality]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Pearson,"

Phrase: "J.,"

Phrase: "McLaurin,"

Phrase: "J.,"

Phrase: "Mathews,"

Phrase: "P."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]

Phrase: "M."

Phrase: ","

Phrase: "Jiang,"

Phrase: "Y.,"

Phrase: "Schmidt,"

Phrase: "S.D.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "Chishti,"

Phrase: "M.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Horne,"

Phrase: "P.,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]

Phrase: "Heslin,"

Phrase: "D."

Phrase: ","

Phrase: "French,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1556084:French [Population Group]

Phrase: "J.,"

Phrase: "Mount,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0181909:Mount [Medical Device]
  1000   C0449878:mount [Finding]

Phrase: "H.T.J.,"

Phrase: "Nixon,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "A.,"

Phrase: "Mercken,"

Phrase: "M."

Phrase: ","

Phrase: "Bergeron,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Fraser,"

Phrase: "P.E.,"

Phrase: "St. George-Hyslop,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1553316:St. George [Population Group]

Phrase: "P.,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]

Phrase: "and"

Phrase: "Westaway,"

Phrase: "D.("

Phrase: "2000"

Phrase: ")"

Phrase: "Nature 408,979-982"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0349590:Nature [Idea or Concept]
   812   C1262865:Nature [Functional Concept]
   741 E C0205296:Natural [Functional Concept]

Phrase: ")."
Processing 00000000.tx.12: Amyloid deposition in TgCRND8 mice was enhanced by the expression of presenilin 1transgenes including familial Alzheimer's disease mutations; 

Phrase: "Amyloid deposition in TgCRND8 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0011560:Amyloid deposition [Pathologic Function]
   806   C1705760:Amyloid Deposition [Finding]
   760   C0333562:Deposition [Functional Concept]

Phrase: "was"

Phrase: "enhanced by the expression of presenilin 1transgenes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   748   C2349975:Enhanced [Activity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "familial Alzheimer's disease mutations"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0026882:Mutations [Genetic Function]
   779 E C1705285:Mutation [Cell or Molecular Dysfunction]
   756   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   708   C0277558:Familial disease [Disease or Syndrome]

Phrase: ";"
Processing 00000000.tx.13: for mice also expressing a M146L+L286V presenilin 1transgene, amyloid deposits were apparent by 1month of age. 

Phrase: "for mice also"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "expressing"

Phrase: "a M146L+L286V presenilin 1transgene,"

Phrase: "amyloid deposits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2936349:Amyloid Deposits [Acquired Abnormality]
   861   C0333562:Deposits [Functional Concept]

Phrase: "were"

Phrase: "apparent by 1month of age."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0521994:Apparent age [Organism Attribute]
   760   C0750489:apparent [Idea or Concept]
Processing 00000000.tx.14: The Tg mice described here suggest a potential to investigate aspects of Alzheimer's disease pathogenesis, prophylaxis, and therapy within short time frames.  

Phrase: "The Tg mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "here"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a potential to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3245505:Potential [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "aspects of Alzheimer's disease pathogenesis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1547011:Aspect [Quantitative Concept]
   726   C1879746:Aspect [Qualitative Concept]

Phrase: "prophylaxis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033107:prophylaxis [Intellectual Product]
  1000   C0199176:Prophylaxis [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "therapy within short time frames."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0039798:therapy [Functional Concept]
   760   C0087111:Therapy [Therapeutic or Preventive Procedure]
   760   C1363945:Therapy [Finding]
Processing 00000000.tx.15: INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES Alzheimer's disease, the most common cause of dementia, has a complex etiology involving both genetic and environmental determinants. 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Alzheimer's disease,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "the most common cause of dementia,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0015127:cause [Functional Concept]
   753   C1524003:Cause [Conceptual Entity]

Phrase: "has"

Phrase: "a complex etiology"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0015127:aetiology [Functional Concept]
   861   C1314792:Aetiology [Functional Concept]
   861   C1524003:Etiology [Conceptual Entity]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "both genetic"
Meta Candidates (Total=16; Excluded=14; Pruned=0; Remaining=2)
  1000   C0017296:GENETIC [Therapeutic or Preventive Procedure]
  1000   C0314603:Genetic [Functional Concept]
   944 E C0005615:Birth [Organism Function]
   944 E C0035150:Reproduction [Organism Function]
   944 E C0079946:origin [Classification]
   944 E C0439659:Origin [Temporal Concept]
   944 E C1550512:origin [Intellectual Product]
   944 E C1550722:birth [Idea or Concept]
   944 E C3245487:birth [Intellectual Product]
   916 E C0454729:Natal [Geographic Area]
   916 E C0559522:Genital [Body System]
   916 E C1546649:Genital [Intellectual Product]
   916 E C1550642:Genital [Body Substance]
   907 E C0205313:Original [Idea or Concept]
   907 E C2347409:Original [Occupational Activity]
   888 E C0598240:originality [Mental Process]

Phrase: "and"

Phrase: "environmental determinants."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1521761:Determinant [Functional Concept]
Processing 00000000.tx.16: It is characterized by cerebral amyloid deposits formed from the amyloid -peptide (A),1 neuronal loss, and intracellular deposits denoted neurofibrillary tangles (NFTs), aggregations of hyper-phosphorylated forms of the microtubule-associated protein tau (). 

Phrase: "It"

Phrase: "is"

Phrase: "characterized by cerebral amyloid deposits"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C2936349:Amyloid Deposits [Acquired Abnormality]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0333562:Deposits [Functional Concept]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1880022:Characterized [Activity]

Phrase: "formed from the amyloid -peptide"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   760   C0205431:Formed [Functional Concept]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   726 E C0348078:Form [Qualitative Concept]
   726 E C0376315:Form [Manufactured Object]
   726 E C1522492:Form [Functional Concept]

Phrase: "(A),1 neuronal loss,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1850496:Neuronal loss [Finding]
   825 E C0598940:neuron loss [Finding]
   812   C1517945:Loss [Quantitative Concept]

Phrase: "and"

Phrase: "intracellular deposits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0333562:Deposits [Functional Concept]

Phrase: "denoted"

Phrase: "neurofibrillary tangles (NFTs),"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "aggregations of"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   799   C0332621:Aggregation [Functional Concept]
   799   C0439168:% aggregation [Quantitative Concept]
   750 E C0205418:Aggregate [Qualitative Concept]

Phrase: "hyper-phosphorylated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0424295:HYPER [Finding]

Phrase: "forms of the microtubule-associated protein tau"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0348078:forms [Qualitative Concept]
   748   C0376315:Forms [Manufactured Object]
   714 E C1522492:Form [Functional Concept]

Phrase: "("

Phrase: ")."
Processing 00000000.tx.17: Genetic analyses of diverse familial Alzheimer's disease (FAD) kindreds indicate biosynthesis of the amyloid -peptide (A), generated by secretase-mediated endoproteolysis of the amyloid precursor protein (APP), is a common denominator in inherited forms of the disease. 

Phrase: "Genetic analyses of diverse familial Alzheimer's disease (FAD) kindreds"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   754   C0679560:genetic analysis [Laboratory Procedure]
   754   C0796344:Genetic Analysis [Laboratory Procedure]
   711   C0002778:Analysis [Laboratory Procedure]
   711   C0936012:Analysis [Research Activity]
   711   C1524024:analysis [Functional Concept]

Phrase: "indicate"

Phrase: "biosynthesis of the amyloid -peptide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1327133:Peptide Biosynthesis [Molecular Function]
   760   C0005572:biosynthesis [Functional Concept]
   760   C0220781:Biosynthesis [Biologic Function]

Phrase: "(A"

Phrase: ")"

Phrase: ","

Phrase: "generated by secretase-mediated endoproteolysis of the amyloid precursor protein (APP),"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   799   C0171484:Amyloid Precursor Protein Secretase [Amino Acid, Peptide, or Protein,Enzyme]
           secretase
   799   C0699919:Amyloid Precursor Protein Secretase [Amino Acid, Peptide, or Protein,Enzyme]
   782   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   782   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   760   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   739   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0011560:Amyloid [Pathologic Function]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0086597:mediated [Social Behavior]
   739   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   739   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C1709634:Precursor [Idea or Concept]
   739   C3146294:Generated [Activity]

Phrase: "is"

Phrase: "a common denominator in inherited forms of the disease."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C2825218:Denominator [Quantitative Concept]
Processing 00000000.tx.18: In the case of chromosome 21-linked FAD kindreds, mutations in APP are found in close proximity to the endoprotease sites where A is excised by the action of - and -secretases (2-6). 

Phrase: "In the case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "of chromosome 21-linked FAD kindreds,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0598429:kindreds [Qualitative Concept]

Phrase: "mutations in APP"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "found in close proximity"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0150312:Found [Quantitative Concept]
   770   C0587267:Close [Functional Concept]
   770   C1514583:Proximity [Spatial Concept]
   737 E C0243095:Find [Finding]

Phrase: "to the endoprotease sites where"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205145:Sites [Spatial Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]

Phrase: "A"

Phrase: "is"

Phrase: "excised by the action of -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441472:Action [Functional Concept]
   760   C3266814:Action [Activity]

Phrase: "and -"

Phrase: "secretases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0171484:Secretases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(2-6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.19: Mutations in presenilins 1and 2are thought to enhance cleavage of APP at the -secretase site (7-9). 

Phrase: "Mutations in presenilins 1and 2are"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "cleavage of APP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0597304:Protein Cleavage [Molecular Function]
   760   C0010813:cleavage [Cell Function]
   760   C0596311:Cleavage [Phenomenon or Process]
   760   C1330957:cleavage [Cell Function]

Phrase: "at the -secretase site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "(7-9"

Phrase: ")."
Processing 00000000.tx.20: Finally, the 4 allele of the ApoE gene, which is correlated with increased susceptibility to late-onset AD (10), is found to enhance the formation of mature plaques in certain APP transgenic mice (11). 

Phrase: "Finally,"

Phrase: "the 4 allele of the ApoE gene,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   831   C1370079:APOE Gene Allele 4 [Gene or Genome]
   804   C3642141:APOE*4 Allele [Gene or Genome]
   748   C0002085:Allele [Gene or Genome]
           allelic gene

Phrase: "which"

Phrase: "is"

Phrase: "correlated with increased susceptibility"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0012655:Susceptibility [Clinical Attribute]
   770   C0205217:Increased [Quantitative Concept]
   770   C0220898:Susceptibility [Organism Attribute]
   770   C0442805:Increased [Functional Concept]
   770   C1264642:Susceptibility [Functional Concept]
   770   C1547045:*Susceptibility [Quantitative Concept]
   770   C1707520:Correlated [Qualitative Concept]

Phrase: "to late-onset AD (10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0205087:Late [Temporal Concept]
   812   C0332162:Onset [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "is"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "the formation of mature plaques"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "in certain APP transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0025936:Mice, Transgenic [Mammal]
   799   C0003069:Transgenic [Animal]
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.21: These genetic data indicate elevated A biogenesis or accumulation is likely a crucial pathogenic event in all forms of AD (i.e. both familial and sporadic AD). 

Phrase: "These genetic data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "indicate"

Phrase: "elevated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205250:Elevated [Qualitative Concept]
  1000   C3163633:Elevated [Qualitative Concept]

Phrase: "A biogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005495:Biogenesis [Natural Phenomenon or Process]
  1000   C0220781:Biogenesis [Biologic Function]

Phrase: "or"

Phrase: "accumulation"

Phrase: "is"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "a crucial pathogenic event in all"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0441471:Event [Event]

Phrase: "forms of AD ("
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0348078:Form [Qualitative Concept]
   790   C0376315:Form [Manufactured Object]
   790   C1522492:Form [Functional Concept]

Phrase: "i.e."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "both familial"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:familial [Family Group]
  1000   C0241888:Familial [Functional Concept]
   928 E C1704727:Family [Conceptual Entity]

Phrase: "and"

Phrase: "sporadic AD"

Phrase: ")."
Processing 00000000.tx.22: This conclusion finds a parallel in studies indicating that A is neurotoxic (12-14). 

Phrase: "This conclusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "finds"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243095:Find [Finding]

Phrase: "a parallel in studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   802   C2826345:Parallel Study [Research Activity]
           PARALLEL
   770   C2348042:Parallel [Qualitative Concept]

Phrase: "indicating"

Phrase: "that"

Phrase: "A"

Phrase: "is"

Phrase: "neurotoxic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0235032:Neurotoxicity [Injury or Poisoning]

Phrase: "(12-14"

Phrase: ")."
Processing 00000000.tx.23: Since there are no naturally occurring rodent forms of AD, there has been great interest in creating accurate transgenic facsimiles of this disease. 

Phrase: "Since"

Phrase: "there"

Phrase: "are"

Phrase: "no naturally"

Phrase: "occurring"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1709305:Occur [Activity]
   966   C2745955:OCCUR [Temporal Concept]

Phrase: "rodent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035804:Rodent [Mammal]

Phrase: "forms of AD,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0348078:Form [Qualitative Concept]
   790   C0376315:Form [Manufactured Object]
   790   C1522492:Form [Functional Concept]

Phrase: "there"

Phrase: "has"

Phrase: "been"

Phrase: "great interest in creating accurate transgenic facsimiles of this disease."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0543488:Interest [Mental Process]
Processing 00000000.tx.24: Such disease models have the potential to stratify pathogenic events and practical utility for testing interventions directed against synthesis or deposition of the A peptide. 

Phrase: "Such disease models"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683033:disease models [Intellectual Product]
  1000   C0684309:disease models [Experimental Model of Disease]
   861   C3161035:Models [Intellectual Product]

Phrase: "have"

Phrase: "the potential to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3245505:Potential [Qualitative Concept]

Phrase: "stratify"

Phrase: "pathogenic events"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441471:Events [Event]
   861   C3541888:Events [Classification]

Phrase: "and"

Phrase: "practical utility for testing interventions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0582205:utility [Organization]

Phrase: "directed against synthesis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0220781:synthesis [Biologic Function]
   790   C1883254:Synthesis [Activity]
   756   C0439851:Direct [Qualitative Concept]
   756   C1947931:Direct [Qualitative Concept]

Phrase: "or"

Phrase: "deposition of the"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0333562:Deposition [Functional Concept]

Phrase: "A peptide."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.25: However, despite intense effort, remarkably few models exist (reviewed in Ref. 15). 

Phrase: "However,"

Phrase: "despite intense effort,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015264:Effort [Organism Function]

Phrase: "remarkably few models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3161035:Models [Intellectual Product]

Phrase: "exist"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2987476:Exist [Conceptual Entity]

Phrase: "("

Phrase: "reviewed in Ref. 15"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0282443:reviewed [Intellectual Product]
   770   C1425988:REF [Gene or Genome]
   770   C1709940:Reviewed [Qualitative Concept]
   737 E C1552617:Review [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.26: Some models fail to produce APP and/or its metabolites by physiologically appropriate pathways, and in cases where this caveat does not apply, the transgenic animals may display only facets of the AD phenotype (16). 

Phrase: "Some models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Models [Intellectual Product]

Phrase: "fail"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "produce"

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "and/or"

Phrase: "its metabolites by physiologically appropriate pathways,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0870883:Metabolites [Biologically Active Substance]
   753   C2698672:METABOLITES [Regulation or Law]

Phrase: "and in cases where"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0868928:Cases [Functional Concept]
   770   C1515981:And [Idea or Concept]
   770   C1533148:Cases [Quantitative Concept]
   737 E C1706255:CASE [Medical Device]
   737 E C1706256:Case [Conceptual Entity]

Phrase: "this caveat"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871599:Caveat [Governmental or Regulatory Activity]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "apply"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0185125:Apply [Health Care Activity]
  1000   C1632850:Apply [Functional Concept]
  1000   C1879355:Apply [Functional Concept]

Phrase: ","

Phrase: "the transgenic animals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003069:Animals, Transgenic [Animal]
   861   C0003062:Animals [Animal]

Phrase: "may"

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "only facets of the AD phenotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0222679:facets [Body Location or Region]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.27: With regard to neuropathology, the phenotypes created thus far include amyloid deposits that closely resemble those seen in AD, selective neuronal loss (in one instance), some hyperphosphorylation of tau, but no deposition of NFTs (17-20). 

Phrase: "With regard to neuropathology,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0876934:Neuropathology [Biomedical Occupation or Discipline]
  1000   C1540677:neuropathology [Pathologic Function]
  1000   C1555824:Neuropathology [Intellectual Product]

Phrase: "the phenotypes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0031437:Phenotypes [Organism Attribute]
   966 E C1285572:Phenotype [Laboratory Procedure]

Phrase: "created"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1706214:Created [Activity]
   966 E C3244320:create [Functional Concept]

Phrase: "thus far"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205108:far [Spatial Concept]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "deposits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333562:Deposit [Functional Concept]

Phrase: "that closely"

Phrase: "resemble"

Phrase: "those"

Phrase: "seen in AD,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0205397:Seen [Qualitative Concept]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]

Phrase: "selective neuronal loss"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C1850496:Neuronal loss [Finding]
   865 E C0598940:neuron loss [Finding]
   827   C1517945:Loss [Quantitative Concept]

Phrase: "("

Phrase: "in one instance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1550608:Instance [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "some hyperphosphorylation of tau,"

Phrase: "but"

Phrase: "no deposition of NFTs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0333562:Deposition [Functional Concept]

Phrase: "(17-20"

Phrase: ")."
Processing 00000000.tx.28: Neuropathological abnormalities in singly transgenic mice may not appear until 6-9 months of age and may not be robust until animals are well in excess of 1year of age (see "Discussion"). 

Phrase: "Neuropathological abnormalities in singly transgenic mice"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0000768:Abnormalities [Congenital Abnormality]
   753   C0000769:abnormalities [Functional Concept]
   719 E C1704258:Abnormality [Finding]

Phrase: "may"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "appear until 6-9 months of age"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   774   C1510828:Age-Months [Organism Attribute]
   748   C0001779:Age [Organism Attribute]
   748   C0439231:months [Temporal Concept]
   748   C0700364:APPEAR [Qualitative Concept]
   714 E C0439507:/month [Temporal Concept]

Phrase: "and"

Phrase: "may"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "robust until animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2986815:Robust [Qualitative Concept]

Phrase: "are"

Phrase: "well in excess of 1year of age (see ""Discussion"""
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   742   C0001779:Age [Organism Attribute]
   742   C0042789:see [Organism Function]
   742   C0205170:Well [Qualitative Concept]
   742   C0557061:Discussion [Therapeutic or Preventive Procedure]
   742   C1947903:See [Activity]
   742   C1979886:Excess [Qualitative Concept]
   742   C2584313:Discussion [Social Behavior]
   742   C3146287:Well [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.29: Other complications encountered in these models include hippocampal atrophy (21), neonatal lethality attributed to overexpression of APP (22, 23), and complex and variable relationships between cognitive dysfunction and transgene expression (18, 21, 23-25). 

Phrase: "Other complications"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0009566:Complications [Pathologic Function]
  1000   C1171258:complications [Pathologic Function]
   966 E C2362589:Complication [Idea or Concept]
   916 E C0231242:Complicated [Functional Concept]

Phrase: "encountered in these models"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C3161035:Models [Intellectual Product]
   737   C0545082:Encounter [Behavior]
   737   C1512346:encounter [Health Care Activity]
   737   C1947978:Encounter [Behavior]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "hippocampal atrophy"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0333641:Atrophy [Pathologic Function]
   789 E C0151514:Atrophic [Disease or Syndrome]

Phrase: "(21"

Phrase: ")"

Phrase: ","

Phrase: "neonatal lethality"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   964   C1857104:Neonatal lethal [Finding]
   789   C3151529:Lethal [Finding]

Phrase: "attributed to overexpression of APP"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   814   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   814   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   778   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   774   C1514559:Protein Overexpression [Genetic Function]
           Overexpression
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1709634:Precursor [Idea or Concept]
   714   C0449234:Attribute [Idea or Concept]
   714   C1704772:Attribute [Conceptual Entity]
   714   C1882133:Attribute [Qualitative Concept]

Phrase: "(22,"

Phrase: "23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439855:Complex [Qualitative Concept]
  1000   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "variable relationships between cognitive dysfunction"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0439849:Relationships [Qualitative Concept]
   726 E C1705630:Relationship [Idea or Concept]
   726 E C1706279:Relationship [Idea or Concept]
   726 E C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "transgene expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]
   861   C0282641:Transgene [Gene or Genome]

Phrase: "(18,"

Phrase: "21,"

Phrase: "23-25"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.30: Here we describe a new line of transgenic mice that exhibits deposition of A-amyloid and robust cognitive deficits by the age of 3months. 

Phrase: "Here"

Phrase: "we"

Phrase: "describe"

Phrase: "a new line of transgenic mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205132:Line [Spatial Concept]
   753   C1550648:Line [Substance]
   753   C1552960:Line [Quantitative Concept]

Phrase: "that"

Phrase: "exhibits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "deposition of A-amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0011560:Amyloid deposition [Pathologic Function]
   819   C1705760:Amyloid Deposition [Finding]
   770   C0333562:Deposition [Functional Concept]

Phrase: "and"

Phrase: "robust cognitive deficits by the age of 3months."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0679466:Cognitive deficits [Mental or Behavioral Dysfunction]
   744   C2987487:deficits [Qualitative Concept]
   711 E C0162429:Deficit, NOS [Disease or Syndrome]
Processing 00000000.tx.31: These mice have a demonstrated utility for assessing procedures that interfere with amyloidogenesis (1) and may serve as a platform to create more sophisticated models of AD.  

Phrase: "These mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "have"

Phrase: "a demonstrated utility for assessing procedures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0582205:utility [Organization]

Phrase: "that"

Phrase: "interfere with amyloidogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0521102:Interfere [Qualitative Concept]
   790   C1706803:Amyloidogenesis [Cell or Molecular Dysfunction]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "may"

Phrase: "serve as a platform to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1710360:Platform [Research Device]

Phrase: "create"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1706214:Create [Activity]
  1000   C3244320:create [Functional Concept]

Phrase: "more sophisticated models of AD."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3161035:Models [Intellectual Product]
Processing 00000000.tx.32: MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES Construction and Analysis of Tg Mice-- The APP695 cDNA cassette was based upon an isolate of the cDNA clone described by Kang et al. 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Construction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441513:Construction [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "Analysis of Tg Mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "-"

Phrase: "-"

Phrase: "The APP695 cDNA cassette"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0450240:Cassette [Medical Device]
   827   C1706210:Cassette [Manufactured Object]

Phrase: "was"

Phrase: "based upon an isolate of the cDNA clone"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   744   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0009013:Clone [Cell]
   744   C0370215:Isolate [Substance]
   744   C1522642:Clone [Tissue]
   744   C1527178:Based [Functional Concept]
   744   C1705938:Based [Idea or Concept]
   744   C1875400:ISOLATE [Pharmacologic Substance]
   711 E C0002055:base [Inorganic Chemical]
   711 E C0178499:Base [Chemical Viewed Functionally]
   711 E C1880279:Base [Biomedical or Dental Material]

Phrase: "described by Kang et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1552738:described [Idea or Concept]
Processing 00000000.tx.33: (26). 

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.34: A SmaI to SpeI fragment including 90and 269base pairs of the wt APP cDNA 5'- and 3'-untranslated region was cloned into the plasmid vector pUC19 (27). 

Phrase: "A SmaI to SpeI fragment"

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "90and 269base"

Phrase: "pairs of the wt APP cDNA 5'-"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   790   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   790   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   764   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1709450:Pair [Qualitative Concept]
   742   C1709634:Precursor [Idea or Concept]
   742   C2700323:WT [Fish]

Phrase: "and"

Phrase: "3'-untranslated region"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0600600:3' Untranslated Region [Biologically Active Substance,Nucleotide Sequence]
   913   C1883633:3' Region [Nucleotide Sequence]
   901   C0600680:Untranslated Region [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "was"

Phrase: "cloned into the plasmid vector pUC19"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C1514152:Plasmid Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0009013:cloned [Cell]
   753   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0442335:Vector [Spatial Concept]
   753   C1705099:Vector [Idea or Concept]
   719 E C1522642:Clone [Tissue]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.35: This clone was subjected to mutagenesis using the "transformer" protocol (CLONTECH) to convert the 5' SmaI site to a SalI site, with a second SalI site deriving from the pUC19 polylinker. 

Phrase: "This clone"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0009013:Clone [Cell]
  1000   C1522642:Clone [Tissue]
   928 E C1704387:Clonal [Qualitative Concept]
   900 E C0796368:clonality [Diagnostic Procedure]

Phrase: "was"

Phrase: "subjected to mutagenesis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0079866:Mutagenesis [Molecular Function]
   790   C3146302:Mutagenesis [Laboratory Procedure]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the ""transformer"" protocol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0442711:Protocol [Intellectual Product]
   861   C1507394:Protocol [Intellectual Product]
   861   C1522729:Protocol [Intellectual Product]
   861   C2348563:Protocol [Intellectual Product]

Phrase: "(CLONTECH"

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "convert"

Phrase: "the 5' SmaI site to a SalI site,"

Phrase: "with a second SalI site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205145:Site [Spatial Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]

Phrase: "deriving from the pUC19 polylinker."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1711343:Deriving [Qualitative Concept]
Processing 00000000.tx.36: The ~2.4-kilobase pair SalI fragment was excised and inserted into the SalI site of pBR322 (28), to exclude extraneous polylinker sites and thereby facilitate swapping of internal APP restriction fragments containing either Swedish (KM670/671NL) or Swedish plus Indiana (V717F) mutations ("Quick-change", Stratagene Inc.). 

Phrase: "The ~2.4-kilobase pair SalI fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0332255:fragment [Functional Concept]
   799   C1708096:Fragment [Qualitative Concept]

Phrase: "was"

Phrase: "excised"

Phrase: "and"

Phrase: "inserted into the SalI site of pBR322"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   778   C2945843:Site of [Qualitative Concept]
   757   C1705686:Insert Site [Nucleotide Sequence]
   748   C0205145:Site [Spatial Concept]
   748   C0441587:Inserted [Health Care Activity]
   748   C1515974:Site [Body Location or Region]
   748   C2825164:Site [Spatial Concept]
   714 E C1743766:Insert [Medical Device]
   714 E C1883719:Insert [Functional Concept]

Phrase: "(28"

Phrase: ")"

Phrase: ","

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "extraneous polylinker sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205145:Sites [Spatial Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "thereby"

Phrase: "facilitate"

Phrase: "swapping of internal APP restriction fragments"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C1416521:SWAP [Gene or Genome]
   711   C1419999:SWAP [Gene or Genome]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "either Swedish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710263:Swedish [Population Group]

Phrase: "(KM670/671NL"

Phrase: ")"

Phrase: "or"

Phrase: "Swedish plus Indiana"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0021206:Indiana [Geographic Area]

Phrase: "(V717F"

Phrase: ")"

Phrase: "mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(""Quick-change"","
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0392747:Change [Functional Concept]
   861   C0439831:quick [Qualitative Concept]
   861   C0443172:change [Quantitative Concept]
   861   C1705241:Change [Quantitative Concept]

Phrase: "Stratagene"

Phrase: "Inc."

Phrase: ")."
Processing 00000000.tx.37: Completed plasmids were sequenced in their entirety with a total of 12sequencing primers covering the APP coding region, to exclude the possible presence of erroneous mutations either present in the starting plasmids or introduced during in vitro manipulations. 

Phrase: "Completed plasmids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "sequenced in their entirety"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   737   C0004793:Sequence [Nucleotide Sequence]
   737   C0162326:Sequence [Nucleotide Sequence]
   737   C0162327:Sequence [Nucleotide Sequence]
   737   C1519249:Sequence [Functional Concept]

Phrase: "with a total"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439175:% total [Quantitative Concept]
  1000   C0439810:Total [Qualitative Concept]

Phrase: "of 12sequencing primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "covering"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0180153:covering [Medical Device]
  1000   C0439844:covering [Functional Concept]
   966 E C1707529:Cover [Medical Device]
   966 E C1999244:Cover [Functional Concept]

Phrase: "the APP coding region,"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   884   C0079941:Protein Coding Region [Gene or Genome]
           Coding Region
   853   C1514562:Protein Region [Amino Acid Sequence]
   804   C0009219:Coding [Occupational Activity]
   804   C0017446:Region [Geographic Area]
   804   C0205147:Region [Spatial Concept]
   771 E C0805701:Code [Intellectual Product]
   733 E C0205276:Regional [Spatial Concept]
   733 E C1947913:Regional [Spatial Concept]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "the possible presence of erroneous mutations either present"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in the starting plasmids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "or"

Phrase: "introduced during in vitro manipulations."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0021135:In Vitro [Intellectual Product]
   806   C1533691:in vitro [Qualitative Concept]
           vitro
   806   C2827718:In Vitro [Functional Concept]
   760   C0185111:MANIPULATIONS [Therapeutic or Preventive Procedure]
   760   C0947647:Manipulations NOS [Therapeutic or Preventive Procedure]
   726   C1292748:introduce [Functional Concept]
Processing 00000000.tx.38: SalI fragments of APP or XhoI fragments of PS1 (9) were then cloned into cos.Tet (29). 

Phrase: "SalI"

Phrase: "fragments of APP"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   862   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   862   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   806   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   797   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0332255:fragment [Functional Concept]
   760   C0486805:Fragments [Body Substance]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1708096:Fragment [Qualitative Concept]
   760   C1709634:Precursor [Idea or Concept]

Phrase: "or"

Phrase: "XhoI"

Phrase: "fragments of PS1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0332255:fragment [Functional Concept]
   790   C0486805:Fragments [Body Substance]
   790   C1418985:PS1 [Gene or Genome]
   790   C1708096:Fragment [Qualitative Concept]
   790   C2986918:PS1 [Gene or Genome]

Phrase: "(9"

Phrase: ")"

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "cloned into cos.Tet (29"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0009013:cloned [Cell]
   760   C0454802:Cos [Geographic Area]
   760   C1515333:Tet [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   726 E C1522642:Clone [Tissue]

Phrase: ")."
Processing 00000000.tx.39: NotI transgene fragments excised from this cosmid vector were purified and injected into oocytes of different genetic backgrounds as noted, and founder animals were identified by dot-blot hybridization analysis of genomic DNA using a probe within the hamster PrP gene 3'-untranslated region as described previously (9, 30). 

Phrase: "NotI transgene fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "excised from this cosmid vector"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1511534:Cosmid Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0010167:Cosmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0442335:Vector [Spatial Concept]
   760   C1705099:Vector [Idea or Concept]

Phrase: "were"

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "and"

Phrase: "injected into oocytes of different genetic backgrounds"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   748   C0029045:Oocytes [Cell]
   748   C0314603:Genetic [Functional Concept]
   748   C1705242:Different [Qualitative Concept]
   714   C1706907:Background [Conceptual Entity]
   714   C1720154:Inject [Functional Concept]

Phrase: "as"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: ","

Phrase: "and"

Phrase: "founder animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "identified by dot-blot hybridization analysis of genomic DNA"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   764   C0013064:dot blot [Laboratory Procedure]
   764   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   762   C0200898:DNA analysis [Laboratory Procedure]
   762   C0221902:DNA hybridisation [Molecular Biology Research Technique]
   762   C0376343:Genomic Hybridization [Natural Phenomenon or Process]
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0017428:Genomic [Gene or Genome]
   742   C0020202:Hybridisation [Genetic Function]
   742   C0205396:Identified [Qualitative Concept]
   742   C0872145:DOT [Therapeutic or Preventive Procedure]
   742   C0887950:genomic [Biomedical Occupation or Discipline]
   742   C0936012:Analysis [Research Activity]
   742   C1300517:Hybridization [Laboratory Procedure]
   742   C1524024:analysis [Functional Concept]
   742   C1550043:Identified [Finding]
   742   C1551388:Identified [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a probe within the hamster PrP gene 3'-untranslated region"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   757   C0441088:Gene probe [Medical Device]
   739   C0182400:Probe [Medical Device]
   739   C1704681:Probe [Gene or Genome]
   739   C2347609:Probe [Chemical Viewed Functionally]
   739   C3536729:Probe [Manufactured Object]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(9,"

Phrase: "30"

Phrase: ")."
Processing 00000000.tx.40: Double transgenic mice deriving from crosses of transgene heterozygotes were identified by dot-blot hybridization analysis using human APP or PS1 cDNA probe fragments. 

Phrase: "Double"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Double [Functional Concept]
  1000   C1705764:Double [Activity]
  1000   C1705765:Double [Qualitative Concept]

Phrase: "transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "deriving from crosses of transgene heterozygotes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0019425:Heterozygotes [Organism Attribute]
   753   C0282641:Transgene [Gene or Genome]
   753   C1711343:Deriving [Qualitative Concept]
   719   C2828360:Cross [Conceptual Entity]

Phrase: "were"

Phrase: "identified by dot-blot hybridization analysis"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0013064:dot blot [Laboratory Procedure]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0020202:Hybridisation [Genetic Function]
   753   C0205396:Identified [Qualitative Concept]
   753   C0872145:DOT [Therapeutic or Preventive Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1300517:Hybridization [Laboratory Procedure]
   753   C1524024:analysis [Functional Concept]
   753   C1550043:Identified [Finding]
   753   C1551388:Identified [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "human APP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   902   C1142652:human protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "or"

Phrase: "PS1 cDNA probe fragments."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0332255:fragments [Functional Concept]
   812   C0486805:Fragments [Body Substance]
   779 E C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.41: Protein Analysis-- Western blots were performed by enhanced chemiluminescence as described previously (9), except ECL-Plus (Amersham Pharmacia Biotech) was used in conjunction with a "Storm" imaging system (Molecular Dynamics) for quantitative analyses. 

Phrase: "Protein Analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1514534:Protein Analysis [Molecular Biology Research Technique]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "--"

Phrase: "Western blots"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0949466:Western Blots [Laboratory Procedure]
   966 E C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   861   C1705493:Western [Spatial Concept]

Phrase: "were"

Phrase: "performed by enhanced chemiluminescence"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C1550369:Performed By [Qualitative Concept]
   770   C0162524:Chemiluminescence [Natural Phenomenon or Process]
   770   C0884358:Performed [Functional Concept]
   770   C1450278:Chemiluminescence [Natural Phenomenon or Process]
   770   C2349975:Enhanced [Activity]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(9"

Phrase: ")"

Phrase: ","

Phrase: "except ECL-Plus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332287:Plus [Qualitative Concept]

Phrase: "(Amersham Pharmacia Biotech"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0331955:Pharmacia [Health Care Related Organization]

Phrase: ")"

Phrase: "was"

Phrase: "used in conjunction with a ""Storm"" imaging system"
Meta Candidates (Total=15; Excluded=6; Pruned=0; Remaining=9)
   770   C2697665:Imaging System [Manufactured Object]
   744   C0011923:Imaging [Diagnostic Procedure]
   744   C0079595:Imaging [Diagnostic Procedure]
   744   C0449913:System [Functional Concept]
   744   C1273517:used [Finding]
   744   C1553451:System [Manufactured Object]
   744   C1704459:System [Medical Device]
   744   C2699427:Conjunction [Idea or Concept]
   744   C2905612:Storm NOS [Injury or Poisoning]
   711 E C0042153:use [Functional Concept]
   711 E C0457083:Use [Functional Concept]
   711 E C1704254:Image [Intellectual Product]
   711 E C1704922:Image [Entity]
   711 E C1947944:Use [Intellectual Product]
   711 E C3542466:Image [Intellectual Product]

Phrase: "(Molecular Dynamics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596957:Molecular Dynamics [Molecular Function]

Phrase: ")"

Phrase: "for quantitative analyses."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
Processing 00000000.tx.42: For ELISA analysis, C3H/B6FVB/N mice at 4,6,8,10,and 26weeks of age were transcardially perfused with cold saline. 

Phrase: "For ELISA analysis,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "C3H/B6FVB/N mice at 4,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0025920:Mice, C3H [Mammal]
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]

Phrase: "6,"

Phrase: "8,"

Phrase: "10,"

Phrase: "and"

Phrase: "26weeks of age"

Phrase: "were"

Phrase: "transcardially"

Phrase: "perfused with cold saline."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0009264:Cold [Natural Phenomenon or Process]
   770   C0009443:Cold [Disease or Syndrome]
   770   C0036082:Saline [Substance]
   770   C0234192:Cold [Physiologic Function]
   737   C1549542:Perfuse [Functional Concept]
Processing 00000000.tx.43: The entire brain was removed and snap-frozen until analysis. 

Phrase: "The entire brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1269537:Entire brain [Body Part, Organ, or Organ Component]
           Brain
   861   C0006104:Brain [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "and"

Phrase: "snap-"

Phrase: "frozen until analysis."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0016701:Frozen [Natural Phenomenon or Process]
   790   C0677542:Frozen [Functional Concept]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]
Processing 00000000.tx.44: Cerebral A was solubilized in a 5M guanidine HCl, 50mM Tris-HCl, pH 8.0buffer (31), agitated, aliquoted, and stored at 80C. 

Phrase: "Cerebral A"

Phrase: "was"

Phrase: "solubilized in a 5M guanidine HCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0018320:guanidine [Organic Chemical]
   753   C0120446:Guanidine [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "50mM Tris-HCl,"

Phrase: "pH 8.0buffer"

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "agitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085631:Agitated [Sign or Symptom]

Phrase: ","

Phrase: "aliquoted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1510844:Aliquot [Quantitative Concept]

Phrase: ","

Phrase: "and"

Phrase: "stored at 80C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1698986:Store [Functional Concept]
Processing 00000000.tx.45: Thawed aliquots were diluted 10-fold or more and assessed for A40 or A42 using commercially available enzyme-linked immunosorbent assays (ELISAs) specific for either A40 or A42 and calibrated with synthetic A peptides (BIOSOURCE International). 

Phrase: "Thawed aliquots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1510844:Aliquot [Quantitative Concept]

Phrase: "were"

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "10-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: "or"

Phrase: "more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "and"

Phrase: "assessed for A40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1516048:Assessed [Activity]

Phrase: "or"

Phrase: "A42"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "commercially available enzyme-linked immunosorbent assays (ELISAs)"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   901   C0014441:Immunosorbent Assays, Enzyme-Linked [Laboratory Procedure]
   858   C2717977:Enzyme Assays [Laboratory Procedure]
   799   C0014442:Enzyme [Enzyme,Organic Chemical]
   799   C0021075:immunosorbent [Indicator, Reagent, or Diagnostic Aid]
   766   C0005507:Assay [Laboratory Procedure]
   766   C0243073:assay [Qualitative Concept]
   766   C1510438:Assay [Laboratory Procedure]
   766   C1517892:Link [Intellectual Product]
   766   C1704666:Link [Intellectual Product]
   716 E C0014445:enzymes [Functional Concept]

Phrase: "specific for either A40"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205369:Specific [Qualitative Concept]
   770   C1552740:specific [Intellectual Product]

Phrase: "or"

Phrase: "A42"

Phrase: "and"

Phrase: "calibrated with synthetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1883254:synthetic [Activity]

Phrase: "A peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "(BIOSOURCE"

Phrase: "International"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512888:International [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.46: The A40 ELISA does not display any cross-reactivity with A42 or A43, and the A42 ELISA does not react with either A40 or A43. 

Phrase: "The A40 ELISA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014441:ELISA [Laboratory Procedure]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "any cross-reactivity with A42"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0010357:Cross Reactivity [Molecular Function]
   806   C0872139:cross reactivity [Molecular Function]
   806   C1880190:CROSS REACTIVITY [Event]
   760   C2828360:Cross [Conceptual Entity]

Phrase: "or"

Phrase: "A43,"

Phrase: "and"

Phrase: "the A42 ELISA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014441:ELISA [Laboratory Procedure]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "react with either A40"

Phrase: "or"

Phrase: "A43."
Processing 00000000.tx.47: Each brain was analyzed in duplicate or triplicate, with the average value reported for each brain. 

Phrase: "Each brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "analyzed in duplicate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205173:Duplicate [Functional Concept]
   790   C0936012:Analyzed [Research Activity]
   790   C3539942:Duplicate [Intellectual Product]

Phrase: "or"

Phrase: "triplicate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205174:Triplicate [Quantitative Concept]

Phrase: ","

Phrase: "with the average value"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1522609:Value [Quantitative Concept]

Phrase: "reported for each brain."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   770   C3496591:Reported [Clinical Attribute]
   737 E C3273238:Report [Intellectual Product]
Processing 00000000.tx.48: Survival Census-- All pups were weaned at an age between 21and 24days. 

Phrase: "Survival Census"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0007663:Census [Quantitative Concept]

Phrase: "-"

Phrase: "-"

Phrase: "All pups"

Phrase: "were"

Phrase: "weaned at an age"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0001779:Age [Organism Attribute]
   770   C0043084:weaned [Organism Function]

Phrase: "between 21and 24days."
Processing 00000000.tx.49: The identification of pups genotypes was carried out between 23and 26days of age. 

Phrase: "The identification of pups genotypes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0020792:Identification [Mental Process]
   760   C0205396:Identification [Qualitative Concept]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out between 23and 26days of age."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0001779:Age [Organism Attribute]
   753   C0439787:Out [Spatial Concept]
   753   C0849355:Out [Qualitative Concept]
Processing 00000000.tx.50: Therefore, the reliable estimation of Tg mice survival is limited to their post-weaning age. 

Phrase: "Therefore,"

Phrase: "the reliable estimation of Tg mice survival"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0680844:estimation [Mental Process]
   748   C0681916:Estimation [Quantitative Concept]
   748   C0750572:Estimation [Quantitative Concept]

Phrase: "is"

Phrase: "limited to their post-weaning age."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   753   C0001779:Age [Organism Attribute]
   753   C0043084:Weaning [Organism Function]
   753   C0439801:Limited [Functional Concept]
   753   C0687676:Post [Temporal Concept]
   753   C1704687:Post [Manufactured Object]
   753   C3542948:Limited [Intellectual Product]
   719 E C1549649:Limit [Idea or Concept]
   719 E C2349209:Limit [Conceptual Entity]
Processing 00000000.tx.51: Statistical analysis of survival as a function of genetic background was carried out on three cohorts of TgCRND8 mice as follows: (C57)(C3H/C57), (FVB)(C3H/C57), and (C3H/C57/129SvEv/Tac)(129SvEv/Tac). 

Phrase: "Statistical analysis of survival"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0871424:statistical analysis [Research Activity]
   819   C0038953:Survival Analysis [Research Activity]
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "as a function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]

Phrase: "of genetic background"
Meta Candidates (Total=17; Excluded=14; Pruned=0; Remaining=3)
   861   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   861   C0314603:Genetic [Functional Concept]
   861   C1706907:Background [Conceptual Entity]
   805 E C0005615:Birth [Organism Function]
   805 E C0035150:Reproduction [Organism Function]
   805 E C0079946:origin [Classification]
   805 E C0439659:Origin [Temporal Concept]
   805 E C1550512:origin [Intellectual Product]
   805 E C1550722:birth [Idea or Concept]
   805 E C3245487:birth [Intellectual Product]
   777 E C0454729:Natal [Geographic Area]
   777 E C0559522:Genital [Body System]
   777 E C1546649:Genital [Intellectual Product]
   777 E C1550642:Genital [Body Substance]
   768 E C0205313:Original [Idea or Concept]
   768 E C2347409:Original [Occupational Activity]
   750 E C0598240:originality [Mental Process]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out on three cohorts of TgCRND8 mice"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0025914:Mice [Mammal]
   748   C0025929:mice [Mammal]
   748   C0026809:Mice [Mammal]
   748   C0205449:Three [Quantitative Concept]
   748   C0439787:Out [Spatial Concept]
   748   C0599755:cohorts [Population Group]
   748   C0849355:Out [Qualitative Concept]

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "(C57"

Phrase: ")"

Phrase: "(C3H/C57"

Phrase: ")"

Phrase: ","

Phrase: "(FVB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517101:FVB [Mammal]

Phrase: ")"

Phrase: "(C3H/C57"

Phrase: ")"

Phrase: ","

Phrase: "and ("

Phrase: "C3H/C57/129SvEv/Tac)(129SvEv/Tac"

Phrase: ")."
Processing 00000000.tx.52: For comparative purposes the survival of non-Tg littermates was included, and the analysis was performed for the 1st year of life. 

Phrase: "For comparative purposes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1285529:purposes [Functional Concept]

Phrase: "the survival of non-Tg littermates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0038952:Survival [Activity]
   753   C0220921:survival [Functional Concept]

Phrase: "was"

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: ","

Phrase: "and"

Phrase: "the analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "performed for the 1st year of life."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   748   C0205435:1st [Quantitative Concept]
   748   C0376558:Life [Idea or Concept]
   748   C0439234:year [Temporal Concept]
   748   C0439508:/year [Temporal Concept]
   748   C0884358:Performed [Functional Concept]
   714 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.53: Since the mortality of non-Tg mice was minimal (1non-Tg mouse out of the total of 158included in the analysis died at the age of 26days), non-Tg mice were pooled across their genetic backgrounds for graphical presentation and statistical analyses. 

Phrase: "Since"

Phrase: "the mortality of non-Tg mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0026565:Mortality [Quantitative Concept]
   753   C0026566:mortality [Quantitative Concept]

Phrase: "was"

Phrase: "minimal"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0547040:Minimal [Qualitative Concept]
  1000   C1524031:MINIMAL [Qualitative Concept]
  1000   C2945599:Minimal [Qualitative Concept]
   928 E C1552614:minimum [Idea or Concept]
   928 E C2826545:MINIMUM [Quantitative Concept]

Phrase: "(1non-Tg mouse out of the total of 158included"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C0025936:Mouse, Transgenic [Mammal]
   742   C0003069:Transgenic [Animal]
   742   C0025914:Mouse [Mammal]
   742   C0025929:mouse [Mammal]
   742   C0026809:Mouse [Mammal]

Phrase: "in the analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]

Phrase: "died at the age of 26days"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0001779:Age [Organism Attribute]
   753   C0011065:Died [Organism Function]
   753   C1546956:Died [Finding]

Phrase: ")"

Phrase: ","

Phrase: "non-Tg mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0025936:Mice, Transgenic [Mammal]
   896   C1513853:NON Mouse [Mammal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "pooled across their genetic backgrounds"
Meta Candidates (Total=14; Excluded=9; Pruned=0; Remaining=5)
   760   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   760   C0314603:Genetic [Functional Concept]
   760   C1709595:Pooled [Conceptual Entity]
   760   C2349200:Pooled [Functional Concept]
   726 E C0337051:Pool [Geographic Area]
   726 E C1509144:pool [Clinical Attribute]
   726   C1706907:Background [Conceptual Entity]
   704 E C0005615:Birth [Organism Function]
   704 E C0035150:Reproduction [Organism Function]
   704 E C0079946:origin [Classification]
   704 E C0439659:Origin [Temporal Concept]
   704 E C1550512:origin [Intellectual Product]
   704 E C1550722:birth [Idea or Concept]
   704 E C3245487:birth [Intellectual Product]

Phrase: "for graphical presentation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449450:Presentation [Idea or Concept]

Phrase: "and"

Phrase: "statistical analyses."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   983   C0871424:statistical analysis [Research Activity]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
Processing 00000000.tx.54: The probability of survival was assessed by the Kaplan-Meier technique (32), computing the probability of survival at every occurrence of death, thus making it particularly suitable for small sample size cases with variable event intervals. 

Phrase: "The probability of survival"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033204:Probability [Quantitative Concept]

Phrase: "was"

Phrase: "assessed by the Kaplan-Meier technique"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0449851:Technique [Functional Concept]
   753   C1516048:Assessed [Activity]

Phrase: "(32"

Phrase: ")"

Phrase: ","

Phrase: "computing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880157:Computing [Activity]

Phrase: "the probability of survival"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033204:Probability [Quantitative Concept]

Phrase: "at every occurrence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243132:occurrence [Functional Concept]
  1000   C1554210:occurrence [Idea or Concept]
  1000   C2745955:Occurrence [Temporal Concept]

Phrase: "of death,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011065:Death [Organism Function]
  1000   C1306577:Death, NOS [Finding]

Phrase: "thus"

Phrase: "making"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "it particularly suitable for small sample size cases"

Phrase: "with variable event intervals."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1272706:intervals [Temporal Concept]
   793 E C1552654:Interval [Idea or Concept]
   793 E C1552713:Interval [Intellectual Product]
Processing 00000000.tx.55: The comparisons of cumulative survival curves for each genetic background of mice were performed using Tarone-Ware test, which weighs early events less than log rank or Breslow tests. 

Phrase: "The comparisons of cumulative survival curves"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1707455:Comparison [Activity]

Phrase: "for each genetic background"
Meta Candidates (Total=17; Excluded=14; Pruned=0; Remaining=3)
   861   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   861   C0314603:Genetic [Functional Concept]
   861   C1706907:Background [Conceptual Entity]
   805 E C0005615:Birth [Organism Function]
   805 E C0035150:Reproduction [Organism Function]
   805 E C0079946:origin [Classification]
   805 E C0439659:Origin [Temporal Concept]
   805 E C1550512:origin [Intellectual Product]
   805 E C1550722:birth [Idea or Concept]
   805 E C3245487:birth [Intellectual Product]
   777 E C0454729:Natal [Geographic Area]
   777 E C0559522:Genital [Body System]
   777 E C1546649:Genital [Intellectual Product]
   777 E C1550642:Genital [Body Substance]
   768 E C0205313:Original [Idea or Concept]
   768 E C2347409:Original [Occupational Activity]
   750 E C0598240:originality [Mental Process]

Phrase: "of mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Tarone-Ware test,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0022885:Test [Laboratory Procedure]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]

Phrase: "which"

Phrase: "weighs"

Phrase: "early events less than log rank"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C1547438:Log Event [Idea or Concept]
   767   C1708728:Event Log [Intellectual Product]
   753   C0441471:Events [Event]
   753   C3541888:Events [Classification]

Phrase: "or"

Phrase: "Breslow tests."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0022885:Tests [Laboratory Procedure]
   861   C0392366:Tests [Intellectual Product]
   827 E C0039593:Test [Functional Concept]
Processing 00000000.tx.56: Histology and Immunohistochemistry-- Mice were anesthetized and perfused with saline in accordance with The Canadian Council for Animal Care guidelines. 

Phrase: "Histology"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0019638:Histology [Biomedical Occupation or Discipline]
  1000   C0205462:histology [Functional Concept]
  1000   C0344441:Histology [Laboratory Procedure]

Phrase: "and"

Phrase: "Immunohistochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021044:Immunohistochemistry [Laboratory Procedure]

Phrase: "--"

Phrase: "Mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "anesthetized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1720436:Anesthetized [Finding]

Phrase: "and"

Phrase: "perfused with saline"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0036082:Saline [Substance]
   756   C1549542:Perfuse [Functional Concept]

Phrase: "in accordance with The Canadian Council"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1551807:Council [Population Group]

Phrase: "for Animal Care guidelines."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0162791:Guidelines [Intellectual Product]
   827   C0220845:guidelines [Intellectual Product]
   827   C0282423:guidelines [Intellectual Product]
   734   C0178478:animal care [Occupation or Discipline]
Processing 00000000.tx.57: Generally, brains were removed and bisected in the mid-sagittal plane. 

Phrase: "Generally,"

Phrase: "brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "and"

Phrase: "bisected in the mid-sagittal plane."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0935598:Sagittal plane [Body Location or Region]
           Sagittal
   753   C0205129:Sagittal [Spatial Concept]
   753   C0444660:Plane [Spatial Concept]
Processing 00000000.tx.58: One-half was snap-frozen, and the portion for immunohistochemistry was fixed in 10% neutral buffered formalin for a minimum of 48h. 

Phrase: "One-half"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2825407:Half [Quantitative Concept]

Phrase: "was"

Phrase: "snap-frozen,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1882516:Snap Frozen [Laboratory Procedure]
   861   C0016701:Frozen [Natural Phenomenon or Process]
   861   C0677542:Frozen [Functional Concept]

Phrase: "and"

Phrase: "the portion for immunohistochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0449719:Portion [Spatial Concept]

Phrase: "was"

Phrase: "fixed in 10% neutral buffered formalin"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   833   C0492002:Neutral buffered formalin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   814   C1550052:Buffered 10% formalin [Biomedical or Dental Material,Organic Chemical]
   814   C1561456:Buffered 10% formalin [Intellectual Product]
   783   C1550067:10% Formalin [Biomedical or Dental Material,Organic Chemical]
   783   C1561470:10% Formalin [Intellectual Product]
   753   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0231441:Fixed [Finding]
   753   C0443218:Fixed [Qualitative Concept]
   753   C0949307:Formalin [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   753   C1882074:Neutral [Qualitative Concept]
   753   C2825492:Neutral [Phenomenon or Process]
   753   C2827483:Fixed [Body Substance]

Phrase: "for a minimum"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1524031:Minimum [Qualitative Concept]
  1000   C1552614:minimum [Idea or Concept]
  1000   C2826545:MINIMUM [Quantitative Concept]
   928 E C0547040:Minimal [Qualitative Concept]
   928 E C2945599:Minimal [Qualitative Concept]

Phrase: "of 48h."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442464:48H [Temporal Concept]
Processing 00000000.tx.59: These specimens were then batch-processed on an automatic tissue processor overnight with vacuum on each station to aid penetration. 

Phrase: "These specimens"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0370003:specimens [Substance]
   966 E C2347026:Specimen [Conceptual Entity]

Phrase: "were"

Phrase: "then batch-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1550176:Batch [Idea or Concept]
   861   C1948031:Batch [Quantitative Concept]

Phrase: "processed on an automatic tissue processor overnight"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   778   C0183957:Tissue Processor [Medical Device]
   748   C0040300:Tissue [Tissue]
   748   C0205554:Automatic [Functional Concept]
   748   C0439583:Overnight [Temporal Concept]
   748   C1522240:Processed [Phenomenon or Process]
   748   C1547928:Tissue [Intellectual Product]
   748   C1707144:Processor [Manufactured Object]
   748   C1707713:Processor [Manufactured Object]
   748   C2985233:Processor [Organization]
   714 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "with vacuum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0042221:Vacuum [Natural Phenomenon or Process]

Phrase: "on each station to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1883167:Station [Manufactured Object]
   789 E C0439835:Stationary [Qualitative Concept]

Phrase: "aid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0018896:Aid [Social Behavior]
  1000   C0449435:Aid [Manufactured Object]
  1000   C3540469:AID [Gene or Genome]

Phrase: "penetration."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205321:Penetration [Functional Concept]
Processing 00000000.tx.60: Paraffin sections were cut at 5microns and affixed to Fisher brand Superfrost/Plus slides to ensure adhesion. 

Phrase: "Paraffin sections"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0030415:Paraffin [Biomedical or Dental Material,Lipid]
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "cut at 5microns"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0000925:Cut [Injury or Poisoning]
   790   C1883724:CUT [Phenomenon or Process]

Phrase: "and"

Phrase: "affixed to Fisher brand Superfrost/Plus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0325045:Fisher [Mammal]
   753   C0332287:Plus [Qualitative Concept]
   753   C0645690:BrAnd [Pharmacologic Substance,Steroid]

Phrase: "slides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0444330:Slide [Research Device]
  1000   C1705201:Slide [Manufactured Object]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "ensure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0218063:Ensure [Food]

Phrase: "adhesion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0001511:Adhesion [Pathologic Function]
  1000   C0175633:Adhesion [Natural Phenomenon or Process]
Processing 00000000.tx.61: Sections were stained by Bielschowsky's silver impregnation, cresyl violet, thioflavine S, and Luxol Fast Blue combined with hematoxylin and eosin, as noted in the figure legends. 

Phrase: "Sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "stained by Bielschowsky's silver impregnation,"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   833   C1293957:Bielschowsky's silver stain [Laboratory Procedure]
           Bielschowsky's stain
   806   C1293950:silver impregnation [Laboratory Procedure]
   781   C1318876:Silver stain [Indicator, Reagent, or Diagnostic Aid]
           Silver
   760   C0015914:impregnation [Organism Function]
   760   C0037125:Silver [Element, Ion, or Isotope]
   760   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   760   C1305285:Silver [Qualitative Concept]
   760   C2986582:Stained [Qualitative Concept]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "cresyl violet,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0056484:cresyl violet [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0330463:Violet [Plant]
   861   C0678580:violet [Natural Phenomenon or Process]

Phrase: "thioflavine S,"

Phrase: "and"

Phrase: "Luxol Fast Blue"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0065274:Luxol fast blue [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   901   C0060083:Fast Blue [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0015663:Fast [Finding]
   827   C0456962:Fast [Qualitative Concept]
   827   C1260957:Blue [Qualitative Concept]

Phrase: "combined with hematoxylin"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0018964:Haematoxylin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   790   C0205195:Combined [Qualitative Concept]
   756 E C0336789:Combine [Manufactured Object]

Phrase: "and"

Phrase: "eosin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014448:Eosin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
  1000   C0885297:eosin [Organic Chemical,Pharmacologic Substance]

Phrase: "as"

Phrase: "noted in the figure legends."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   726   C1316572:Note [Clinical Attribute]
   726   C1317574:Note [Intellectual Product]
   726   C1369612:Note [Clinical Attribute]
   726   C2729544:Legend [Pharmacologic Substance]
Processing 00000000.tx.62: For general morphological characteristics, 12TgCRND8 mice from the hybrid C3H/B6 background, age 43-440 days, were studied. 

Phrase: "For general morphological characteristics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1521970:Characteristics [Qualitative Concept]

Phrase: "12TgCRND8 mice from the hybrid C3H/B6 background,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0025920:Mice, C3H [Mammal]
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]

Phrase: "age 43-440 days,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0439228:days [Temporal Concept]
   779 E C0332173:/day [Temporal Concept]
   779 E C0439505:/day [Temporal Concept]

Phrase: "were"

Phrase: "studied."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]
Processing 00000000.tx.63: Additionally, 5TgCRND8 mice (n=2,213days; n=3,282days) and 4non-transgenic controls (n=3,213days; n=1,282days) were sectioned coronally to investigate hippocampal morphology. 

Phrase: "Additionally,"

Phrase: "5TgCRND8 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "(n=2,213days"

Phrase: "; n=3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "282days"

Phrase: ")"

Phrase: "and"

Phrase: "4non-transgenic controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0243148:control [Qualitative Concept]
   793   C1550141:Control [Substance]
   793   C1882979:Control [Conceptual Entity]
   793   C2587213:Control [Functional Concept]
   793   C3274648:Control [Qualitative Concept]

Phrase: "(n=3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "213days"

Phrase: "; n=1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "282days"

Phrase: ")"

Phrase: "were"

Phrase: "sectioned"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "coronally to"

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "hippocampal morphology."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0332437:Morphology [Qualitative Concept]
   861   C0543482:morphology [Spatial Concept]
   861   C0700329:Morphology, NOS [Finding]
   861   C0700619:Morphology [Biomedical Occupation or Discipline]
Processing 00000000.tx.64: The percent volume occupied by the dorsal hippocampus within the surrounding brain regions was estimated using the Cavaleri point counting method. 

Phrase: "The percent volume"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1690016:Percent volume [Qualitative Concept]
           % volume
   861   C0449468:*Volume [Quantitative Concept]
   861   C1705102:Volume [Intellectual Product]
   861   C2700258:Volume [Laboratory Procedure]

Phrase: "occupied by the dorsal hippocampus"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   760   C0205095:Dorsal [Spatial Concept]
   760   C0949582:Hippocampus [Fish]
   760   C1029104:Hippocampus [Fish]
   760   C1284077:Hippocampus [Body Part, Organ, or Organ Component]
   760   C1548223:Occupied [Idea or Concept]

Phrase: "within the surrounding brain regions"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   901   C1273723:brain regions [Body Location or Region]
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   793   C0017446:Region [Geographic Area]
   793   C0205147:Region [Spatial Concept]
   743 E C0205276:Regional [Spatial Concept]
   743 E C1947913:Regional [Spatial Concept]

Phrase: "was"

Phrase: "estimated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimated [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Cavaleri point counting method."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025663:Method [Intellectual Product]
   812   C0449851:Method [Functional Concept]
   812   C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.65: Paraffin-embedded brains were serially sectioned on a rotary microtome at a thickness of 10m (as described above) and stained with either hematoxylin and eosin or cresyl violet to delineate the hippocampal borders. 

Phrase: "Paraffin-embedded brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0006104:Brains [Body Part, Organ, or Organ Component]
   793 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "serially"

Phrase: "sectioned on a rotary microtome"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0181858:MICROTOME, ROTARY [Medical Device]
   760   C0181856:microtome [Medical Device]
   760   C0700320:microtome [Laboratory Procedure]
   726   C0205155:Section [Spatial Concept]
   726   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   726   C1522472:Section [Substance]
   726   C1552923:Section [Quantitative Concept]
   726   C1705191:Section [Physical Object]

Phrase: "at a thickness"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1280412:Thickness [Qualitative Concept]

Phrase: "of 10m"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442446:10M [Temporal Concept]

Phrase: "("

Phrase: "as"

Phrase: "described above"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1552738:described [Idea or Concept]

Phrase: ")"

Phrase: "and"

Phrase: "stained with either hematoxylin"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   802   C0018964:Haematoxylin stain [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           Haematoxylin
   770   C2986582:Stained [Qualitative Concept]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "eosin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014448:Eosin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
  1000   C0885297:eosin [Organic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "cresyl violet to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0056484:cresyl violet [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0330463:Violet [Plant]
   827   C0678580:violet [Natural Phenomenon or Process]

Phrase: "delineate"

Phrase: "the hippocampal borders."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205284:Border [Spatial Concept]
   861   C1522411:Border [Body Location or Region]
   861   C2828371:Border [Classification]
Processing 00000000.tx.66: The hippocampus was defined to include all regions of the hippocampus proper, hilus, and dentate gyrus. 

Phrase: "The hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "defined"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704788:Defined [Conceptual Entity]
  1000   C3539106:Defined [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "all regions of the hippocampus proper, hilus,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C0017446:Region [Geographic Area]
   714   C0205147:Region [Spatial Concept]

Phrase: "and"

Phrase: "dentate gyrus."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0152314:Dentate Gyrus [Body Part, Organ, or Organ Component]
  1000   C1281026:Dentate gyrus [Body Part, Organ, or Organ Component]
Processing 00000000.tx.67: To represent the dorsal hippocampal region a total of 6serial sections were collected for analysis (every 15th section, starting with the first section in which the hippocampus was visible). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the dorsal hippocampal region"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   913   C1456859:Dorsal region [Body Location or Region]
   901   C3496509:hippocampal region [Body Location or Region]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "a total of 6serial sections"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439175:% total [Quantitative Concept]
   760   C0439810:Total [Qualitative Concept]

Phrase: "were"

Phrase: "collected for analysis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1516695:Collected [Idea or Concept]
   790   C1516698:Collected [Functional Concept]
   790   C1524024:analysis [Functional Concept]

Phrase: "("

Phrase: "every 15th section,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205155:Section [Spatial Concept]
   861   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   861   C1522472:Section [Substance]
   861   C1552923:Section [Quantitative Concept]
   861   C1705191:Section [Physical Object]

Phrase: "starting with the first section"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0205155:Section [Spatial Concept]
   760   C0205435:First [Quantitative Concept]
   760   C1279901:First [Qualitative Concept]
   760   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   760   C1522472:Section [Substance]
   760   C1552923:Section [Quantitative Concept]
   760   C1705191:Section [Physical Object]
   726   C0439659:Start [Temporal Concept]

Phrase: "in which"

Phrase: "the hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "visible"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205379:Visible [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.68: Brain sections were visualized using a video microscopy system (Zeiss Axoplan, using a lens for4magnification) and a superimposed point grid (680m spacing). 

Phrase: "Brain sections"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "visualized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234621:Visualized [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a video microscopy system"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]
   734   C0242940:Microscopy, Video [Laboratory Procedure]

Phrase: "(Zeiss Axoplan,"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a lens for4magnification"

Phrase: ")"

Phrase: "and"

Phrase: "a superimposed point grid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1415284:GRID [Gene or Genome]
   827   C2348395:Grid [Medical Device]
   827   C2825313:Grid [Manufactured Object]

Phrase: "(680m spacing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710137:Spacing [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.69: Points falling over the hemisphere and those falling over the hippocampus were tallied. 

Phrase: "Points"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1552961:Point [Quantitative Concept]
   966   C2347617:point [Quantitative Concept]

Phrase: "falling over the hemisphere"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0085639:FALLING [Finding]
   737 E C0238715:Fall [Temporal Concept]

Phrase: "and"

Phrase: "those falling over the hippocampus"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0085639:FALLING [Finding]
   726 E C0238715:Fall [Temporal Concept]

Phrase: "were"

Phrase: "tallied."
Processing 00000000.tx.70: Volumes were then estimated using the formula: V=pointsarea per pointsection thicknesssection spacing. 

Phrase: "Volumes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0449468:volumes [Quantitative Concept]
   966 E C1690016:% volume [Qualitative Concept]
   966 E C1705102:Volume [Intellectual Product]
   966 E C2700258:Volume [Laboratory Procedure]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "estimated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimated [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the formula"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0489829:Formula [Intellectual Product]
  1000   C1705501:Formula [Intellectual Product]

Phrase: ":"

Phrase: "V=pointsarea per pointsection thicknesssection spacing."
Processing 00000000.tx.71: Student t tests were performed to compare mean volume data. 

Phrase: "Student t tests"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   827   C0022885:Tests [Laboratory Procedure]
   827   C0038492:student [Professional or Occupational Group]
   827   C0392366:Tests [Intellectual Product]
   827   C1551041:student [Idea or Concept]
   827   C1552573:student [Intellectual Product]
   793 E C0039593:Test [Functional Concept]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "mean volume data."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]
Processing 00000000.tx.72: For immunohistochemistry, all sections were blocked in dilute (3%) hydrogen peroxide and non-immune goat serum. 

Phrase: "For immunohistochemistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021044:Immunohistochemistry [Laboratory Procedure]

Phrase: "all sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "blocked in dilute"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   790   C0028778:Blocked [Pathologic Function]
   790   C0332206:Blocked [Functional Concept]
   790   C1720119:Dilute [Functional Concept]
   790   C1948037:Dilute [Functional Concept]
   790   C2983591:BLOCKED [Research Activity]
   756 E C1533157:Block [Substance]
   756 E C1706084:Block [Geographic Area]
   756 E C2828370:Block [Quantitative Concept]

Phrase: "(3%"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "hydrogen peroxide"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0020281:Hydrogen Peroxide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0020275:Hydrogen [Element, Ion, or Isotope]
   861   C0031180:Peroxide [Inorganic Chemical]
   861   C0523702:HYDROGEN [Laboratory Procedure]
   861   C0885426:hydrogen [Inorganic Chemical]

Phrase: "and"

Phrase: "non-immune goat serum."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C0020960:immune serum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   812   C0229671:Serum [Body Substance]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
Processing 00000000.tx.73: Epitope retrieval, in the form of a 5-min immersion in formic acid, was carried out prior to demonstration of amyloid and synaptophysin immuoreactivity. 

Phrase: "Epitope retrieval,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1514918:Retrieval [Health Care Activity]

Phrase: "in the form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "of a 5-min immersion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0020940:Immersion [Therapeutic or Preventive Procedure]
   827   C0038561:Immersion [Injury or Poisoning]
   827   C2827727:Immersion [Functional Concept]

Phrase: "in formic acid,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0016576:formic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
  1000   C0885348:formic acid [Organic Chemical]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out prior to demonstration of amyloid"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0332152:Prior to [Temporal Concept]
           Prior
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0439787:Out [Spatial Concept]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0849355:Out [Qualitative Concept]
   753   C2826257:PRIOR [Event]

Phrase: "and"

Phrase: "synaptophysin immuoreactivity."
Processing 00000000.tx.74: In all cases the primary antibody was left to react overnight at 4C. 

Phrase: "In all cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "the primary antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "react"

Phrase: "overnight at 4C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0439583:Overnight [Temporal Concept]
Processing 00000000.tx.75: The remaining steps using the Dako StreptABC complex-horseradish peroxidase-conjugated "Duet" anti-mouse/rabbit antibody kit were completed according to the protocols provided by the manufacturer. 

Phrase: "The remaining steps"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C1261552:steps [Conceptual Entity]
   827 E C1704379:Step [Functional Concept]
   827 E C1705117:Step [Quantitative Concept]
   827 E C2825408:Step [Manufactured Object]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Dako StreptABC complex-horseradish peroxidase-conjugated ""Duet"" anti-mouse/rabbit antibody kit"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   787   C0812225:KIT [Medical Device]
   787   C1150635:KIT [Molecular Function]
   787   C1705212:Kit [Medical Device]
   787   C1705213:KIT [Medical Device]
   787   C3273202:Kit [Manufactured Object]

Phrase: "were"

Phrase: "completed according to the protocols"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0205197:COMPLETED [Qualitative Concept]
   760   C0442711:Protocols [Intellectual Product]
   760   C0680240:according [Social Behavior]
   726 E C1507394:Protocol [Intellectual Product]
   726 E C1522729:Protocol [Intellectual Product]
   726 E C2348563:Protocol [Intellectual Product]

Phrase: "provided by the manufacturer."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0947322:Manufacturer [Intellectual Product]
   770   C1705426:Manufacturer [Population Group]
   770   C1999230:Provided [Activity]
Processing 00000000.tx.76: End products were visualized with diaminobenzidine. 

Phrase: "End products"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0444930:End [Spatial Concept]
   861   C1514468:Products [Entity]
   861   C2746065:End [Temporal Concept]
   827 E C1704444:Product [Quantitative Concept]
   805 E C0205088:Terminal [Temporal Concept]
   805 E C1705314:Terminal [Manufactured Object]
   805 E C1705315:Terminal [Spatial Concept]

Phrase: "were"

Phrase: "visualized with diaminobenzidine."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0234621:Visualized [Functional Concept]
Processing 00000000.tx.77: Sections were lightly counterstained with hematoxylin and were resin-mounted. 

Phrase: "Sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "lightly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881376:Lightly [Qualitative Concept]

Phrase: "counterstained with hematoxylin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0018964:Haematoxylin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "were"

Phrase: "resin-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035191:Resin [Biomedical or Dental Material]

Phrase: "mounted."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449878:mounted [Finding]
   966 E C0181909:Mount [Medical Device]
Processing 00000000.tx.78: The sources of the antibodies used were as follows: 369from Sam Gandy; 

Phrase: "The sources of the antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   822   C0449424:Source of antibody [Finding]
   760   C0449416:sources [Finding]
   726 E C1705919:Source [Idea or Concept]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "were"

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "369from Sam Gandy"

Phrase: ";"
Processing 00000000.tx.79: 4G8 versus A residues 17-24 from Richard Rubenstein; 

Phrase: "4G8"

Phrase: "versus"

Phrase: "A residues 17-24 from Richard Rubenstein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0050288:A 17 [Organic Chemical,Pharmacologic Substance]
   714   C1709915:Residue [Conceptual Entity]
   714   C1882936:RESIDUE [Phenomenon or Process]

Phrase: ";"
Processing 00000000.tx.80: A42, 3542from Frdric Checler; 

Phrase: "A42,"

Phrase: "3542from Frdric Checler"

Phrase: ";"
Processing 00000000.tx.81: 6F/3D versus A residues 8-17, synaptophysin, and anti-ubiquitin from Dako Inc.; 

Phrase: "6F/3D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450363:3D [Spatial Concept]
   861   C2986797:3D [Functional Concept]

Phrase: "versus"

Phrase: "A residues 8-17,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]

Phrase: "synaptophysin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085255:Synaptophysin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420554:SYNAPTOPHYSIN [Gene or Genome]

Phrase: "and"

Phrase: "anti-ubiquitin from Dako Inc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.82: 6E10 versus A residues 1-16 from Senetek Inc.; 

Phrase: "6E10"

Phrase: "versus"

Phrase: "A residues 1-16 from Senetek Inc."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1709915:Residue [Conceptual Entity]
   714   C1882936:RESIDUE [Phenomenon or Process]

Phrase: ";"
Processing 00000000.tx.83: glial fibrillary acidic protein monoclonal from Roche Molecular Biochemicals; 

Phrase: "glial fibrillary acidic protein"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0017626:Glial Fibrillary Acidic Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1325793:glial fibrillary acidic protein [Cell Component]
  1000   C1415042:GLIAL FIBRILLARY ACIDIC PROTEIN [Gene or Genome]
   812   C0001128:Acidic [Chemical]
   812   C0027836:Glial [Cell]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   741 E C0202406:Acid [Laboratory Procedure]
   741 E C1087003:Glia [Plant]

Phrase: "monoclonal from Roche Molecular Biochemicals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0746619:monoclonal [Finding]

Phrase: ";"
Processing 00000000.tx.84: NF200 from Novo Castra Laboratories; 

Phrase: "NF200 from Novo Castra Laboratories"

Phrase: ";"
Processing 00000000.tx.85: CD11b from Chemicon Labs; 

Phrase: "CD11b from Chemicon Labs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C3541224:CD11B [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.86: and hyperphosphorylated tau, AT8, from Innogenetics, Gent, Belgium. 

Phrase: "and"

Phrase: "hyperphosphorylated tau,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "AT8,"

Phrase: "from Innogenetics,"

Phrase: "Gent,"

Phrase: "Belgium."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004950:Belgium [Geographic Area]
Processing 00000000.tx.87: The 6F/3D antibody was of particular use for quantitative studies using image analysis software as it visualized structures (i.e. dense-cored plaques) with sharp boundaries. 

Phrase: "The 6F/3D antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was of particular use"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   819   C1524063:Use of [Functional Concept]
   770   C0042153:use [Functional Concept]
   770   C0043194:WAS [Disease or Syndrome]
   770   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0457083:Use [Functional Concept]
   770   C1421478:WAS [Gene or Genome]
   770   C1947944:Use [Intellectual Product]

Phrase: "for quantitative studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "image analysis software"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037585:Software [Intellectual Product,Manufactured Object]
   734   C0200765:Image analysis [Laboratory Procedure]

Phrase: "as"

Phrase: "it"

Phrase: "visualized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234621:Visualized [Functional Concept]

Phrase: "structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:structures [Spatial Concept]

Phrase: "(i.e. dense-cored plaques"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   836   C1817256:dense plaque [Cell Component]
   804   C0333463:plaques [Acquired Abnormality]
   771 E C0011389:Plaque [Disease or Syndrome]
   771 E C0332461:Plaque [Finding]

Phrase: ")"

Phrase: "with sharp boundaries."
Processing 00000000.tx.88: Behavioral Tests and Data Analysis-- Experimentally naive TgCRND8 mice were tested at 11weeks of age in two cohorts (NTg=10,Nnon-Tg=7in total) in the reference memory version of Morris water maze test. 

Phrase: "Behavioral Tests"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   983   C0683444:behavioral test [Diagnostic Procedure]
   861   C0022885:Tests [Laboratory Procedure]
   861   C0392366:Tests [Intellectual Product]
   827 E C0039593:Test [Functional Concept]

Phrase: "and"

Phrase: "Data Analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0010992:Data Analysis [Occupational Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1511726:Data [Idea or Concept]
   861   C1524024:analysis [Functional Concept]
   861   C3245479:data [Medical Device]

Phrase: "--"

Phrase: "Experimentally naive TgCRND8 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "tested at 11weeks of age"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0001779:Age [Organism Attribute]
   760   C0392366:tested [Intellectual Product]
   726 E C0022885:Test [Laboratory Procedure]
   726 E C0039593:Test [Functional Concept]

Phrase: "in two cohorts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0599755:cohorts [Population Group]

Phrase: "(NTg=10,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1417953:NTG [Gene or Genome]
   861   C1847730:NTG [Finding]

Phrase: "Nnon-Tg"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003069:Transgenic [Animal]

Phrase: "=7in total"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439175:% total [Quantitative Concept]
   861   C0439810:Total [Qualitative Concept]

Phrase: ")"

Phrase: "in the reference memory version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0333052:Version [Functional Concept]
   827   C2607870:Version [Spatial Concept]

Phrase: "of Morris water maze test."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0022885:Test [Laboratory Procedure]
   812   C0039593:Test [Functional Concept]
   812   C0392366:test [Intellectual Product]
Processing 00000000.tx.89: The water maze apparatus, mouse handling, and general testing procedure are described elsewhere (1, 33). 

Phrase: "The water maze apparatus,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0243111:apparatus [Manufactured Object]
   827   C1947951:Apparatus [Anatomical Structure]

Phrase: "mouse handling,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0018578:Handling [Behavior]
   861   C1832073:Handling [Finding]

Phrase: "and"

Phrase: "general testing procedure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   827   C1948041:Procedure [Therapeutic or Preventive Procedure]
   827   C2700391:Procedure [Activity]
   827   C3274430:PROCEDURE [Health Care Activity]
   827   C3538935:Procedure [Idea or Concept]
   827   C3539779:Procedure [Intellectual Product]

Phrase: "are"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "elsewhere"

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "33"

Phrase: ")."
Processing 00000000.tx.90: Prior to the spatial learning training, all mice underwent non-spatial pre-training (NSP), to assess swimming abilities and familiarize mice with the test (1). 

Phrase: "Prior to the spatial learning training,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0040607:Training [Educational Activity]
   827   C0220931:Training [Educational Activity]
   827   C2673163:training [Qualitative Concept]
   734   C0582587:spatial learning [Mental Process]

Phrase: "all mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "underwent"

Phrase: "non-spatial"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1428114:spatial [Gene or Genome]
   861   C1518422:Non [Functional Concept]

Phrase: "pre-training"
Meta Candidates (Total=13; Excluded=6; Pruned=0; Remaining=7)
   964   C1709632:Pre-condition [Conceptual Entity]
   861   C0040607:Training [Educational Activity]
   861   C0220931:Training [Educational Activity]
   861   C0332152:Pre [Temporal Concept]
   861   C0740175:Pre [Qualitative Concept]
   861   C2257086:PRE [Genetic Function]
   861   C2673163:training [Qualitative Concept]
   827 E C0336809:Train [Manufactured Object]
   827 E C1552514:Train [Manufactured Object]
   789 E C0009647:Conditioned [Mental Process]
   789 E C0012634:condition [Disease or Syndrome]
   789 E C0348080:Condition [Qualitative Concept]
   789 E C1705253:Condition [Conceptual Entity]

Phrase: "(NSP"

Phrase: ")"

Phrase: ","

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "swimming abilities"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Abilities [Organism Attribute]
   777 E C1299581:Able [Finding]

Phrase: "and"

Phrase: "familiarize"

Phrase: "mice with the test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.91: Two days following the NSP phase, all mice underwent a reference memory training with a hidden platform placed in the center of one quadrant of the pool (northeast) for 5days, with 4trials per day. 

Phrase: "Two days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the NSP phase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205390:Phase [Temporal Concept]

Phrase: "all mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "underwent"

Phrase: "a reference memory training with a hidden platform"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0729377:Memory Training [Therapeutic or Preventive Procedure]
   744   C0040607:Training [Educational Activity]
   744   C0220931:Training [Educational Activity]
   744   C2673163:training [Qualitative Concept]

Phrase: "placed in the center of one quadrant of the pool"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   739   C0205099:Center [Spatial Concept]
   739   C0205447:One [Quantitative Concept]
   739   C0337051:Pool [Geographic Area]
   739   C1509144:pool [Clinical Attribute]
   739   C1631280:Quadrant [Spatial Concept]
   739   C2349200:Pool [Functional Concept]
   706   C0442504:Place [Spatial Concept]
   706   C1704765:Place [Functional Concept]
   706   C1882509:Place [Activity]
   706   C3496241:place [Disease or Syndrome]

Phrase: "(northeast"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709272:Northeast [Spatial Concept]

Phrase: ")"

Phrase: "for 5days,"

Phrase: "with 4trials"

Phrase: "per day."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332173:/day [Temporal Concept]
  1000   C0439228:day [Temporal Concept]
  1000   C0439505:/day [Temporal Concept]
Processing 00000000.tx.92: After the last trial of day 5,the platform was removed from the pool and each mouse received one 60-s swim "probe trial." 

Phrase: "After the last trial"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0008976:Trial [Research Activity]

Phrase: "of day 5,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: "the platform"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710360:Platform [Research Device]

Phrase: "was"

Phrase: "removed from the pool"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0337051:Pool [Geographic Area]
   770   C0849355:Removed [Qualitative Concept]
   770   C1509144:pool [Clinical Attribute]
   770   C2349200:Pool [Functional Concept]
   737 E C1883720:Remove [Activity]
   737 E C3244314:remove [Functional Concept]

Phrase: "and"

Phrase: "each mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "one 60-s swim ""probe trial."""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0008976:Trial [Research Activity]
Processing 00000000.tx.93: Escape latency (in seconds), length of swim path (centimeter) and swim speed (cm/s), were recorded using an on-line HVS image video tracking system (33). 

Phrase: "Escape latency"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C0205275:Latent [Qualitative Concept]

Phrase: "("

Phrase: "in seconds"
Meta Candidates (Total=7; Excluded=6; Pruned=0; Remaining=1)
  1000   C0457385:seconds [Temporal Concept]
   966 E C0205436:Second [Quantitative Concept]
   966 E C0565930:/second [Quantitative Concept]
   966 E C1561503:second [Idea or Concept]
   966 E C1705190:Second [Qualitative Concept]
   916 E C0027627:secondary [Neoplastic Process]
   916 E C0175668:Secondary [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "length of swim path"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1444754:Length [Quantitative Concept]
   770   C1706316:LENGTH [Research Activity]

Phrase: "(centimeter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0475210:centimeter [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "swim speed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678536:Speed [Quantitative Concept]

Phrase: "(cm/s"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439392:cm/s [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "were"

Phrase: "recorded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0034869:Record [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an on-line HVS image video tracking system"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   900   C0029038:On-Line System [Intellectual Product,Manufactured Object]
   795   C0449913:System [Functional Concept]
   795   C1553451:System [Manufactured Object]
   795   C1704459:System [Medical Device]
   724 E C0205373:Systemic [Functional Concept]

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.94: For the probe trials, an annulus crossing index was calculated, which represents the number of passes over the platform site minus the mean of passes over alternative sites in other quadrants. 

Phrase: "For the probe trials,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0008976:Trial [Research Activity]

Phrase: "an annulus crossing index"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0918012:Index [Intellectual Product]
   827   C1552854:index [Idea or Concept]
   827   C1637833:% index [Quantitative Concept]

Phrase: "was"

Phrase: "calculated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]

Phrase: ","

Phrase: "which"

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the number of passes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "over the platform site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "minus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332288:Minus [Qualitative Concept]

Phrase: "the mean of passes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0444504:Mean [Quantitative Concept]
   770   C2347634:Mean [Quantitative Concept]
   770   C2348143:Mean [Quantitative Concept]

Phrase: "over alternative sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]

Phrase: "in other quadrants."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1631280:Quadrant [Spatial Concept]
Processing 00000000.tx.95: The index expresses the spatial place preference and controls for alternative search strategies without place preferences, such as circular search (34, 35). 

Phrase: "The index"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0918012:Index [Intellectual Product]
  1000   C1552854:index [Idea or Concept]
  1000   C1637833:% index [Quantitative Concept]

Phrase: "expresses"

Phrase: "the spatial place preference"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0558295:preference [Idea or Concept]
   827   C1549513:Preference [Idea or Concept]

Phrase: "and"

Phrase: "controls for alternative search strategies"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0243148:control [Qualitative Concept]
   760   C0679199:strategies [Mental Process]
   760   C1523987:Alternative [Conceptual Entity]
   760   C1550141:Control [Substance]
   760   C1552603:search [Intellectual Product]
   760   C1706202:Search [Activity]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "without place preferences,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0558295:Preferences [Idea or Concept]
   827 E C1549513:Preference [Idea or Concept]

Phrase: "such as circular search"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1552603:search [Intellectual Product]
   861   C1706202:Search [Activity]

Phrase: "(34,"

Phrase: "35"

Phrase: ")."
Processing 00000000.tx.96: Behavioral data was analyzed using a mixed model of factorial analysis of variance. 

Phrase: "Behavioral data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "was"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a mixed model of factorial analysis of variance."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C3161035:Model [Intellectual Product]
Processing 00000000.tx.97: Degrees of freedom were adjusted by Greenhouse-Geisser epsilon correction for heterogeneity of variance.  

Phrase: "Degrees of freedom"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0449286:degrees [Quantitative Concept]
   790   C0542560:degrees [Intellectual Product]
   756 E C0441889:Degree [Qualitative Concept]
   756 E C1561545:degree [Quantitative Concept]
   756 E C2348088:Degree [Quantitative Concept]

Phrase: "were"

Phrase: "adjusted by Greenhouse-Geisser epsilon correction"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0439098:Epsilon [Intellectual Product]
   753   C0456081:Adjusted [Functional Concept]
   753   C1705565:CORRECTION [Intellectual Product]
   753   C1947976:Correction [Functional Concept]

Phrase: "for heterogeneity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0019409:Heterogeneity [Qualitative Concept]
   916 E C1512426:Heterogenous [Idea or Concept]

Phrase: "of variance."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1711260:Variance [Qualitative Concept]
  1000   C2348152:Variance [Quantitative Concept]
   928 E C0205419:Variant [Qualitative Concept]
Processing 00000000.tx.98: RESULTS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES Creation of TgCRND8 Mice Expressing Mutant APP Previous experiments have indicated that overexpression of APP above a threshold of ~4 endogenous is a prerequisite for deposition of amyloid plaques in the central nervous system (18, 22). 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Creation of TgCRND8 Mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0441513:Creation [Therapeutic or Preventive Procedure]
   770   C1706214:Creation [Activity]

Phrase: "Expressing"

Phrase: "Mutant APP Previous experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   799   C0681814:Experiments [Research Activity]
   766 E C1706386:Experiment [Conceptual Entity]
   716 E C1517586:Experimental [Qualitative Concept]

Phrase: "have"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that overexpression of APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1514559:Protein Overexpression [Genetic Function]
           Overexpression

Phrase: "above a threshold of ~4 endogenous"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205227:Endogenous [Functional Concept]

Phrase: "is"

Phrase: "a prerequisite for deposition of amyloid plaques"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0679209:prerequisite [Idea or Concept]

Phrase: "in the central nervous system"
Meta Candidates (Total=19; Excluded=7; Pruned=0; Remaining=12)
  1000   C0927232:Central Nervous System [Body System]
  1000   C1269563:Central nervous system [Body System]
   901   C0027763:Nervous System [Body System]
   901   C0422837:NERVOUS SYSTEM [Finding]
   901   C1269560:Nervous system [Body System]
   845 E C0205494:Neurologic [Qualitative Concept]
   827   C0027769:Nervous [Sign or Symptom]
   827   C0205099:Central [Spatial Concept]
   827   C0449913:System [Functional Concept]
   827   C0599851:Nervous [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   827   C1879652:Central - [Laboratory Procedure]
   808 E C0027855:Neurology [Biomedical Occupation or Discipline]
   790 E C2707261:Neurological [Clinical Attribute]
   755 E C0205373:Systemic [Functional Concept]
   711 E C0027740:Nerve [Tissue]
   711 E C0027757:NERVE [Tissue]
   711 E C1280541:Nerve [Body Part, Organ, or Organ Component]

Phrase: "(18,"

Phrase: "22"

Phrase: ")."
Processing 00000000.tx.99: To avoid the toxic effects associated with these levels of APP overexpression (22, 23, 36, 37), we exploited (i) permissive strain backgrounds and (ii) APP cassettes, including multiple mutations, to maximize production of A for a given level of APP expression. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "avoid"

Phrase: "the toxic effects"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   966   C0600688:Toxic effect [Injury or Poisoning]
           toxic
   861   C1280500:effects [Qualitative Concept]
   861   C1407029:Toxic [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: "associated with these levels of APP overexpression"
Meta Candidates (Total=21; Excluded=5; Pruned=0; Remaining=16)
   790   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   790   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   781   C0368670:Amyloid associated protein [Amino Acid, Peptide, or Protein]
   764   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0332281:Associated with [Qualitative Concept]
           Associated
   764   C1514559:Protein Overexpression [Genetic Function]
           Overexpression
   762   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   745   C0428479:Protein level [Laboratory or Test Result]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0441889:Levels [Qualitative Concept]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1709634:Precursor [Idea or Concept]
   708 E C0456079:Level [Classification]
   708 E C0750490:Associate [Idea or Concept]
   708 E C1547707:Level [Geographic Area]
   708 E C1706221:Associate [Professional or Occupational Group]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "(22,"

Phrase: "23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "36,"

Phrase: "37"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "exploited"

Phrase: "(i) permissive strain backgrounds"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1706907:Background [Conceptual Entity]

Phrase: "and ("

Phrase: "ii"

Phrase: ")"

Phrase: "APP cassettes,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   812   C0450240:cassettes [Medical Device]
   779 E C1706210:Cassette [Manufactured Object]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "multiple mutations,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "maximize"

Phrase: "production of A for a given level of APP expression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C0033268:production [Occupational Activity]
Processing 00000000.tx.100: Transgene constructs were based upon a cDNA cassette encoding the major APP isoform in human brain, APP695. 

Phrase: "Transgene constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2827421:Construct [Classification]

Phrase: "were"

Phrase: "based upon a cDNA cassette"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0450240:Cassette [Medical Device]
   760   C1527178:Based [Functional Concept]
   760   C1705938:Based [Idea or Concept]
   760   C1706210:Cassette [Manufactured Object]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C1880279:Base [Biomedical or Dental Material]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "the major APP isoform in human brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C0597298:protein isoform [Amino Acid, Peptide, or Protein]
           Isoform

Phrase: "APP695."
Processing 00000000.tx.101: This cassette was modified to include either one or two FAD mutations: the "Swedish" mutation (K670N, M671L) and the "Indiana" mutation (V717F), lying adjacent to the N- and C-terminal boundaries of the APP A domain, respectively. 

Phrase: "This cassette"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450240:Cassette [Medical Device]
  1000   C1706210:Cassette [Manufactured Object]

Phrase: "was"

Phrase: "modified"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Modified [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "either one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205447:One [Quantitative Concept]

Phrase: "or"

Phrase: "two FAD mutations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C0026882:Mutations [Genetic Function]
   771 E C1705285:Mutation [Cell or Molecular Dysfunction]
   717   C0276496:Alzheimer disease, familial [Disease or Syndrome]

Phrase: ":"

Phrase: "the ""Swedish"" mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(K670N,"

Phrase: "M671L"

Phrase: ")"

Phrase: "and"

Phrase: "the ""Indiana"" mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(V717F"

Phrase: ")"

Phrase: ","

Phrase: "lying"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038846:Lying [Spatial Concept]
  1000   C0600261:Lying [Individual Behavior]

Phrase: "adjacent to the N-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0205117:Adjacent to [Spatial Concept]
           Adjacent

Phrase: "and"

Phrase: "C-terminal boundaries of the APP"

Phrase: "A domain,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1880389:Domain [Functional Concept]
  1000   C1883221:Domain [Conceptual Entity]
  1000   C3541951:Domain [Intellectual Product]

Phrase: "respectively."
Processing 00000000.tx.102: APPSwe and APPSwe+717 cDNAs were introduced into cos.Tet (29), a cosmid-based expression vector derived from the Syrian hamster prion protein gene. 

Phrase: "APPSwe"

Phrase: "and"

Phrase: "APPSwe+717 cDNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "introduced into cos.Tet (29"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0454802:Cos [Geographic Area]
   760   C1515333:Tet [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   726   C1292748:introduce [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "a cosmid-based expression vector"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   902   C1511534:Cosmid Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0599566:expression vector [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0442335:Vector [Spatial Concept]
   812   C1705099:Vector [Idea or Concept]

Phrase: "derived from the Syrian hamster prion protein gene."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   770   C0018561:Syrian hamster [Mammal]
           Syrian
   770   C0033164:Prion protein [Amino Acid, Peptide, or Protein]
           Prion
   770   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1418941:PRION PROTEIN [Gene or Genome]
   744   C0017337:Gene [Gene or Genome]
   744   C0018557:Hamster [Mammal]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0337819:Syrian [Population Group]
   744   C1441547:Derived [Qualitative Concept]
   744   C3245521:derived [Idea or Concept]
Processing 00000000.tx.103: This vector directs position-independent transgene expression in central nervous system neurons and, to a much lesser extent, astrocytes (38-41). 

Phrase: "This vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vector [Spatial Concept]
  1000   C1705099:Vector [Idea or Concept]

Phrase: "directs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439851:Direct [Qualitative Concept]
  1000   C1947931:Direct [Qualitative Concept]

Phrase: "position-independent transgene expression in central nervous system neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0185117:Expression [Therapeutic or Preventive Procedure]
   742   C0282641:Transgene [Gene or Genome]

Phrase: "and"

Phrase: ","

Phrase: "to a much lesser extent,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439792:Extent [Spatial Concept]

Phrase: "astrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004112:Astrocytes [Cell]

Phrase: "(38-41"

Phrase: ")."
Processing 00000000.tx.104: Microinjections into C3H/HeJC57BL/6J or (C3H/HeJC57BL/6J)C57BL/6J oocytes (the strains are hereafter referred to as C57 and C3H) yielded a number of putative founders but just two stable transgenic lines designated Tg CRND6 and TgCRND8. 

Phrase: "Microinjections into C3H/HeJC57BL/6J"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0025991:Microinjections [Therapeutic or Preventive Procedure]

Phrase: "or (C3H/HeJC57BL/6J)"

Phrase: "C57BL/6J oocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0029045:Oocytes [Cell]

Phrase: "("

Phrase: "the strains"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0080194:Strains [Injury or Poisoning]
  1000   C0456178:strains [Intellectual Product]
   966 E C1518614:Strain [Organism]
   966 E C2987481:Strain [Mental Process]

Phrase: "are"

Phrase: "hereafter"

Phrase: "referred"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205543:referred [Functional Concept]
  1000   C1691010:Referred [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "as"

Phrase: "C57"

Phrase: "and"

Phrase: "C3H/HeJC57BL/6J"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025920:C3H [Mammal]

Phrase: ")"

Phrase: "yielded"

Phrase: "a number of putative founders"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "but"

Phrase: "just two stable transgenic lines"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   804   C0003069:Transgenic [Animal]
   804   C0205132:lines [Spatial Concept]
   771 E C1550648:Line [Substance]
   771 E C1552960:Line [Quantitative Concept]

Phrase: "designated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1524084:Designated [Functional Concept]

Phrase: "Tg CRND6"

Phrase: "and"

Phrase: "TgCRND8."
Processing 00000000.tx.105: These lines harbor APPSwe and APPSwe+V717F transgenes, respectively. 

Phrase: "These lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205132:lines [Spatial Concept]
   966 E C1550648:Line [Substance]
   966 E C1552960:Line [Quantitative Concept]

Phrase: "harbor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0475311:Harbor [Manufactured Object]

Phrase: "APPSwe"

Phrase: "and"

Phrase: "APPSwe+V717F transgenes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0282641:Transgenes [Gene or Genome]

Phrase: "respectively."
Processing 00000000.tx.106: Expression of APP and A Peptide in TgCRND8 Mice APP-specific antibodies were used to establish transgene expression from founder lines, with previously characterized TgAPPwt6209 transgenic mice providing a point of reference (22). 

Phrase: "Expression of APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1171362:expression protein [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "A Peptide in TgCRND8 Mice APP-specific antibodies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "establish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establish [Qualitative Concept]

Phrase: "transgene expression from founder lines,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C0282641:Transgene [Gene or Genome]

Phrase: "with previously characterized TgAPPwt6209 transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0025936:Mice, Transgenic [Mammal]
   804   C0003069:Transgenic [Animal]
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "providing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1999230:Provide [Activity]

Phrase: "a point of reference"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C2924612:A point [Body Location or Region]
   819   C1709878:Reference Point [Spatial Concept]
   770   C1552961:Point [Quantitative Concept]
   770   C2347617:point [Quantitative Concept]

Phrase: "(the strains are hereafter referred to as C57 and C3H) yielded a number of putative founders but just two stable transgenic lines designated Tg CRND6 and TgCRND8. These lines harbor APPSwe and APPSwe+V717F transgenes, respectively. Expression of APP and A Peptide in TgCRND8 Mice APP-specific antibodies were used to establish transgene expression from founder lines, with previously characterized TgAPPwt6209 transgenic mice providing a point of reference (22"

Phrase: ") yielded a number of putative founders but just two stable transgenic lines designated Tg CRND6 and TgCRND8. These lines harbor APPSwe and APPSwe+V717F transgenes, respectively. Expression of APP and A Peptide in TgCRND8 Mice APP-specific antibodies were used to establish transgene expression from founder lines, with previously characterized TgAPPwt6209 transgenic mice providing a point of reference (22)."
Processing 00000000.tx.107: Use of the N-terminal antibody 22C11, which reacts with mouse and human APP, demonstrated overexpression of the full-length mature form of APP of ~120 kDa and different lower molecular mass species of 100kDa (which are not resolved in this gel system), including immature APP, and APP cleaved at the - and -secretase sites, APPS and APPS (Fig. 1A). 

Phrase: "Use of the N-terminal antibody 22C11,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C1524063:Use of [Functional Concept]
   748   C0042153:use [Functional Concept]
   748   C0457083:Use [Functional Concept]
   748   C1947944:Use [Intellectual Product]

Phrase: "which"

Phrase: "reacts with mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0025914:Mouse [Mammal]
   790   C0025929:mouse [Mammal]
   790   C0026809:Mouse [Mammal]

Phrase: "and"

Phrase: "human APP,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   902   C1142652:human protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "demonstrated overexpression of the full-length mature form"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1514559:Overexpression [Genetic Function]

Phrase: "of APP of ~120 kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1532717:kDa [Quantitative Concept]

Phrase: "and"

Phrase: "different"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1705242:Different [Qualitative Concept]
   928 E C1705241:*Difference [Quantitative Concept]
   900 E C0443199:Differential [Qualitative Concept]

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "molecular mass species of 100kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1705920:Species [Conceptual Entity]

Phrase: "("

Phrase: "which"

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "resolved in this gel system"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0017243:Gel [Biomedical or Dental Material]
   760   C0449913:System [Functional Concept]
   760   C1382104:Gel [Substance]
   760   C1514893:Resolved [Idea or Concept]
   760   C1553451:System [Manufactured Object]
   760   C1704459:System [Medical Device]
   760   C2699488:Resolved [Conceptual Entity]

Phrase: ")"

Phrase: ","

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "immature APP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "cleaved at the -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205242:Cleaved [Spatial Concept]
   790   C0333853:Cleaved [Cell]

Phrase: "and -"

Phrase: "secretase sites,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]

Phrase: "APPS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3538722:APP [Laboratory Procedure]

Phrase: "and"

Phrase: "APPS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3538722:APP [Laboratory Procedure]

Phrase: "(which are not resolved in this gel system), including immature APP, and APP cleaved at the - and -secretase sites, APPS and APPS (Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "), including immature APP, and APP cleaved at the - and -secretase sites, APPS and APPS (Fig. 1A)."
Processing 00000000.tx.108: Overexpression in the TgCRND8 line relative to mouse APP holoprotein detected in non-Tg controls was estimated by quantitative image analysis at ~5-fold. 

Phrase: "Overexpression in the TgCRND8 line"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1514559:Overexpression [Genetic Function]

Phrase: "relative to mouse APP holoprotein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0080103:Relative [Family Group]
   748   C0205345:Relative [Qualitative Concept]
   748   C1547039:*Relative [Quantitative Concept]

Phrase: "detected in non-Tg controls"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0003069:Transgenic [Animal]
   760   C0442726:Detected [Finding]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   760   C1518422:Non [Functional Concept]
   726   C0243148:control [Qualitative Concept]
   726   C1550141:Control [Substance]
   726   C1882979:Control [Conceptual Entity]
   726   C2587213:Control [Functional Concept]
   726   C3274648:Control [Qualitative Concept]

Phrase: "was"

Phrase: "estimated by quantitative image analysis at ~5-fold."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   800   C0200767:Image analysis, quantitative [Laboratory Procedure]
   770   C0200765:Image analysis [Laboratory Procedure]
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0332462:Fold [Spatial Concept]
   744   C0392762:Quantitative [Quantitative Concept]
   744   C0750572:Estimated [Quantitative Concept]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]
   744   C1704254:Image [Intellectual Product]
   744   C1704922:Image [Entity]
   744   C1880834:FOLD [Phenomenon or Process]
   744   C3542466:Image [Intellectual Product]
Processing 00000000.tx.109: Similar results for high molecular weight APP species were obtained with antibody 369,which reacts with an epitope close to the C terminus of APP shared by mouse and human APP (Fig. 1A). 

Phrase: "Similar results for high molecular weight APP species"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   706   C1274040:Result [Functional Concept]
   706   C1546471:Result [Idea or Concept]
   706   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained with antibody 369,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "which"

Phrase: "reacts with an epitope"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0003316:Epitope [Immunologic Factor]

Phrase: "close to the C terminus of APP"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   790   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   790   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   764   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   762   C1168438:Protein C [Laboratory Procedure]
   762   C1418943:PROTEIN C [Gene or Genome]
   762   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   762   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0587267:Close [Functional Concept]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1709634:Precursor [Idea or Concept]

Phrase: "shared by mouse"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0025914:Mouse [Mammal]
   790   C0025929:mouse [Mammal]
   790   C0026809:Mouse [Mammal]
   790   C0237876:shared [Social Behavior]
   790   C1522138:Shared [Functional Concept]

Phrase: "and"

Phrase: "human APP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   902   C1142652:human protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "(Fig. 1A). Overexpression in the TgCRND8 line relative to mouse APP holoprotein detected in non-Tg controls was estimated by quantitative image analysis at ~5-fold. Similar results for high molecular weight APP species were obtained with antibody 369,which reacts with an epitope close to the C terminus of APP shared by mouse and human APP (Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "). Overexpression in the TgCRND8 line relative to mouse APP holoprotein detected in non-Tg controls was estimated by quantitative image analysis at ~5-fold. Similar results for high molecular weight APP species were obtained with antibody 369,which reacts with an epitope close to the C terminus of APP shared by mouse and human APP (Fig. 1A)."
Processing 00000000.tx.110: Lower molecular weight species deriving from APP processing were also observed in brain extracts of TgCRND8 and TgCRND6 mice analyzed with the human APP-specific monoclonal antibody 6E10 antiserum (epitope positioned N-terminal to the -secretase cleavage site) and antibody 369.

Phrase: "Lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "molecular weight species"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1705920:Species [Conceptual Entity]
   734   C0026385:Molecular Weight [Quantitative Concept]

Phrase: "deriving from APP processing"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   833   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   833   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   790   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0033666:protein processing [Molecular Function]
   783   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1709634:Precursor [Idea or Concept]
   753   C1709694:Processing [Activity]
   753   C1711343:Deriving [Qualitative Concept]

Phrase: "were"

Phrase: "also"

Phrase: "observed in brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0006104:Brain [Body Part, Organ, or Organ Component]
   790   C1269537:Brain [Body Part, Organ, or Organ Component]
   790   C1441672:Observed [Functional Concept]

Phrase: "extracts of TgCRND8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2828366:Extract [Substance]

Phrase: "and"

Phrase: "TgCRND6 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "analyzed with the human APP-specific monoclonal antibody 6E10 antiserum"
Meta Candidates (Total=24; Excluded=0; Pruned=0; Remaining=24)
   770   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   770   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   753   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   751   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   751   C0443737:Monoclonal protein [Amino Acid, Peptide, or Protein,Immunologic Factor]
   751   C0700271:monoclonal protein [Amino Acid, Peptide, or Protein,Immunologic Factor]
   751   C1142652:human protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   751   C1317659:Protein.monoclonal [Laboratory or Test Result]
   751   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   751   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   736   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   736   C0011560:Amyloid [Pathologic Function]
   736   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   736   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   736   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0086418:Human [Human]
   736   C0205369:Specific [Qualitative Concept]
   736   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0746619:monoclonal [Finding]
   736   C0936012:Analyzed [Research Activity]
   736   C1552740:specific [Intellectual Product]
   736   C1709634:Precursor [Idea or Concept]

Phrase: "(Fig. 1A). Lower molecular weight species deriving from APP processing were also observed in brain extracts of TgCRND8 and TgCRND6 mice analyzed with the human APP-specific monoclonal antibody 6E10 antiserum (epitope"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003316:Epitope [Immunologic Factor]

Phrase: "positioned"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0733755:Position [Spatial Concept]

Phrase: "N-terminal to the -secretase cleavage site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0205088:Terminal [Temporal Concept]
   748   C1705314:Terminal [Manufactured Object]
   748   C1705315:Terminal [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "antibody 369."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.111: These polypeptides represent APP C-terminal stubs arising from cleavage at the - and -secretase sites, with antibody 369recognizing both species and antibody 6E10 recognizing only the longer -stubs. 

Phrase: "These polypeptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1305923:Polypeptides [Amino Acid, Peptide, or Protein]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "APP C-terminal stubs"

Phrase: "arising from cleavage"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0010813:cleavage [Cell Function]
   790   C0332284:arising [Qualitative Concept]
   790   C0596311:Cleavage [Phenomenon or Process]
   790   C1330957:cleavage [Cell Function]

Phrase: "at the -"

Phrase: "and -"

Phrase: "secretase sites,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]

Phrase: "with antibody 369recognizing"

Phrase: "both species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705920:Species [Conceptual Entity]

Phrase: "and"

Phrase: "antibody 6E10"

Phrase: "recognizing"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "the longer -stubs."
Processing 00000000.tx.112: As anticipated, the APP6209 Tg line encoding wt human APP does not exhibit -stubs (as it lacks the Swedish mutation that favors cleavage at this position) but exhibits -stubs with a reduced electrophoretic mobility due to the inclusion of a c-Myc epitope tag within the C terminus of the APP cDNA cassette (22). 

Phrase: "As"

Phrase: "anticipated"

Phrase: ","

Phrase: "the APP6209 Tg line encoding wt human APP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   829   C1142652:human protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   827   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   817   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   807   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   791   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   791   C0011560:Amyloid [Pathologic Function]
   791   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   791   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   791   C1709634:Precursor [Idea or Concept]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "exhibit -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "stubs"

Phrase: "("

Phrase: "as"

Phrase: "it"

Phrase: "lacks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:lack [Qualitative Concept]

Phrase: "the Swedish mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "that favors cleavage at this position"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0010813:cleavage [Cell Function]
   753   C0596311:Cleavage [Phenomenon or Process]
   753   C1330957:cleavage [Cell Function]

Phrase: ")"

Phrase: "but"

Phrase: "exhibits -stubs with a reduced electrophoretic mobility"

Phrase: "due to the inclusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512693:Inclusion [Qualitative Concept]

Phrase: "of a c-Myc epitope tag"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0037293:Tag [Neoplastic Process]
   804   C0181496:Tag [Manufactured Object]
   804   C1710492:TAG [Gene or Genome]

Phrase: "within the C terminus"

Phrase: "of the APP cDNA cassette"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0450240:Cassette [Medical Device]
   804   C1706210:Cassette [Manufactured Object]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "(as it lacks the Swedish mutation that favors cleavage at this position) but exhibits -stubs with a reduced electrophoretic mobility due to the inclusion of a c-Myc epitope tag within the C terminus of the APP cDNA cassette (22"

Phrase: ") but exhibits -stubs with a reduced electrophoretic mobility due to the inclusion of a c-Myc epitope tag within the C terminus of the APP cDNA cassette (22)."
Processing 00000000.tx.113: View larger version (42K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(22). View larger version (42K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.114: 1.  

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.115: Western blot analysis of transgene expression. 

Phrase: "Western blot analysis of transgene expression."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   790   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]
   753   C1705493:Western [Spatial Concept]
Processing 00000000.tx.116: 10% brain homogenates made in 0.32M sucrose were diluted with Laemmli buffer, sonicated, and run on 10-20% Tricine gradient gels (NOVEX). 

Phrase: "10% brain homogenates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "made in 0.32M sucrose"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]
   760   C1552113:32m [Body Part, Organ, or Organ Component]
   726   C1881534:Make [Functional Concept]

Phrase: "were"

Phrase: "diluted with Laemmli buffer,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0258024:Laemmli buffer [Organic Chemical]
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   737   C1720119:Dilute [Functional Concept]
   737   C1948037:Dilute [Functional Concept]

Phrase: "sonicated"

Phrase: ","

Phrase: "and"

Phrase: "run on 10-20% Tricine gradient gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   795   C0017243:Gels [Biomedical or Dental Material]
   762 E C1382104:Gel [Substance]

Phrase: "(42K): [in this window] [in a new window]  Fig. 1.  Western blot analysis of transgene expression. 10% brain homogenates made in 0.32M sucrose were diluted with Laemmli buffer, sonicated, and run on 10-20% Tricine gradient gels (NOVEX"

Phrase: "): [in this window] [in a new window]  Fig. 1.  Western blot analysis of transgene expression. 10% brain homogenates made in 0.32M sucrose were diluted with Laemmli buffer, sonicated, and run on 10-20% Tricine gradient gels (NOVEX)."
Processing 00000000.tx.117: Following transfer to nitrocellulose, human APP and PS1 were detected using C- and N-terminal-specific mAbs and developed by ECL (Amersham Pharmacia Biotech). 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "transfer to nitrocellulose,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0040671:Transfer [Mental Process]
   790   C1705822:Transfer [Activity]

Phrase: "human APP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   902   C1142652:human protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "were"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "C-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "N-terminal-specific mAbs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "developed by ECL (Amersham Pharmacia Biotech"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0331955:Pharmacia [Health Care Related Organization]
   753   C1332684:ECL [Gene or Genome]

Phrase: "). Following transfer to nitrocellulose, human APP and PS1 were detected using C- and N-terminal-specific mAbs and developed by ECL (Amersham Pharmacia Biotech)."
Processing 00000000.tx.118: A, comparison of APP expression levels in Tg lines. 

Phrase: "A,"

Phrase: "comparison of APP expression levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1707455:Comparison [Activity]

Phrase: "in Tg lines."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0003069:Transgenic [Animal]
   861   C0205132:lines [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]
Processing 00000000.tx.119: 1st lane, Non-Tg; 

Phrase: "1st lane,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "Non-Tg"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003069:Transgenic [Animal]
   861   C1518422:Non [Functional Concept]

Phrase: ";"
Processing 00000000.tx.120: 2nd lane, Tg CRND6; 

Phrase: "2nd lane,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "Tg CRND6"

Phrase: ";"
Processing 00000000.tx.121: 3rd lane, Tg CRND8; 

Phrase: "3rd lane,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "Tg CRND8"

Phrase: ";"
Processing 00000000.tx.122: and 4th lane, Tg APP6209. 

Phrase: "and"

Phrase: "4th lane,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "Tg APP6209."
Processing 00000000.tx.123: Proteins were detected with human APP-specific C-terminal mAb 6E10 (left panel), C-terminal antibody 369reactive against mouse and human APP (right panel), and N-terminal antibody 22C11, also reactive against mouse and human APP (lower panel). 

Phrase: "Proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "detected with human APP-specific C-terminal mAb 6E10"
Meta Candidates (Total=25; Excluded=0; Pruned=0; Remaining=25)
   775   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   775   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   770   C1271487:Protein C human [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   756   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C1707271:C-Terminal [Amino Acid Sequence]
   754   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   754   C1142652:human protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   754   C1168438:Protein C [Laboratory Procedure]
   754   C1418943:PROTEIN C [Gene or Genome]
   754   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   754   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   738   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]
   738   C0011560:Amyloid [Pathologic Function]
   738   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0086418:Human [Human]
   738   C0205088:Terminal [Temporal Concept]
   738   C0205369:Specific [Qualitative Concept]
   738   C0442726:Detected [Finding]
   738   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C1511790:Detected [Therapeutic or Preventive Procedure]
   738   C1552740:specific [Intellectual Product]
   738   C1705314:Terminal [Manufactured Object]
   738   C1705315:Terminal [Spatial Concept]
   738   C1709634:Precursor [Idea or Concept]

Phrase: "(NOVEX). Following transfer to nitrocellulose, human APP and PS1 were detected using C- and N-terminal-specific mAbs and developed by ECL (Amersham Pharmacia Biotech). A, comparison of APP expression levels in Tg lines. 1st lane, Non-Tg; 2nd lane, Tg CRND6; 3rd lane, Tg CRND8; and 4th lane, Tg APP6209. Proteins were detected with human APP-specific C-terminal mAb 6E10 (left panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: ","

Phrase: "C-terminal antibody 369reactive against mouse"

Phrase: "and"

Phrase: "human APP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   902   C1142652:human protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "(left panel), C-terminal antibody 369reactive against mouse and human APP (right panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "N-terminal antibody 22C11,"

Phrase: "also reactive against mouse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205332:Reactive [Qualitative Concept]

Phrase: "and"

Phrase: "human APP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   902   C1142652:human protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "(right panel), and N-terminal antibody 22C11, also reactive against mouse and human APP (lower panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "), and N-terminal antibody 22C11, also reactive against mouse and human APP (lower panel)."
Processing 00000000.tx.124: Positions of high molecular weight APP holoprotein and holoprotein derivatives ("APP holoprotein"), and C-terminal stubs are indicated. 

Phrase: "Positions of high molecular weight APP holoprotein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0733755:positions [Spatial Concept]

Phrase: "and"

Phrase: "holoprotein derivatives"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243072:derivatives [Chemical Viewed Structurally]
   827 E C1527240:Derivative [Functional Concept]

Phrase: "(lower panel). Positions of high molecular weight APP holoprotein and holoprotein derivatives (""APP holoprotein"""
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "C-terminal stubs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1707271:C-Terminal [Amino Acid Sequence]

Phrase: "are"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.125: B, time course of A accumulation in Tg CRND8 mice: 1st lane, 60days; 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "time course of A accumulation"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   806   C0449247:Time course [Temporal Concept]
   760   C0040223:Time [Temporal Concept]
   760   C0750729:Course [Temporal Concept]
   760   C3541383:Time [Temporal Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "in Tg CRND8 mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0025936:Mice, Transgenic [Mammal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: ":"

Phrase: "1st lane,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "60days"

Phrase: ";"
Processing 00000000.tx.126: 2nd lane, 120days; 

Phrase: "2nd lane,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "120days"

Phrase: ";"
Processing 00000000.tx.127: 3rd lane, 180days; 

Phrase: "3rd lane,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "180days"

Phrase: ";"
Processing 00000000.tx.128: 4th lane, 240days; 

Phrase: "4th lane,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "240days"

Phrase: ";"
Processing 00000000.tx.129: and 5th lane, 300days. 

Phrase: "and"

Phrase: "5th lane,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "300days."
Processing 00000000.tx.130: Detected with human-specific APP C-terminal mAb 6E10. 

Phrase: "Detected with human-specific APP C-terminal mAb 6E10."
Meta Candidates (Total=25; Excluded=0; Pruned=0; Remaining=25)
   775   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   775   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   772   C1271487:Protein C human [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   756   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   756   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C1168438:Protein C [Laboratory Procedure]
   756   C1418943:PROTEIN C [Gene or Genome]
   756   C1707271:C-Terminal [Amino Acid Sequence]
   756   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   754   C1142652:human protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   754   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   738   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]
   738   C0011560:Amyloid [Pathologic Function]
   738   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0086418:Human [Human]
   738   C0205088:Terminal [Temporal Concept]
   738   C0205369:Specific [Qualitative Concept]
   738   C0442726:Detected [Finding]
   738   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C1511790:Detected [Therapeutic or Preventive Procedure]
   738   C1552740:specific [Intellectual Product]
   738   C1705314:Terminal [Manufactured Object]
   738   C1705315:Terminal [Spatial Concept]
   738   C1709634:Precursor [Idea or Concept]
Processing 00000000.tx.131: C, comparison of protein expression levels in Tg mice expressing single and double mutants of PS1. 

Phrase: "C,"

Phrase: "comparison of protein expression levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1707455:Comparison [Activity]

Phrase: "in Tg mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "expressing"

Phrase: "single"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037179:Single [Population Group]
  1000   C0087136:single [Finding]
  1000   C0205171:Single [Quantitative Concept]

Phrase: "and"

Phrase: "double mutants of PS1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0596988:mutants [Cell or Molecular Dysfunction]
Processing 00000000.tx.132: Normalized samples of brain homogenates are presented. 

Phrase: "Normalized samples of brain homogenates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0370003:Sample [Substance]
   726   C2347026:Sample [Conceptual Entity]

Phrase: "are"

Phrase: "presented."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]
Processing 00000000.tx.133: Detection is with the human-specific PS1 N-terminal mAb NT-1 (72). 

Phrase: "Detection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "is with the human-specific PS1 N-terminal mAb NT-1"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   756   C0128167:NT-1 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   738   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]
   738   C0086418:Human [Human]
   738   C0205088:Terminal [Temporal Concept]
   738   C0205369:Specific [Qualitative Concept]
   738   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0332126:NT [Qualitative Concept]
   738   C1418985:PS1 [Gene or Genome]
   738   C1449832:NT [Diagnostic Procedure]
   738   C1552740:specific [Intellectual Product]
   738   C1705314:Terminal [Manufactured Object]
   738   C1705315:Terminal [Spatial Concept]
   738   C2986918:PS1 [Gene or Genome]

Phrase: "(""APP holoprotein""), and C-terminal stubs are indicated. B, time course of A accumulation in Tg CRND8 mice: 1st lane, 60days; 2nd lane, 120days; 3rd lane, 180days; 4th lane, 240days; and 5th lane, 300days. Detected with human-specific APP C-terminal mAb 6E10. C, comparison of protein expression levels in Tg mice expressing single and double mutants of PS1. Normalized samples of brain homogenates are presented. Detection is with the human-specific PS1 N-terminal mAb NT-1 (72"

Phrase: "), and C-terminal stubs are indicated. B, time course of A accumulation in Tg CRND8 mice: 1st lane, 60days; 2nd lane, 120days; 3rd lane, 180days; 4th lane, 240days; and 5th lane, 300days. Detected with human-specific APP C-terminal mAb 6E10. C, comparison of protein expression levels in Tg mice expressing single and double mutants of PS1. Normalized samples of brain homogenates are presented. Detection is with the human-specific PS1 N-terminal mAb NT-1 (72)."
Processing 00000000.tx.134: Lane 1,Non-Tg; 

Phrase: "Lane 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "Non-Tg"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003069:Transgenic [Animal]
   861   C1518422:Non [Functional Concept]

Phrase: ";"
Processing 00000000.tx.135: lane 2, TgPS1(L286V)1274; 

Phrase: "lane 2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "TgPS1"

Phrase: "(72). Lane 1,Non-Tg; lane 2, TgPS1(L286V"

Phrase: ")"

Phrase: "1274"

Phrase: ";"
Processing 00000000.tx.136: lane 3, TgPS1(WT)1098; 

Phrase: "lane 3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "TgPS1"

Phrase: "(L286V)1274; lane 3, TgPS1(WT)1098"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2700323:WT [Fish]

Phrase: ";"
Processing 00000000.tx.137: and lanes 4and 5represent samples from TgPS1(L286V+M146L)6500 mice. 

Phrase: "and"

Phrase: "lanes 4and 5represent samples from TgPS1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C0370003:Sample [Substance]
   719   C2347026:Sample [Conceptual Entity]

Phrase: "(WT)1098; and lanes 4and 5represent samples from TgPS1(L286V+M146L"

Phrase: ")"

Phrase: "6500 mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
Processing 00000000.tx.138: In TgCRND8 mice, increasing levels of a 4-kDa species (but not -stubs) were detected by Western blot analysis as the animals aged (Fig. 1B). 

Phrase: "In TgCRND8 mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "levels of a 4-kDa species"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   767   C0456950:Level 4 [Qualitative Concept]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "("

Phrase: "but"

Phrase: "not -stubs"

Phrase: ")"

Phrase: "were"

Phrase: "detected by Western blot analysis"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   862   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0442726:Detected [Finding]
   760   C0936012:Analysis [Research Activity]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   760   C1524024:analysis [Functional Concept]
   760   C1705493:Western [Spatial Concept]

Phrase: "as the animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "aged"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0001779:Aged [Organism Attribute]
  1000   C0001792:Aged [Population Group]
  1000   C1999167:aged [Population Group]

Phrase: "(but not -stubs) were detected by Western blot analysis as the animals aged (Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ") were detected by Western blot analysis as the animals aged (Fig. 1B)."
Processing 00000000.tx.139: To investigate the composition of these 4-kDa A peptide species, we performed ELISAs specific for A40 and A42. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the composition of these 4-kDa"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0486616:Composition [Clinical Attribute]
   753   C1555710:composition [Idea or Concept]

Phrase: "A peptide species,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705920:Species [Conceptual Entity]

Phrase: "we"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "ELISAs"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0014441:Immunosorbent Assays, Enzyme-Linked [Laboratory Procedure]
   902   C2717977:Enzyme Assays [Laboratory Procedure]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021075:immunosorbent [Indicator, Reagent, or Diagnostic Aid]
   779   C0005507:Assay [Laboratory Procedure]
   779   C0243073:assay [Qualitative Concept]
   779   C1510438:Assay [Laboratory Procedure]
   779   C1517892:Link [Intellectual Product]
   779   C1704666:Link [Intellectual Product]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "specific for A40"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205369:Specific [Qualitative Concept]
   790   C1552740:specific [Intellectual Product]

Phrase: "and"

Phrase: "A42."
Processing 00000000.tx.140: Both human A40 and A42 were detected in the brains of Tg CRND8 mice. 

Phrase: "Both human A40"

Phrase: "and"

Phrase: "A42"

Phrase: "were"

Phrase: "detected in the brains of Tg CRND8 mice."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   767   C0025936:Mice, Transgenic [Mammal]
   744   C0003069:Transgenic [Animal]
   744   C0006104:Brains [Body Part, Organ, or Organ Component]
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]
   744   C0442726:Detected [Finding]
   744   C1511790:Detected [Therapeutic or Preventive Procedure]
   734   C1521713:Mouse Brain [Tissue]
   711 E C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.141: No signals above background were detected in non-Tg animals. 

Phrase: "No signals above background"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1710082:Signal [Phenomenon or Process]

Phrase: "were"

Phrase: "detected in non-Tg animals."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0003069:Animals, Transgenic [Animal]
           Transgenic
   760   C0003062:Animals [Animal]
   760   C0442726:Detected [Finding]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   760   C1518422:Non [Functional Concept]
Processing 00000000.tx.142: Levels of both peptides increased with age, although in different fashions (Table I). 

Phrase: "Levels of both peptides"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "increased with age,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0001779:Age [Organism Attribute]
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "although in different fashions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1705242:Different [Qualitative Concept]

Phrase: "(Fig. 1B). To investigate the composition of these 4-kDa A peptide species, we performed ELISAs specific for A40 and A42. Both human A40 and A42 were detected in the brains of Tg CRND8 mice. No signals above background were detected in non-Tg animals. Levels of both peptides increased with age, although in different fashions (Table I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "). To investigate the composition of these 4-kDa A peptide species, we performed ELISAs specific for A40 and A42. Both human A40 and A42 were detected in the brains of Tg CRND8 mice. No signals above background were detected in non-Tg animals. Levels of both peptides increased with age, although in different fashions (Table I)."
Processing 00000000.tx.143: Thus A40 levels were stable between 4and 10weeks of age. 

Phrase: "Thus A40 levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "stable between 4and 10weeks of age."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205360:Stable [Qualitative Concept]
   753   C1547311:Stable [Intellectual Product]
Processing 00000000.tx.144: A42 increased slowly between 4and 8weeks, with a potent increase at age 10weeks, such that it predominated over A40 by a ratio of ~5:1. 

Phrase: "A42"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "slowly between 4and 8weeks,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439834:Slowly [Qualitative Concept]

Phrase: "with a potent increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442805:Increase [Functional Concept]

Phrase: "at age 10weeks,"

Phrase: "such"

Phrase: "that"

Phrase: "it"

Phrase: "predominated over A40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0332251:predominated [Qualitative Concept]

Phrase: "by a ratio of ~5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0456603:Ratio [Quantitative Concept]
   827   C1547037:Ratio [Intellectual Product]

Phrase: ":"

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.145: There was considerable spread in A40 and A42 levels in 10-week-old mice, with levels of A40 varying from 25to 234ng/g of brain and A42 ranging from 115to 728ng/g of brain. 

Phrase: "There"

Phrase: "was"

Phrase: "considerable"

Phrase: "spread in A40"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332261:Spread [Qualitative Concept]
   790   C1947932:Spread [Activity]

Phrase: "and"

Phrase: "A42 levels in 10-week-old mice,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "with levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]

Phrase: "of A40"

Phrase: "varying from 25to 234ng/g of brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0006104:Brain [Body Part, Organ, or Organ Component]
   748   C0439267:g% [Quantitative Concept]
   748   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "A42 ranging from 115to 728ng/g of brain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   711   C1514721:Range [Quantitative Concept]
   711   C2348147:Range [Quantitative Concept]
   711   C3542016:Range [Intellectual Product]
Processing 00000000.tx.146: The increase in A42 and the sample-to-sample variation between mice at age 10weeks likely represents a transition point as A42, first present in soluble form, begins to assemble into insoluble amyloid deposits. 

Phrase: "The increase in A42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0442805:Increase [Functional Concept]

Phrase: "and"

Phrase: "the sample-to-sample variation between mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205419:Variation [Qualitative Concept]

Phrase: "at age 10weeks likely"

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a transition point as A42,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C2924612:A point [Body Location or Region]
   760   C0599156:Transition [Cell or Molecular Dysfunction]
   760   C1552961:Point [Quantitative Concept]
   760   C2347617:point [Quantitative Concept]
   760   C2700061:Transition [Activity]

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "present in soluble form,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0150312:Present [Quantitative Concept]
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C0449450:Present [Idea or Concept]
   770   C1522492:Form [Functional Concept]
   770   C1749467:soluble [Cell Component]
   770   C1948047:Soluble [Qualitative Concept]

Phrase: "begins to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0439659:Begin [Temporal Concept]

Phrase: "assemble into insoluble amyloid deposits."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C2936349:Amyloid Deposits [Acquired Abnormality]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0333562:Deposits [Functional Concept]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1706853:Assemble [Activity]
Processing 00000000.tx.147: Measured at 6months of age, levels of both A42 and A40 were enormously increased and were ~510 and 190times, respectively, the levels observed in 4-week-old mice (which are free of amyloid plaque deposits; Fig. 5A).  

Phrase: "Measured at 6months of age,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0001779:Age [Organism Attribute]
   760   C0444706:Measured [Qualitative Concept]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]

Phrase: "levels of both A42"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "A40"

Phrase: "were"

Phrase: "enormously"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "and"

Phrase: "were"

Phrase: "~510"

Phrase: "and"

Phrase: "190times,"

Phrase: "respectively,"

Phrase: "the levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]

Phrase: "observed in 4-week-old mice"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C0332174:/week [Temporal Concept]
   753   C0439230:week [Temporal Concept]
   753   C0580836:Old [Temporal Concept]
   753   C1441672:Observed [Functional Concept]

Phrase: "("

Phrase: "which"

Phrase: "are"

Phrase: "free of amyloid plaque deposits"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0332296:free [Functional Concept]
   760   C1880497:Free [Qualitative Concept]
   760   C1996904:Free [Qualitative Concept]

Phrase: "; Fig. 5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: "). Thus A40 levels were stable between 4and 10weeks of age. A42 increased slowly between 4and 8weeks, with a potent increase at age 10weeks, such that it predominated over A40 by a ratio of ~5:1. There was considerable spread in A40 and A42 levels in 10-week-old mice, with levels of A40 varying from 25to 234ng/g of brain and A42 ranging from 115to 728ng/g of brain. The increase in A42 and the sample-to-sample variation between mice at age 10weeks likely represents a transition point as A42, first present in soluble form, begins to assemble into insoluble amyloid deposits. Measured at 6months of age, levels of both A42 and A40 were enormously increased and were ~510 and 190times, respectively, the levels observed in 4-week-old mice (which are free of amyloid plaque deposits; Fig. 5A)."
Processing 00000000.tx.148: View this table: [in this window] [in a new window]  Table I A peptide species in young TgCRND8 mice Postnatal Lethality in TgCRND8 Mice To gain insight into the ability of genetic backgrounds to modulate lethality associated with APP overexpression (and, from a practical point of view, to preempt premature extinction), the newly established TgCRND8 line was bred to different strain backgrounds. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "A peptide species in young TgCRND8 mice Postnatal Lethality"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1705920:Species [Conceptual Entity]

Phrase: "in TgCRND8 Mice To"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "gain"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1517378:Gain [Quantitative Concept]
   944 E C0205217:Increased [Quantitative Concept]
   944 E C0439661:Acquired [Temporal Concept]
   944 E C0442805:Increase [Functional Concept]
   944 E C0442808:Increasing [Functional Concept]
   944 E C1301820:Obtain [Functional Concept]
   944 E C1706701:Acquire [Activity]
   944 E C3245488:acquired [Intellectual Product]

Phrase: "insight into the ability of genetic backgrounds to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0233820:Insight [Mental Process]

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "lethality"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C3151529:Lethal [Finding]

Phrase: "associated with APP overexpression"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   833   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   833   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   814   C0368670:Amyloid associated protein [Amino Acid, Peptide, or Protein]
   790   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C1514559:Protein Overexpression [Genetic Function]
           Overexpression
   783   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1709634:Precursor [Idea or Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "("

Phrase: "and"

Phrase: ","

Phrase: "from a practical point"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1552961:Point [Quantitative Concept]
   861   C2347617:point [Quantitative Concept]

Phrase: "of view,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "preempt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0676278:preempt [Pharmacologic Substance]

Phrase: "premature extinction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015347:extinction [Mental Process]

Phrase: ")"

Phrase: ","

Phrase: "the newly established TgCRND8 line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0205132:Line [Spatial Concept]
   812   C1550648:Line [Substance]
   812   C1552960:Line [Quantitative Concept]

Phrase: "was"

Phrase: "bred to different strain backgrounds."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0080194:Strain [Injury or Poisoning]
   760   C0456178:strain [Intellectual Product]
   760   C1518614:Strain [Organism]
   760   C1705242:Different [Qualitative Concept]
   760   C2987481:Strain [Mental Process]
   726   C0006159:breed [Organism Function]
   726   C1704650:Breed [Classification]
   726   C1706907:Background [Conceptual Entity]
Processing 00000000.tx.149: Progeny of an F1 cross to the C3H/HeJ ("C3H") strain were bred to mice derived from FVB/N and 129SvEv/Tac backgrounds. 

Phrase: "Progeny of an F1 cross"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0680063:Progeny [Family Group]

Phrase: "to the C3H/HeJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511362:C3H/HeJ [Mammal]

Phrase: "(and, from a practical point of view, to preempt premature extinction), the newly established TgCRND8 line was bred to different strain backgrounds. Progeny of an F1 cross to the C3H/HeJ (""C3H"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025920:C3H [Mammal]

Phrase: ")"

Phrase: "strain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0080194:Strain [Injury or Poisoning]
  1000   C0456178:strain [Intellectual Product]
  1000   C1518614:Strain [Organism]
  1000   C2987481:Strain [Mental Process]

Phrase: "were"

Phrase: "bred to mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0025914:Mice [Mammal]
   790   C0025929:mice [Mammal]
   790   C0026809:Mice [Mammal]
   756   C0006159:breed [Organism Function]
   756   C1704650:Breed [Classification]

Phrase: "derived from FVB/N"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1517102:FVB/N [Mammal]
   770   C1441547:Derived [Qualitative Concept]
   770   C1517101:FVB [Mammal]
   770   C3245521:derived [Idea or Concept]

Phrase: "and"

Phrase: "129SvEv/Tac backgrounds."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1706907:Background [Conceptual Entity]
Processing 00000000.tx.150: Estimated Kaplan-Meier cumulative survival curves for TgCRND8 mice and their littermates during post-natal development are presented in Fig. 

Phrase: "Estimated Kaplan-Meier cumulative survival curves for TgCRND8 mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   807   C1720944:Kaplan-Meier Survival Curves [Quantitative Concept]
   742   C0038952:Survival [Activity]
   742   C0220921:survival [Functional Concept]
   708   C0205134:Curve [Spatial Concept]

Phrase: "and"

Phrase: "their littermates during post-natal development"

Phrase: "are"

Phrase: "presented in Fig."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C0449450:Presented [Idea or Concept]
   790   C1337208:FIG [Food]
   756 E C0150312:Present [Quantitative Concept]
Processing 00000000.tx.151: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.152: Inspection of the curves clearly indicates improved survival of mice with the APP transgene expressed on the (C57)(C3H/C57) genetic background. 

Phrase: "Inspection of the curves clearly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0199219:Inspection [Functional Concept]

Phrase: "indicates"

Phrase: "improved survival of mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0038952:Survival [Activity]
   770   C0220921:survival [Functional Concept]

Phrase: "with the APP transgene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0282641:Transgene [Gene or Genome]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "expressed on the (C57"

Phrase: ")"

Phrase: "(""C3H"") strain were bred to mice derived from FVB/N and 129SvEv/Tac backgrounds. Estimated Kaplan-Meier cumulative survival curves for TgCRND8 mice and their littermates during post-natal development are presented in Fig. 2. Inspection of the curves clearly indicates improved survival of mice with the APP transgene expressed on the (C57)(C3H/C57"

Phrase: ")"

Phrase: "genetic background."
Meta Candidates (Total=17; Excluded=14; Pruned=0; Remaining=3)
   861   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   861   C0314603:Genetic [Functional Concept]
   861   C1706907:Background [Conceptual Entity]
   805 E C0005615:Birth [Organism Function]
   805 E C0035150:Reproduction [Organism Function]
   805 E C0079946:origin [Classification]
   805 E C0439659:Origin [Temporal Concept]
   805 E C1550512:origin [Intellectual Product]
   805 E C1550722:birth [Idea or Concept]
   805 E C3245487:birth [Intellectual Product]
   777 E C0454729:Natal [Geographic Area]
   777 E C0559522:Genital [Body System]
   777 E C1546649:Genital [Intellectual Product]
   777 E C1550642:Genital [Body Substance]
   768 E C0205313:Original [Idea or Concept]
   768 E C2347409:Original [Occupational Activity]
   750 E C0598240:originality [Mental Process]
Processing 00000000.tx.153: In this cohort of Tg mice (n=52), 20mice died before the age of 120days, decreasing their survival to 60% and with three deaths at 130days and three further deaths after 250days. 

Phrase: "In this cohort"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599755:Cohort [Population Group]

Phrase: "of Tg mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "(C3H/C57) genetic background. In this cohort of Tg mice (n=52"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "20mice"

Phrase: "died before the age of 120days,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0001779:Age [Organism Attribute]
   753   C0011065:Died [Organism Function]
   753   C1546956:Died [Finding]

Phrase: "decreasing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0442797:Decreasing [Qualitative Concept]
   966 E C0392756:Decrease [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "their survival to 60%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0038952:Survival [Activity]
   770   C0220921:survival [Functional Concept]

Phrase: "and with three deaths"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0011065:deaths [Organism Function]
   770   C0205449:Three [Quantitative Concept]
   770   C1306577:DEATHS [Finding]
   770   C1515981:And [Idea or Concept]

Phrase: "at 130days"

Phrase: "and"

Phrase: "three further deaths after 250days."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0011065:deaths [Organism Function]
   760   C1306577:DEATHS [Finding]
Processing 00000000.tx.154: When the APP transgene was expressed on either (C3H/C57/129SvEv/Tac)(129SvEv/Tac) or (FVB)(C3H/C57) genetic backgrounds (n=12and n=41respectively), survival dropped rapidly to 25-40% within the first 120days of their post-natal life (Fig. 2). 

Phrase: "When"

Phrase: "the APP transgene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0282641:Transgene [Gene or Genome]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "was"

Phrase: "expressed on either"

Phrase: "(n=52), 20mice died before the age of 120days, decreasing their survival to 60% and with three deaths at 130days and three further deaths after 250days. When the APP transgene was expressed on either (C3H/C57/129SvEv/Tac)(129SvEv/Tac) or (FVB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1517101:FVB [Mammal]

Phrase: ")"

Phrase: "(C3H/C57/129SvEv/Tac)(129SvEv/Tac) or (FVB)(C3H/C57"

Phrase: ")"

Phrase: "genetic backgrounds"
Meta Candidates (Total=17; Excluded=14; Pruned=0; Remaining=3)
   861   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   861   C0314603:Genetic [Functional Concept]
   827   C1706907:Background [Conceptual Entity]
   805 E C0005615:Birth [Organism Function]
   805 E C0035150:Reproduction [Organism Function]
   805 E C0079946:origin [Classification]
   805 E C0439659:Origin [Temporal Concept]
   805 E C1550512:origin [Intellectual Product]
   805 E C1550722:birth [Idea or Concept]
   805 E C3245487:birth [Intellectual Product]
   777 E C0454729:Natal [Geographic Area]
   777 E C0559522:Genital [Body System]
   777 E C1546649:Genital [Intellectual Product]
   777 E C1550642:Genital [Body Substance]
   768 E C0205313:Original [Idea or Concept]
   768 E C2347409:Original [Occupational Activity]
   750 E C0598240:originality [Mental Process]

Phrase: "(C3H/C57) genetic backgrounds (n=12and n=41respectively"

Phrase: ")"

Phrase: ","

Phrase: "survival"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038952:Survival [Activity]
  1000   C0220921:survival [Functional Concept]

Phrase: "dropped"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1705648:Dropped [Activity]
   966 E C1321095:Drop [Quantitative Concept]
   966 E C2347093:Drop [Quantitative Concept]
   966 E C2348338:Drop [Quantitative Concept]

Phrase: "rapidly to 25-40%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439509:/40 [Temporal Concept]
   770   C1637379:Rapidly [Qualitative Concept]

Phrase: "within the first 120days"

Phrase: "of their post-natal life"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0376558:Life [Idea or Concept]
   743 E C0595998:lives [Finding]

Phrase: "(n=12and n=41respectively), survival dropped rapidly to 25-40% within the first 120days of their post-natal life (Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "), survival dropped rapidly to 25-40% within the first 120days of their post-natal life (Fig. 2)."
Processing 00000000.tx.155: After this time point, survival with the (C3H/C57/129SvEv/Tac)(129SvEv/Tac) genetic background dropped slightly to 33% (one death at 159days) with only 25% (3mice) of the cohort surviving until 365days. 

Phrase: "After this time point,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C2348792:Time Point [Temporal Concept]
   861   C0040223:Time [Temporal Concept]
   861   C1552961:Point [Quantitative Concept]
   861   C2347617:point [Quantitative Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "survival"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038952:Survival [Activity]
  1000   C0220921:survival [Functional Concept]

Phrase: "with the (C3H/C57/129SvEv/Tac)(129SvEv/Tac) genetic background"
Meta Candidates (Total=16; Excluded=13; Pruned=0; Remaining=3)
   793   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   793   C0314603:Genetic [Functional Concept]
   793   C1706907:Background [Conceptual Entity]
   737 E C0005615:Birth [Organism Function]
   737 E C0035150:Reproduction [Organism Function]
   737 E C0079946:origin [Classification]
   737 E C0439659:Origin [Temporal Concept]
   737 E C1550512:origin [Intellectual Product]
   737 E C1550722:birth [Idea or Concept]
   737 E C3245487:birth [Intellectual Product]
   710 E C0454729:Natal [Geographic Area]
   710 E C0559522:Genital [Body System]
   710 E C1546649:Genital [Intellectual Product]
   710 E C1550642:Genital [Body Substance]
   700 E C0205313:Original [Idea or Concept]
   700 E C2347409:Original [Occupational Activity]

Phrase: "dropped"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1705648:Dropped [Activity]
   966 E C1321095:Drop [Quantitative Concept]
   966 E C2347093:Drop [Quantitative Concept]
   966 E C2348338:Drop [Quantitative Concept]

Phrase: "slightly to 33%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0750482:Slightly [Idea or Concept]

Phrase: "(Fig. 2). After this time point, survival with the (C3H/C57/129SvEv/Tac)(129SvEv/Tac) genetic background dropped slightly to 33% (one death at 159days"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0011065:Death [Organism Function]
   770   C1306577:Death, NOS [Finding]

Phrase: ")"

Phrase: "with only 25%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205171:Only [Quantitative Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "(one death at 159days) with only 25% (3mice"

Phrase: ")"

Phrase: "of the cohort surviving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0310255:SURVIVE [Pharmacologic Substance]

Phrase: "until 365days."
Processing 00000000.tx.156: Similarly, the survival of the TgCRND8 mice with (FVB)(C3H/C57) background dropped rapidly within the first 120days of post-natal age (Fig. 2) with 17% of mice (n=7) surviving until 365days of age. 

Phrase: "Similarly,"

Phrase: "the survival of the TgCRND8 mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0038952:Survival [Activity]
   753   C0220921:survival [Functional Concept]

Phrase: "with"

Phrase: "(3mice) of the cohort surviving until 365days. Similarly, the survival of the TgCRND8 mice with (FVB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517101:FVB [Mammal]

Phrase: ")"

Phrase: "(FVB)(C3H/C57"

Phrase: ")"

Phrase: "background"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706907:Background [Conceptual Entity]

Phrase: "dropped"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1705648:Dropped [Activity]
   966 E C1321095:Drop [Quantitative Concept]
   966 E C2347093:Drop [Quantitative Concept]
   966 E C2348338:Drop [Quantitative Concept]

Phrase: "rapidly within the first 120days of post-natal age"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   742   C0001779:Age [Organism Attribute]
   742   C0205435:First [Quantitative Concept]
   742   C0454729:Natal [Geographic Area]
   742   C0687676:Post [Temporal Concept]
   742   C1279901:First [Qualitative Concept]
   742   C1637379:Rapidly [Qualitative Concept]
   742   C1704687:Post [Manufactured Object]

Phrase: "(C3H/C57) background dropped rapidly within the first 120days of post-natal age (Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "with 17%"

Phrase: "of mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "(Fig. 2) with 17% of mice (n=7"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "surviving until 365days of age."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0310255:SURVIVE [Pharmacologic Substance]
Processing 00000000.tx.157: The survival of mice with the (C57)(C3H/C57) was significantly better than survival of Tg mice with (FVB)(C3H/C57) or (C3H/C57/129SvEv/Tac)(129SvEv/Tac) backgrounds (Tarone-Ware statistics: 5.13,p<0.05,and 19.01,p<0.001,respectively). 

Phrase: "The survival of mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0038952:Survival [Activity]
   770   C0220921:survival [Functional Concept]

Phrase: "with the (C57"

Phrase: ")"

Phrase: "(n=7) surviving until 365days of age. The survival of mice with the (C57)(C3H/C57"

Phrase: ")"

Phrase: "was"

Phrase: "significantly better than survival of Tg mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0332272:Better [Qualitative Concept]

Phrase: "with"

Phrase: "(C3H/C57) was significantly better than survival of Tg mice with (FVB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517101:FVB [Mammal]

Phrase: ")"

Phrase: "(FVB)(C3H/C57"

Phrase: ")"

Phrase: "C3H/HeJC57BL/6J)C57BL/6J oocytes (the strains are hereafter referred to as C57 and C3H) yielded a number of putative founders but just two stable transgenic lines designated Tg CRND6 and TgCRND8. These lines harbor APPSwe and APPSwe+V717F transgenes, respectively. Expression of APP and A Peptide in TgCRND8 Mice APP-specific antibodies were used to establish transgene expression from founder lines, with previously characterized TgAPPwt6209 transgenic mice providing a point of reference (22). Use of the N-terminal antibody 22C11, which reacts with mouse and human APP, demonstrated overexpression of the full-length mature form of APP of ~120 kDa and different lower molecular mass species of 100kDa (which are not resolved in this gel system), including immature APP, and APP cleaved at the - and -secretase sites, APPS and APPS (Fig. 1A). Overexpression in the TgCRND8 line relative to mouse APP holoprotein detected in non-Tg controls was estimated by quantitative image analysis at ~5-fold. Similar results for high molecular weight APP species were obtained with antibody 369,which reacts with an epitope close to the C terminus of APP shared by mouse and human APP (Fig. 1A). Lower molecular weight species deriving from APP processing were also observed in brain extracts of TgCRND8 and TgCRND6 mice analyzed with the human APP-specific monoclonal antibody 6E10 antiserum (epitope positioned N-terminal to the -secretase cleavage site) and antibody 369.These polypeptides represent APP C-terminal stubs arising from cleavage at the - and -secretase sites, with antibody 369recognizing both species and antibody 6E10 recognizing only the longer -stubs. As anticipated, the APP6209 Tg line encoding wt human APP does not exhibit -stubs (as it lacks the Swedish mutation that favors cleavage at this position) but exhibits -stubs with a reduced electrophoretic mobility due to the inclusion of a c-Myc epitope tag within the C terminus of the APP cDNA cassette (22). View larger version (42K): [in this window] [in a new window]  Fig. 1.  Western blot analysis of transgene expression. 10% brain homogenates made in 0.32M sucrose were diluted with Laemmli buffer, sonicated, and run on 10-20% Tricine gradient gels (NOVEX). Following transfer to nitrocellulose, human APP and PS1 were detected using C- and N-terminal-specific mAbs and developed by ECL (Amersham Pharmacia Biotech). A, comparison of APP expression levels in Tg lines. 1st lane, Non-Tg; 2nd lane, Tg CRND6; 3rd lane, Tg CRND8; and 4th lane, Tg APP6209. Proteins were detected with human APP-specific C-terminal mAb 6E10 (left panel), C-terminal antibody 369reactive against mouse and human APP (right panel), and N-terminal antibody 22C11, also reactive against mouse and human APP (lower panel). Positions of high molecular weight APP holoprotein and holoprotein derivatives (""APP holoprotein""), and C-terminal stubs are indicated. B, time course of A accumulation in Tg CRND8 mice: 1st lane, 60days; 2nd lane, 120days; 3rd lane, 180days; 4th lane, 240days; and 5th lane, 300days. Detected with human-specific APP C-terminal mAb 6E10. C, comparison of protein expression levels in Tg mice expressing single and double mutants of PS1. Normalized samples of brain homogenates are presented. Detection is with the human-specific PS1 N-terminal mAb NT-1 (72). Lane 1,Non-Tg; lane 2, TgPS1(L286V)1274; lane 3, TgPS1(WT)1098; and lanes 4and 5represent samples from TgPS1(L286V+M146L)6500 mice. In TgCRND8 mice, increasing levels of a 4-kDa species (but not -stubs) were detected by Western blot analysis as the animals aged (Fig. 1B). To investigate the composition of these 4-kDa A peptide species, we performed ELISAs specific for A40 and A42. Both human A40 and A42 were detected in the brains of Tg CRND8 mice. No signals above background were detected in non-Tg animals. Levels of both peptides increased with age, although in different fashions (Table I). Thus A40 levels were stable between 4and 10weeks of age. A42 increased slowly between 4and 8weeks, with a potent increase at age 10weeks, such that it predominated over A40 by a ratio of ~5:1. There was considerable spread in A40 and A42 levels in 10-week-old mice, with levels of A40 varying from 25to 234ng/g of brain and A42 ranging from 115to 728ng/g of brain. The increase in A42 and the sample-to-sample variation between mice at age 10weeks likely represents a transition point as A42, first present in soluble form, begins to assemble into insoluble amyloid deposits. Measured at 6months of age, levels of both A42 and A40 were enormously increased and were ~510 and 190times, respectively, the levels observed in 4-week-old mice (which are free of amyloid plaque deposits; Fig. 5A).  View this table: [in this window] [in a new window]  Table I A peptide species in young TgCRND8 mice Postnatal Lethality in TgCRND8 Mice To gain insight into the ability of genetic backgrounds to modulate lethality associated with APP overexpression (and, from a practical point of view, to preempt premature extinction), the newly established TgCRND8 line was bred to different strain backgrounds. Progeny of an F1 cross to the C3H/HeJ (""C3H"") strain were bred to mice derived from FVB/N and 129SvEv/Tac backgrounds. Estimated Kaplan-Meier cumulative survival curves for TgCRND8 mice and their littermates during post-natal development are presented in Fig. 2. Inspection of the curves clearly indicates improved survival of mice with the APP transgene expressed on the (C57)(C3H/C57) genetic background. In this cohort of Tg mice (n=52), 20mice died before the age of 120days, decreasing their survival to 60% and with three deaths at 130days and three further deaths after 250days. When the APP transgene was expressed on either (C3H/C57/129SvEv/Tac)(129SvEv/Tac) or (FVB)(C3H/C57) genetic backgrounds (n=12and n=41respectively), survival dropped rapidly to 25-40% within the first 120days of their post-natal life (Fig. 2). After this time point, survival with the (C3H/C57/129SvEv/Tac)(129SvEv/Tac) genetic background dropped slightly to 33% (one death at 159days) with only 25% (3mice) of the cohort surviving until 365days. Similarly, the survival of the TgCRND8 mice with (FVB)(C3H/C57) background dropped rapidly within the first 120days of post-natal age (Fig. 2) with 17% of mice (n=7) surviving until 365days of age. The survival of mice with the (C57)(C3H/C57) was significantly better than survival of Tg mice with (FVB)(C3H/C57) or (C3H/C57/129SvEv/Tac)(129SvEv/Tac) backgrounds"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1706907:Background [Conceptual Entity]

Phrase: "(C3H/C57/129SvEv/Tac)(129SvEv/Tac) backgrounds (Tarone-Ware statistics"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0038215:Statistics [Occupation or Discipline]
   827   C0600673:Statistics [Intellectual Product]
   793 E C2348149:Statistic [Quantitative Concept]
   793 E C2828391:Statistic [Quantitative Concept]

Phrase: ":"

Phrase: "5.13,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439084:>5 [Quantitative Concept]
   861   C0728893:+5 [Quantitative Concept]

Phrase: "p<0.05,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "19.01,"

Phrase: "p<0.001,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "respectively"

Phrase: ") or (C3H/C57/129SvEv/Tac)(129SvEv/Tac) backgrounds (Tarone-Ware statistics: 5.13,p<0.05,and 19.01,p<0.001,respectively)."
Processing 00000000.tx.158: The survival curves of the latter two genetic backgrounds did not differ significantly from each other (Tarone-Ware statistics: 0.42,p>0.05), and the survival of TgCRND8 mice with the three genetic backgrounds was significantly different from the survival of non-Tg littermates (Tarone-Ware statistics >50, all p values<0.001. 

Phrase: "The survival curves of the latter two genetic backgrounds"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0038952:Survival [Activity]
   742   C0220921:survival [Functional Concept]
   708   C0205134:Curve [Spatial Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "differ"

Phrase: "significantly from each other"

Phrase: "(Tarone-Ware statistics: 5.13,p<0.05,and 19.01,p<0.001,respectively). The survival curves of the latter two genetic backgrounds did not differ significantly from each other (Tarone-Ware statistics"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0038215:Statistics [Occupation or Discipline]
   827   C0600673:Statistics [Intellectual Product]
   793 E C2348149:Statistic [Quantitative Concept]
   793 E C2828391:Statistic [Quantitative Concept]

Phrase: ":"

Phrase: "0.42,"

Phrase: "p>0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the survival of TgCRND8 mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0038952:Survival [Activity]
   760   C0220921:survival [Functional Concept]

Phrase: "with the three genetic backgrounds"
Meta Candidates (Total=17; Excluded=14; Pruned=0; Remaining=3)
   827   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   827   C0314603:Genetic [Functional Concept]
   793   C1706907:Background [Conceptual Entity]
   771 E C0005615:Birth [Organism Function]
   771 E C0035150:Reproduction [Organism Function]
   771 E C0079946:origin [Classification]
   771 E C0439659:Origin [Temporal Concept]
   771 E C1550512:origin [Intellectual Product]
   771 E C1550722:birth [Idea or Concept]
   771 E C3245487:birth [Intellectual Product]
   743 E C0454729:Natal [Geographic Area]
   743 E C0559522:Genital [Body System]
   743 E C1546649:Genital [Intellectual Product]
   743 E C1550642:Genital [Body Substance]
   734 E C0205313:Original [Idea or Concept]
   734 E C2347409:Original [Occupational Activity]
   716 E C0598240:originality [Mental Process]

Phrase: "was"

Phrase: "significantly different from the survival of non-Tg littermates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1705242:Different [Qualitative Concept]

Phrase: "(Tarone-Ware statistics: 0.42,p>0.05), and the survival of TgCRND8 mice with the three genetic backgrounds was significantly different from the survival of non-Tg littermates (Tarone-Ware statistics"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0038215:Statistics [Occupation or Discipline]
   827   C0600673:Statistics [Intellectual Product]
   793 E C2348149:Statistic [Quantitative Concept]
   793 E C2828391:Statistic [Quantitative Concept]

Phrase: ">50,"

Phrase: "all p values"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1709380:P-Value [Quantitative Concept]
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "<0.001."
Processing 00000000.tx.159: View larger version (20K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(Tarone-Ware statistics >50, all p values<0.001. View larger version (20K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.160: 2.  

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.161: Cumulative survival curves (Kaplan-Meier survival analysis) of TgCRND8 mice in different genetic backgrounds. 

Phrase: "Cumulative survival curves"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0038952:Survival [Activity]
   827   C0220921:survival [Functional Concept]
   793   C0205134:Curve [Spatial Concept]

Phrase: "(20K): [in this window] [in a new window]  Fig. 2.  Cumulative survival curves (Kaplan-Meier survival analysis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C1720943:Kaplan-Meier Analysis [Quantitative Concept]
   861   C0038953:Survival Analysis [Research Activity]
   812   C0002778:Analysis [Laboratory Procedure]
   812   C0936012:Analysis [Research Activity]
   812   C1524024:analysis [Functional Concept]

Phrase: ")"

Phrase: "of TgCRND8 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "in different genetic backgrounds."
Meta Candidates (Total=17; Excluded=14; Pruned=0; Remaining=3)
   827   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   827   C0314603:Genetic [Functional Concept]
   793   C1706907:Background [Conceptual Entity]
   771 E C0005615:Birth [Organism Function]
   771 E C0035150:Reproduction [Organism Function]
   771 E C0079946:origin [Classification]
   771 E C0439659:Origin [Temporal Concept]
   771 E C1550512:origin [Intellectual Product]
   771 E C1550722:birth [Idea or Concept]
   771 E C3245487:birth [Intellectual Product]
   743 E C0454729:Natal [Geographic Area]
   743 E C0559522:Genital [Body System]
   743 E C1546649:Genital [Intellectual Product]
   743 E C1550642:Genital [Body Substance]
   734 E C0205313:Original [Idea or Concept]
   734 E C2347409:Original [Occupational Activity]
   716 E C0598240:originality [Mental Process]
Processing 00000000.tx.162: Cumulative survival curves of TgCRND8 mice as a function of the transgene genetic background. 

Phrase: "Cumulative survival curves of TgCRND8 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0038952:Survival [Activity]
   753   C0220921:survival [Functional Concept]
   719   C0205134:Curve [Spatial Concept]

Phrase: "as a function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]

Phrase: "of the transgene genetic background."
Meta Candidates (Total=17; Excluded=14; Pruned=0; Remaining=3)
   827   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   827   C0314603:Genetic [Functional Concept]
   827   C1706907:Background [Conceptual Entity]
   771 E C0005615:Birth [Organism Function]
   771 E C0035150:Reproduction [Organism Function]
   771 E C0079946:origin [Classification]
   771 E C0439659:Origin [Temporal Concept]
   771 E C1550512:origin [Intellectual Product]
   771 E C1550722:birth [Idea or Concept]
   771 E C3245487:birth [Intellectual Product]
   743 E C0454729:Natal [Geographic Area]
   743 E C0559522:Genital [Body System]
   743 E C1546649:Genital [Intellectual Product]
   743 E C1550642:Genital [Body Substance]
   734 E C0205313:Original [Idea or Concept]
   734 E C2347409:Original [Occupational Activity]
   716 E C0598240:originality [Mental Process]
Processing 00000000.tx.163: The survival of Tg mice on the (C57)(C3H/C57) genetic background (n=52) was the highest, with 50% of mice surviving until 365days of age (upper cut-off of the analysis). 

Phrase: "The survival of Tg mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0038952:Survival [Activity]
   760   C0220921:survival [Functional Concept]

Phrase: "on the (C57"

Phrase: ")"

Phrase: "(Kaplan-Meier survival analysis) of TgCRND8 mice in different genetic backgrounds. Cumulative survival curves of TgCRND8 mice as a function of the transgene genetic background. The survival of Tg mice on the (C57)(C3H/C57"

Phrase: ")"

Phrase: "genetic background"
Meta Candidates (Total=17; Excluded=14; Pruned=0; Remaining=3)
   861   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   861   C0314603:Genetic [Functional Concept]
   861   C1706907:Background [Conceptual Entity]
   805 E C0005615:Birth [Organism Function]
   805 E C0035150:Reproduction [Organism Function]
   805 E C0079946:origin [Classification]
   805 E C0439659:Origin [Temporal Concept]
   805 E C1550512:origin [Intellectual Product]
   805 E C1550722:birth [Idea or Concept]
   805 E C3245487:birth [Intellectual Product]
   777 E C0454729:Natal [Geographic Area]
   777 E C0559522:Genital [Body System]
   777 E C1546649:Genital [Intellectual Product]
   777 E C1550642:Genital [Body Substance]
   768 E C0205313:Original [Idea or Concept]
   768 E C2347409:Original [Occupational Activity]
   750 E C0598240:originality [Mental Process]

Phrase: "(C3H/C57) genetic background (n=52"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "was"

Phrase: "the highest,"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C1522410:Highest [Qualitative Concept]
   966 E C0205250:High [Qualitative Concept]
   966 E C1299351:High [Qualitative Concept]
   966 E C2700149:HIGH [Intellectual Product]
   916 E C0489786:Height [Organism Attribute]

Phrase: "with 50%"

Phrase: "of mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "surviving until 365days of age (upper cut-off of the analysis"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   756   C1442160:Cutoff [Functional Concept]
   738   C0000925:Cut [Injury or Poisoning]
   738   C0001779:Age [Organism Attribute]
   738   C0002778:Analysis [Laboratory Procedure]
   738   C0936012:Analysis [Research Activity]
   738   C1282910:Upper [Spatial Concept]
   738   C1524024:analysis [Functional Concept]
   738   C1883724:CUT [Phenomenon or Process]
   704   C0310255:SURVIVE [Pharmacologic Substance]

Phrase: ") was the highest, with 50% of mice surviving until 365days of age (upper cut-off of the analysis)."
Processing 00000000.tx.164: In contrast, the survival of the Tg mice on (C3H/C57/129SvEv/Tac)(129SvEv/Tac) and (FVB)(C3H/C57) backgrounds (n=12and n=41respectively) was affected by increased mortality within the first 120days of their post-natal age. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the survival"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038952:Survival [Activity]
  1000   C0220921:survival [Functional Concept]

Phrase: "of the Tg mice on (C3H/C57/129SvEv/Tac)(129SvEv/Tac)"

Phrase: "and ("

Phrase: "FVB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517101:FVB [Mammal]

Phrase: ")"

Phrase: "(n=52) was the highest, with 50% of mice surviving until 365days of age (upper cut-off of the analysis). In contrast, the survival of the Tg mice on (C3H/C57/129SvEv/Tac)(129SvEv/Tac) and (FVB)(C3H/C57"

Phrase: ")"

Phrase: "backgrounds"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1706907:Background [Conceptual Entity]

Phrase: "(C3H/C57) backgrounds (n=12and n=41respectively"

Phrase: ")"

Phrase: "was"

Phrase: "affected by increased mortality"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0026565:Mortality [Quantitative Concept]
   770   C0026566:mortality [Quantitative Concept]
   770   C0205217:Increased [Quantitative Concept]
   770   C0392760:Affected [Functional Concept]
   770   C0442805:Increased [Functional Concept]
   770   C1314939:Affected [Functional Concept]
   737 E C0001721:Affect [Mental Process]

Phrase: "within the first 120days"

Phrase: "of their post-natal age."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0001779:Age [Organism Attribute]
   827   C0454729:Natal [Geographic Area]
   827   C0687676:Post [Temporal Concept]
   827   C1704687:Post [Manufactured Object]
   755 E C1514253:Postal [Functional Concept]
Processing 00000000.tx.165: In the case of Tg mice with the (C3H/C57/129SvEv/Tac)(129SvEv/Tac) genetic background, only 3(25%) out of 12mice survived until the age of 365days, and only 17% (7out of 41) of the (FVB)(C3H/C57) Tg mice reached the age of 365days. 

Phrase: "In the case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "of Tg mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "with the (C3H/C57/129SvEv/Tac)(129SvEv/Tac) genetic background,"
Meta Candidates (Total=16; Excluded=13; Pruned=0; Remaining=3)
   793   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   793   C0314603:Genetic [Functional Concept]
   793   C1706907:Background [Conceptual Entity]
   737 E C0005615:Birth [Organism Function]
   737 E C0035150:Reproduction [Organism Function]
   737 E C0079946:origin [Classification]
   737 E C0439659:Origin [Temporal Concept]
   737 E C1550512:origin [Intellectual Product]
   737 E C1550722:birth [Idea or Concept]
   737 E C3245487:birth [Intellectual Product]
   710 E C0454729:Natal [Geographic Area]
   710 E C0559522:Genital [Body System]
   710 E C1546649:Genital [Intellectual Product]
   710 E C1550642:Genital [Body Substance]
   700 E C0205313:Original [Idea or Concept]
   700 E C2347409:Original [Occupational Activity]

Phrase: "only 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205171:Only [Quantitative Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "(n=12and n=41respectively) was affected by increased mortality within the first 120days of their post-natal age. In the case of Tg mice with the (C3H/C57/129SvEv/Tac)(129SvEv/Tac) genetic background, only 3(25%"

Phrase: ")"

Phrase: "out of 12mice"

Phrase: "survived until the age of 365days,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0001779:Age [Organism Attribute]
   719   C0310255:SURVIVE [Pharmacologic Substance]

Phrase: "and"

Phrase: "only 17%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205171:Only [Quantitative Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "(25%) out of 12mice survived until the age of 365days, and only 17% (7out of 41"

Phrase: ")"

Phrase: "of the (FVB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517101:FVB [Mammal]

Phrase: ")"

Phrase: "(7out of 41) of the (FVB)(C3H/C57"

Phrase: ")"

Phrase: "Tg mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "reached"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2584321:Reach [Organism Function]

Phrase: "the age of 365days."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0001779:Age [Organism Attribute]
Processing 00000000.tx.166: Although these data suggest significantly increased mortality of TgCRND8 mice as a consequence of a genetic contribution of 129SvEv/Tac or FVB mouse strains, some caveats have to be taken into consideration. 

Phrase: "Although"

Phrase: "these data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "significantly increased mortality of TgCRND8 mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0026565:Mortality [Quantitative Concept]
   753   C0026566:mortality [Quantitative Concept]

Phrase: "as a consequence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0686907:Consequence [Functional Concept]

Phrase: "of a genetic contribution"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1880177:Contribution [Activity]

Phrase: "of 129SvEv/Tac"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1883257:TAC [Therapeutic or Preventive Procedure]
   861   C2962221:TAC [Pharmacologic Substance]
   861   C2986848:TAC [Quantitative Concept]

Phrase: "or"

Phrase: "FVB mouse strains,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   901   C1513684:Mouse Strains [Mammal]
   827   C0080194:Strains [Injury or Poisoning]
   827   C0456178:strains [Intellectual Product]
   793 E C1518614:Strain [Organism]
   793 E C2987481:Strain [Mental Process]
   734   C1517101:FVB Mouse [Mammal]

Phrase: "some caveats"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0871599:Caveat [Governmental or Regulatory Activity]

Phrase: "have"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "taken into consideration."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0518609:consideration [Finding]
   790   C1883727:Taken [Conceptual Entity]
   756 E C1515187:Take [Health Care Activity]
Processing 00000000.tx.167: First, the relatively small sample sizes of the studied cohorts, especially with the 129SvEv/Tac strain, where only a few mice survived for a long period, may not reliably reflect survival rates at later stages of life. 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "the relatively small sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "sizes of the studied cohorts,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0456389:SIZES [Spatial Concept]
   760   C0599755:cohorts [Population Group]

Phrase: "especially with the 129SvEv/Tac strain,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0080194:Strain [Injury or Poisoning]
   753   C0456178:strain [Intellectual Product]
   753   C1518614:Strain [Organism]
   753   C1883257:TAC [Therapeutic or Preventive Procedure]
   753   C2962221:TAC [Pharmacologic Substance]
   753   C2986848:TAC [Quantitative Concept]
   753   C2987481:Strain [Mental Process]

Phrase: "where only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205171:Only [Quantitative Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "a few mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "survived for a long period,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205166:Long [Qualitative Concept]
   760   C0439531:/period [Temporal Concept]
   760   C1706317:Long [Qualitative Concept]
   760   C1948053:Period [Temporal Concept]
   726   C0310255:SURVIVE [Pharmacologic Substance]

Phrase: "may"

Phrase: "not reliably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "survival rates at later stages of life."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0038954:Survival Rates [Quantitative Concept]
   748   C0038952:Survival [Activity]
   748   C0220921:survival [Functional Concept]
   714   C0871208:Rate [Activity]
   714   C1521828:Rate [Quantitative Concept]
Processing 00000000.tx.168: The comparisons of larger cohorts should provide better estimation of survival curves. 

Phrase: "The comparisons of larger cohorts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1707455:Comparison [Activity]

Phrase: "should"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "better estimation of survival curves."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0680844:estimation [Mental Process]
   760   C0681916:Estimation [Quantitative Concept]
   760   C0750572:Estimation [Quantitative Concept]
Processing 00000000.tx.169: Second, future survival censuses must be extended to the pre-weaning developmental stage. 

Phrase: "Second, future survival censuses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0007663:Censuses [Quantitative Concept]

Phrase: "must"

Phrase: "be"

Phrase: "extended to the pre-weaning developmental stage."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   778   C0870411:Developmental Stage [Temporal Concept]
   748   C0043084:Weaning [Organism Function]
   748   C0205390:Stage [Temporal Concept]
   748   C0231448:Extended [Functional Concept]
   748   C0231449:Extended [Spatial Concept]
   748   C0332152:Pre [Temporal Concept]
   748   C0439792:extended [Spatial Concept]
   748   C0458003:Developmental [Qualitative Concept]
   748   C0678723:Developmental [Organism Function]
   748   C0740175:Pre [Qualitative Concept]
   748   C1300072:Stage [Clinical Attribute]
   748   C1306673:Stage [Qualitative Concept]
   748   C2257086:PRE [Genetic Function]
Processing 00000000.tx.170: The selective survival of pups before weaning, or for that matter at the pre-natal stage of development, may cause a bias of a particular cohort entering post-weaning stage. 

Phrase: "The selective survival of pups"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0038952:Survival [Activity]
   760   C0220921:survival [Functional Concept]

Phrase: "before weaning,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043084:Weaning [Organism Function]

Phrase: "or FVB mouse strains, some caveats have to be taken into consideration. First, the relatively small sample sizes of the studied cohorts, especially with the 129SvEv/Tac strain, where only a few mice survived for a long period, may not reliably reflect survival rates at later stages of life. The comparisons of larger cohorts should provide better estimation of survival curves. Second, future survival censuses must be extended to the pre-weaning developmental stage. The selective survival of pups before weaning, or for"

Phrase: "that matter at the pre-natal stage of development,"

Phrase: "may"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "a bias of a particular cohort entering post-weaning stage."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   739   C0242568:Bias [Idea or Concept]
   739   C1504315:Bias [Bird]
   706 E C1061346:Bia [Eukaryote]
   706 E C1704746:BIA [Diagnostic Procedure]
Processing 00000000.tx.171: Also, the genetic composition of the particular outbred TgCRND8 parent might be a greater contributor to the differences in survival among the crosses than the composition of the inbred parent. 

Phrase: "Also,"

Phrase: "the genetic composition of the particular outbred TgCRND8 parent"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0486616:Composition [Clinical Attribute]
   742   C1555710:composition [Idea or Concept]

Phrase: "might"

Phrase: "be"

Phrase: "a greater contributor to the differences"

Phrase: "in survival"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038952:Survival [Activity]
  1000   C0220921:survival [Functional Concept]

Phrase: "among the crosses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2828360:Cross [Conceptual Entity]

Phrase: "than the composition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0486616:Composition [Clinical Attribute]
  1000   C1555710:composition [Idea or Concept]

Phrase: "of the inbred parent."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0030551:parent [Family Group]
   861   C2699423:Parent [Conceptual Entity]
Processing 00000000.tx.172: Nonetheless, the major finding of the survival analysis, that the (C57)(C3H/C57) genetic background significantly reduces mortality in TgCRND8 mice, is in accord with our starting hypothesis. 

Phrase: "Nonetheless,"

Phrase: "the major finding of the survival analysis,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0037088:Finding [Sign or Symptom]
   748   C0243095:Finding [Finding]
   748   C2825141:Finding [Finding]

Phrase: "that"

Phrase: "the (C57"

Phrase: ")"

Phrase: "(C3H/C57) Tg mice reached the age of 365days. Although these data suggest significantly increased mortality of TgCRND8 mice as a consequence of a genetic contribution of 129SvEv/Tac or FVB mouse strains, some caveats have to be taken into consideration. First, the relatively small sample sizes of the studied cohorts, especially with the 129SvEv/Tac strain, where only a few mice survived for a long period, may not reliably reflect survival rates at later stages of life. The comparisons of larger cohorts should provide better estimation of survival curves. Second, future survival censuses must be extended to the pre-weaning developmental stage. The selective survival of pups before weaning, or for that matter at the pre-natal stage of development, may cause a bias of a particular cohort entering post-weaning stage. Also, the genetic composition of the particular outbred TgCRND8 parent might be a greater contributor to the differences in survival among the crosses than the composition of the inbred parent. Nonetheless, the major finding of the survival analysis, that the (C57)(C3H/C57"

Phrase: ")"

Phrase: "genetic background significantly"
Meta Candidates (Total=17; Excluded=14; Pruned=0; Remaining=3)
   827   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   827   C0314603:Genetic [Functional Concept]
   827   C1706907:Background [Conceptual Entity]
   771 E C0005615:Birth [Organism Function]
   771 E C0035150:Reproduction [Organism Function]
   771 E C0079946:origin [Classification]
   771 E C0439659:Origin [Temporal Concept]
   771 E C1550512:origin [Intellectual Product]
   771 E C1550722:birth [Idea or Concept]
   771 E C3245487:birth [Intellectual Product]
   743 E C0454729:Natal [Geographic Area]
   743 E C0559522:Genital [Body System]
   743 E C1546649:Genital [Intellectual Product]
   743 E C1550642:Genital [Body Substance]
   734 E C0205313:Original [Idea or Concept]
   734 E C2347409:Original [Occupational Activity]
   716 E C0598240:originality [Mental Process]

Phrase: "reduces"

Phrase: "mortality in TgCRND8 mice,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0026565:Mortality [Quantitative Concept]
   770   C0026566:mortality [Quantitative Concept]

Phrase: "is in accord"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0680240:accord [Social Behavior]

Phrase: "with our starting hypothesis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1512571:Hypothesis [Idea or Concept]
Processing 00000000.tx.173: Fifty percent of the studied cohort of 52mice survived for a year with minimal mortality observed after the first 3months of age. 

Phrase: "Fifty percent of the studied cohort of 52mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0439165:Percent [Quantitative Concept]

Phrase: "survived for a year"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439234:year [Temporal Concept]
   770   C0439508:/year [Temporal Concept]
   737   C0310255:SURVIVE [Pharmacologic Substance]

Phrase: "with minimal mortality"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026565:Mortality [Quantitative Concept]
   861   C0026566:mortality [Quantitative Concept]

Phrase: "observed after the first 3months of age."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0001779:Age [Organism Attribute]
   748   C0205435:First [Quantitative Concept]
   748   C1279901:First [Qualitative Concept]
   748   C1441672:Observed [Functional Concept]
Processing 00000000.tx.174: As shown in previous investigations, the cause of post-natal lethality was not obvious (22). 

Phrase: "As"

Phrase: "shown in previous investigations,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0205156:Previous [Temporal Concept]
   770   C1261322:Investigations [Health Care Activity]
   770   C1552607:previous [Temporal Concept]
   737   C1547282:Show [Intellectual Product]
   737 E C1552578:investigation [Idea or Concept]

Phrase: "the cause of post-natal lethality"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0015127:cause [Functional Concept]
   753   C1524003:Cause [Conceptual Entity]

Phrase: "was"

Phrase: "not obvious"

Phrase: "(C3H/C57) genetic background significantly reduces mortality in TgCRND8 mice, is in accord with our starting hypothesis. Fifty percent of the studied cohort of 52mice survived for a year with minimal mortality observed after the first 3months of age. As shown in previous investigations, the cause of post-natal lethality was not obvious (22"

Phrase: ") genetic background significantly reduces mortality in TgCRND8 mice, is in accord with our starting hypothesis. Fifty percent of the studied cohort of 52mice survived for a year with minimal mortality observed after the first 3months of age. As shown in previous investigations, the cause of post-natal lethality was not obvious (22)."
Processing 00000000.tx.175: No overt changes were revealed by routine histopathology, although it should be noted that seizures were observed in a small fraction of TgCRND8 animals, and APP transgenes have been correlated with altered vascular responses (37). 

Phrase: "No overt changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "were"

Phrase: "revealed by routine histopathology,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205547:Routine [Qualitative Concept]
   770   C0243140:histopathology [Functional Concept]
   770   C0443289:Revealed [Qualitative Concept]
   770   C0677043:Histopathology [Biomedical Occupation or Discipline]

Phrase: "although"

Phrase: "it"

Phrase: "should"

Phrase: "be"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "that seizures"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0036572:Seizures [Sign or Symptom]
   966 E C1959629:Seizure [Finding]

Phrase: "were"

Phrase: "observed in a small fraction of TgCRND8 animals,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C1264633:Fraction of [Quantitative Concept]
           Fraction
   744   C0003062:Animals [Animal]
   744   C0700321:Small [Quantitative Concept]
   744   C1441672:Observed [Functional Concept]
   744   C1554103:Fraction [Idea or Concept]

Phrase: "and"

Phrase: "APP transgenes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0282641:Transgenes [Gene or Genome]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "have"

Phrase: "been"

Phrase: "correlated with altered vascular responses"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   760   C0005847:vascular [Body Part, Organ, or Organ Component]
   760   C0392747:Altered [Functional Concept]
   760   C0871261:responses [Organism Attribute]
   760   C1558950:VASCULAR [Finding]
   760   C1707520:Correlated [Qualitative Concept]
   760   C1801960:Vascular [Qualitative Concept]
   726 E C1704632:Response [Finding]
   726 E C1706817:Response [Intellectual Product]
   726 E C2911692:Response [Mental Process]
   704 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   704 E C1511228:VESSEL, BLOOD [Tissue]

Phrase: "(22). No overt changes were revealed by routine histopathology, although it should be noted that seizures were observed in a small fraction of TgCRND8 animals, and APP transgenes have been correlated with altered vascular responses (37"

Phrase: "). No overt changes were revealed by routine histopathology, although it should be noted that seizures were observed in a small fraction of TgCRND8 animals, and APP transgenes have been correlated with altered vascular responses (37)."
Processing 00000000.tx.176: Cognitive Changes in TgCRND8 Mice Non-spatial Pre-training-- Partial results related to the impaired acquisition of spatial information, as measured by the escape latency, were reported previously for a small cohort of mice (1). 

Phrase: "Cognitive Changes in TgCRND8 Mice"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C1392786:COGNITIVE CHANGES [Mental or Behavioral Dysfunction]
   760   C0392747:changes [Functional Concept]
   760   C0443172:changes [Quantitative Concept]
   760   C1516691:Cognitive [Functional Concept]
   726 E C1705241:Change [Quantitative Concept]

Phrase: "Non-spatial"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1428114:spatial [Gene or Genome]
   861   C1518422:Non [Functional Concept]

Phrase: "Pre-training"
Meta Candidates (Total=13; Excluded=6; Pruned=0; Remaining=7)
   964   C1709632:Pre-condition [Conceptual Entity]
   861   C0040607:Training [Educational Activity]
   861   C0220931:Training [Educational Activity]
   861   C0332152:Pre [Temporal Concept]
   861   C0740175:Pre [Qualitative Concept]
   861   C2257086:PRE [Genetic Function]
   861   C2673163:training [Qualitative Concept]
   827 E C0336809:Train [Manufactured Object]
   827 E C1552514:Train [Manufactured Object]
   789 E C0009647:Conditioned [Mental Process]
   789 E C0012634:condition [Disease or Syndrome]
   789 E C0348080:Condition [Qualitative Concept]
   789 E C1705253:Condition [Conceptual Entity]

Phrase: "--"

Phrase: "Partial results"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1548163:Partial results [Idea or Concept]
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "related to the impaired acquisition of spatial information,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   767   C0681316:information acquisition [Occupational Activity]
   744   C0221099:Impaired [Functional Concept]
   744   C0439849:Related [Qualitative Concept]
   744   C0445223:Related [Finding]
   744   C0684336:Impaired [Pathologic Function]
   744   C1428114:spatial [Gene or Genome]
   744   C1533716:Information [Idea or Concept]
   744   C1706701:Acquisition [Activity]
   711 E C0163712:Relate [Organic Chemical]

Phrase: "as"

Phrase: "measured by the escape latency,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0444706:Measured [Qualitative Concept]
   760   C0870509:escape [Mental Process]
   760   C1880554:ESCAPE [Event]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]

Phrase: "were"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "previously for a small cohort of mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0025914:Mice [Mammal]
   748   C0025929:mice [Mammal]
   748   C0026809:Mice [Mammal]
   748   C0599755:Cohort [Population Group]
   748   C0700321:Small [Quantitative Concept]

Phrase: "(37). Cognitive Changes in TgCRND8 Mice Non-spatial Pre-training-- Partial results related to the impaired acquisition of spatial information, as measured by the escape latency, were reported previously for a small cohort of mice (1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "). Cognitive Changes in TgCRND8 Mice Non-spatial Pre-training-- Partial results related to the impaired acquisition of spatial information, as measured by the escape latency, were reported previously for a small cohort of mice (1)."
Processing 00000000.tx.177: Here we present a characterization of a larger cohort of mice, and we include their behavioral analysis during NSP. 

Phrase: "Here"

Phrase: "we"

Phrase: "present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "a characterization of a larger cohort of mice,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1880022:Characterization [Activity]

Phrase: "and"

Phrase: "we"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "their behavioral analysis during NSP."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1160858:Behavioral analysis [Health Care Activity]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
Processing 00000000.tx.178: The analysis showed that during NSP at age 10.5weeks TgCRND8 mice performed comparably to non-Tg littermates when randomly searching the pool for a hidden platform. 

Phrase: "The analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that during NSP"

Phrase: "at age 10.5weeks TgCRND8 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "comparably to non-Tg littermates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0003069:Transgenic [Animal]
   760   C1518422:Non [Functional Concept]

Phrase: "when"

Phrase: "randomly"

Phrase: "searching"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1552603:search [Intellectual Product]
   966   C1706202:Search [Activity]

Phrase: "the pool for a hidden platform."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0337051:Pool [Geographic Area]
   753   C1509144:pool [Clinical Attribute]
   753   C2349200:Pool [Functional Concept]
Processing 00000000.tx.179: Escape latencies and lengths of search paths in the last trial of NSP for the groups were not significantly different (50.07.3versus 57.68.8s for latency and 961.1165.0versus 1351247.4cm for path-length, for the non-Tg and Tg mice, respectively). 

Phrase: "Escape latencies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   777   C0205275:Latent [Qualitative Concept]

Phrase: "and"

Phrase: "lengths of search paths"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1444754:Lengths [Quantitative Concept]
   737 E C1706316:LENGTH [Research Activity]

Phrase: "in the last trial"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0008976:Trial [Research Activity]

Phrase: "of NSP"

Phrase: "for the groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1552839:groups [Idea or Concept]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "were"

Phrase: "not significantly different"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1705242:Different [Qualitative Concept]
   755 E C1705241:*Difference [Quantitative Concept]
   727 E C0443199:Differential [Qualitative Concept]

Phrase: "(1). Here we present a characterization of a larger cohort of mice, and we include their behavioral analysis during NSP. The analysis showed that during NSP at age 10.5weeks TgCRND8 mice performed comparably to non-Tg littermates when randomly searching the pool for a hidden platform. Escape latencies and lengths of search paths in the last trial of NSP for the groups were not significantly different (50.07.3versus 57.68.8s for latency"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1552122:8s [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "961.1165.0versus 1351247.4cm for path-length,"

Phrase: "for the non-Tg"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003069:Transgenic [Animal]
   861   C1518422:Non [Functional Concept]

Phrase: "and"

Phrase: "Tg mice,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "respectively"

Phrase: "). Here we present a characterization of a larger cohort of mice, and we include their behavioral analysis during NSP. The analysis showed that during NSP at age 10.5weeks TgCRND8 mice performed comparably to non-Tg littermates when randomly searching the pool for a hidden platform. Escape latencies and lengths of search paths in the last trial of NSP for the groups were not significantly different (50.07.3versus 57.68.8s for latency and 961.1165.0versus 1351247.4cm for path-length, for the non-Tg and Tg mice, respectively)."
Processing 00000000.tx.180: A "visible platform trial" administered during NSP, where the position of the submerged platform was marked by a striped beacon, also failed to reveal differences in performance between non-Tg and Tg groups. 

Phrase: "A ""visible platform trial"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0008976:Trial [Research Activity]

Phrase: "administered during NSP,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1521801:Administered [Functional Concept]
   756 E C1621583:Administer [Functional Concept]

Phrase: "where"

Phrase: "the position of the submerged platform"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0733755:Position [Spatial Concept]

Phrase: "was"

Phrase: "marked by a striped beacon,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0522501:Marked [Qualitative Concept]
   760   C1532935:Striped [Qualitative Concept]
   760   C1706089:Marked [Qualitative Concept]

Phrase: "also"

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "reveal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "differences in performance"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   756   C1705241:*Difference [Quantitative Concept]
   756   C1705242:Difference [Qualitative Concept]
   706 E C0443199:Differential [Qualitative Concept]

Phrase: "between non-Tg"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003069:Transgenic [Animal]
   861   C1518422:Non [Functional Concept]

Phrase: "and"

Phrase: "Tg groups."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]
Processing 00000000.tx.181: Average latencies to reach the cued platform were 9.92.0and 9.11.6s for non-Tg and Tg mice, respectively. 

Phrase: "Average latencies to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   743   C0205275:Latent [Qualitative Concept]

Phrase: "reach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2584321:Reach [Organism Function]

Phrase: "the cued platform"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710360:Platform [Research Device]

Phrase: "were"

Phrase: "9.92.0and 9.11.6s for non-Tg"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1552120:6s [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "Tg mice,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "respectively."
Processing 00000000.tx.182: The swim paths were 167.316.1cm for non-Tg and 153.114.2cm for Tg mice, and both groups had comparable swim speeds of 21.61.4and 20.21.7cm/s for non-Tg and Tg mice, respectively. 

Phrase: "The swim paths"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0919386:PATH [Laboratory Procedure]
   827   C1705483:Path [Intellectual Product]

Phrase: "were"

Phrase: "167.316.1cm for non-Tg"

Phrase: "and"

Phrase: "153.114.2cm for Tg mice,"

Phrase: "and"

Phrase: "both groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1552839:groups [Idea or Concept]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "had"

Phrase: "comparable swim"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039003:Swim [Daily or Recreational Activity]

Phrase: "speeds of 21.61.4and 20.21.7cm/s"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0678536:Speed [Quantitative Concept]

Phrase: "for non-Tg"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003069:Transgenic [Animal]
   861   C1518422:Non [Functional Concept]

Phrase: "and"

Phrase: "Tg mice,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "respectively."
Processing 00000000.tx.183: In conclusion, these analyses showed TgCRND8 mice performed a random search comparable to non-Tg littermates when presented with the submerged platform and had similar swim paths to a visible platform when extra-maze distal spatial cues were occluded by a curtain. 

Phrase: "In conclusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "these analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0002778:Analysis [Laboratory Procedure]
   966   C0936012:Analysis [Research Activity]
   966   C1524024:analysis [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "TgCRND8 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "a random search"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1552603:search [Intellectual Product]
   861   C1706202:Search [Activity]

Phrase: "comparable to non-Tg littermates"

Phrase: "when"

Phrase: "presented with the submerged platform"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0449450:Presented [Idea or Concept]
   760   C1710360:Platform [Research Device]
   726 E C0150312:Present [Quantitative Concept]

Phrase: "and"

Phrase: "had"

Phrase: "similar swim paths to a visible platform"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C0919386:PATH [Laboratory Procedure]
   714   C1705483:Path [Intellectual Product]

Phrase: "when"

Phrase: "extra-maze distal spatial cues"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0010439:Cues [Idea or Concept]

Phrase: "were"

Phrase: "occluded by a curtain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0028778:occluded [Pathologic Function]
   770   C0180239:curtain [Manufactured Object]
   770   C1947917:Occluded [Functional Concept]
Processing 00000000.tx.184: Water Maze, Reference Memory Test-- TgCRND8 mice at 11weeks showed impairment in the acquisition of spatial information during place discrimination training. 

Phrase: "Water Maze,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   861   C0083355:MAZE [Therapeutic or Preventive Procedure]
   861   C0599638:WATER [Substance]
   861   C0870866:maze [Manufactured Object]
   861   C1550678:Water [Inorganic Chemical]
   789 E C0443350:Watery [Qualitative Concept]

Phrase: "Reference Memory Test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0022885:Test [Laboratory Procedure]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]

Phrase: "--"

Phrase: "TgCRND8 mice at 11weeks"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "impairment in the acquisition of spatial information"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0684336:Impairment [Pathologic Function]

Phrase: "during place discrimination training."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0040607:Training [Educational Activity]
   827   C0220931:Training [Educational Activity]
   827   C2673163:training [Qualitative Concept]
Processing 00000000.tx.185: They had significantly longer escape latencies to reach the escape platform (Fig. 3A; F(1,15)=17.98,p<0.001) and longer search paths (F(1,15)=15.91,p<0.001). 

Phrase: "They"

Phrase: "had"

Phrase: "significantly longer escape latencies to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   721   C0205275:Latent [Qualitative Concept]

Phrase: "reach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2584321:Reach [Organism Function]

Phrase: "the escape platform"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710360:Platform [Research Device]

Phrase: "(50.07.3versus 57.68.8s for latency and 961.1165.0versus 1351247.4cm for path-length, for the non-Tg and Tg mice, respectively). A ""visible platform trial"" administered during NSP, where the position of the submerged platform was marked by a striped beacon, also failed to reveal differences in performance between non-Tg and Tg groups. Average latencies to reach the cued platform were 9.92.0and 9.11.6s for non-Tg and Tg mice, respectively. The swim paths were 167.316.1cm for non-Tg and 153.114.2cm for Tg mice, and both groups had comparable swim speeds of 21.61.4and 20.21.7cm/s for non-Tg and Tg mice, respectively. In conclusion, these analyses showed TgCRND8 mice performed a random search comparable to non-Tg littermates when presented with the submerged platform and had similar swim paths to a visible platform when extra-maze distal spatial cues were occluded by a curtain. Water Maze, Reference Memory Test-- TgCRND8 mice at 11weeks showed impairment in the acquisition of spatial information during place discrimination training. They had significantly longer escape latencies to reach the escape platform (Fig. 3A"

Phrase: "; F(1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "15"

Phrase: ")"

Phrase: "=17.98,"

Phrase: "p<0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "longer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0205166:Long [Qualitative Concept]
   966   C1706317:Long [Qualitative Concept]

Phrase: "search"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552603:search [Intellectual Product]
  1000   C1706202:Search [Activity]

Phrase: "paths"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0919386:PATH [Laboratory Procedure]
   966   C1705483:Path [Intellectual Product]

Phrase: "(Fig. 3A; F(1,15)=17.98,p<0.001) and longer search paths (F(1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "15"

Phrase: ")"

Phrase: "=15.91,"

Phrase: "p<0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")=15.91,p<0.001)."
Processing 00000000.tx.186: Both, Tg and non-Tg groups significantly improved during training (F(4,60)=3.29,p<0.02; F(4,60)=3.33,p<0.02,the latency and path, respectively), and no significant interaction between the groups and sessions was found in both measures. 

Phrase: "Both,"

Phrase: "Tg"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003069:Transgenic [Animal]

Phrase: "and"

Phrase: "non-Tg groups significantly"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0441833:Group [Idea or Concept]
   812   C0687744:group [Population Group]
   812   C1257890:Group [Population Group]
   812   C1552516:Group [Health Care Related Organization]
   812   C1552839:groups [Idea or Concept]
   812   C1705428:Group [Conceptual Entity]
   812   C1705429:Group [Population Group]

Phrase: "improved during training"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0040607:Training [Educational Activity]
   790   C0184511:Improved [Qualitative Concept]
   790   C0220931:Training [Educational Activity]
   790   C0332272:Improved [Qualitative Concept]
   790   C1561611:Improved [Intellectual Product]
   790   C2673163:training [Qualitative Concept]

Phrase: "(F(1,15)=15.91,p<0.001). Both, Tg and non-Tg groups significantly improved during training (F(4,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0602385:F 4 [Organic Chemical,Pharmacologic Substance]
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "60"

Phrase: ")"

Phrase: "=3.29,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]

Phrase: "p<0.02"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "; F(4,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0602385:F 4 [Organic Chemical,Pharmacologic Substance]
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "60"

Phrase: ")"

Phrase: "=3.33,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]

Phrase: "p<0.02,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "the latency"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0205275:Latent [Qualitative Concept]

Phrase: "and"

Phrase: "path,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0919386:PATH [Laboratory Procedure]
  1000   C1705483:Path [Intellectual Product]

Phrase: "respectively"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "no significant interaction between the groups"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "sessions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1883016:Session [Event]
   966   C1883017:Session [Conceptual Entity]

Phrase: "was"

Phrase: "found in both measures."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0079809:Measures [Quantitative Concept]
   770   C0150312:Found [Quantitative Concept]
   770   C1879489:Measures [Functional Concept]
   737 E C0242485:Measure [Functional Concept]
   737 E C0243095:Find [Finding]
Processing 00000000.tx.187: The concordance between measures of latency and search path is not surprising, because the TgCRND8 mice did not differ significantly from the non-Tg littermates in their swim speed during the test (F(1,15)=2.53,p>0.05). 

Phrase: "The concordance between measures of latency"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0680240:concordance [Social Behavior]

Phrase: "and"

Phrase: "search path"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0919386:PATH [Laboratory Procedure]
   861   C1705483:Path [Intellectual Product]

Phrase: "is"

Phrase: "not surprising,"

Phrase: "because"

Phrase: "the TgCRND8 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "differ"

Phrase: "significantly from the non-Tg littermates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0003069:Transgenic [Animal]
   753   C1518422:Non [Functional Concept]

Phrase: "in their swim speed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678536:Speed [Quantitative Concept]

Phrase: "during the test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "(F(4,60)=3.29,p<0.02; F(4,60)=3.33,p<0.02,the latency and path, respectively), and no significant interaction between the groups and sessions was found in both measures. The concordance between measures of latency and search path is not surprising, because the TgCRND8 mice did not differ significantly from the non-Tg littermates in their swim speed during the test (F(1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "15"

Phrase: ")"

Phrase: "=2.53,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "p>0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")=2.53,p>0.05)."
Processing 00000000.tx.188: The pronounced spatial learning impairment of Tg mice was confirmed during the probe trial administered after the completion of training. 

Phrase: "The pronounced spatial learning impairment of Tg mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0684336:Impairment [Pathologic Function]

Phrase: "was"

Phrase: "confirmed during the probe trial"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   760   C0008976:Trial [Research Activity]
   760   C0182400:Probe [Medical Device]
   760   C0521093:confirmed [Qualitative Concept]
   760   C0750484:Confirmed [Idea or Concept]
   760   C1704681:Probe [Gene or Genome]
   760   C2347609:Probe [Chemical Viewed Functionally]
   760   C3536729:Probe [Manufactured Object]
   726 E C1456348:Confirm [Qualitative Concept]

Phrase: "administered after the completion of training."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0040607:Training [Educational Activity]
   753   C0205197:Completion [Qualitative Concept]
   753   C0220931:Training [Educational Activity]
   753   C1521801:Administered [Functional Concept]
   753   C1554962:completion [Qualitative Concept]
   753   C2673163:training [Qualitative Concept]
   719 E C1621583:Administer [Functional Concept]
Processing 00000000.tx.189: They showed lower (t(15)=2.99,p=0.01) annulus crossing index (Fig. 3B), searching the pool in a circular fashion and frequently crossing the centers of alternative quadrants (with an annulus crossing index approaching a zero value). 

Phrase: "They"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "(F(1,15)=2.53,p>0.05). The pronounced spatial learning impairment of Tg mice was confirmed during the probe trial administered after the completion of training. They showed lower (t(15"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: ")"

Phrase: "=2.99,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "p=0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "annulus crossing index"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0918012:Index [Intellectual Product]
   827   C1552854:index [Idea or Concept]
   827   C1637833:% index [Quantitative Concept]

Phrase: "(t(15)=2.99,p=0.01) annulus crossing index (Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")"

Phrase: ","

Phrase: "searching"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1552603:search [Intellectual Product]
   966   C1706202:Search [Activity]

Phrase: "the pool in a circular fashion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0337051:Pool [Geographic Area]
   753   C1509144:pool [Clinical Attribute]
   753   C2349200:Pool [Functional Concept]

Phrase: "and"

Phrase: "frequently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332183:Frequently [Temporal Concept]

Phrase: "crossing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2828360:Cross [Conceptual Entity]

Phrase: "the centers of alternative quadrants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205099:centers [Spatial Concept]

Phrase: "("

Phrase: "with an annulus crossing index"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0918012:Index [Intellectual Product]
   827   C1552854:index [Idea or Concept]
   827   C1637833:% index [Quantitative Concept]

Phrase: "approaching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449445:approaching [Spatial Concept]

Phrase: "a zero value"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1522609:Value [Quantitative Concept]

Phrase: "), searching the pool in a circular fashion and frequently crossing the centers of alternative quadrants (with an annulus crossing index approaching a zero value)."
Processing 00000000.tx.190: View larger version (15K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(with an annulus crossing index approaching a zero value). View larger version (15K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.191: 3.  

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.192: Reference memory version of Morris water maze test in TgCRND8 mice. 

Phrase: "Reference memory version of Morris water maze test"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0333052:Version [Functional Concept]
   744   C2607870:Version [Spatial Concept]

Phrase: "in TgCRND8 mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
Processing 00000000.tx.193: A, at 11weeks of age, experimentally naive TgCRND8 mice (NTg=10) show significant impairment in the acquisition of the spatial information relative to their non-Tg littermates (Nnon-Tg=7). 

Phrase: "A,"

Phrase: "at 11weeks"

Phrase: "of age,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "experimentally naive TgCRND8 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "(15K): [in this window] [in a new window]  Fig. 3.  Reference memory version of Morris water maze test in TgCRND8 mice. A, at 11weeks of age, experimentally naive TgCRND8 mice (NTg=10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1417953:NTG [Gene or Genome]
   861   C1847730:NTG [Finding]

Phrase: ")"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "significant impairment in the acquisition of the spatial information"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0684336:Impairment [Pathologic Function]

Phrase: "relative to their non-Tg littermates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0080103:Relative [Family Group]
   753   C0205345:Relative [Qualitative Concept]
   753   C1547039:*Relative [Quantitative Concept]

Phrase: "(NTg=10) show significant impairment in the acquisition of the spatial information relative to their non-Tg littermates (Nnon-Tg"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003069:Transgenic [Animal]

Phrase: "=7"

Phrase: ") show significant impairment in the acquisition of the spatial information relative to their non-Tg littermates (Nnon-Tg=7)."
Processing 00000000.tx.194: B, represents an annulus crossing index (the number of passes over the platform site in TQ, minus the mean of passes over alternative sites in other quadrants) during the probe trial administered after the last training trial of day 5.A positive index indicates selective focal search of the previous platform position, an index approximating zero reflects non-spatial or circular search of the pool. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "an annulus crossing index"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0918012:Index [Intellectual Product]
   827   C1552854:index [Idea or Concept]
   827   C1637833:% index [Quantitative Concept]

Phrase: "("

Phrase: "the number of passes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "over the platform site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "in TQ,"

Phrase: "minus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332288:Minus [Qualitative Concept]

Phrase: "the mean of passes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0444504:Mean [Quantitative Concept]
   770   C2347634:Mean [Quantitative Concept]
   770   C2348143:Mean [Quantitative Concept]

Phrase: "over alternative sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]

Phrase: "in other quadrants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1631280:Quadrant [Spatial Concept]

Phrase: ")"

Phrase: "during the probe trial"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0008976:Trial [Research Activity]

Phrase: "administered after the last training trial of day 5."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   742   C0008976:Trial [Research Activity]
   742   C0040607:Training [Educational Activity]
   742   C0220931:Training [Educational Activity]
   742   C0332173:/day [Temporal Concept]
   742   C0439228:day [Temporal Concept]
   742   C0439505:/day [Temporal Concept]
   742   C1521801:Administered [Functional Concept]
   742   C2673163:training [Qualitative Concept]
   708 E C0336809:Train [Manufactured Object]
   708 E C1552514:Train [Manufactured Object]
   708 E C1621583:Administer [Functional Concept]

Phrase: "A positive index"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0918012:Index [Intellectual Product]
   861   C1552854:index [Idea or Concept]
   861   C1637833:% index [Quantitative Concept]

Phrase: "indicates"

Phrase: "selective focal search of the previous platform position,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1552603:search [Intellectual Product]
   744   C1706202:Search [Activity]

Phrase: "an index approximating zero"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0919414:Zero [Quantitative Concept]

Phrase: "reflects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "non-spatial"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1428114:spatial [Gene or Genome]
   861   C1518422:Non [Functional Concept]

Phrase: "or"

Phrase: "circular search of the pool."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1552603:search [Intellectual Product]
   760   C1706202:Search [Activity]
Processing 00000000.tx.195: The TgCRND8 mice showed a significantly impaired (p<0.01) spatial bias for the platform position as compared with their non-Tg littermates. 

Phrase: "The TgCRND8 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a significantly"

Phrase: "impaired"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0221099:Impaired [Functional Concept]
  1000   C0684336:Impaired [Pathologic Function]

Phrase: "(the number of passes over the platform site in TQ, minus the mean of passes over alternative sites in other quadrants) during the probe trial administered after the last training trial of day 5.A positive index indicates selective focal search of the previous platform position, an index approximating zero reflects non-spatial or circular search of the pool. The TgCRND8 mice showed a significantly impaired (p<0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "spatial bias for the platform position"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0242568:Bias [Idea or Concept]
   753   C1504315:Bias [Bird]
   719 E C1061346:Bia [Eukaryote]
   719 E C1704746:BIA [Diagnostic Procedure]

Phrase: "as"

Phrase: "compared with their non-Tg littermates."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0003069:Transgenic [Animal]
   753   C1518422:Non [Functional Concept]
   753   C1707455:Compared [Activity]
Processing 00000000.tx.196: *, p<0.01.

Phrase: "*,"

Phrase: "p<0.01."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.197: Vertical bars represent S.E. 

Phrase: "Vertical bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "S."

Phrase: "E."
Processing 00000000.tx.198: Neuropathology in TgCRND8 Mice TgCRND6 mice expressing the Swedish mutant form of APP (see Fig. 1) on a B6C3H background failed to exhibit cerebral amyloid at ages up to 450days. 

Phrase: "Neuropathology in TgCRND8 Mice TgCRND6 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0876934:Neuropathology [Biomedical Occupation or Discipline]
   753   C1540677:neuropathology [Pathologic Function]
   753   C1555824:Neuropathology [Intellectual Product]

Phrase: "expressing"

Phrase: "the Swedish mutant form of APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0348078:Form [Qualitative Concept]
   744   C0376315:Form [Manufactured Object]
   744   C1522492:Form [Functional Concept]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "on a B6C3H background"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1706907:Background [Conceptual Entity]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "cerebral amyloid at ages"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0011560:Amyloid [Pathologic Function]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "up to 450days."
Processing 00000000.tx.199: Similar results were obtained for two other Tg lines resulting from the microinjection of the same DNA construct into a FVB/N129SvEv/Tac background (not shown). 

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained for two"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0205448:Two [Quantitative Concept]
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "other Tg lines"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0003069:Transgenic [Animal]
   861   C0205132:lines [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "resulting from the microinjection of the same DNA construct"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   764   C0012931:DNA Construct [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0025991:Microinjection [Therapeutic or Preventive Procedure]
   742   C0445247:Same [Qualitative Concept]
   742   C0678226:resulting [Functional Concept]
   742   C2827421:Construct [Classification]
   708 E C1274040:Result [Functional Concept]
   708 E C1546471:Result [Idea or Concept]
   708 E C2825142:Result [Finding]

Phrase: "into a FVB/N129SvEv/Tac background"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1706907:Background [Conceptual Entity]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ") on a B6C3H background failed to exhibit cerebral amyloid at ages up to 450days. Similar results were obtained for two other Tg lines resulting from the microinjection of the same DNA construct into a FVB/N129SvEv/Tac background (not shown)."
Processing 00000000.tx.200: On the other hand, hemizygous TgCRND8 mice expressing the double mutant form of APP exhibited potent deposition of cerebral amyloid, present in all animals by 90days of age. 

Phrase: "On the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "hemizygous TgCRND8 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "expressing"

Phrase: "the double mutant form of APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0348078:Form [Qualitative Concept]
   744   C0376315:Form [Manufactured Object]
   744   C1522492:Form [Functional Concept]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "potent deposition of cerebral amyloid,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0011560:Amyloid deposition [Pathologic Function]
   797   C1705760:Amyloid Deposition [Finding]
   760   C0333562:Deposition [Functional Concept]

Phrase: "present in all animals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "by 90days"

Phrase: "of age."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]
Processing 00000000.tx.201: In contrast to PDAPP mice expressing a V717F APP transgene (21), no difference in the volume of the dorsal hippocampus (or in the surrounding regions) was detected between Tg and non-Tg mice (p<0.05for all values). 

Phrase: "In contrast to PDAPP mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "expressing"

Phrase: "a V717F APP transgene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0282641:Transgene [Gene or Genome]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "(not shown). On the other hand, hemizygous TgCRND8 mice expressing the double mutant form of APP exhibited potent deposition of cerebral amyloid, present in all animals by 90days of age. In contrast to PDAPP mice expressing a V717F APP transgene (21"

Phrase: ")"

Phrase: ","

Phrase: "no difference in the volume of the dorsal hippocampus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1705241:*Difference [Quantitative Concept]
   742   C1705242:Difference [Qualitative Concept]

Phrase: "("

Phrase: "or circular search of the pool. The TgCRND8 mice showed a significantly impaired (p<0.01) spatial bias for the platform position as compared with their non-Tg littermates. *, p<0.01.Vertical bars represent S.E. Neuropathology in TgCRND8 Mice TgCRND6 mice expressing the Swedish mutant form of APP (see Fig. 1) on a B6C3H background failed to exhibit cerebral amyloid at ages up to 450days. Similar results were obtained for two other Tg lines resulting from the microinjection of the same DNA construct into a FVB/N129SvEv/Tac background (not shown). On the other hand, hemizygous TgCRND8 mice expressing the double mutant form of APP exhibited potent deposition of cerebral amyloid, present in all animals by 90days of age. In contrast to PDAPP mice expressing a V717F APP transgene (21), no difference in the volume of the dorsal hippocampus (or in the surrounding regions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1282914:Surrounding [Spatial Concept]
   726   C0017446:Region [Geographic Area]
   726   C0205147:Region [Spatial Concept]

Phrase: ")"

Phrase: "was"

Phrase: "detected between Tg"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0003069:Transgenic [Animal]
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "non-Tg mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0025936:Mice, Transgenic [Mammal]
   896   C1513853:NON Mouse [Mammal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "(or in the surrounding regions) was detected between Tg and non-Tg mice (p<0.05for"

Phrase: "all values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: ") was detected between Tg and non-Tg mice (p<0.05for all values)."
Processing 00000000.tx.202: In TgCRND8 mice, the dorsal hippocampus occupied ~11.00.3% of the volume of coronal sections (meansS.E. of the mean), whereas in the non-Tg mice this value was 10.30.2%. 

Phrase: "In TgCRND8 mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "the dorsal hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   861   C0949582:Hippocampus [Fish]
   861   C1029104:Hippocampus [Fish]
   861   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "occupied"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1548223:Occupied [Idea or Concept]

Phrase: "~11.00.3% of the volume of coronal sections"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   742   C0205123:Coronal [Spatial Concept]
   742   C0449468:*Volume [Quantitative Concept]
   742   C1690016:% volume [Qualitative Concept]
   742   C1705102:Volume [Intellectual Product]
   742   C2700258:Volume [Laboratory Procedure]
   708   C0205155:Section [Spatial Concept]
   708   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   708   C1522472:Section [Substance]
   708   C1552923:Section [Quantitative Concept]
   708   C1705191:Section [Physical Object]

Phrase: "(p<0.05for all values). In TgCRND8 mice, the dorsal hippocampus occupied ~11.00.3% of the volume of coronal sections (meansS.E."

Phrase: "of the mean"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444504:Mean [Quantitative Concept]
  1000   C2347634:Mean [Quantitative Concept]
  1000   C2348143:Mean [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "whereas in the non-Tg mice"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0025936:Mice, Transgenic [Mammal]
   767   C1513853:NON Mouse [Mammal]
   753   C0003069:Transgenic [Animal]
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C1518422:Non [Functional Concept]

Phrase: "this value"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522609:Value [Quantitative Concept]

Phrase: "was"

Phrase: "10.30.2%."
Processing 00000000.tx.203: Also, the neuronal cytoarchitecture of the TgCRND8 mice appeared normal. 

Phrase: "Also,"

Phrase: "the neuronal cytoarchitecture of the TgCRND8 mice"

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "normal."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]
Processing 00000000.tx.204: Amyloid deposits in TgCRND8 mice were successfully stained with A42-specific antibodies, as anticipated from prior studies of the mechanism of action of the V717F mutation (5). 

Phrase: "Amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "deposits in TgCRND8 mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C0333562:Deposit [Functional Concept]

Phrase: "were"

Phrase: "successfully"

Phrase: "stained with A42-specific antibodies,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0205369:Specific [Qualitative Concept]
   760   C1552740:specific [Intellectual Product]
   760   C2986582:Stained [Qualitative Concept]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "as"

Phrase: "anticipated from prior studies of the mechanism of action of the V717F mutation"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   762   C0031327:mechanism of action [Physiologic Function]
   762   C1524059:mechanism of action [Functional Concept]
   735   C0026882:Mutation [Genetic Function]
   735   C0332152:Prior [Temporal Concept]
   735   C0441472:Action [Functional Concept]
   735   C0441712:Mechanism [Functional Concept]
   735   C0947630:studies [Laboratory Procedure]
   735   C1705285:Mutation [Cell or Molecular Dysfunction]
   735   C1706376:Mechanism [Manufactured Object]
   735   C2826257:PRIOR [Event]
   735   C3266814:Action [Activity]
   732   C2986485:Action Study [Research Activity]
   713   C2698671:MECHANISTIC STUDIES [Regulation or Law]
   702 E C0557651:Study [Manufactured Object]
   702 E C2603343:Study [Research Activity]

Phrase: "(meansS.E. of the mean), whereas in the non-Tg mice this value was 10.30.2%. Also, the neuronal cytoarchitecture of the TgCRND8 mice appeared normal. Amyloid deposits in TgCRND8 mice were successfully stained with A42-specific antibodies, as anticipated from prior studies of the mechanism of action of the V717F mutation (5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "), whereas in the non-Tg mice this value was 10.30.2%. Also, the neuronal cytoarchitecture of the TgCRND8 mice appeared normal. Amyloid deposits in TgCRND8 mice were successfully stained with A42-specific antibodies, as anticipated from prior studies of the mechanism of action of the V717F mutation (5)."
Processing 00000000.tx.205: In addition to confirming dense-cored deposits in aged TgCRND8 mice, the human APP-specific monoclonal antibody 4G8, and to a lesser extent monoclonal antibody 6F/3D, also detected diffuse immuno-staining in the neuropil (using formic acid-treated sections: Fig. 

Phrase: "In addition to confirming dense-cored deposits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0333562:Deposits [Functional Concept]

Phrase: "in aged TgCRND8 mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "the human APP-specific monoclonal antibody 4G8,"

Phrase: "and to a lesser extent monoclonal antibody 6F/3D, also"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   739   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   739   C0439792:Extent [Spatial Concept]
   739   C0450363:3D [Spatial Concept]
   739   C0547044:Lesser [Qualitative Concept]
   739   C0746619:monoclonal [Finding]
   739   C1515981:And [Idea or Concept]
   739   C2986797:3D [Functional Concept]

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "diffuse immuno-staining in the neuropil"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0487602:Staining [Laboratory Procedure]
   753   C1704680:Staining [Finding]
   719 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "("

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "formic acid-treated sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   779   C0205155:Section [Spatial Concept]
   779   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   779   C1522472:Section [Substance]
   779   C1552923:Section [Quantitative Concept]
   779   C1705191:Section [Physical Object]

Phrase: ":"

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.206: 4B). 

Phrase: "4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450375:4b [Intellectual Product]

Phrase: "). In addition to confirming dense-cored deposits in aged TgCRND8 mice, the human APP-specific monoclonal antibody 4G8, and to a lesser extent monoclonal antibody 6F/3D, also detected diffuse immuno-staining in the neuropil (using formic acid-treated sections: Fig. 4B)."
Processing 00000000.tx.207: These findings were compatible with both the previously described specificity of the 4G8 antibody (42, 43), and the propensity of other mice expressing APP codon 717mutations to generate "diffuse" amyloid deposits (19, 21, 23). 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "were"

Phrase: "compatible with both"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332290:compatible [Idea or Concept]
   790   C1524057:Compatible [Qualitative Concept]

Phrase: "the previously described specificity of the 4G8 antibody"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   767   C0003264:Antibody Specificity [Molecular Function]
   744   C0037791:Specificity [Quantitative Concept]
   744   C1511884:Specificity [Quantitative Concept]
   731 E C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(using formic acid-treated sections: Fig. 4B). These findings were compatible with both the previously described specificity of the 4G8 antibody (42,"

Phrase: "43"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the propensity of other mice"

Phrase: "expressing"

Phrase: "APP codon 717mutations to"

Phrase: "generate"

Phrase: """"

Phrase: "diffuse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205219:Diffuse [Qualitative Concept]

Phrase: """ amyloid deposits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2936349:Amyloid Deposits [Acquired Abnormality]
   861   C0333562:Deposits [Functional Concept]

Phrase: "(42, 43), and the propensity of other mice expressing APP codon 717mutations to generate ""diffuse"" amyloid deposits (19,"

Phrase: "21,"

Phrase: "23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "), and the propensity of other mice expressing APP codon 717mutations to generate ""diffuse"" amyloid deposits (19, 21, 23)."
Processing 00000000.tx.208: Although human APP was also expressed systemically in TgCRND8 mice, in accord with the tropism of the PrP gene promoter (44), amyloid deposits were not apparent by immunostaining in the kidney, lung, skeletal, and cardiac muscle of aged animals (not shown). 

Phrase: "Although"

Phrase: "human APP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   902   C1142652:human protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "was"

Phrase: "also"

Phrase: "expressed"

Phrase: "systemically in TgCRND8 mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]

Phrase: "in accord"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680240:accord [Social Behavior]

Phrase: "with the tropism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242732:Tropism [Physiologic Function]

Phrase: "of the PrP gene promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(19, 21, 23). Although human APP was also expressed systemically in TgCRND8 mice, in accord with the tropism of the PrP gene promoter (44"

Phrase: ")"

Phrase: ","

Phrase: "amyloid deposits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2936349:Amyloid Deposits [Acquired Abnormality]
   861   C0333562:Deposits [Functional Concept]

Phrase: "were"

Phrase: "not apparent by immunostaining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0750489:apparent [Idea or Concept]

Phrase: "in the kidney,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0022646:Kidney [Body Part, Organ, or Organ Component]
  1000   C0227665:kidney [Body Part, Organ, or Organ Component]
  1000   C1278978:Kidney [Body Part, Organ, or Organ Component]
  1000   C1514845:KIDNEY [Tissue]
   907 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "lung,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0024109:Lung [Body Part, Organ, or Organ Component]
  1000   C0819757:LUNG [Tissue]
  1000   C1278908:Lung [Body Part, Organ, or Organ Component]
   944 E C2707265:Pulmonary [Clinical Attribute]
   944 E C2709248:Pulmonary [Qualitative Concept]
   907 E C0032285:Pneumonia [Disease or Syndrome]

Phrase: "skeletal,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0037253:skeletal [Body System]
  1000   C0521324:Skeletal [Spatial Concept]

Phrase: "and"

Phrase: "cardiac muscle of aged animals"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0027061:Muscle, Cardiac [Tissue]
   760   C0018787:Cardiac [Body Part, Organ, or Organ Component]
   760   C0026845:Muscle [Tissue]
   760   C1522601:Cardiac [Spatial Concept]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "), amyloid deposits were not apparent by immunostaining in the kidney, lung, skeletal, and cardiac muscle of aged animals (not shown)."
Processing 00000000.tx.209: These observations suggest a role for tissue-specific factors affecting amyloid deposition and/or APP processing. 

Phrase: "These observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a role for tissue-specific factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "affecting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affecting [Functional Concept]
  1000   C1314939:Affecting [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "amyloid deposition"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011560:Amyloid deposition [Pathologic Function]
  1000   C1705760:Amyloid Deposition [Finding]
   861   C0333562:Deposition [Functional Concept]

Phrase: "and/or"

Phrase: "APP processing."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0033666:protein processing [Molecular Function]
   812   C1709694:Processing [Activity]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.210: View larger version (124K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(not shown). These observations suggest a role for tissue-specific factors affecting amyloid deposition and/or APP processing. View larger version (124K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.211: 4.  

Phrase: "4."
Processing 00000000.tx.212: Properties of amyloid deposits from TgCRND8 mice. 

Phrase: "Properties of amyloid"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0871161:properties [Qualitative Concept]
   790   C1292721:properties [Functional Concept]
   756 E C1882134:Property [Conceptual Entity]
   756 E C2347695:Property [Entity]

Phrase: "deposits from TgCRND8 mice."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C0333562:Deposit [Functional Concept]
Processing 00000000.tx.213: A, sagittal section of an 8-month-old TgCRND8 mouse immunostained with 4G8 anti-A antibody: Cer, cerebellum; 

Phrase: "A,"

Phrase: "sagittal section of an 8-month-old TgCRND8 mouse"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   742   C0205129:Sagittal [Spatial Concept]
   742   C0205155:Section [Spatial Concept]
   742   C0935598:Sagittal [Body Location or Region]
   742   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   742   C1522472:Section [Substance]
   742   C1552923:Section [Quantitative Concept]
   742   C1705191:Section [Physical Object]

Phrase: "immunostained with 4G8 anti-A antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0432616:Anti A [Amino Acid, Peptide, or Protein,Immunologic Factor]
   783   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: ":"

Phrase: "Cer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237504:CER [Intellectual Product]

Phrase: "cerebellum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1268981:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1707522:Cerebellum [Tissue]

Phrase: ";"
Processing 00000000.tx.214: HPC, hippocampus; 

Phrase: "HPC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0238339:HPC [Disease or Syndrome]

Phrase: "hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: ";"
Processing 00000000.tx.215: N, neocortex; 

Phrase: "N,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "neocortex"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0175173:Neocortex [Body Part, Organ, or Organ Component]

Phrase: ";"
Processing 00000000.tx.216: OB, olfactory bulb. 

Phrase: "OB,"

Phrase: "olfactory bulb."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0028936:Olfactory Bulb [Body Part, Organ, or Organ Component]
  1000   C1281094:Olfactory bulb [Body Part, Organ, or Organ Component]
   861   C0025148:Bulb [Body Part, Organ, or Organ Component]
   861   C0037361:olfactory [Organism Function]
   861   C0439826:Olfactory [Organism Function]
   861   C1449865:Bulb [Plant]
   861   C1947952:Bulb [Anatomical Structure]
Processing 00000000.tx.217: B, dentate gyrus (400magnification) in a 12-month-old TgCRND8 mouse immunostained with 6F/3D antibody and illustrating different varieties of amyloid deposits: dense-cored (red arrow), multicored (gray arrow), and diffuse (black arrow). 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "dentate gyrus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0152314:Dentate Gyrus [Body Part, Organ, or Organ Component]
  1000   C1281026:Dentate gyrus [Body Part, Organ, or Organ Component]

Phrase: "(124K): [in this window] [in a new window]  Fig. 4.  Properties of amyloid deposits from TgCRND8 mice. A, sagittal section of an 8-month-old TgCRND8 mouse immunostained with 4G8 anti-A antibody: Cer, cerebellum; HPC, hippocampus; N, neocortex; OB, olfactory bulb. B, dentate gyrus (400magnification"

Phrase: ")"

Phrase: "in a 12-month-old TgCRND8 mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025914:Mouse [Mammal]
   804   C0025929:mouse [Mammal]
   804   C0026809:Mouse [Mammal]

Phrase: "immunostained with 6F/3D antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0450363:3D [Spatial Concept]
   760   C2986797:3D [Functional Concept]

Phrase: "and"

Phrase: "illustrating different varieties of amyloid deposits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1883525:Variety [Conceptual Entity]
   719   C2346866:Variety [Conceptual Entity]

Phrase: ":"

Phrase: "dense-cored"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0444669:Core [Spatial Concept]
   827   C1167518:core [Cell Component]
   827   C1706352:Core [Medical Device]
   827   C1882467:Core [Manufactured Object]
   827   C3274653:Core [Body Substance]

Phrase: "(400magnification) in a 12-month-old TgCRND8 mouse immunostained with 6F/3D antibody and illustrating different varieties of amyloid deposits: dense-cored (red arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0336721:Arrow [Manufactured Object]

Phrase: ")"

Phrase: ","

Phrase: "multicored"

Phrase: "(red arrow), multicored (gray arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0336721:Arrow [Manufactured Object]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "diffuse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205219:Diffuse [Qualitative Concept]

Phrase: "(gray arrow), and diffuse (black arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0336721:Arrow [Manufactured Object]

Phrase: "), and diffuse (black arrow)."
Processing 00000000.tx.218: C-K illustrate the tinctorial and immunostaining profiles of amyloid deposits in a 5.5-month-old TgCRND8 mice (400magnification). 

Phrase: "C-K"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "illustrate"

Phrase: "the tinctorial"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   944   C0487602:Staining [Laboratory Procedure]
   944   C1704680:Staining [Finding]

Phrase: "and"

Phrase: "immunostaining profiles of amyloid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1979963:Profile [Laboratory Procedure]
   737   C2003903:Profile [Functional Concept]

Phrase: "deposits in a 5.5-month-old TgCRND8 mice"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   742   C0025914:Mice [Mammal]
   742   C0025929:mice [Mammal]
   742   C0026809:Mice [Mammal]
   742   C0333562:Deposit [Functional Concept]
   742   C0439231:month [Temporal Concept]
   742   C0439507:/month [Temporal Concept]
   742   C0580836:Old [Temporal Concept]

Phrase: "(black arrow). C-K illustrate the tinctorial and immunostaining profiles of amyloid deposits in a 5.5-month-old TgCRND8 mice (400magnification"

Phrase: "). C-K illustrate the tinctorial and immunostaining profiles of amyloid deposits in a 5.5-month-old TgCRND8 mice (400magnification)."
Processing 00000000.tx.219: C, staining with Congo Red showed typical apple green and orange birefringence with a polarized light source. 

Phrase: "C,"

Phrase: "staining with Congo Red"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   881   C0009742:congo red staining [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           Congo Red
   881   C1293958:congo red staining [Laboratory Procedure]
   770   C0009738:Congo [Geographic Area]
   770   C0332575:Red [Finding]
   770   C0487602:Staining [Laboratory Procedure]
   770   C1260956:Red [Qualitative Concept]
   770   C1704680:Staining [Finding]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "typical apple green"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0003625:Apple [Plant]
   827   C0332583:Green [Qualitative Concept]
   827   C0475653:APPLE [Food]
   827   C1095830:Apple [Food]
   827   C3257517:apple [Pharmacologic Substance]

Phrase: "and"

Phrase: "orange birefringence with a polarized light source."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0005597:Birefringence [Natural Phenomenon or Process]
Processing 00000000.tx.220: D, perivascular amyloid stained with thioflavine S (white arrows). 

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "perivascular amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "stained with thioflavine"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0950261:thioflavine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   790   C2986582:Stained [Qualitative Concept]
   756 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "S ("

Phrase: "white arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0336721:arrows [Manufactured Object]

Phrase: "). C, staining with Congo Red showed typical apple green and orange birefringence with a polarized light source. D, perivascular amyloid stained with thioflavine S (white arrows)."
Processing 00000000.tx.221: Bielschowsky stain (E) and NF-200 (F) reveal dystrophic neurites (arrows) adjacent to plaques (P). 

Phrase: "Bielschowsky stain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1293957:Bielschowsky's stain [Laboratory Procedure]
   861   C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(400magnification). C, staining with Congo Red showed typical apple green and orange birefringence with a polarized light source. D, perivascular amyloid stained with thioflavine S (white arrows). Bielschowsky stain (E)"

Phrase: "and"

Phrase: "NF-200"

Phrase: "(E) and NF-200 (F)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "reveal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "dystrophic neurites"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2674684:Dystrophic neurites [Finding]
   861   C0085103:Neurites [Cell Component]

Phrase: "(F) reveal dystrophic neurites (arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:arrows [Manufactured Object]

Phrase: ")"

Phrase: "adjacent to plaques (P)."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   882   C0205117:Adjacent to [Spatial Concept]
           Adjacent
   718 E C3242705:adjacency [Idea or Concept]
Processing 00000000.tx.222: G and H represent synaptophysin and ubiquitin-positive structures in the periphery of plaque deposits, indicative of dystrophic buttons. 

Phrase: "G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "synaptophysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085255:Synaptophysin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420554:SYNAPTOPHYSIN [Gene or Genome]

Phrase: "and"

Phrase: "ubiquitin-positive structures in the periphery of plaque deposits,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0678594:structures [Spatial Concept]

Phrase: "indicative of dystrophic buttons."
Processing 00000000.tx.223: I-K illustrate focal inflammatory responses. 

Phrase: "I-K"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "illustrate"

Phrase: "focal inflammatory responses."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   901   C1155266:inflammatory responses [Pathologic Function]
   827   C0871261:responses [Organism Attribute]
   793 E C1704632:Response [Finding]
   793 E C1706817:Response [Intellectual Product]
   793 E C2911692:Response [Mental Process]
Processing 00000000.tx.224: I, anti-CD11b antibody, J, thioflavine S stain of an adjacent section, and K, GFAP staining of a third adjacent section. 

Phrase: "I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "anti-CD11b antibody,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "J,"

Phrase: "thioflavine S stain of an adjacent section,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "GFAP staining of a third adjacent section."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0487602:Staining [Laboratory Procedure]
   748   C1704680:Staining [Finding]
Processing 00000000.tx.225: Plaque Ontogeny-- A single plaque was noted in one TgCRND8 animal at 43days. 

Phrase: "Plaque Ontogeny"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0018270:ontogeny [Organism Function]
   861   C1621967:Ontogeny [Organism Function]

Phrase: "-"

Phrase: "-"

Phrase: "A single plaque"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011389:Plaque [Disease or Syndrome]
   861   C0332461:Plaque [Finding]
   861   C0333463:plaque [Acquired Abnormality]

Phrase: "was"

Phrase: "noted in one TgCRND8 animal"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0003062:Animal [Animal]
   760   C0205447:One [Quantitative Concept]
   726   C1316572:Note [Clinical Attribute]
   726   C1317574:Note [Intellectual Product]
   726   C1369612:Note [Clinical Attribute]

Phrase: "at 43days."
Processing 00000000.tx.226: Plaque load increased with age and spread to more regions of the brain such that multiple plaque deposits were present per sagittal section in most mice at 65days of age, and in all mice by 90days of age. 

Phrase: "Plaque load"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1550025:Load [Idea or Concept]
   861   C1704782:Load [Manufactured Object]
   861   C1708715:Load [Activity]

Phrase: "increased with age"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0001779:Age [Organism Attribute]
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "and"

Phrase: "spread"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332261:Spread [Qualitative Concept]
  1000   C1947932:Spread [Activity]

Phrase: "to more regions of the brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1273723:brain regions [Body Location or Region]
   719   C0017446:Region [Geographic Area]
   719   C0205147:Region [Spatial Concept]

Phrase: "such"

Phrase: "that multiple plaque deposits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0333562:Deposits [Functional Concept]

Phrase: "were"

Phrase: "present per sagittal section"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "in most mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "at 65days"

Phrase: "of age,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "and in all mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C1515981:And [Idea or Concept]

Phrase: "by 90days"

Phrase: "of age."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]
Processing 00000000.tx.227: Although studies on large cohorts of mice are in progress, analyses of representative mice revealed between 11-35 and 22-43 plaques in a mid-sagittal section of the cortex at the ages of 90and 150days, whereas burdens were greatly increased at 240and 350days of age (127-416 and 528-1024 plaques, respectively). 

Phrase: "Although"

Phrase: "studies on large cohorts of mice"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   767   C0009247:Cohort Studies [Quantitative Concept]
   753   C0947630:studies [Laboratory Procedure]
   719 E C0557651:Study [Manufactured Object]
   719 E C2603343:Study [Research Activity]

Phrase: "are"

Phrase: "in progress, analyses of representative mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0002778:Analysis [Laboratory Procedure]
   719   C0936012:Analysis [Research Activity]
   719   C1524024:analysis [Functional Concept]

Phrase: "revealed between 11-35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0443289:Revealed [Qualitative Concept]

Phrase: "and"

Phrase: "22-43 plaques in a mid-sagittal section of the cortex"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   738   C0333463:plaques [Acquired Abnormality]
   704 E C0011389:Plaque [Disease or Syndrome]
   704 E C0332461:Plaque [Finding]

Phrase: "at the ages"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "of 90and 150days,"

Phrase: "whereas"

Phrase: "burdens"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2828008:Burden [Idea or Concept]

Phrase: "were"

Phrase: "greatly"

Phrase: "increased at 240and 350days of age (127-416"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0001779:Age [Organism Attribute]
   744   C0205217:Increased [Quantitative Concept]
   744   C0442805:Increased [Functional Concept]

Phrase: "and"

Phrase: "528-1024 plaques,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0333463:plaques [Acquired Abnormality]
   793 E C0011389:Plaque [Disease or Syndrome]
   793 E C0332461:Plaque [Finding]

Phrase: "respectively"

Phrase: ") adjacent to plaques (P). G and H represent synaptophysin and ubiquitin-positive structures in the periphery of plaque deposits, indicative of dystrophic buttons. I-K illustrate focal inflammatory responses. I, anti-CD11b antibody, J, thioflavine S stain of an adjacent section, and K, GFAP staining of a third adjacent section. Plaque Ontogeny-- A single plaque was noted in one TgCRND8 animal at 43days. Plaque load increased with age and spread to more regions of the brain such that multiple plaque deposits were present per sagittal section in most mice at 65days of age, and in all mice by 90days of age. Although studies on large cohorts of mice are in progress, analyses of representative mice revealed between 11-35 and 22-43 plaques in a mid-sagittal section of the cortex at the ages of 90and 150days, whereas burdens were greatly increased at 240and 350days of age (127-416 and 528-1024 plaques, respectively)."
Processing 00000000.tx.228: A similar pattern of increase pertained to the hippocampal formation with 1-5 and 11-12 plaques at 90and 150days and 39-65 and 123-147 plaques at 240and 360days, respectively. 

Phrase: "A similar pattern of increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449774:Pattern [Spatial Concept]

Phrase: "pertained to the hippocampal formation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0175202:Hippocampal Formation [Body Part, Organ, or Organ Component]
   760   C0019564:Hippocampal [Body Part, Organ, or Organ Component]
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "with 1-5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0450316:1/5 [Quantitative Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "11-12 plaques at 90and 150days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0333463:plaques [Acquired Abnormality]
   719 E C0011389:Plaque [Disease or Syndrome]
   719 E C0332461:Plaque [Finding]

Phrase: "and"

Phrase: "39-65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450385:65 [Intellectual Product]

Phrase: "and"

Phrase: "123-147 plaques at 240and 360days,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0333463:plaques [Acquired Abnormality]
   719 E C0011389:Plaque [Disease or Syndrome]
   719 E C0332461:Plaque [Finding]

Phrase: "respectively."
Processing 00000000.tx.229: Thus, the time period for a rapid increase in amyloid burden assessed histologically lags slightly behind that determined biochemically by ELISA assays (Table I). 

Phrase: "Thus,"

Phrase: "the time period for a rapid increase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0439582:Time period [Temporal Concept]
   748   C0040223:Time [Temporal Concept]
   748   C0439531:/period [Temporal Concept]
   748   C1948053:Period [Temporal Concept]
   748   C3541383:Time [Temporal Concept]

Phrase: "in amyloid burden"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2828008:Burden [Idea or Concept]

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "histologically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205462:Histologically [Functional Concept]

Phrase: "lags"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1416797:Lag [Gene or Genome]

Phrase: "slightly behind that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0750482:Slightly [Idea or Concept]

Phrase: "determined"

Phrase: "biochemically by ELISA assays"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   816   C0014441:ELISA assay [Laboratory Procedure]
           ELISA
   737   C0005507:Assay [Laboratory Procedure]
   737   C0243073:assay [Qualitative Concept]
   737   C1510438:Assay [Laboratory Procedure]

Phrase: "(arrows) adjacent to plaques (P). G and H represent synaptophysin and ubiquitin-positive structures in the periphery of plaque deposits, indicative of dystrophic buttons. I-K illustrate focal inflammatory responses. I, anti-CD11b antibody, J, thioflavine S stain of an adjacent section, and K, GFAP staining of a third adjacent section. Plaque Ontogeny-- A single plaque was noted in one TgCRND8 animal at 43days. Plaque load increased with age and spread to more regions of the brain such that multiple plaque deposits were present per sagittal section in most mice at 65days of age, and in all mice by 90days of age. Although studies on large cohorts of mice are in progress, analyses of representative mice revealed between 11-35 and 22-43 plaques in a mid-sagittal section of the cortex at the ages of 90and 150days, whereas burdens were greatly increased at 240and 350days of age (127-416 and 528-1024 plaques, respectively). A similar pattern of increase pertained to the hippocampal formation with 1-5 and 11-12 plaques at 90and 150days and 39-65 and 123-147 plaques at 240and 360days, respectively. Thus, the time period for a rapid increase in amyloid burden assessed histologically lags slightly behind that determined biochemically by ELISA assays (Table I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "). A similar pattern of increase pertained to the hippocampal formation with 1-5 and 11-12 plaques at 90and 150days and 39-65 and 123-147 plaques at 240and 360days, respectively. Thus, the time period for a rapid increase in amyloid burden assessed histologically lags slightly behind that determined biochemically by ELISA assays (Table I)."
Processing 00000000.tx.230: Plaque Distribution-- The plaque present at 43days was located in the subiculum. 

Phrase: "Plaque Distribution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0520511:distribution [Idea or Concept]
   861   C1704711:Distribution [Functional Concept]

Phrase: "-"

Phrase: "-"

Phrase: "The plaque present at 43days"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]

Phrase: "was"

Phrase: "located in the subiculum."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0152316:Subiculum [Body Part, Organ, or Organ Component]
Processing 00000000.tx.231: The frontal cortex of TgCRND8 mice often had several plaques by 65days, whereas plaques were rare or absent in the white matter tracts (corpus callosum and alveus) and CA1 region of the hippocampus at this time. 

Phrase: "The frontal cortex of TgCRND8 mice often"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0016733:Frontal cortex [Body Part, Organ, or Organ Component]
   748   C0007776:Cortex [Body Part, Organ, or Organ Component]
   748   C0205123:Frontal [Spatial Concept]
   748   C1176472:Cortex [Body Part, Organ, or Organ Component]
   748   C2700441:Cortex [Plant]

Phrase: "had"

Phrase: "several plaques by 65days,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0333463:plaques [Acquired Abnormality]
   737 E C0011389:Plaque [Disease or Syndrome]
   737 E C0332461:Plaque [Finding]

Phrase: "whereas"

Phrase: "plaques"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]

Phrase: "were"

Phrase: "rare"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521114:Rare [Temporal Concept]
  1000   C0522498:Rare [Qualitative Concept]
  1000   C1514917:RARE [Gene or Genome]

Phrase: "or"

Phrase: "absent in the white matter tracts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332197:Absent [Quantitative Concept]
   753   C2699517:ABSENT [Finding]

Phrase: "(Table I). Plaque Distribution-- The plaque present at 43days was located in the subiculum. The frontal cortex of TgCRND8 mice often had several plaques by 65days, whereas plaques were rare or absent in the white matter tracts (corpus callosum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010090:Corpus Callosum [Body Part, Organ, or Organ Component]
   861   C0227813:Corpus [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "alveus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0228247:Alveus [Body Part, Organ, or Organ Component]

Phrase: ")"

Phrase: "and"

Phrase: "CA1 region of the hippocampus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0017446:Region [Geographic Area]
   760   C0205147:Region [Spatial Concept]

Phrase: "at this time."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]
Processing 00000000.tx.232: By 101days plaques were widespread in many regions of the cortex as well as in the hippocampus proper, the dentate gyrus, the olfactory bulb, and within the pial vessels. 

Phrase: "By 101days plaques"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0333463:plaques [Acquired Abnormality]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]

Phrase: "were"

Phrase: "widespread in many regions of the cortex"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205391:Widespread [Spatial Concept]

Phrase: "as well as in the hippocampus"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   753   C0205170:Well [Qualitative Concept]
   753   C0949582:Hippocampus [Fish]
   753   C1029104:Hippocampus [Fish]
   753   C1284077:Hippocampus [Body Part, Organ, or Organ Component]
   753   C3146287:Well [Manufactured Object]

Phrase: "proper,"

Phrase: "the dentate gyrus,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0152314:Dentate Gyrus [Body Part, Organ, or Organ Component]
  1000   C1281026:Dentate gyrus [Body Part, Organ, or Organ Component]

Phrase: "the olfactory bulb,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0028936:Olfactory Bulb [Body Part, Organ, or Organ Component]
  1000   C1281094:Olfactory bulb [Body Part, Organ, or Organ Component]
   861   C0025148:Bulb [Body Part, Organ, or Organ Component]
   861   C0037361:olfactory [Organism Function]
   861   C0439826:Olfactory [Organism Function]
   861   C1449865:Bulb [Plant]
   861   C1947952:Bulb [Anatomical Structure]

Phrase: "and within the pial vessels."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0005847:Vessels [Body Part, Organ, or Organ Component]
   760   C1515981:And [Idea or Concept]
   726 E C1511228:Vessel [Tissue]
Processing 00000000.tx.233: The thalamus (111days), then the cerebral vasculature and striatum (196days), followed by the cerebellum and brain stem (243days) all became progressively burdened by plaques. 

Phrase: "The thalamus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0039729:Thalamus [Body Part, Organ, or Organ Component]
  1000   C1269896:Thalamus [Body Part, Organ, or Organ Component]

Phrase: "(corpus callosum and alveus) and CA1 region of the hippocampus at this time. By 101days plaques were widespread in many regions of the cortex as well as in the hippocampus proper, the dentate gyrus, the olfactory bulb, and within the pial vessels. The thalamus (111days"

Phrase: ")"

Phrase: ","

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "the cerebral vasculature"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005839:vasculature [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "striatum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010097:Striatum [Body Part, Organ, or Organ Component]
  1000   C0162512:Striatum [Body Part, Organ, or Organ Component]

Phrase: "(111days), then the cerebral vasculature and striatum (196days"

Phrase: ")"

Phrase: ","

Phrase: "followed by the cerebellum"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0332283:Followed by [Temporal Concept]
           followed
   770   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
   770   C1268981:Cerebellum [Body Part, Organ, or Organ Component]
   770   C1707522:Cerebellum [Tissue]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "and"

Phrase: "brain stem"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0006121:Brain Stem [Body Part, Organ, or Organ Component]
  1000   C1306665:Brainstem [Body Part, Organ, or Organ Component]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0242767:Stem [Plant]
   861   C1186763:Stem [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(196days), followed by the cerebellum and brain stem (243days"

Phrase: ")"

Phrase: "all"

Phrase: "became"

Phrase: "progressively"

Phrase: "burdened by plaques."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0333463:plaques [Acquired Abnormality]
   756 E C0011389:Plaque [Disease or Syndrome]
   756 E C0332461:Plaque [Finding]
   756   C2828008:Burden [Idea or Concept]
Processing 00000000.tx.234: This pattern of deposition, with cortex and hippocampus affected early on and the cerebellum spared until a late stage in disease, is similar to that seen in AD (45). 

Phrase: "This pattern of deposition,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0449774:Pattern [Spatial Concept]

Phrase: "with cortex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007776:Cortex [Body Part, Organ, or Organ Component]
  1000   C1176472:Cortex [Body Part, Organ, or Organ Component]
  1000   C2700441:Cortex [Plant]

Phrase: "and"

Phrase: "hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "affected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "early on"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1279919:Early [Temporal Concept]

Phrase: "and"

Phrase: "the cerebellum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1268981:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1707522:Cerebellum [Tissue]

Phrase: "spared until a late stage"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1279941:Late stage [Temporal Concept]
   760   C0205087:Late [Temporal Concept]
   760   C0205390:Stage [Temporal Concept]
   760   C1300072:Stage [Clinical Attribute]
   760   C1306673:Stage [Qualitative Concept]

Phrase: "in disease,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "seen in AD (45"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0205397:Seen [Qualitative Concept]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]

Phrase: ") all became progressively burdened by plaques. This pattern of deposition, with cortex and hippocampus affected early on and the cerebellum spared until a late stage in disease, is similar to that seen in AD (45)."
Processing 00000000.tx.235: Plaque Morphology-- The first plaques observed were small, cored deposits, with no radiating amyloid surrounding them (65days). 

Phrase: "Plaque Morphology"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0332437:Morphology [Qualitative Concept]
   861   C0543482:morphology [Spatial Concept]
   861   C0700329:Morphology, NOS [Finding]
   861   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "-"

Phrase: "-"

Phrase: "The first plaques"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0333463:plaques [Acquired Abnormality]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "were"

Phrase: "small, cored deposits,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0333562:Deposits [Functional Concept]

Phrase: "with no radiating amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "surrounding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1282914:Surrounding [Spatial Concept]

Phrase: "them"

Phrase: "(243days) all became progressively burdened by plaques. This pattern of deposition, with cortex and hippocampus affected early on and the cerebellum spared until a late stage in disease, is similar to that seen in AD (45). Plaque Morphology-- The first plaques observed were small, cored deposits, with no radiating amyloid surrounding them (65days"

Phrase: "). Plaque Morphology-- The first plaques observed were small, cored deposits, with no radiating amyloid surrounding them (65days)."
Processing 00000000.tx.236: By 101days, the plaques varied in size, with some larger plaques having haloes of radiating amyloid. 

Phrase: "By 101days,"

Phrase: "the plaques"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]

Phrase: "varied in size,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0456389:size [Spatial Concept]

Phrase: "with some larger plaques"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0333463:plaques [Acquired Abnormality]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]

Phrase: "having"

Phrase: "haloes of radiating amyloid."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0271188:HALO [Sign or Symptom]
   737   C3541466:halo [Cell Component]
Processing 00000000.tx.237: By 131days the plaques became more heterogeneous in nature. 

Phrase: "By 131days"

Phrase: "the plaques"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]

Phrase: "became"

Phrase: "more heterogeneous in nature."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0019409:Heterogeneous [Qualitative Concept]
Processing 00000000.tx.238: Plaques varied greatly in size as the age of the mice increased, with some being multicored in older animals. 

Phrase: "Plaques"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]

Phrase: "varied"

Phrase: "greatly in size"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0456389:size [Spatial Concept]

Phrase: "as the age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "of the mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: ","

Phrase: "with some"

Phrase: "being"

Phrase: "multicored in older animals."
Processing 00000000.tx.239: Diffuse amyloid deposits appeared in the olfactory bulb at an early stage (101days). 

Phrase: "Diffuse amyloid deposits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2936349:Amyloid Deposits [Acquired Abnormality]
   827   C0333562:Deposits [Functional Concept]

Phrase: "appeared in the olfactory bulb"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0028936:Olfactory Bulb [Body Part, Organ, or Organ Component]
   806   C1281094:Olfactory bulb [Body Part, Organ, or Organ Component]
   760   C0025148:Bulb [Body Part, Organ, or Organ Component]
   760   C0037361:olfactory [Organism Function]
   760   C0439826:Olfactory [Organism Function]
   760   C1449865:Bulb [Plant]
   760   C1947952:Bulb [Anatomical Structure]
   726   C0700364:APPEAR [Qualitative Concept]

Phrase: "at an early stage"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1517886:Early Stage [Classification]
  1000   C2363430:Early stage [Temporal Concept]
   861   C0205390:Stage [Temporal Concept]
   861   C1300072:Stage [Clinical Attribute]
   861   C1306673:Stage [Qualitative Concept]

Phrase: "(65days). By 101days, the plaques varied in size, with some larger plaques having haloes of radiating amyloid. By 131days the plaques became more heterogeneous in nature. Plaques varied greatly in size as the age of the mice increased, with some being multicored in older animals. Diffuse amyloid deposits appeared in the olfactory bulb at an early stage (101days"

Phrase: "). By 101days, the plaques varied in size, with some larger plaques having haloes of radiating amyloid. By 131days the plaques became more heterogeneous in nature. Plaques varied greatly in size as the age of the mice increased, with some being multicored in older animals. Diffuse amyloid deposits appeared in the olfactory bulb at an early stage (101days)."
Processing 00000000.tx.240: However, outside of the olfactory bulb, diffuse amyloid (i.e. amyloid not obviously associated with a cored plaque) did not appear until 243days, as detected with the 6F/3D antibody. 

Phrase: "However,"

Phrase: "outside of the olfactory bulb,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0028936:Olfactory Bulb [Body Part, Organ, or Organ Component]
  1000   C1281094:Olfactory bulb [Body Part, Organ, or Organ Component]
   861   C0025148:Bulb [Body Part, Organ, or Organ Component]
   861   C0037361:olfactory [Organism Function]
   861   C0439826:Olfactory [Organism Function]
   861   C1449865:Bulb [Plant]
   861   C1947952:Bulb [Anatomical Structure]

Phrase: "diffuse amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(101days). However, outside of the olfactory bulb, diffuse amyloid (i.e. amyloid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0683454:I-E [Diagnostic Procedure,Intellectual Product]

Phrase: "not obviously"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "associated with a cored plaque"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0011389:Plaque [Disease or Syndrome]
   760   C0332461:Plaque [Finding]
   760   C0333463:plaque [Acquired Abnormality]
   726   C0444669:Core [Spatial Concept]
   726 E C0750490:Associate [Idea or Concept]
   726   C1167518:core [Cell Component]
   726 E C1706221:Associate [Professional or Occupational Group]
   726   C1706352:Core [Medical Device]
   726   C1882467:Core [Manufactured Object]
   726   C3274653:Core [Body Substance]

Phrase: ")"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "appear until 243days,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0700364:APPEAR [Qualitative Concept]

Phrase: "as"

Phrase: "detected with the 6F/3D antibody."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0442726:Detected [Finding]
   753   C0450363:3D [Spatial Concept]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   753   C2986797:3D [Functional Concept]
Processing 00000000.tx.241: Diffuse amyloid was found primarily in the caudate, cerebellum, and molecular layer of the dentate gyrus (all at 243days). 

Phrase: "Diffuse amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "primarily in the caudate, cerebellum,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
   760   C1268981:Cerebellum [Body Part, Organ, or Organ Component]
   760   C1707522:Cerebellum [Tissue]

Phrase: "and"

Phrase: "molecular layer of the dentate gyrus"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C2333870:molecular layer of the dentate gyrus [Body Part, Organ, or Organ Component]
           Molecular layer of dentate gyrus
   858   C2330890:Layer of dentate gyrus [Body Part, Organ, or Organ Component]
           Dentate gyrus layer
   753   C0934502:Layer [Body Part, Organ, or Organ Component]
   753   C1521991:Molecular [Qualitative Concept]
   753   C1522408:Layer [Qualitative Concept]
   753   C1561599:Layer [Intellectual Product]

Phrase: "("

Phrase: "all at 243days"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0444868:All [Quantitative Concept]
   790   C3539085:All [Idea or Concept]

Phrase: ") did not appear until 243days, as detected with the 6F/3D antibody. Diffuse amyloid was found primarily in the caudate, cerebellum, and molecular layer of the dentate gyrus (all at 243days)."
Processing 00000000.tx.242: By 315days diffuse amyloid appeared throughout the cortex (see Fig. 4B). 

Phrase: "By 315days"

Phrase: "diffuse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205219:Diffuse [Qualitative Concept]

Phrase: "amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "appeared throughout the cortex"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0007776:Cortex [Body Part, Organ, or Organ Component]
   770   C1176472:Cortex [Body Part, Organ, or Organ Component]
   770   C2700441:Cortex [Plant]
   737   C0700364:APPEAR [Qualitative Concept]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: "). By 315days diffuse amyloid appeared throughout the cortex (see Fig. 4B)."
Processing 00000000.tx.243: The majority of amyloid plaque deposits in TgCRND8 mice, including those first to appear at 65days, stained positive for thioflavine S.

Phrase: "The majority of amyloid plaque"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0680220:majority [Social Behavior]

Phrase: "deposits in TgCRND8 mice,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C0333562:Deposit [Functional Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "those first to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205435:First [Quantitative Concept]
   861   C1279901:First [Qualitative Concept]

Phrase: "appear at 65days,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0700364:APPEAR [Qualitative Concept]

Phrase: "stained positive for thioflavine S."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439178:% Positive [Quantitative Concept]
   760   C1446409:Positive [Qualitative Concept]
   760   C1514241:Positive [Finding]
   760   C2825490:Positive [Qualitative Concept]
Processing 00000000.tx.244: These early deposits also revealed Congo Red birefringence. 

Phrase: "These early deposits also revealed Congo Red birefringence."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0005597:Birefringence [Natural Phenomenon or Process]
Processing 00000000.tx.245: Together these data indicate the deposited amyloid peptide adopts a -sheet conformation. 

Phrase: "Together"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "indicate"

Phrase: "the deposited amyloid peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "adopts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0425382:adopt [Finding]

Phrase: "a -sheet conformation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0026377:Conformation [Spatial Concept]
Processing 00000000.tx.246: Amyloid plaques in TgCRND8 mice were associated with dystrophic neurites, as indicated by a variety of histochemical and immunohistochemical stains (Fig. 4). 

Phrase: "Amyloid plaques in TgCRND8 mice"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   806   C0333463:amyloid plaques [Acquired Abnormality]
           plaques
   806   C2936349:Plaques, Amyloid [Acquired Abnormality]
   726 E C0011389:Plaque [Disease or Syndrome]
   726 E C0332461:Plaque [Finding]

Phrase: "were"

Phrase: "associated with dystrophic neurites,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C2674684:Dystrophic neurites [Finding]
   770   C0085103:Neurites [Cell Component]
   770   C0333607:Dystrophic [Functional Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "as"

Phrase: "indicated by a variety of histochemical"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1444656:Indicated [Finding]
   753   C1883525:Variety [Conceptual Entity]
   753   C2346866:Variety [Conceptual Entity]

Phrase: "and"

Phrase: "immunohistochemical stains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0038128:Stains [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(see Fig. 4B). The majority of amyloid plaque deposits in TgCRND8 mice, including those first to appear at 65days, stained positive for thioflavine S.These early deposits also revealed Congo Red birefringence. Together these data indicate the deposited amyloid peptide adopts a -sheet conformation. Amyloid plaques in TgCRND8 mice were associated with dystrophic neurites, as indicated by a variety of histochemical and immunohistochemical stains (Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "). The majority of amyloid plaque deposits in TgCRND8 mice, including those first to appear at 65days, stained positive for thioflavine S.These early deposits also revealed Congo Red birefringence. Together these data indicate the deposited amyloid peptide adopts a -sheet conformation. Amyloid plaques in TgCRND8 mice were associated with dystrophic neurites, as indicated by a variety of histochemical and immunohistochemical stains (Fig. 4)."
Processing 00000000.tx.247: For example, Bielschowsky silver impregnation revealed dystrophic neuritic processes around plaque cores (Fig. 4E). 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "Bielschowsky silver impregnation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1293950:silver impregnation [Laboratory Procedure]
   827   C0015914:impregnation [Organism Function]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "dystrophic neuritic processes around plaque cores"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1184743:Process [Body Part, Organ, or Organ Component]
   719   C1522240:Process [Phenomenon or Process]

Phrase: "(Fig. 4). For example, Bielschowsky silver impregnation revealed dystrophic neuritic processes around plaque cores (Fig. 4E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450378:4e [Intellectual Product]

Phrase: "). For example, Bielschowsky silver impregnation revealed dystrophic neuritic processes around plaque cores (Fig. 4E)."
Processing 00000000.tx.248: Similar structures were imaged by antibodies raised against the 200-kDa isoform of neurofilament (NF-200; Fig. 4F), synaptophysin (Fig. 4G), and ubiquitin (Fig. 4H). 

Phrase: "Similar structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:structures [Spatial Concept]

Phrase: "were"

Phrase: "imaged by antibodies"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   756   C1704254:Image [Intellectual Product]
   756   C1704922:Image [Entity]
   756   C3542466:Image [Intellectual Product]

Phrase: "raised against the 200-kDa isoform of neurofilament"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0068589:neurofilament 200 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0027834:Neurofilament [Cell Component]
   744   C0442818:Raised [Quantitative Concept]
   744   C0597298:Isoform [Amino Acid, Peptide, or Protein]
   744   C1532717:kDa [Quantitative Concept]

Phrase: "(Fig. 4E). Similar structures were imaged by antibodies raised against the 200-kDa isoform of neurofilament (NF-200"

Phrase: "; Fig. 4F"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450379:4f [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "synaptophysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085255:Synaptophysin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420554:SYNAPTOPHYSIN [Gene or Genome]

Phrase: "(NF-200; Fig. 4F), synaptophysin (Fig. 4G"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "ubiquitin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 4G), and ubiquitin (Fig. 4H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1292426:4H [Temporal Concept]

Phrase: "), and ubiquitin (Fig. 4H)."
Processing 00000000.tx.249: The first enlarged plaque-associated neurites were seen with Bielschowsky, synaptophysin, and NF-200 staining at 111days of age. 

Phrase: "The first enlarged plaque-associated neurites"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0085103:Neurites [Cell Component]

Phrase: "were"

Phrase: "seen with Bielschowsky,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0205397:Seen [Qualitative Concept]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]

Phrase: "synaptophysin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085255:Synaptophysin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420554:SYNAPTOPHYSIN [Gene or Genome]

Phrase: "and"

Phrase: "NF-200 staining at 111days of age."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0487602:Staining [Laboratory Procedure]
   748   C1704680:Staining [Finding]
Processing 00000000.tx.250: Dystrophic pathology became more evident as the mice aged further and the frequency of large, dense-cored plaques increased. 

Phrase: "Dystrophic pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0030664:Pathology [Biomedical Occupation or Discipline]
   861   C0205469:pathology [Functional Concept]
   861   C0677042:pathology [Pathologic Function]
   789 E C1521733:Pathologic [Functional Concept]

Phrase: "became"

Phrase: "more evident as the mice"

Phrase: "aged"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0001779:Aged [Organism Attribute]
  1000   C0001792:Aged [Population Group]
  1000   C1999167:aged [Population Group]

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "and"

Phrase: "the frequency of large, dense-cored plaques"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0376249:frequency [Quantitative Concept]
   748   C0439603:Frequency [Temporal Concept]
   748   C0871396:Frequency [Quantitative Concept]
   748   C1561548:Frequency [Qualitative Concept]
   748   C1705502:Frequency [Quantitative Concept]

Phrase: "increased."
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]
Processing 00000000.tx.251: Finally, it was noteworthy that dystrophic neurites were only observed in the immediate vicinity of plaques, indicating these structures are a direct consequence of amyloid deposition in the TgCRND8 mice. 

Phrase: "Finally,"

Phrase: "it"

Phrase: "was"

Phrase: "noteworthy"

Phrase: "that dystrophic neurites"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2674684:Dystrophic neurites [Finding]
   861   C0085103:Neurites [Cell Component]

Phrase: "were"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "observed in the immediate vicinity of plaques,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   748   C0205253:Immediate [Temporal Concept]
   748   C0205548:Immediate [Temporal Concept]
   748   C0333463:plaques [Acquired Abnormality]
   748   C1441672:Observed [Functional Concept]
   714 E C0011389:Plaque [Disease or Syndrome]
   714 E C0332461:Plaque [Finding]

Phrase: "indicating"

Phrase: "these structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:structures [Spatial Concept]

Phrase: "are"

Phrase: "a direct consequence of amyloid deposition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0686907:Consequence of [Functional Concept]
           Consequence

Phrase: "in the TgCRND8 mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
Processing 00000000.tx.252: Neuroinflammation-- Mature plaques in TgCRND8 mice were associated with a focal inflammatory response. 

Phrase: "Neuroinflammation"

Phrase: "--"

Phrase: "Mature plaques in TgCRND8 mice"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0333463:plaques [Acquired Abnormality]
   726 E C0011389:Plaque [Disease or Syndrome]
   726 E C0332461:Plaque [Finding]

Phrase: "were"

Phrase: "associated with a focal inflammatory response."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C1155266:Inflammatory Response [Pathologic Function]
   753   C0205234:Focal [Spatial Concept]
   753   C0333348:Inflammatory [Functional Concept]
   753   C0871261:Response [Organism Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.253: Elongated cells in periphery of dense-cored amyloid deposits visualized by Luxol fast blue staining or focal staining with a Griffonia simplicifolia lectin I isolectin B4 stain (not presented) and staining with anti-CD11b antibody probe (Fig. 4I) were consistent with the presence of microglial cells. 

Phrase: "Elongated cells in periphery of dense-cored amyloid deposits"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   745   C1622967:cell periphery [Cell Component]
   742   C0007634:Cells [Cell]
   742   C3282337:Cells [Cell]
   709   C0162339:Cell Density [Quantitative Concept]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "visualized by Luxol fast blue staining"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0065274:Luxol fast blue [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   790   C0060083:Fast Blue [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0015663:Fast [Finding]
   753   C0234621:Visualized [Functional Concept]
   753   C0456962:Fast [Qualitative Concept]
   753   C0487602:Staining [Laboratory Procedure]
   753   C1260957:Blue [Qualitative Concept]
   753   C1704680:Staining [Finding]

Phrase: "or"

Phrase: "focal staining with a Griffonia simplicifolia lectin I isolectin B4 stain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0487602:Staining [Laboratory Procedure]
   738   C1704680:Staining [Finding]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "staining with anti-CD11b antibody probe"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0487602:Staining [Laboratory Procedure]
   753   C1704680:Staining [Finding]

Phrase: "(not presented) and staining with anti-CD11b antibody probe (Fig. 4I"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552168:4i [Medical Device]

Phrase: ")"

Phrase: "were"

Phrase: "consistent with the presence of microglial cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0332290:Consistent with [Idea or Concept]
           Consistent
Processing 00000000.tx.254: This microglial activation was accompanied by intense local astrocytic gliosis, illustrated by GFAP staining of adjacent sections encompassing a thioflavin-positive plaque (Fig. 4, K and J). 

Phrase: "This microglial activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "was"

Phrase: "accompanied by intense local astrocytic gliosis,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1843800:Astrocytic gliosis [Finding]
   753   C0017639:Gliosis [Pathologic Function]
   753   C0205276:Local [Spatial Concept]
   753   C0521395:Astrocytic [Body Location or Region]
   753   C0522510:Intense [Qualitative Concept]

Phrase: "illustrated by GFAP staining of adjacent sections"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   748   C0017626:GFAP [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0205117:Adjacent [Spatial Concept]
   748   C0487602:Staining [Laboratory Procedure]
   748   C1415042:GFAP [Gene or Genome]
   748   C1704680:Staining [Finding]
   714   C0205155:Section [Spatial Concept]
   714   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   714   C1522472:Section [Substance]
   714   C1552923:Section [Quantitative Concept]
   714   C1705191:Section [Physical Object]

Phrase: "encompassing"

Phrase: "a thioflavin-positive plaque"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0011389:Plaque [Disease or Syndrome]
   827   C0332461:Plaque [Finding]
   827   C0333463:plaque [Acquired Abnormality]

Phrase: "(Fig. 4I) were consistent with the presence of microglial cells. This microglial activation was accompanied by intense local astrocytic gliosis, illustrated by GFAP staining of adjacent sections encompassing a thioflavin-positive plaque (Fig. 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "K"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "J"

Phrase: ") were consistent with the presence of microglial cells. This microglial activation was accompanied by intense local astrocytic gliosis, illustrated by GFAP staining of adjacent sections encompassing a thioflavin-positive plaque (Fig. 4, K and J)."
Processing 00000000.tx.255: This astrocytic response clearly exceeded a low basal level of staining of GFAP-positive astrocytes (mostly evident within white matter tracts) noted in both transgenic and non-transgenic mice. 

Phrase: "This astrocytic response clearly"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "exceeded"

Phrase: "a low basal level of staining of GFAP-positive astrocytes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C0441889:Level [Qualitative Concept]
   739   C0456079:Level [Classification]
   739   C1547707:Level [Geographic Area]
   739   C2946261:Level [Pharmacologic Substance]

Phrase: "(Fig. 4, K and J). This astrocytic response clearly exceeded a low basal level of staining of GFAP-positive astrocytes (mostly evident within white matter tracts"

Phrase: ")"

Phrase: "noted in both transgenic"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0003069:Transgenic [Animal]
   737   C1316572:Note [Clinical Attribute]
   737   C1317574:Note [Intellectual Product]
   737   C1369612:Note [Clinical Attribute]

Phrase: "and"

Phrase: "non-transgenic mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0025936:Mice, Transgenic [Mammal]
   896   C1513853:NON Mouse [Mammal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
Processing 00000000.tx.256: Acceleration of Amyloid Deposition by Co-expression of Presenilin-1 Transgenes Amyloid deposition in TgCRND8 mice was enhanced by mutant human PS1 transgenes co-expressed with human APP via usage of the same cos.Tet transgene vector (Fig. 5, right-hand panels). 

Phrase: "Acceleration of Amyloid Deposition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0000894:Acceleration [Phenomenon or Process]

Phrase: "by Co-expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of Presenilin-1 Transgenes Amyloid deposition"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0011560:Amyloid deposition [Pathologic Function]
   840   C1705760:Amyloid Deposition [Finding]
   804   C0333562:Deposition [Functional Concept]

Phrase: "in TgCRND8 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "was"

Phrase: "enhanced by mutant human PS1 transgenes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0086418:Human [Human]
   753   C0282641:Transgenes [Gene or Genome]
   753   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0596988:Mutant [Cell or Molecular Dysfunction]
   753   C1418985:PS1 [Gene or Genome]
   753   C2349975:Enhanced [Activity]
   753   C2986918:PS1 [Gene or Genome]

Phrase: "co-expressed with human APP"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   814   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   814   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   778   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1142652:human protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0086418:Human [Human]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1709634:Precursor [Idea or Concept]

Phrase: "via usage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0457083:Usage [Functional Concept]

Phrase: "of the same cos.Tet transgene vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0442335:Vector [Spatial Concept]
   804   C1705099:Vector [Idea or Concept]

Phrase: "(mostly evident within white matter tracts) noted in both transgenic and non-transgenic mice. Acceleration of Amyloid Deposition by Co-expression of Presenilin-1 Transgenes Amyloid deposition in TgCRND8 mice was enhanced by mutant human PS1 transgenes co-expressed with human APP via usage of the same cos.Tet transgene vector (Fig. 5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "right-hand panels"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0441833:Panel [Idea or Concept]
   827   C1999270:Panel [Intellectual Product]
   827   C3537156:Panel [Manufactured Object]
   734   C0230370:Right hand [Body Part, Organ, or Organ Component]
   734   C1288948:Right hand [Body Part, Organ, or Organ Component]

Phrase: ") noted in both transgenic and non-transgenic mice. Acceleration of Amyloid Deposition by Co-expression of Presenilin-1 Transgenes Amyloid deposition in TgCRND8 mice was enhanced by mutant human PS1 transgenes co-expressed with human APP via usage of the same cos.Tet transgene vector (Fig. 5, right-hand panels)."
Processing 00000000.tx.257: This effect was evident in terms of a potent increment in plaque burden over age-matched TgCRND8 single transgenic controls. 

Phrase: "This effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "evident in terms of a potent increment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0332120:Evidence of [Functional Concept]

Phrase: "in plaque burden"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2828008:Burden [Idea or Concept]

Phrase: "over age-matched TgCRND8 single transgenic controls."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   766   C0243148:control [Qualitative Concept]
   766   C1550141:Control [Substance]
   766   C1882979:Control [Conceptual Entity]
   766   C2587213:Control [Functional Concept]
   766   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.258: Conversely, expression of wt human PS1 had no overt effect upon amyloid burden (not shown). 

Phrase: "Conversely,"

Phrase: "expression of wt human PS1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "had"

Phrase: "no overt effect upon amyloid burden"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1301751:No effect [Qualitative Concept]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "). This effect was evident in terms of a potent increment in plaque burden over age-matched TgCRND8 single transgenic controls. Conversely, expression of wt human PS1 had no overt effect upon amyloid burden (not shown)."
Processing 00000000.tx.259: With a PS1 transgene incorporating two FAD mutations in cis (M146L and L286V (46)), the potentiation was particularly remarkable. 

Phrase: "With a PS1 transgene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0282641:Transgene [Gene or Genome]

Phrase: "incorporating"

Phrase: "two FAD mutations in cis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   795   C0026882:Mutations [Genetic Function]
   762 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(not shown). With a PS1 transgene incorporating two FAD mutations in cis (M146L"

Phrase: "and"

Phrase: "L286V"

Phrase: "(M146L and L286V (46"

Phrase: ")"

Phrase: ")"

Phrase: ","

Phrase: "the potentiation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0279023:Potentiation [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "particularly remarkable."
Processing 00000000.tx.260: Here there was robust deposition of plaques by 30-45 days of age (33days of age presented in Fig. 5B). 

Phrase: "Here there"

Phrase: "was"

Phrase: "robust deposition of plaques"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0333562:Deposition [Functional Concept]

Phrase: "by 30-45 days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0439228:days [Temporal Concept]
   793 E C0332173:/day [Temporal Concept]
   793 E C0439505:/day [Temporal Concept]

Phrase: "of age (33days"

Phrase: "of age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "presented in Fig. 5B"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0349966:Fig [Food]
   770   C0449450:Presented [Idea or Concept]
   770   C1337208:FIG [Food]
   737 E C0150312:Present [Quantitative Concept]

Phrase: "), the potentiation was particularly remarkable. Here there was robust deposition of plaques by 30-45 days of age (33days of age presented in Fig. 5B)."
Processing 00000000.tx.261: Notably, the graded effects observed for wild type, single, and double mutant transgenes upon amyloid deposition cannot be attributed to different PS1 expression levels, as these were very closely matched between the three selected TgPS1 lines (wild type, mutant, and double mutant, Fig. 1C). 

Phrase: "Notably,"

Phrase: "the graded effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: "observed for wild type, single,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0037179:Single [Population Group]
   760   C0087136:single [Finding]
   760   C0205171:Single [Quantitative Concept]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1441672:Observed [Functional Concept]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "double mutant transgenes upon amyloid deposition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0282641:Transgenes [Gene or Genome]

Phrase: "cannot"

Phrase: "be"

Phrase: "attributed to different PS1 expression levels,"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   756   C3244092:expression level [Idea or Concept]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0441889:Levels [Qualitative Concept]
   753   C1418985:PS1 [Gene or Genome]
   753   C1705242:Different [Qualitative Concept]
   753   C2986918:PS1 [Gene or Genome]
   719   C0449234:Attribute [Idea or Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719   C1704772:Attribute [Conceptual Entity]
   719   C1882133:Attribute [Qualitative Concept]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "as"

Phrase: "these"

Phrase: "were"

Phrase: "very closely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442824:Very [Qualitative Concept]

Phrase: "matched between the three selected TgPS1 lines"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   748   C0150103:matched [Research Activity]
   748   C0205132:lines [Spatial Concept]
   748   C0205449:Three [Quantitative Concept]
   748   C1708943:Matched [Qualitative Concept]
   714 E C1550648:Line [Substance]
   714 E C1552960:Line [Quantitative Concept]
   714   C1707391:Select [Activity]

Phrase: "(46)), the potentiation was particularly remarkable. Here there was robust deposition of plaques by 30-45 days of age (33days of age presented in Fig. 5B). Notably, the graded effects observed for wild type, single, and double mutant transgenes upon amyloid deposition cannot be attributed to different PS1 expression levels, as these were very closely matched between the three selected TgPS1 lines (wild type, mutant,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0596988:Mutant [Cell or Molecular Dysfunction]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "and"

Phrase: "double mutant,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "Fig. 1C"

Phrase: "). Notably, the graded effects observed for wild type, single, and double mutant transgenes upon amyloid deposition cannot be attributed to different PS1 expression levels, as these were very closely matched between the three selected TgPS1 lines (wild type, mutant, and double mutant, Fig. 1C)."
Processing 00000000.tx.262: View larger version (136K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(wild type, mutant, and double mutant, Fig. 1C). View larger version (136K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.263: 5.  

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.264: A-containing plaques in the cortex of single and double transgenic mice. 

Phrase: "A-containing plaques in the cortex of single"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   744   C0333463:plaques [Acquired Abnormality]
   711 E C0011389:Plaque [Disease or Syndrome]
   711 E C0332461:Plaque [Finding]

Phrase: "and"

Phrase: "double transgenic mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0025936:Mice, Transgenic [Mammal]
   827   C0003069:Transgenic [Animal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
Processing 00000000.tx.265: Panels show sagittal sections of the neocortex adjacent to the hippocampus. 

Phrase: "Panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "sagittal sections of the neocortex"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0205129:Sagittal [Spatial Concept]
   760   C0935598:Sagittal [Body Location or Region]
   726   C0205155:Section [Spatial Concept]
   726   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   726   C1522472:Section [Substance]
   726   C1552923:Section [Quantitative Concept]
   726   C1705191:Section [Physical Object]

Phrase: "adjacent to the hippocampus."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0205117:Adjacent to [Spatial Concept]
           Adjacent
Processing 00000000.tx.266: Left-hand panels (A and C) depict "single" transgenic TgCRND8 mice. 

Phrase: "Left-hand panels"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0441833:Panel [Idea or Concept]
   827   C1999270:Panel [Intellectual Product]
   827   C3537156:Panel [Manufactured Object]
   734   C0230371:Left hand [Body Part, Organ, or Organ Component]
   734   C1288949:Left hand [Body Part, Organ, or Organ Component]

Phrase: "(136K): [in this window] [in a new window]  Fig. 5.  A-containing plaques in the cortex of single and double transgenic mice. Panels show sagittal sections of the neocortex adjacent to the hippocampus. Left-hand panels (A"

Phrase: "and"

Phrase: "C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "depict"

Phrase: """single"" transgenic TgCRND8 mice."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C0025936:Mice, Transgenic [Mammal]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]
Processing 00000000.tx.267: Right-hand panels (B and D) depict "double" transgenic TgCRND8 mice co-expressing either human presenilin 1(B, TgPS1(M146L+L286V)6500; 

Phrase: "Right-hand panels"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0441833:Panel [Idea or Concept]
   827   C1999270:Panel [Intellectual Product]
   827   C3537156:Panel [Manufactured Object]
   734   C0230370:Right hand [Body Part, Organ, or Organ Component]
   734   C1288948:Right hand [Body Part, Organ, or Organ Component]

Phrase: "(A and C) depict ""single"" transgenic TgCRND8 mice. Right-hand panels (B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "D)"

Phrase: "depict"

Phrase: """"

Phrase: "double"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Double [Functional Concept]
  1000   C1705764:Double [Activity]
  1000   C1705765:Double [Qualitative Concept]

Phrase: """ transgenic TgCRND8 mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0025936:Mice, Transgenic [Mammal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "co-expressing"

Phrase: "either human presenilin 1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C1311407:presenilin-1, human [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418985:PRESENILIN 1 [Gene or Genome]
   812   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(B and D) depict ""double"" transgenic TgCRND8 mice co-expressing either human presenilin 1(B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "TgPS1"

Phrase: "(B, TgPS1(M146L+L286V"

Phrase: ")"

Phrase: "6500"

Phrase: ";"
Processing 00000000.tx.268: D, TgPS1(L286V)1274). 

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "TgPS1"

Phrase: "(M146L+L286V)6500; D, TgPS1(L286V"

Phrase: ")"

Phrase: "1274"

Phrase: ")1274)."
Processing 00000000.tx.269: Each horizontal row represents single and double -Tg littermates at the same age: A and B, 33days; 

Phrase: "Each horizontal row"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552846:Row [Idea or Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "single"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037179:Single [Population Group]
  1000   C0087136:single [Finding]
  1000   C0205171:Single [Quantitative Concept]

Phrase: "and"

Phrase: "double -"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Double [Functional Concept]
  1000   C1705764:Double [Activity]
  1000   C1705765:Double [Qualitative Concept]

Phrase: "Tg littermates at the same age"

Phrase: ":"

Phrase: "A"

Phrase: "and"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "33days"

Phrase: ";"
Processing 00000000.tx.270: C and D, 62days. 

Phrase: "C"

Phrase: "and"

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "62days."
Processing 00000000.tx.271: Immunohistochemical analyses presented were obtained with the 4G8 monoclonal antibody. 

Phrase: "Immunohistochemical analyses"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1441616:Immunohistochemical [Laboratory Procedure]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "were"

Phrase: "obtained with the 4G8 monoclonal antibody."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0746619:monoclonal [Finding]
   753   C1301820:Obtained [Functional Concept]
   719 E C1706701:Obtain [Activity]
Processing 00000000.tx.272: Note enhanced plaque deposition in double Tg animals.400magnification.  

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "enhanced plaque deposition in double Tg animals.400magnification."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0333562:Deposition [Functional Concept]
Processing 00000000.tx.273: DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES Factors Affecting APP Transgenesis-- Although transgenesis is generally regarded as a routine technique, the APP gene, first cloned over a decade ago, can be seen to present particular challenges. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1521761:Factor [Functional Concept]
   966   C2827422:Factor [Conceptual Entity]

Phrase: "Affecting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affecting [Functional Concept]
  1000   C1314939:Affecting [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "APP Transgenesis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0886519:Transgenesis [Research Activity]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "-"

Phrase: "-"

Phrase: "Although"

Phrase: "transgenesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0886519:Transgenesis [Research Activity]

Phrase: "is"

Phrase: "generally"

Phrase: "regarded as a routine technique,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205547:Routine [Qualitative Concept]
   760   C0449851:Technique [Functional Concept]

Phrase: "the APP gene,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0017337:Gene [Gene or Genome]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "cloned over a decade ago,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0009013:cloned [Cell]
   760   C2981279:Decade [Quantitative Concept]
   726 E C1522642:Clone [Tissue]

Phrase: "can"

Phrase: "be"

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "particular challenges."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0805586:challenges [Health Care Activity]
   827 E C0798503:Challenge [Clinical Attribute]
   827 E C3274764:Challenge [Conceptual Entity]
Processing 00000000.tx.274: Difficulties encountered thus far include low expression levels in first generation Tg mice, neonatal lethality associated with high level expression in second generation mice, and physiological endoproteolysis to generate multiple subfragments with diverse biological activities, some of which (e.g. neuroprotection (reviewed in Ref. 47) may confound the study of neuropathogenesis. 

Phrase: "Difficulties"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1299586:difficulties [Finding]
   916 E C0332218:Difficult [Qualitative Concept]

Phrase: "encountered"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0545082:Encounter [Behavior]
   966   C1512346:encounter [Health Care Activity]
   966   C1947978:Encounter [Behavior]

Phrase: "thus far"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205108:far [Spatial Concept]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "low expression levels in first generation Tg mice,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0441889:Levels [Qualitative Concept]
   737   C3244092:expression level [Idea or Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "neonatal lethality"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   964   C1857104:Neonatal lethal [Finding]
   789   C3151529:Lethal [Finding]

Phrase: "associated with high level expression"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   797   C3244092:expression level [Idea or Concept]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C0205250:High [Qualitative Concept]
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1299351:High [Qualitative Concept]
   760   C1547707:Level [Geographic Area]
   760   C2700149:HIGH [Intellectual Product]
   760   C2946261:Level [Pharmacologic Substance]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in second generation mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "and"

Phrase: "physiological endoproteolysis to"

Phrase: "generate"

Phrase: "multiple subfragments with diverse biological activities,"

Phrase: "some of which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205392:Some [Quantitative Concept]
   790   C3540770:Some [Intellectual Product]

Phrase: "("

Phrase: "e.g. neuroprotection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0598958:Neuroprotection [Cell Function]

Phrase: "("

Phrase: "reviewed in Ref. 47"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0282443:reviewed [Intellectual Product]
   770   C1425988:REF [Gene or Genome]
   770   C1709940:Reviewed [Qualitative Concept]
   737 E C1552617:Review [Idea or Concept]

Phrase: ")"

Phrase: "may"

Phrase: "confound"

Phrase: "the study of neuropathogenesis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0557651:Study [Manufactured Object]
   770   C2603343:Study [Research Activity]
Processing 00000000.tx.275: We modified a number of parameters in our experimental design in an effort to reduce the "noise" from these confounding effects and thereby facilitate study of the pathogenic attributes of the A peptide; 

Phrase: "We"

Phrase: "modified"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Modified [Functional Concept]

Phrase: "a number of parameters"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "in our experimental design"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0015320:Experimental Design [Research Activity]
  1000   C0035171:Experimental Design [Research Activity]
   861   C1517586:Experimental [Qualitative Concept]
   861   C1707689:Design [Activity]
   861   C2983265:DESIGN [Intellectual Product]

Phrase: "in an effort to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015264:Effort [Organism Function]

Phrase: "reduce"

Phrase: "the ""noise"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028263:Noise [Phenomenon or Process]

Phrase: "from these confounding effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "thereby"

Phrase: "facilitate"

Phrase: "study of the pathogenic attributes of the"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0557651:Study [Manufactured Object]
   748   C2603343:Study [Research Activity]

Phrase: "A peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: ";"
Processing 00000000.tx.276: such pathogenic attributes are clearly suggested by genetic, neuropathological, and toxicological studies (12-14, 48). 

Phrase: "such pathogenic attributes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0449234:Attribute [Idea or Concept]
   827   C1704772:Attribute [Conceptual Entity]
   827   C1882133:Attribute [Qualitative Concept]

Phrase: "are"

Phrase: "clearly"

Phrase: "suggested by genetic, neuropathological,"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
   770   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   770   C0314603:Genetic [Functional Concept]
   737   C1705535:Suggest [Idea or Concept]
   715 E C0005615:Birth [Organism Function]
   715 E C0035150:Reproduction [Organism Function]
   715 E C0079946:origin [Classification]
   715 E C0439659:Origin [Temporal Concept]
   715 E C1550512:origin [Intellectual Product]
   715 E C1550722:birth [Idea or Concept]
   715 E C3245487:birth [Intellectual Product]

Phrase: "and"

Phrase: "toxicological studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   964   C0808279:Toxicology studies [Research Activity]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "(reviewed in Ref. 47) may confound the study of neuropathogenesis. We modified a number of parameters in our experimental design in an effort to reduce the ""noise"" from these confounding effects and thereby facilitate study of the pathogenic attributes of the A peptide; such pathogenic attributes are clearly suggested by genetic, neuropathological, and toxicological studies (12-14,"

Phrase: "48"

Phrase: ") may confound the study of neuropathogenesis. We modified a number of parameters in our experimental design in an effort to reduce the ""noise"" from these confounding effects and thereby facilitate study of the pathogenic attributes of the A peptide; such pathogenic attributes are clearly suggested by genetic, neuropathological, and toxicological studies (12-14, 48)."
Processing 00000000.tx.277: Our strategy involved using the following: (i) an expression cassette that retained ~90 nucleotides of the APP mRNA 5'-untranslated region adjacent to the start codon, as APP is expressed at high levels for a single copy gene and likely already contains optimized translational initiation signals; 

Phrase: "Our strategy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0679199:strategy [Mental Process]

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "(12-14, 48). Our strategy involved using the following: (i)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "an expression cassette"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450240:Cassette [Medical Device]
   861   C1706210:Cassette [Manufactured Object]

Phrase: "that retained ~90 nucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "of the APP mRNA 5'-untranslated region"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C1514562:Protein Region [Amino Acid Sequence]
   818   C0600680:Untranslated Region [Nucleic Acid, Nucleoside, or Nucleotide]
   795   C0017446:Region [Geographic Area]
   795   C0205147:Region [Spatial Concept]
   724 E C0205276:Regional [Spatial Concept]
   724 E C1947913:Regional [Spatial Concept]

Phrase: "adjacent to the start codon,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0205117:Adjacent to [Spatial Concept]
           Adjacent

Phrase: "as"

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "is"

Phrase: "expressed at high levels"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0205250:High [Qualitative Concept]
   770   C0441889:Levels [Qualitative Concept]
   770   C1299351:High [Qualitative Concept]
   770   C2700149:HIGH [Intellectual Product]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "for a single copy gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0017337:Gene [Gene or Genome]
   827   C0037179:Single [Population Group]
   827   C0087136:single [Finding]
   827   C0205171:Single [Quantitative Concept]
   827   C1948062:Copy [Manufactured Object]

Phrase: "and"

Phrase: "likely already"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "optimized translational initiation signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1710082:Signal [Phenomenon or Process]

Phrase: ";"
Processing 00000000.tx.278: (ii) a prion protein cosmid vector that can drive high level pan-neuronal expression in the central nervous system; 

Phrase: "(i) an expression cassette that retained ~90 nucleotides of the APP mRNA 5'-untranslated region adjacent to the start codon, as APP is expressed at high levels for a single copy gene and likely already contains optimized translational initiation signals; (ii"

Phrase: ")"

Phrase: "a prion protein cosmid vector"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1511534:Cosmid Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0442335:Vector [Spatial Concept]
   812   C1705099:Vector [Idea or Concept]

Phrase: "that"

Phrase: "can"

Phrase: "drive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013126:Drive [Mental Process]

Phrase: "high level pan-neuronal expression in the central nervous system"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C3244092:expression level [Idea or Concept]
   739   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: ";"
Processing 00000000.tx.279: (iii) two pro-endoproteolytic FAD mutations, to obtain a high level of A peptide for a given level of APP expression; 

Phrase: "(ii) a prion protein cosmid vector that can drive high level pan-neuronal expression in the central nervous system; (iii"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: "two pro-endoproteolytic FAD mutations,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   795   C0026882:Mutations [Genetic Function]
   762 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "a high level of A peptide"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0205250:High [Qualitative Concept]
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1299351:High [Qualitative Concept]
   753   C1547707:Level [Geographic Area]
   753   C2700149:HIGH [Intellectual Product]
   753   C2946261:Level [Pharmacologic Substance]

Phrase: "for a given level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1547707:Level [Geographic Area]
   861   C2946261:Level [Pharmacologic Substance]

Phrase: "of APP expression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1171362:protein expression [Genetic Function]
   812   C0185117:Expression [Therapeutic or Preventive Procedure]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.280: and (iv) use of a genetic background that may offer a degree of protection against high level APP expression favored by parameters i and ii. 

Phrase: "and ("

Phrase: "iv)"

Phrase: "use of a genetic background"
Meta Candidates (Total=14; Excluded=7; Pruned=0; Remaining=7)
   806   C1524063:Use of [Functional Concept]
   760   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   760   C0042153:use [Functional Concept]
   760   C0314603:Genetic [Functional Concept]
   760   C0457083:Use [Functional Concept]
   760   C1706907:Background [Conceptual Entity]
   760   C1947944:Use [Intellectual Product]
   704 E C0005615:Birth [Organism Function]
   704 E C0035150:Reproduction [Organism Function]
   704 E C0079946:origin [Classification]
   704 E C0439659:Origin [Temporal Concept]
   704 E C1550512:origin [Intellectual Product]
   704 E C1550722:birth [Idea or Concept]
   704 E C3245487:birth [Intellectual Product]

Phrase: "that"

Phrase: "may"

Phrase: "offer"

Phrase: "a degree of protection"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0441889:Degree [Qualitative Concept]
   770   C0449286:Degree [Quantitative Concept]
   770   C0542560:Degree [Intellectual Product]
   770   C1561545:degree [Quantitative Concept]
   770   C2348088:Degree [Quantitative Concept]

Phrase: "against high level APP expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1171362:protein expression [Genetic Function]
   799   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "favored by parameters i"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0021966:I- [Inorganic Chemical]
   770   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0449381:Parameters [Finding]
   737   C0309049:FAVOR [Organic Chemical,Pharmacologic Substance,Vitamin]
   737 E C0549193:Parameter [Spatial Concept]
   737 E C1704769:Parameter [Conceptual Entity]
   737 E C2350001:Parameter [Quantitative Concept]

Phrase: "and"

Phrase: "ii."
Processing 00000000.tx.281: It is possible that genetic background may have been important for establishing the TgCRND8 line. 

Phrase: "It"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that genetic background"
Meta Candidates (Total=17; Excluded=14; Pruned=0; Remaining=3)
   861   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   861   C0314603:Genetic [Functional Concept]
   861   C1706907:Background [Conceptual Entity]
   805 E C0005615:Birth [Organism Function]
   805 E C0035150:Reproduction [Organism Function]
   805 E C0079946:origin [Classification]
   805 E C0439659:Origin [Temporal Concept]
   805 E C1550512:origin [Intellectual Product]
   805 E C1550722:birth [Idea or Concept]
   805 E C3245487:birth [Intellectual Product]
   777 E C0454729:Natal [Geographic Area]
   777 E C0559522:Genital [Body System]
   777 E C1546649:Genital [Intellectual Product]
   777 E C1550642:Genital [Body Substance]
   768 E C0205313:Original [Idea or Concept]
   768 E C2347409:Original [Occupational Activity]
   750 E C0598240:originality [Mental Process]

Phrase: "may"

Phrase: "have"

Phrase: "been"

Phrase: "important for establishing"

Phrase: "the TgCRND8 line."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]
Processing 00000000.tx.282: Our strategy was based upon the hypothesis that dominant alleles protective against APP overexpression present in the C3H background (36) would facilitate the establishment of Tg lines with high levels of expression. 

Phrase: "Our strategy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0679199:strategy [Mental Process]

Phrase: "was"

Phrase: "based upon the hypothesis"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C1512571:Hypothesis [Idea or Concept]
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]

Phrase: "that dominant alleles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0683222:dominant allele [Gene or Genome]
   861   C0002085:Alleles [Gene or Genome]

Phrase: "protective against APP overexpression present"

Phrase: "in the C3H background"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1706907:Background [Conceptual Entity]

Phrase: "(iii) two pro-endoproteolytic FAD mutations, to obtain a high level of A peptide for a given level of APP expression; and (iv) use of a genetic background that may offer a degree of protection against high level APP expression favored by parameters i and ii. It is possible that genetic background may have been important for establishing the TgCRND8 line. Our strategy was based upon the hypothesis that dominant alleles protective against APP overexpression present in the C3H background (36"

Phrase: ")"

Phrase: "would"

Phrase: "facilitate"

Phrase: "the establishment of Tg lines"

Phrase: "with high levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "of expression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.283: As injections into C3H oocytes are not usually attempted, the TgCRND8 line was established in an outbred C3H/B6 background. 

Phrase: "As injections"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0021485:injections [Therapeutic or Preventive Procedure]
  1000   C1533685:INJECTIONS [Therapeutic or Preventive Procedure]
  1000   C1828121:Injections [Functional Concept]
   966 E C1272883:Injection [Biomedical or Dental Material]

Phrase: "into C3H oocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0029045:Oocytes [Cell]

Phrase: "are"

Phrase: "not usually"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "attempted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1516084:Attempt [Event]

Phrase: ","

Phrase: "the TgCRND8 line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: "was"

Phrase: "established in an outbred C3H/B6 background."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0025920:C3H [Mammal]
   748   C0443211:Established [Qualitative Concept]
   748   C0507115:B6 [Body Part, Organ, or Organ Component]
   748   C1272684:Established [Qualitative Concept]
   748   C1521751:B6 [Mammal]
   748   C1706907:Background [Conceptual Entity]
Processing 00000000.tx.284: Survival curves presented here document that in TgCRND8 mice high levels of A peptide and modest levels of APP - and -stubs can be tolerated in a C3H/B6 genetic background without grossly compromising viability (Fig. 2). 

Phrase: "Survival curves"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0038952:Survival [Activity]
   861   C0220921:survival [Functional Concept]
   827   C0205134:Curve [Spatial Concept]

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "here"

Phrase: "document"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1301746:document [Intellectual Product]
  1000   C1547673:Document [Intellectual Product]

Phrase: "that in TgCRND8 mice high levels of A peptide"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   742   C0025914:Mice [Mammal]
   742   C0025929:mice [Mammal]
   742   C0026809:Mice [Mammal]
   742   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   742   C0205250:High [Qualitative Concept]
   742   C0441889:Levels [Qualitative Concept]
   742   C1299351:High [Qualitative Concept]
   742   C2700149:HIGH [Intellectual Product]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "modest levels of APP -"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   767   C0428479:Protein level [Laboratory or Test Result]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "and -"

Phrase: "stubs"

Phrase: "can"

Phrase: "be"

Phrase: "tolerated in a C3H/B6 genetic background"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   748   C0025920:C3H [Mammal]
   748   C0314603:Genetic [Functional Concept]
   748   C0507115:B6 [Body Part, Organ, or Organ Component]
   748   C1521751:B6 [Mammal]
   748   C1706907:Background [Conceptual Entity]

Phrase: "without grossly"

Phrase: "compromising"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2945640:compromise [Finding]

Phrase: "viability"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443348:viability [Qualitative Concept]

Phrase: "(36) would facilitate the establishment of Tg lines with high levels of expression. As injections into C3H oocytes are not usually attempted, the TgCRND8 line was established in an outbred C3H/B6 background. Survival curves presented here document that in TgCRND8 mice high levels of A peptide and modest levels of APP - and -stubs can be tolerated in a C3H/B6 genetic background without grossly compromising viability (Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ") would facilitate the establishment of Tg lines with high levels of expression. As injections into C3H oocytes are not usually attempted, the TgCRND8 line was established in an outbred C3H/B6 background. Survival curves presented here document that in TgCRND8 mice high levels of A peptide and modest levels of APP - and -stubs can be tolerated in a C3H/B6 genetic background without grossly compromising viability (Fig. 2)."
Processing 00000000.tx.285: Whereas these data are in accord with the starting hypothesis, they are incompatible with facile genetic analysis, as confounding effects due to independent segregation of alleles from the C3H and B6 strains conferring protection or sensitivity to APP overexpression cannot be excluded. 

Phrase: "Whereas"

Phrase: "these data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are in accord"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0680240:accord [Social Behavior]
   790   C1551058:Are [Quantitative Concept]

Phrase: "with the starting hypothesis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1512571:Hypothesis [Idea or Concept]

Phrase: "they"

Phrase: "are"

Phrase: "incompatible with facile genetic analysis,"

Phrase: "as"

Phrase: "confounding effects due to independent segregation of alleles"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C1280500:effects [Qualitative Concept]
   711 E C2348382:Effect [Qualitative Concept]

Phrase: "from the C3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025920:C3H [Mammal]

Phrase: "and"

Phrase: "B6 strains"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0080194:Strains [Injury or Poisoning]
   861   C0456178:strains [Intellectual Product]
   827 E C1518614:Strain [Organism]
   827 E C2987481:Strain [Mental Process]

Phrase: "conferring"

Phrase: "protection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1545588:Protection [Finding]

Phrase: "or"

Phrase: "sensitivity to APP overexpression"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   754   C0332324:Sensitive to [Functional Concept]
   753   C0036667:Sensitivity [Quantitative Concept]
   753   C0312418:Sensitivity [Mental Process]
   753   C0427965:Sensitivity [Finding]
   753   C1511883:Sensitivity [Quantitative Concept]
   753   C1522640:Sensitivity [Qualitative Concept]
   753   C2346484:SENSITIVITY [Phenomenon or Process]
   753   C2349185:Sensitivity [Qualitative Concept]

Phrase: "cannot"

Phrase: "be"

Phrase: "excluded."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1554077:Excluded [Idea or Concept]
  1000   C2828389:Excluded [Activity]
   966 E C0332196:Exclude [Functional Concept]
Processing 00000000.tx.286: Experiments to establish C3H congenic lines of TgCRND8 mice will lead to more definitive information on this point. 

Phrase: "Experiments to"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "establish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establish [Qualitative Concept]

Phrase: "C3H) yielded a number of putative founders but just two stable transgenic lines designated Tg CRND6 and TgCRND8. These lines harbor APPSwe and APPSwe+V717F transgenes, respectively. Expression of APP and A Peptide in TgCRND8 Mice APP-specific antibodies were used to establish transgene expression from founder lines, with previously characterized TgAPPwt6209 transgenic mice providing a point of reference (22). Use of the N-terminal antibody 22C11, which reacts with mouse and human APP, demonstrated overexpression of the full-length mature form of APP of ~120 kDa and different lower molecular mass species of 100kDa (which are not resolved in this gel system), including immature APP, and APP cleaved at the - and -secretase sites, APPS and APPS (Fig. 1A). Overexpression in the TgCRND8 line relative to mouse APP holoprotein detected in non-Tg controls was estimated by quantitative image analysis at ~5-fold. Similar results for high molecular weight APP species were obtained with antibody 369,which reacts with an epitope close to the C terminus of APP shared by mouse and human APP (Fig. 1A). Lower molecular weight species deriving from APP processing were also observed in brain extracts of TgCRND8 and TgCRND6 mice analyzed with the human APP-specific monoclonal antibody 6E10 antiserum (epitope positioned N-terminal to the -secretase cleavage site) and antibody 369.These polypeptides represent APP C-terminal stubs arising from cleavage at the - and -secretase sites, with antibody 369recognizing both species and antibody 6E10 recognizing only the longer -stubs. As anticipated, the APP6209 Tg line encoding wt human APP does not exhibit -stubs (as it lacks the Swedish mutation that favors cleavage at this position) but exhibits -stubs with a reduced electrophoretic mobility due to the inclusion of a c-Myc epitope tag within the C terminus of the APP cDNA cassette (22). View larger version (42K): [in this window] [in a new window]  Fig. 1.  Western blot analysis of transgene expression. 10% brain homogenates made in 0.32M sucrose were diluted with Laemmli buffer, sonicated, and run on 10-20% Tricine gradient gels (NOVEX). Following transfer to nitrocellulose, human APP and PS1 were detected using C- and N-terminal-specific mAbs and developed by ECL (Amersham Pharmacia Biotech). A, comparison of APP expression levels in Tg lines. 1st lane, Non-Tg; 2nd lane, Tg CRND6; 3rd lane, Tg CRND8; and 4th lane, Tg APP6209. Proteins were detected with human APP-specific C-terminal mAb 6E10 (left panel), C-terminal antibody 369reactive against mouse and human APP (right panel), and N-terminal antibody 22C11, also reactive against mouse and human APP (lower panel). Positions of high molecular weight APP holoprotein and holoprotein derivatives (""APP holoprotein""), and C-terminal stubs are indicated. B, time course of A accumulation in Tg CRND8 mice: 1st lane, 60days; 2nd lane, 120days; 3rd lane, 180days; 4th lane, 240days; and 5th lane, 300days. Detected with human-specific APP C-terminal mAb 6E10. C, comparison of protein expression levels in Tg mice expressing single and double mutants of PS1. Normalized samples of brain homogenates are presented. Detection is with the human-specific PS1 N-terminal mAb NT-1 (72). Lane 1,Non-Tg; lane 2, TgPS1(L286V)1274; lane 3, TgPS1(WT)1098; and lanes 4and 5represent samples from TgPS1(L286V+M146L)6500 mice. In TgCRND8 mice, increasing levels of a 4-kDa species (but not -stubs) were detected by Western blot analysis as the animals aged (Fig. 1B). To investigate the composition of these 4-kDa A peptide species, we performed ELISAs specific for A40 and A42. Both human A40 and A42 were detected in the brains of Tg CRND8 mice. No signals above background were detected in non-Tg animals. Levels of both peptides increased with age, although in different fashions (Table I). Thus A40 levels were stable between 4and 10weeks of age. A42 increased slowly between 4and 8weeks, with a potent increase at age 10weeks, such that it predominated over A40 by a ratio of ~5:1. There was considerable spread in A40 and A42 levels in 10-week-old mice, with levels of A40 varying from 25to 234ng/g of brain and A42 ranging from 115to 728ng/g of brain. The increase in A42 and the sample-to-sample variation between mice at age 10weeks likely represents a transition point as A42, first present in soluble form, begins to assemble into insoluble amyloid deposits. Measured at 6months of age, levels of both A42 and A40 were enormously increased and were ~510 and 190times, respectively, the levels observed in 4-week-old mice (which are free of amyloid plaque deposits; Fig. 5A).  View this table: [in this window] [in a new window]  Table I A peptide species in young TgCRND8 mice Postnatal Lethality in TgCRND8 Mice To gain insight into the ability of genetic backgrounds to modulate lethality associated with APP overexpression (and, from a practical point of view, to preempt premature extinction), the newly established TgCRND8 line was bred to different strain backgrounds. Progeny of an F1 cross to the C3H/HeJ (""C3H"") strain were bred to mice derived from FVB/N and 129SvEv/Tac backgrounds. Estimated Kaplan-Meier cumulative survival curves for TgCRND8 mice and their littermates during post-natal development are presented in Fig. 2. Inspection of the curves clearly indicates improved survival of mice with the APP transgene expressed on the (C57)(C3H/C57) genetic background. In this cohort of Tg mice (n=52), 20mice died before the age of 120days, decreasing their survival to 60% and with three deaths at 130days and three further deaths after 250days. When the APP transgene was expressed on either (C3H/C57/129SvEv/Tac)(129SvEv/Tac) or (FVB)(C3H/C57) genetic backgrounds (n=12and n=41respectively), survival dropped rapidly to 25-40% within the first 120days of their post-natal life (Fig. 2). After this time point, survival with the (C3H/C57/129SvEv/Tac)(129SvEv/Tac) genetic background dropped slightly to 33% (one death at 159days) with only 25% (3mice) of the cohort surviving until 365days. Similarly, the survival of the TgCRND8 mice with (FVB)(C3H/C57) background dropped rapidly within the first 120days of post-natal age (Fig. 2) with 17% of mice (n=7) surviving until 365days of age. The survival of mice with the (C57)(C3H/C57) was significantly better than survival of Tg mice with (FVB)(C3H/C57) or (C3H/C57/129SvEv/Tac)(129SvEv/Tac) backgrounds (Tarone-Ware statistics: 5.13,p<0.05,and 19.01,p<0.001,respectively). The survival curves of the latter two genetic backgrounds did not differ significantly from each other (Tarone-Ware statistics: 0.42,p>0.05), and the survival of TgCRND8 mice with the three genetic backgrounds was significantly different from the survival of non-Tg littermates (Tarone-Ware statistics >50, all p values<0.001. View larger version (20K): [in this window] [in a new window]  Fig. 2.  Cumulative survival curves (Kaplan-Meier survival analysis) of TgCRND8 mice in different genetic backgrounds. Cumulative survival curves of TgCRND8 mice as a function of the transgene genetic background. The survival of Tg mice on the (C57)(C3H/C57) genetic background (n=52) was the highest, with 50% of mice surviving until 365days of age (upper cut-off of the analysis). In contrast, the survival of the Tg mice on (C3H/C57/129SvEv/Tac)(129SvEv/Tac) and (FVB)(C3H/C57) backgrounds (n=12and n=41respectively) was affected by increased mortality within the first 120days of their post-natal age. In the case of Tg mice with the (C3H/C57/129SvEv/Tac)(129SvEv/Tac) genetic background, only 3(25%) out of 12mice survived until the age of 365days, and only 17% (7out of 41) of the (FVB)(C3H/C57) Tg mice reached the age of 365days. Although these data suggest significantly increased mortality of TgCRND8 mice as a consequence of a genetic contribution of 129SvEv/Tac or FVB mouse strains, some caveats have to be taken into consideration. First, the relatively small sample sizes of the studied cohorts, especially with the 129SvEv/Tac strain, where only a few mice survived for a long period, may not reliably reflect survival rates at later stages of life. The comparisons of larger cohorts should provide better estimation of survival curves. Second, future survival censuses must be extended to the pre-weaning developmental stage. The selective survival of pups before weaning, or for that matter at the pre-natal stage of development, may cause a bias of a particular cohort entering post-weaning stage. Also, the genetic composition of the particular outbred TgCRND8 parent might be a greater contributor to the differences in survival among the crosses than the composition of the inbred parent. Nonetheless, the major finding of the survival analysis, that the (C57)(C3H/C57) genetic background significantly reduces mortality in TgCRND8 mice, is in accord with our starting hypothesis. Fifty percent of the studied cohort of 52mice survived for a year with minimal mortality observed after the first 3months of age. As shown in previous investigations, the cause of post-natal lethality was not obvious (22). No overt changes were revealed by routine histopathology, although it should be noted that seizures were observed in a small fraction of TgCRND8 animals, and APP transgenes have been correlated with altered vascular responses (37). Cognitive Changes in TgCRND8 Mice Non-spatial Pre-training-- Partial results related to the impaired acquisition of spatial information, as measured by the escape latency, were reported previously for a small cohort of mice (1). Here we present a characterization of a larger cohort of mice, and we include their behavioral analysis during NSP. The analysis showed that during NSP at age 10.5weeks TgCRND8 mice performed comparably to non-Tg littermates when randomly searching the pool for a hidden platform. Escape latencies and lengths of search paths in the last trial of NSP for the groups were not significantly different (50.07.3versus 57.68.8s for latency and 961.1165.0versus 1351247.4cm for path-length, for the non-Tg and Tg mice, respectively). A ""visible platform trial"" administered during NSP, where the position of the submerged platform was marked by a striped beacon, also failed to reveal differences in performance between non-Tg and Tg groups. Average latencies to reach the cued platform were 9.92.0and 9.11.6s for non-Tg and Tg mice, respectively. The swim paths were 167.316.1cm for non-Tg and 153.114.2cm for Tg mice, and both groups had comparable swim speeds of 21.61.4and 20.21.7cm/s for non-Tg and Tg mice, respectively. In conclusion, these analyses showed TgCRND8 mice performed a random search comparable to non-Tg littermates when presented with the submerged platform and had similar swim paths to a visible platform when extra-maze distal spatial cues were occluded by a curtain. Water Maze, Reference Memory Test-- TgCRND8 mice at 11weeks showed impairment in the acquisition of spatial information during place discrimination training. They had significantly longer escape latencies to reach the escape platform (Fig. 3A; F(1,15)=17.98,p<0.001) and longer search paths (F(1,15)=15.91,p<0.001). Both, Tg and non-Tg groups significantly improved during training (F(4,60)=3.29,p<0.02; F(4,60)=3.33,p<0.02,the latency and path, respectively), and no significant interaction between the groups and sessions was found in both measures. The concordance between measures of latency and search path is not surprising, because the TgCRND8 mice did not differ significantly from the non-Tg littermates in their swim speed during the test (F(1,15)=2.53,p>0.05). The pronounced spatial learning impairment of Tg mice was confirmed during the probe trial administered after the completion of training. They showed lower (t(15)=2.99,p=0.01) annulus crossing index (Fig. 3B), searching the pool in a circular fashion and frequently crossing the centers of alternative quadrants (with an annulus crossing index approaching a zero value). View larger version (15K): [in this window] [in a new window]  Fig. 3.  Reference memory version of Morris water maze test in TgCRND8 mice. A, at 11weeks of age, experimentally naive TgCRND8 mice (NTg=10) show significant impairment in the acquisition of the spatial information relative to their non-Tg littermates (Nnon-Tg=7). B, represents an annulus crossing index (the number of passes over the platform site in TQ, minus the mean of passes over alternative sites in other quadrants) during the probe trial administered after the last training trial of day 5.A positive index indicates selective focal search of the previous platform position, an index approximating zero reflects non-spatial or circular search of the pool. The TgCRND8 mice showed a significantly impaired (p<0.01) spatial bias for the platform position as compared with their non-Tg littermates. *, p<0.01.Vertical bars represent S.E. Neuropathology in TgCRND8 Mice TgCRND6 mice expressing the Swedish mutant form of APP (see Fig. 1) on a B6C3H background failed to exhibit cerebral amyloid at ages up to 450days. Similar results were obtained for two other Tg lines resulting from the microinjection of the same DNA construct into a FVB/N129SvEv/Tac background (not shown). On the other hand, hemizygous TgCRND8 mice expressing the double mutant form of APP exhibited potent deposition of cerebral amyloid, present in all animals by 90days of age. In contrast to PDAPP mice expressing a V717F APP transgene (21), no difference in the volume of the dorsal hippocampus (or in the surrounding regions) was detected between Tg and non-Tg mice (p<0.05for all values). In TgCRND8 mice, the dorsal hippocampus occupied ~11.00.3% of the volume of coronal sections (meansS.E. of the mean), whereas in the non-Tg mice this value was 10.30.2%. Also, the neuronal cytoarchitecture of the TgCRND8 mice appeared normal. Amyloid deposits in TgCRND8 mice were successfully stained with A42-specific antibodies, as anticipated from prior studies of the mechanism of action of the V717F mutation (5). In addition to confirming dense-cored deposits in aged TgCRND8 mice, the human APP-specific monoclonal antibody 4G8, and to a lesser extent monoclonal antibody 6F/3D, also detected diffuse immuno-staining in the neuropil (using formic acid-treated sections: Fig. 4B). These findings were compatible with both the previously described specificity of the 4G8 antibody (42, 43), and the propensity of other mice expressing APP codon 717mutations to generate ""diffuse"" amyloid deposits (19, 21, 23). Although human APP was also expressed systemically in TgCRND8 mice, in accord with the tropism of the PrP gene promoter (44), amyloid deposits were not apparent by immunostaining in the kidney, lung, skeletal, and cardiac muscle of aged animals (not shown). These observations suggest a role for tissue-specific factors affecting amyloid deposition and/or APP processing. View larger version (124K): [in this window] [in a new window]  Fig. 4.  Properties of amyloid deposits from TgCRND8 mice. A, sagittal section of an 8-month-old TgCRND8 mouse immunostained with 4G8 anti-A antibody: Cer, cerebellum; HPC, hippocampus; N, neocortex; OB, olfactory bulb. B, dentate gyrus (400magnification) in a 12-month-old TgCRND8 mouse immunostained with 6F/3D antibody and illustrating different varieties of amyloid deposits: dense-cored (red arrow), multicored (gray arrow), and diffuse (black arrow). C-K illustrate the tinctorial and immunostaining profiles of amyloid deposits in a 5.5-month-old TgCRND8 mice (400magnification). C, staining with Congo Red showed typical apple green and orange birefringence with a polarized light source. D, perivascular amyloid stained with thioflavine S (white arrows). Bielschowsky stain (E) and NF-200 (F) reveal dystrophic neurites (arrows) adjacent to plaques (P). G and H represent synaptophysin and ubiquitin-positive structures in the periphery of plaque deposits, indicative of dystrophic buttons. I-K illustrate focal inflammatory responses. I, anti-CD11b antibody, J, thioflavine S stain of an adjacent section, and K, GFAP staining of a third adjacent section. Plaque Ontogeny-- A single plaque was noted in one TgCRND8 animal at 43days. Plaque load increased with age and spread to more regions of the brain such that multiple plaque deposits were present per sagittal section in most mice at 65days of age, and in all mice by 90days of age. Although studies on large cohorts of mice are in progress, analyses of representative mice revealed between 11-35 and 22-43 plaques in a mid-sagittal section of the cortex at the ages of 90and 150days, whereas burdens were greatly increased at 240and 350days of age (127-416 and 528-1024 plaques, respectively). A similar pattern of increase pertained to the hippocampal formation with 1-5 and 11-12 plaques at 90and 150days and 39-65 and 123-147 plaques at 240and 360days, respectively. Thus, the time period for a rapid increase in amyloid burden assessed histologically lags slightly behind that determined biochemically by ELISA assays (Table I). Plaque Distribution-- The plaque present at 43days was located in the subiculum. The frontal cortex of TgCRND8 mice often had several plaques by 65days, whereas plaques were rare or absent in the white matter tracts (corpus callosum and alveus) and CA1 region of the hippocampus at this time. By 101days plaques were widespread in many regions of the cortex as well as in the hippocampus proper, the dentate gyrus, the olfactory bulb, and within the pial vessels. The thalamus (111days), then the cerebral vasculature and striatum (196days), followed by the cerebellum and brain stem (243days) all became progressively burdened by plaques. This pattern of deposition, with cortex and hippocampus affected early on and the cerebellum spared until a late stage in disease, is similar to that seen in AD (45). Plaque Morphology-- The first plaques observed were small, cored deposits, with no radiating amyloid surrounding them (65days). By 101days, the plaques varied in size, with some larger plaques having haloes of radiating amyloid. By 131days the plaques became more heterogeneous in nature. Plaques varied greatly in size as the age of the mice increased, with some being multicored in older animals. Diffuse amyloid deposits appeared in the olfactory bulb at an early stage (101days). However, outside of the olfactory bulb, diffuse amyloid (i.e. amyloid not obviously associated with a cored plaque) did not appear until 243days, as detected with the 6F/3D antibody. Diffuse amyloid was found primarily in the caudate, cerebellum, and molecular layer of the dentate gyrus (all at 243days). By 315days diffuse amyloid appeared throughout the cortex (see Fig. 4B). The majority of amyloid plaque deposits in TgCRND8 mice, including those first to appear at 65days, stained positive for thioflavine S.These early deposits also revealed Congo Red birefringence. Together these data indicate the deposited amyloid peptide adopts a -sheet conformation. Amyloid plaques in TgCRND8 mice were associated with dystrophic neurites, as indicated by a variety of histochemical and immunohistochemical stains (Fig. 4). For example, Bielschowsky silver impregnation revealed dystrophic neuritic processes around plaque cores (Fig. 4E). Similar structures were imaged by antibodies raised against the 200-kDa isoform of neurofilament (NF-200; Fig. 4F), synaptophysin (Fig. 4G), and ubiquitin (Fig. 4H). The first enlarged plaque-associated neurites were seen with Bielschowsky, synaptophysin, and NF-200 staining at 111days of age. Dystrophic pathology became more evident as the mice aged further and the frequency of large, dense-cored plaques increased. Finally, it was noteworthy that dystrophic neurites were only observed in the immediate vicinity of plaques, indicating these structures are a direct consequence of amyloid deposition in the TgCRND8 mice. Neuroinflammation-- Mature plaques in TgCRND8 mice were associated with a focal inflammatory response. Elongated cells in periphery of dense-cored amyloid deposits visualized by Luxol fast blue staining or focal staining with a Griffonia simplicifolia lectin I isolectin B4 stain (not presented) and staining with anti-CD11b antibody probe (Fig. 4I) were consistent with the presence of microglial cells. This microglial activation was accompanied by intense local astrocytic gliosis, illustrated by GFAP staining of adjacent sections encompassing a thioflavin-positive plaque (Fig. 4, K and J). This astrocytic response clearly exceeded a low basal level of staining of GFAP-positive astrocytes (mostly evident within white matter tracts) noted in both transgenic and non-transgenic mice. Acceleration of Amyloid Deposition by Co-expression of Presenilin-1 Transgenes Amyloid deposition in TgCRND8 mice was enhanced by mutant human PS1 transgenes co-expressed with human APP via usage of the same cos.Tet transgene vector (Fig. 5, right-hand panels). This effect was evident in terms of a potent increment in plaque burden over age-matched TgCRND8 single transgenic controls. Conversely, expression of wt human PS1 had no overt effect upon amyloid burden (not shown). With a PS1 transgene incorporating two FAD mutations in cis (M146L and L286V (46)), the potentiation was particularly remarkable. Here there was robust deposition of plaques by 30-45 days of age (33days of age presented in Fig. 5B). Notably, the graded effects observed for wild type, single, and double mutant transgenes upon amyloid deposition cannot be attributed to different PS1 expression levels, as these were very closely matched between the three selected TgPS1 lines (wild type, mutant, and double mutant, Fig. 1C). View larger version (136K): [in this window] [in a new window]  Fig. 5.  A-containing plaques in the cortex of single and double transgenic mice. Panels show sagittal sections of the neocortex adjacent to the hippocampus. Left-hand panels (A and C) depict ""single"" transgenic TgCRND8 mice. Right-hand panels (B and D) depict ""double"" transgenic TgCRND8 mice co-expressing either human presenilin 1(B, TgPS1(M146L+L286V)6500; D, TgPS1(L286V)1274). Each horizontal row represents single and double -Tg littermates at the same age: A and B, 33days; C and D, 62days. Immunohistochemical analyses presented were obtained with the 4G8 monoclonal antibody. Note enhanced plaque deposition in double Tg animals.400magnification.  DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES Factors Affecting APP Transgenesis-- Although transgenesis is generally regarded as a routine technique, the APP gene, first cloned over a decade ago, can be seen to present particular challenges. Difficulties encountered thus far include low expression levels in first generation Tg mice, neonatal lethality associated with high level expression in second generation mice, and physiological endoproteolysis to generate multiple subfragments with diverse biological activities, some of which (e.g. neuroprotection (reviewed in Ref. 47) may confound the study of neuropathogenesis. We modified a number of parameters in our experimental design in an effort to reduce the ""noise"" from these confounding effects and thereby facilitate study of the pathogenic attributes of the A peptide; such pathogenic attributes are clearly suggested by genetic, neuropathological, and toxicological studies (12-14, 48). Our strategy involved using the following: (i) an expression cassette that retained ~90 nucleotides of the APP mRNA 5'-untranslated region adjacent to the start codon, as APP is expressed at high levels for a single copy gene and likely already contains optimized translational initiation signals; (ii) a prion protein cosmid vector that can drive high level pan-neuronal expression in the central nervous system; (iii) two pro-endoproteolytic FAD mutations, to obtain a high level of A peptide for a given level of APP expression; and (iv) use of a genetic background that may offer a degree of protection against high level APP expression favored by parameters i and ii. It is possible that genetic background may have been important for establishing the TgCRND8 line. Our strategy was based upon the hypothesis that dominant alleles protective against APP overexpression present in the C3H background (36) would facilitate the establishment of Tg lines with high levels of expression. As injections into C3H oocytes are not usually attempted, the TgCRND8 line was established in an outbred C3H/B6 background. Survival curves presented here document that in TgCRND8 mice high levels of A peptide and modest levels of APP - and -stubs can be tolerated in a C3H/B6 genetic background without grossly compromising viability (Fig. 2). Whereas these data are in accord with the starting hypothesis, they are incompatible with facile genetic analysis, as confounding effects due to independent segregation of alleles from the C3H and B6 strains conferring protection or sensitivity to APP overexpression cannot be excluded. Experiments to establish C3H congenic lines of TgCRND8 mice"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0205132:lines [Spatial Concept]
   719 E C1550648:Line [Substance]
   719 E C1552960:Line [Quantitative Concept]

Phrase: "will"

Phrase: "lead"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
  1000   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
  1000   C1522538:Lead [Functional Concept]
  1000   C2348269:Lead [Element, Ion, or Isotope]
  1000   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "to more definitive information on this point."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1533716:Information [Idea or Concept]
Processing 00000000.tx.287: Furthermore, it is of interest to note that the KM670/NL671+V717F construct injected into oocytes from another potentially protective genetic background (129SvEvTacFVB/N (36)) yielded a transgenic line designated Tg19959, which also exhibits cerebral plaques at 3months of age (data not shown). 

Phrase: "Furthermore,"

Phrase: "it"

Phrase: "is of interest to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0543488:Interest [Mental Process]

Phrase: "note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "the KM670/NL671+V717F construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2827421:Construct [Classification]

Phrase: "injected into oocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0029045:Oocytes [Cell]
   756   C1720154:Inject [Functional Concept]

Phrase: "from another potentially protective genetic background"
Meta Candidates (Total=17; Excluded=14; Pruned=0; Remaining=3)
   812   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   812   C0314603:Genetic [Functional Concept]
   812   C1706907:Background [Conceptual Entity]
   756 E C0005615:Birth [Organism Function]
   756 E C0035150:Reproduction [Organism Function]
   756 E C0079946:origin [Classification]
   756 E C0439659:Origin [Temporal Concept]
   756 E C1550512:origin [Intellectual Product]
   756 E C1550722:birth [Idea or Concept]
   756 E C3245487:birth [Intellectual Product]
   729 E C0454729:Natal [Geographic Area]
   729 E C0559522:Genital [Body System]
   729 E C1546649:Genital [Intellectual Product]
   729 E C1550642:Genital [Body Substance]
   719 E C0205313:Original [Idea or Concept]
   719 E C2347409:Original [Occupational Activity]
   701 E C0598240:originality [Mental Process]

Phrase: "(Fig. 2). Whereas these data are in accord with the starting hypothesis, they are incompatible with facile genetic analysis, as confounding effects due to independent segregation of alleles from the C3H and B6 strains conferring protection or sensitivity to APP overexpression cannot be excluded. Experiments to establish C3H congenic lines of TgCRND8 mice will lead to more definitive information on this point. Furthermore, it is of interest to note that the KM670/NL671+V717F construct injected into oocytes from another potentially protective genetic background (129SvEvTacFVB/N (36"

Phrase: ")"

Phrase: ")"

Phrase: "yielded"

Phrase: "a transgenic line"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0003069:Transgenic [Animal]
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: "designated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1524084:Designated [Functional Concept]

Phrase: "Tg19959,"

Phrase: "which also"

Phrase: "exhibits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "cerebral plaques at 3months of age (data"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   748   C0333463:plaques [Acquired Abnormality]
   714 E C0011389:Plaque [Disease or Syndrome]
   714 E C0332461:Plaque [Finding]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ") yielded a transgenic line designated Tg19959, which also exhibits cerebral plaques at 3months of age (data not shown)."
Processing 00000000.tx.288: In sum, our results suggest manipulation of genetic background may reduce postnatal death associated with APP overexpression and should be considered in strategies for APP transgenesis. 

Phrase: "In sum,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515051:Sum [Quantitative Concept]

Phrase: "our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "manipulation of genetic background"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0178659:genetic manipulation [Molecular Biology Research Technique]
   770   C0185111:Manipulation, NOS [Therapeutic or Preventive Procedure]
   770   C0947647:Manipulation [Therapeutic or Preventive Procedure]

Phrase: "may"

Phrase: "reduce"

Phrase: "postnatal death"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011065:Death [Organism Function]
   861   C0443281:Postnatal [Temporal Concept]
   861   C1306577:Death, NOS [Finding]

Phrase: "associated with APP overexpression"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   833   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   833   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   814   C0368670:Amyloid associated protein [Amino Acid, Peptide, or Protein]
   790   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C1514559:Protein Overexpression [Genetic Function]
           Overexpression
   783   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1709634:Precursor [Idea or Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "should"

Phrase: "be"

Phrase: "considered in strategies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0679199:strategies [Mental Process]
   790   C0750591:considered [Idea or Concept]

Phrase: "for APP transgenesis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0886519:Transgenesis [Research Activity]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.289: However, insofar as parameters i-iv have been used individually in the creation of APP Tg mice (8, 17-19, 22, 23), it is plausible that a synergism between all four parameters contributes to the desirable properties of TgCRND8 mice. 

Phrase: "However,"

Phrase: "insofar as"

Phrase: "parameters i-iv"

Phrase: "have"

Phrase: "been"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "individually in the creation of APP Tg mice"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   782   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   782   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   760   C0025936:Mice, Transgenic [Mammal]
   760   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   741   C1334805:Mouse Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0003069:Transgenic [Animal]
   739   C0011560:Amyloid [Pathologic Function]
   739   C0025914:Mice [Mammal]
   739   C0025929:mice [Mammal]
   739   C0026809:Mice [Mammal]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0441513:Creation [Therapeutic or Preventive Procedure]
   739   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C1706214:Creation [Activity]
   739   C1709634:Precursor [Idea or Concept]

Phrase: "(129SvEvTacFVB/N (36)) yielded a transgenic line designated Tg19959, which also exhibits cerebral plaques at 3months of age (data not shown). In sum, our results suggest manipulation of genetic background may reduce postnatal death associated with APP overexpression and should be considered in strategies for APP transgenesis. However, insofar as parameters i-iv have been used individually in the creation of APP Tg mice (8,"

Phrase: "17-19,"

Phrase: "22,"

Phrase: "23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "it"

Phrase: "is"

Phrase: "plausible"

Phrase: "that"

Phrase: "a synergism between all four parameters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0599739:synergism [Molecular Function]

Phrase: "contributes to the desirable properties of TgCRND8 mice."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]
   744   C0871161:properties [Qualitative Concept]
   744   C1292721:properties [Functional Concept]
   744   C1880177:Contribute [Activity]
   711 E C1882134:Property [Conceptual Entity]
   711 E C2347695:Property [Entity]
Processing 00000000.tx.290: Biochemistry of TgCRND8 Mice-- With the possible exception of the Tg19959 line, TgCRND8 mice are currently unique among single transgenic APP mice with regard to the severity of A deposition. 

Phrase: "Biochemistry of TgCRND8 Mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "-"

Phrase: "-"

Phrase: "With the possible exception"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1554961:exception [Idea or Concept]
   861   C1705847:Exception [Conceptual Entity]

Phrase: "of the Tg19959 line,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: "TgCRND8 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "are"

Phrase: "currently unique among single transgenic APP mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1710548:Unique [Qualitative Concept]

Phrase: "with regard to the severity"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0439793:Severity [Qualitative Concept]
  1000   C2983285:Severity [Intellectual Product]
   928 E C0205082:Severe [Qualitative Concept]

Phrase: "of A deposition."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333562:Deposition [Functional Concept]
Processing 00000000.tx.291: Histological deposition of A in amyloid plaques in TgCRND8 mice is evident in 100% of animals by 3months after birth (n=28), earlier than in APP transgenic lines described previously (17-19, 49). 

Phrase: "Histological deposition of A in amyloid plaques"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0011560:Amyloid deposition [Pathologic Function]
   774   C1705760:Amyloid Deposition [Finding]
   748   C0333562:Deposition [Functional Concept]

Phrase: "in TgCRND8 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "is"

Phrase: "evident in 100% of animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   762   C0332120:Evidence of [Functional Concept]

Phrase: "by 3months"

Phrase: "after birth"
Meta Candidates (Total=18; Excluded=13; Pruned=0; Remaining=5)
   861   C0005615:Birth [Organism Function]
   861   C0231290:After [Temporal Concept]
   861   C0687676:After [Temporal Concept]
   861   C1550722:birth [Idea or Concept]
   861   C3245487:birth [Intellectual Product]
   805 E C0017296:GENETIC [Therapeutic or Preventive Procedure]
   805 E C0314603:Genetic [Functional Concept]
   805 E C0454729:Natal [Geographic Area]
   777 E C0035150:Reproduction [Organism Function]
   777 E C0079946:origin [Classification]
   777 E C0439659:Origin [Temporal Concept]
   777 E C1550512:origin [Intellectual Product]
   761 E C0559522:Genital [Body System]
   761 E C1546649:Genital [Intellectual Product]
   761 E C1550642:Genital [Body Substance]
   755 E C0205313:Original [Idea or Concept]
   755 E C2347409:Original [Occupational Activity]
   742 E C0598240:originality [Mental Process]

Phrase: "(8, 17-19, 22, 23), it is plausible that a synergism between all four parameters contributes to the desirable properties of TgCRND8 mice. Biochemistry of TgCRND8 Mice-- With the possible exception of the Tg19959 line, TgCRND8 mice are currently unique among single transgenic APP mice with regard to the severity of A deposition. Histological deposition of A in amyloid plaques in TgCRND8 mice is evident in 100% of animals by 3months after birth (n=28"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "earlier than"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1279919:Early [Temporal Concept]

Phrase: "in APP transgenic lines"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   804   C0003069:Transgenic [Animal]
   804   C0205132:lines [Spatial Concept]
   771 E C1550648:Line [Substance]
   771 E C1552960:Line [Quantitative Concept]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(n=28), earlier than in APP transgenic lines described previously (17-19,"

Phrase: "49"

Phrase: "), earlier than in APP transgenic lines described previously (17-19, 49)."
Processing 00000000.tx.292: These results find a parallel in measurements of A40 and A42 derived from ELISA assays (Tables I and II); 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "find"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243095:Find [Finding]

Phrase: "a parallel in measurements of A40"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C2348042:Parallel [Qualitative Concept]
   753   C2826345:PARALLEL [Research Activity]

Phrase: "and"

Phrase: "A42"

Phrase: "derived from ELISA assays"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   816   C0014441:ELISA assay [Laboratory Procedure]
           ELISA
   770   C1441547:Derived [Qualitative Concept]
   770   C3245521:derived [Idea or Concept]
   737   C0005507:Assay [Laboratory Procedure]
   737   C0243073:assay [Qualitative Concept]
   737   C1510438:Assay [Laboratory Procedure]

Phrase: "(17-19, 49). These results find a parallel in measurements of A40 and A42 derived from ELISA assays (Tables I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "II"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.293: for example, levels of A42 in 6-month-old TgCRND8 mice approximate those seen in PDAPP mice at 16months of age (31). 

Phrase: "for example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "levels of A42"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0441889:Levels [Qualitative Concept]
   756 E C0456079:Level [Classification]
   756 E C1547707:Level [Geographic Area]
   756 E C2946261:Level [Pharmacologic Substance]

Phrase: "in 6-month-old TgCRND8 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "approximate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332232:Approximate [Qualitative Concept]

Phrase: "those"

Phrase: "seen in PDAPP mice"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C0205397:Seen [Qualitative Concept]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]

Phrase: "at 16months"

Phrase: "of age (31"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001779:Age [Organism Attribute]
   861   C0450355:31 [Intellectual Product]

Phrase: "); for example, levels of A42 in 6-month-old TgCRND8 mice approximate those seen in PDAPP mice at 16months of age (31)."
Processing 00000000.tx.294: Furthermore, two results emerging from these ELISAs show a direct parallel to AD pathogenesis and bear particular emphasis. 

Phrase: "Furthermore,"

Phrase: "two results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "emerging from these ELISAs"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   853   C0014441:Immunosorbent Assays, Enzyme-Linked [Laboratory Procedure]
   774   C2717977:Enzyme Assays [Laboratory Procedure]
   748   C0014442:Enzyme [Enzyme,Organic Chemical]
   748   C0021075:immunosorbent [Indicator, Reagent, or Diagnostic Aid]
   714   C0005507:Assay [Laboratory Procedure]
   714   C0243073:assay [Qualitative Concept]
   714   C1510438:Assay [Laboratory Procedure]
   714   C1517892:Link [Intellectual Product]
   714   C1704666:Link [Intellectual Product]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a direct parallel to AD pathogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C2348042:Parallel [Qualitative Concept]
   753   C2826345:PARALLEL [Research Activity]

Phrase: "and"

Phrase: "bear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004897:Bear [Mammal]

Phrase: "particular emphasis."
Processing 00000000.tx.295: First, the levels of total A in TgCRND8 mice at 6months of age, 3,200-4,600 pmol/g brain (as determined by two independent ELISA configurations employing different antibodies), fall into the range observed for sporadic AD cases, 500-5000 pmol/g wet tissue (50). 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "the levels of total A"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "in TgCRND8 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "at 6months"

Phrase: "of age,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "3,200-4,600 pmol/g brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0006104:Brain [Body Part, Organ, or Organ Component]
   795   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "("

Phrase: "as"

Phrase: "determined by two independent ELISA configurations"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0014441:ELISA [Laboratory Procedure]
   753   C0085862:Independent [Idea or Concept]
   753   C0205448:Two [Quantitative Concept]
   753   C0449830:configurations [Spatial Concept]
   753   C1299583:Independent [Finding]
   719 E C2827597:Configuration [Conceptual Entity]

Phrase: "employing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557351:employing [Finding]
   966 E C0457083:Employ [Functional Concept]

Phrase: "different antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "fall into the range"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0085639:Fall [Finding]
   770   C0238715:Fall [Temporal Concept]

Phrase: "observed for sporadic AD cases,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0205422:Sporadic [Temporal Concept]
   760   C0868928:Cases [Functional Concept]
   760   C1441672:Observed [Functional Concept]
   760   C1533148:Cases [Quantitative Concept]
   726 E C1706255:CASE [Medical Device]
   726 E C1706256:Case [Conceptual Entity]

Phrase: "500-5000 pmol/g wet tissue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0040300:Tissue [Tissue]
   799   C1547928:Tissue [Intellectual Product]

Phrase: "(as determined by two independent ELISA configurations employing different antibodies), fall into the range observed for sporadic AD cases, 500-5000 pmol/g wet tissue (50"

Phrase: "), fall into the range observed for sporadic AD cases, 500-5000 pmol/g wet tissue (50)."
Processing 00000000.tx.296: Second, the ratio of A42 to A40 exceeds unity, as is also the case in sporadic AD (50) (and in PDAPP mice expressing a V717F mutation (31)). 

Phrase: "Second,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "the ratio of A42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0456603:Ratio [Quantitative Concept]
   770   C1547037:Ratio [Intellectual Product]

Phrase: "to A40"

Phrase: "exceeds"

Phrase: "unity,"

Phrase: "as is also"

Phrase: "the case in sporadic AD (50"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0868928:Case [Functional Concept]
   753   C1706255:CASE [Medical Device]
   753   C1706256:Case [Conceptual Entity]

Phrase: ")"

Phrase: "("

Phrase: "and in PDAPP mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C1515981:And [Idea or Concept]

Phrase: "expressing"

Phrase: "a V717F mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(and in PDAPP mice expressing a V717F mutation (31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: "))."
Processing 00000000.tx.297: Insofar as A42 is thought to be the most aggregation-prone and toxic form of A, the skew toward the production of A42 apparent in these mice presumably contributes to the unusually early onset of amyloid deposition.  

Phrase: "Insofar as"

Phrase: "A42"

Phrase: "is"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "the most aggregation-prone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033422:Prone [Spatial Concept]

Phrase: "and"

Phrase: "toxic form of A,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1522492:Form [Functional Concept]

Phrase: "the skew toward the production of A42"

Phrase: "apparent in these mice presumably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0750489:apparent [Idea or Concept]

Phrase: "contributes to the unusually early onset of amyloid deposition."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   764   C0011560:Amyloid deposition [Pathologic Function]
           Amyloid
   764   C1705760:Amyloid Deposition [Finding]
   764   C1833334:Early-onset [Finding]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0332162:Onset [Qualitative Concept]
   742   C0333562:Deposition [Functional Concept]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1279919:Early [Temporal Concept]
   742   C1880177:Contribute [Activity]
Processing 00000000.tx.298: View this table: [in this window] [in a new window]  Table II Amyloid deposition in APP transgenic mice Although the combined effect of the two FAD mutations affecting both - and -secretase processing of APP is presumed to be a powerful determinant of this potent amyloidogenesis, it is notable that other "double mutant" TgAPP mice only show 100% of animals positive for plaques at 8-10, 18,or 21-25 months of age (19, 49, 51). 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table II Amyloid deposition in APP transgenic mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0011560:Amyloid deposition [Pathologic Function]
   760   C1705760:Amyloid Deposition [Finding]
   757   C0333584:Protein deposition [Pathologic Function]
   739   C0333562:Deposition [Functional Concept]

Phrase: "Although"

Phrase: "the combined effect of the two FAD mutations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1280500:Effect [Qualitative Concept]
   739   C2348382:Effect [Qualitative Concept]

Phrase: "affecting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affecting [Functional Concept]
  1000   C1314939:Affecting [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "both -"

Phrase: "and -"

Phrase: "secretase processing of APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0033666:protein processing [Molecular Function]
   753   C1709694:Processing [Activity]

Phrase: "is"

Phrase: "presumed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "a powerful determinant of this potent amyloidogenesis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1521761:Determinant [Functional Concept]

Phrase: "it"

Phrase: "is"

Phrase: "notable"

Phrase: "that"

Phrase: "other ""double mutant"" TgAPP mice only"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "100% of animals positive"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0003062:Animals [Animal]
   770   C0439178:% Positive [Quantitative Concept]
   770   C1446409:Positive [Qualitative Concept]
   770   C1514241:Positive [Finding]
   770   C2825490:Positive [Qualitative Concept]

Phrase: "for plaques"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]

Phrase: "at 8-10,"

Phrase: "18,"

Phrase: "or"

Phrase: "21-25 months of age (19,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   783   C1510828:Age-Months [Organism Attribute]
   753   C0439231:months [Temporal Concept]
   719 E C0439507:/month [Temporal Concept]

Phrase: "49,"

Phrase: "51"

Phrase: "). Insofar as A42 is thought to be the most aggregation-prone and toxic form of A, the skew toward the production of A42 apparent in these mice presumably contributes to the unusually early onset of amyloid deposition.  View this table: [in this window] [in a new window]  Table II Amyloid deposition in APP transgenic mice Although the combined effect of the two FAD mutations affecting both - and -secretase processing of APP is presumed to be a powerful determinant of this potent amyloidogenesis, it is notable that other ""double mutant"" TgAPP mice only show 100% of animals positive for plaques at 8-10, 18,or 21-25 months of age (19, 49, 51)."
Processing 00000000.tx.299: Although the degree of APP overexpression could also prove crucial in distinguishing TgCRND8 mice from other double mutant TgAPP lines, further variables include PrP, thy-1, or platelet-derived growth factor- promoters with different tropisms and different APP coding region cassettes (APP695, APP751, or intron-containing cassettes capable of producing all three APP isoforms). 

Phrase: "Although"

Phrase: "the degree of APP overexpression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0441889:Degree [Qualitative Concept]
   748   C0449286:Degree [Quantitative Concept]
   748   C0542560:Degree [Intellectual Product]
   748   C1561545:degree [Quantitative Concept]
   748   C2348088:Degree [Quantitative Concept]

Phrase: "could"

Phrase: "also"

Phrase: "prove"

Phrase: "crucial in distinguishing TgCRND8 mice"

Phrase: "from other double mutant TgAPP lines,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0205132:lines [Spatial Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]

Phrase: "further variables"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439828:variables [Qualitative Concept]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "PrP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032027:PRP [Disease or Syndrome]

Phrase: "thy-1,"

Phrase: "or"

Phrase: "platelet-derived growth factor- promoters with different tropisms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0086860:promoters [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "different APP coding region cassettes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   795   C0450240:cassettes [Medical Device]
   762 E C1706210:Cassette [Manufactured Object]

Phrase: "(31)). Insofar as A42 is thought to be the most aggregation-prone and toxic form of A, the skew toward the production of A42 apparent in these mice presumably contributes to the unusually early onset of amyloid deposition.  View this table: [in this window] [in a new window]  Table II Amyloid deposition in APP transgenic mice Although the combined effect of the two FAD mutations affecting both - and -secretase processing of APP is presumed to be a powerful determinant of this potent amyloidogenesis, it is notable that other ""double mutant"" TgAPP mice only show 100% of animals positive for plaques at 8-10, 18,or 21-25 months of age (19, 49, 51). Although the degree of APP overexpression could also prove crucial in distinguishing TgCRND8 mice from other double mutant TgAPP lines, further variables include PrP, thy-1, or platelet-derived growth factor- promoters with different tropisms and different APP coding region cassettes (APP695,"

Phrase: "APP751,"

Phrase: "or"

Phrase: "intron-containing cassettes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0450240:cassettes [Medical Device]
   793 E C1706210:Cassette [Manufactured Object]

Phrase: "capable of producing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C2698977:Capability [Qualitative Concept]

Phrase: "all three APP isoforms"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0597298:Protein Isoforms [Amino Acid, Peptide, or Protein]
           Isoforms
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "). Although the degree of APP overexpression could also prove crucial in distinguishing TgCRND8 mice from other double mutant TgAPP lines, further variables include PrP, thy-1, or platelet-derived growth factor- promoters with different tropisms and different APP coding region cassettes (APP695, APP751, or intron-containing cassettes capable of producing all three APP isoforms)."
Processing 00000000.tx.300: Finally, it is remarkable that even though TgCRND8 mice exhibit a high basal synthesis of A, levels of this peptide can be elevated to yet higher levels by mutant versions of PS1. 

Phrase: "Finally,"

Phrase: "it"

Phrase: "is"

Phrase: "remarkable"

Phrase: "that even"

Phrase: "though"

Phrase: "TgCRND8 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "a high basal synthesis of A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0220781:synthesis [Biologic Function]
   753   C1883254:Synthesis [Activity]

Phrase: "levels of this peptide"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "can"

Phrase: "be"

Phrase: "elevated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205250:Elevated [Qualitative Concept]
  1000   C3163633:Elevated [Qualitative Concept]

Phrase: "to yet higher levels by mutant versions of PS1."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   742   C0441889:Levels [Qualitative Concept]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.301: Importantly, two PS1 mutations in cis shown to act in an additive way in transfected cells (46) behave in a similar fashion in vivo. 

Phrase: "Importantly,"

Phrase: "two PS1 mutations in cis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0026882:Mutations [Genetic Function]
   771 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "act in an additive way"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0079613:ACT [Therapeutic or Preventive Procedure]
   760   C0442796:Additive [Qualitative Concept]
   760   C1550602:Additive [Substance]

Phrase: "in transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(APP695, APP751, or intron-containing cassettes capable of producing all three APP isoforms). Finally, it is remarkable that even though TgCRND8 mice exhibit a high basal synthesis of A, levels of this peptide can be elevated to yet higher levels by mutant versions of PS1. Importantly, two PS1 mutations in cis shown to act in an additive way in transfected cells (46"

Phrase: ")"

Phrase: "behave in a similar fashion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similar [Qualitative Concept]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.302: Thus, double transgenic mice incorporating 4FAD mutations can develop A deposits by 1month of age (Fig. 5B). 

Phrase: "Thus,"

Phrase: "double transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0025936:Mice, Transgenic [Mammal]
   827   C0003069:Transgenic [Animal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "incorporating"

Phrase: "4FAD mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "can"

Phrase: "develop"

Phrase: "A deposits by 1month of age (Fig. 5B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0333562:Deposits [Functional Concept]

Phrase: ") behave in a similar fashion in vivo. Thus, double transgenic mice incorporating 4FAD mutations can develop A deposits by 1month of age (Fig. 5B)."
Processing 00000000.tx.303: Neuropathology in Transgenic Models of Alzheimer's Disease-- TgCRND8 mice exhibit AD-like amyloid plaque deposits with a variety of morphologies. 

Phrase: "Neuropathology in Transgenic Models of Alzheimer's Disease"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C1540677:neuropathology disease [Pathologic Function]
           neuropathology
   748   C0876934:Neuropathology [Biomedical Occupation or Discipline]
   748   C1555824:Neuropathology [Intellectual Product]

Phrase: "--"

Phrase: "TgCRND8 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "AD-like amyloid plaque"

Phrase: "deposits with a variety of morphologies."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0333562:Deposit [Functional Concept]
   753   C1883525:Variety [Conceptual Entity]
   753   C2346866:Variety [Conceptual Entity]
   719   C0332437:Morphology [Qualitative Concept]
   719   C0543482:morphology [Spatial Concept]
   719   C0700329:Morphology, NOS [Finding]
   719   C0700619:Morphology [Biomedical Occupation or Discipline]
Processing 00000000.tx.304: Dense-cored deposits are present from an early stage, and the majority of these (>80%) can be stained with either Congo Red or thioflavine S.

Phrase: "Dense-cored deposits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0333562:Deposits [Functional Concept]

Phrase: "are"

Phrase: "present from an early stage,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "the majority of these"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0680220:majority [Social Behavior]

Phrase: "("

Phrase: ">80%"

Phrase: ")"

Phrase: "can"

Phrase: "be"

Phrase: "stained with either Congo Red"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   827   C0009742:Congo red stain [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           Congo Red
   760   C0009738:Congo [Geographic Area]
   760   C0332575:Red [Finding]
   760   C1260956:Red [Qualitative Concept]
   760   C2986582:Stained [Qualitative Concept]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "or"

Phrase: "thioflavine S."
Processing 00000000.tx.305: With aging, the plaques become larger and multicentric dense-cored deposits appear. 

Phrase: "With aging,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001811:Ageing [Organism Function]

Phrase: "the plaques"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]

Phrase: "become"

Phrase: "larger"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0443228:larger [Quantitative Concept]
  1000   C0549177:Larger [Quantitative Concept]
  1000   C1704243:Larger [Quantitative Concept]

Phrase: "and"

Phrase: "multicentric dense-cored deposits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0333562:Deposits [Functional Concept]

Phrase: "appear."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]
Processing 00000000.tx.306: Diffuse A immunostaining is also apparent at later stages, being particularly prominent after formic acid pretreatment. 

Phrase: "Diffuse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205219:Diffuse [Qualitative Concept]

Phrase: "A immunostaining"

Phrase: "is"

Phrase: "also apparent at later stages,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0750489:apparent [Idea or Concept]

Phrase: "being"

Phrase: "particularly prominent after formic acid pretreatment."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205402:Prominent [Qualitative Concept]
Processing 00000000.tx.307: Diffuse staining is evident as a penumbra around large plaques and also in the form of isolated deposits (i.e. not obviously associated with plaques) throughout the neuropil. 

Phrase: "Diffuse staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "is"

Phrase: "evident as a penumbra"

Phrase: "around large plaques"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0333463:plaques [Acquired Abnormality]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]

Phrase: "and"

Phrase: "also in the form of isolated deposits"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0205409:Isolated [Functional Concept]
   748   C0333562:Deposits [Functional Concept]
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C1522492:Form [Functional Concept]
   748   C1548221:Isolated [Idea or Concept]

Phrase: "(>80%) can be stained with either Congo Red or thioflavine S.With aging, the plaques become larger and multicentric dense-cored deposits appear. Diffuse A immunostaining is also apparent at later stages, being particularly prominent after formic acid pretreatment. Diffuse staining is evident as a penumbra around large plaques and also in the form of isolated deposits (i.e."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "not obviously"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "associated with plaques"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0333463:plaques [Acquired Abnormality]
   756 E C0011389:Plaque [Disease or Syndrome]
   756 E C0332461:Plaque [Finding]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: ")"

Phrase: "throughout the neuropil."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0228081:Neuropil [Cell Component]
Processing 00000000.tx.308: From 5months of age the mature plaques in TgCRND8 mice exhibit neuritic changes strikingly similar to those seen in AD (Fig. 4). 

Phrase: "From 5months"

Phrase: "of age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "the mature plaques in TgCRND8 mice"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0333463:plaques [Acquired Abnormality]
   719 E C0011389:Plaque [Disease or Syndrome]
   719 E C0332461:Plaque [Finding]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "neuritic changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "strikingly similar to those"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]

Phrase: "seen in AD (Fig. 4"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0205397:Seen [Qualitative Concept]
   760   C0349966:Fig [Food]
   760   C1337208:FIG [Food]
   726 E C0042789:see [Organism Function]
   726 E C1947903:See [Activity]

Phrase: ") throughout the neuropil. From 5months of age the mature plaques in TgCRND8 mice exhibit neuritic changes strikingly similar to those seen in AD (Fig. 4)."
Processing 00000000.tx.309: Dystrophic neurites are revealed by silver impregnation or NF-200 immunostaining, with dystrophic boutons visualized by synaptophysin or ubiquitin antibodies. 

Phrase: "Dystrophic neurites"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2674684:Dystrophic neurites [Finding]
   861   C0085103:Neurites [Cell Component]

Phrase: "are"

Phrase: "revealed by silver impregnation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C1293950:silver impregnation [Laboratory Procedure]
   770   C0015914:impregnation [Organism Function]
   770   C0037125:Silver [Element, Ion, or Isotope]
   770   C0443289:Revealed [Qualitative Concept]
   770   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   770   C1305285:Silver [Qualitative Concept]
   770   C1318876:Silver [Indicator, Reagent, or Diagnostic Aid]

Phrase: "or"

Phrase: "NF-200 immunostaining,"

Phrase: "with dystrophic boutons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206181:bouton [Cell Component]

Phrase: "visualized by synaptophysin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0085255:Synaptophysin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0234621:Visualized [Functional Concept]
   790   C1420554:SYNAPTOPHYSIN [Gene or Genome]

Phrase: "or"

Phrase: "ubiquitin antibodies."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.310: Astrocytes and microglial cells often encircle dense-cored deposits, indicating the plaques are capable of initiating an inflammatory response. 

Phrase: "Astrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004112:Astrocytes [Cell]

Phrase: "and"

Phrase: "microglial cells often"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   884   C0206116:Microglial cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "encircle"

Phrase: "dense-cored deposits,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0333562:Deposits [Functional Concept]

Phrase: "indicating"

Phrase: "the plaques"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]

Phrase: "are"

Phrase: "capable of initiating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C2698977:Capability [Qualitative Concept]

Phrase: "an inflammatory response."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1155266:Inflammatory Response [Pathologic Function]
   861   C0871261:Response [Organism Attribute]
   861   C1704632:Response [Finding]
   861   C1706817:Response [Intellectual Product]
   861   C2911692:Response [Mental Process]
Processing 00000000.tx.311: The other pathological hallmarks of AD are generally accepted to include neuronal loss and the accumulation of NFTs. 

Phrase: "The"

Phrase: "other pathological hallmarks of AD"

Phrase: "are"

Phrase: "generally"

Phrase: "accepted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1272684:Accepted [Qualitative Concept]
  1000   C1548435:Accepted [Idea or Concept]
   966 E C1548601:Accept [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "neuronal loss"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1850496:Neuronal loss [Finding]
   964 E C0598940:neuron loss [Finding]
   861   C1517945:Loss [Quantitative Concept]

Phrase: "and"

Phrase: "the accumulation of NFTs."
Processing 00000000.tx.312: Focal neuronal loss has been reported in only one Tg model of AD (20, 52, 53), and analogous studies in TgCRND8 mice are underway. 

Phrase: "Focal neuronal loss"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C1850496:Neuronal loss [Finding]
   865 E C0598940:neuron loss [Finding]
   827   C1517945:Loss [Quantitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "reported in only one Tg model of AD (20,"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   764   C0050714:AD 20 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   764   C1519606:Transgenic Model [Experimental Model of Disease]
   742   C0003069:Transgenic [Animal]
   742   C0205171:Only [Quantitative Concept]
   742   C0205447:One [Quantitative Concept]
   742   C0684224:Reported [Intellectual Product]
   742   C0700287:Reported [Health Care Activity]
   742   C1720467:Only [Intellectual Product]
   742   C3161035:Model [Intellectual Product]
   742   C3496591:Reported [Clinical Attribute]
   708 E C3273238:Report [Intellectual Product]

Phrase: "52,"

Phrase: "53"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "analogous studies in TgCRND8 mice"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0947630:studies [Laboratory Procedure]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]

Phrase: "are"

Phrase: "underway."
Processing 00000000.tx.313: NFTs are absent in TgCRND8 mice, as indeed they are in other TgAPP mice. 

Phrase: "NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "are"

Phrase: "absent in TgCRND8 mice,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:Absent [Quantitative Concept]
   770   C2699517:ABSENT [Finding]

Phrase: "as"

Phrase: "indeed"

Phrase: "they"

Phrase: "are in other TgAPP mice."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C1551058:Are [Quantitative Concept]
Processing 00000000.tx.314: It is possible coding sequence divergence between mouse and human may be of importance, and expression of human tau and cognate tau kinases, perhaps the p25 fragment of p35 (54, 55) or glycogen synthese kinase 3, may be required to fully recapitulate this pathology. 

Phrase: "It"

Phrase: "is"

Phrase: "possible coding sequence divergence between mouse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0443204:Divergence [Spatial Concept]

Phrase: "and"

Phrase: "human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]

Phrase: "may"

Phrase: "be of importance,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2987476:Be [Conceptual Entity]

Phrase: "and"

Phrase: "expression of human tau"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "cognate tau kinases,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "perhaps"

Phrase: "the p25 fragment of p35"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332255:fragment [Functional Concept]
   760   C1708096:Fragment [Qualitative Concept]

Phrase: "(i.e. not obviously associated with plaques) throughout the neuropil. From 5months of age the mature plaques in TgCRND8 mice exhibit neuritic changes strikingly similar to those seen in AD (Fig. 4). Dystrophic neurites are revealed by silver impregnation or NF-200 immunostaining, with dystrophic boutons visualized by synaptophysin or ubiquitin antibodies. Astrocytes and microglial cells often encircle dense-cored deposits, indicating the plaques are capable of initiating an inflammatory response. The other pathological hallmarks of AD are generally accepted to include neuronal loss and the accumulation of NFTs. Focal neuronal loss has been reported in only one Tg model of AD (20, 52, 53), and analogous studies in TgCRND8 mice are underway. NFTs are absent in TgCRND8 mice, as indeed they are in other TgAPP mice. It is possible coding sequence divergence between mouse and human may be of importance, and expression of human tau and cognate tau kinases, perhaps the p25 fragment of p35 (54,"

Phrase: "55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ")"

Phrase: "or"

Phrase: "glycogen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]

Phrase: "synthese"

Phrase: "kinase 3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "may"

Phrase: "be"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to fully"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "recapitulate"

Phrase: "this pathology."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0030664:Pathology [Biomedical Occupation or Discipline]
  1000   C0205469:pathology [Functional Concept]
  1000   C0677042:pathology [Pathologic Function]
   928 E C1521733:Pathologic [Functional Concept]
Processing 00000000.tx.315: The Origins of Cognitive Dysfunction in Alzheimer's Disease-- In Alzheimer's disease patients, pathological changes detected post-mortem are foreshadowed in the clinical presentation by erosion of mental function leading to frank dementia. 

Phrase: "The Origins of Cognitive Dysfunction"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0079946:origins [Classification]
   760   C0439659:Origins [Temporal Concept]
   726 E C1550512:origin [Intellectual Product]

Phrase: "in Alzheimer's Disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "-"

Phrase: "-"

Phrase: "In Alzheimer's disease patients,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0030705:Patients [Patient or Disabled Group]
   734   C0002395:Alzheimer's Disease [Disease or Syndrome]
   734   C1521724:Alzheimer's Disease [Pathologic Function]

Phrase: "pathological changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "post-mortem"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0004398:postmortem [Diagnostic Procedure]
  1000   C0580205:Postmortem [Temporal Concept]
  1000   C0848632:post mortem [Finding]
   861   C0687676:Post [Temporal Concept]
   861   C1704687:Post [Manufactured Object]
   789 E C1514253:Postal [Functional Concept]

Phrase: "are"

Phrase: "foreshadowed in the clinical presentation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C2708283:Clinical presentation [Intellectual Product]
   760   C0205210:Clinical [Qualitative Concept]
   760   C0449450:Presentation [Idea or Concept]

Phrase: "by erosion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0333307:Erosion [Acquired Abnormality]
  1000   C1880549:EROSION [Phenomenon or Process]
  1000   C1959609:Erosion [Pathologic Function]

Phrase: "of mental function"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0563143:Mental function [Mental Process]
   950 E C0678866:diaphragm function [Organ or Tissue Function]
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "leading"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0332152:Leading [Temporal Concept]
  1000   C1522538:Leading [Functional Concept]
   966 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   966 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   966 E C2348269:Lead [Element, Ion, or Isotope]
   966 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "frank"

Phrase: "dementia."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]
Processing 00000000.tx.316: Therefore, plausible animal models of AD should develop cognitive deficits at least by the time of appearance of AD-related neuropathology. 

Phrase: "Therefore,"

Phrase: "plausible animal models of AD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0599779:Models, Animal [Animal]
   760   C0003062:Animal [Animal]
   760   C3161035:Models [Intellectual Product]

Phrase: "should"

Phrase: "develop"

Phrase: "cognitive deficits at least"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C0679466:Cognitive deficits [Mental or Behavioral Dysfunction]
   770   C2987487:deficits [Qualitative Concept]
   737 E C0162429:Deficit, NOS [Disease or Syndrome]

Phrase: "by the time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "of appearance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0233426:Appearance [Organism Attribute]
  1000   C0700364:Appearance [Qualitative Concept]

Phrase: "of AD-related neuropathology."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0876934:Neuropathology [Biomedical Occupation or Discipline]
   827   C1540677:neuropathology [Pathologic Function]
   827   C1555824:Neuropathology [Intellectual Product]
Processing 00000000.tx.317: TgCRND8 mice fulfill this expectation. 

Phrase: "TgCRND8 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "fulfill"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550543:Fulfill [Idea or Concept]

Phrase: "this expectation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0679138:Expectation [Idea or Concept]
Processing 00000000.tx.318: They represent an example of mice expressing full-length APP where deficits in acquisition of spatial reference memory are present at the onset of AD-related neuropathology (Fig. 3) (1) and thus exhibit some similarities to Tg2576 mice (18, 24). 

Phrase: "They"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "an example of mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707959:Example [Conceptual Entity]

Phrase: "expressing"

Phrase: "full-length APP where deficits in acquisition of spatial reference memory"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   749   C0233794:Memory Deficits [Mental or Behavioral Dysfunction]
   735   C2987487:deficits [Qualitative Concept]
   702 E C0162429:Deficit, NOS [Disease or Syndrome]

Phrase: "are"

Phrase: "present at the onset of AD-related neuropathology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0150312:Present [Quantitative Concept]
   744   C0449450:Present [Idea or Concept]

Phrase: "(54, 55) or glycogen synthese kinase 3, may be required to fully recapitulate this pathology. The Origins of Cognitive Dysfunction in Alzheimer's Disease-- In Alzheimer's disease patients, pathological changes detected post-mortem are foreshadowed in the clinical presentation by erosion of mental function leading to frank dementia. Therefore, plausible animal models of AD should develop cognitive deficits at least by the time of appearance of AD-related neuropathology. TgCRND8 mice fulfill this expectation. They represent an example of mice expressing full-length APP where deficits in acquisition of spatial reference memory are present at the onset of AD-related neuropathology (Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "(Fig. 3) (1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "thus"

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "some similarities to Tg2576 mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C2348205:Similarity [Qualitative Concept]

Phrase: "(1) and thus exhibit some similarities to Tg2576 mice (18,"

Phrase: "24"

Phrase: ") and thus exhibit some similarities to Tg2576 mice (18, 24)."
Processing 00000000.tx.319: In studies of other TgAPP mice, impaired performance in the water maze test preceded neuropathological changes (23) or was not reported (19). 

Phrase: "In studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "of other TgAPP mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "impaired performance in the water maze test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0871060:performance test [Diagnostic Procedure]
   748   C0597198:Performance [Individual Behavior]
   748   C1882330:Performance [Activity]

Phrase: "preceded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332152:preceded [Temporal Concept]

Phrase: "neuropathological changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "(18, 24). In studies of other TgAPP mice, impaired performance in the water maze test preceded neuropathological changes (23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: "or"

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "(23) or was not reported (19"

Phrase: ") or was not reported (19)."
Processing 00000000.tx.320: Impaired performance in other testing paradigms has been reported in PDAPP V717F mice, but here a subset of cognitive deficits was better correlated to confounding neuroanatomical abnormalities than to AD-related pathologies (21, 25). 

Phrase: "Impaired performance in other testing paradigms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0871060:performance testing [Diagnostic Procedure]
   753   C0597198:Performance [Individual Behavior]
   753   C1882330:Performance [Activity]

Phrase: "has"

Phrase: "been"

Phrase: "reported in PDAPP V717F mice,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C0684224:Reported [Intellectual Product]
   760   C0700287:Reported [Health Care Activity]
   760   C3496591:Reported [Clinical Attribute]
   726 E C3273238:Report [Intellectual Product]

Phrase: "but"

Phrase: "here"

Phrase: "a subset of cognitive deficits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1515021:Subset [Classification]

Phrase: "was"

Phrase: "better"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332272:Better [Qualitative Concept]

Phrase: "correlated to confounding neuroanatomical abnormalities"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0000768:Abnormalities [Congenital Abnormality]
   760   C0000769:abnormalities [Functional Concept]
   760   C1707520:Correlated [Qualitative Concept]
   726 E C1704258:Abnormality [Finding]

Phrase: "than"

Phrase: "to AD-related pathologies"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0030664:Pathologies [Biomedical Occupation or Discipline]
   793 E C0205469:pathology [Functional Concept]
   793 E C0677042:pathology [Pathologic Function]
   743 E C1521733:Pathologic [Functional Concept]

Phrase: "(19). Impaired performance in other testing paradigms has been reported in PDAPP V717F mice, but here a subset of cognitive deficits was better correlated to confounding neuroanatomical abnormalities than to AD-related pathologies (21,"

Phrase: "25"

Phrase: "). Impaired performance in other testing paradigms has been reported in PDAPP V717F mice, but here a subset of cognitive deficits was better correlated to confounding neuroanatomical abnormalities than to AD-related pathologies (21, 25)."
Processing 00000000.tx.321: In the most recent studies, an age-related deficit in learning capacity was detected in PDAPP mice using a new water maze testing regimen (56). 

Phrase: "In the most recent studies,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   734   C1513491:Most Recent [Temporal Concept]

Phrase: "an age-related deficit in learning capacity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0162429:Deficit, NOS [Disease or Syndrome]
   748   C2987487:Deficit [Qualitative Concept]

Phrase: "was"

Phrase: "detected in PDAPP mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a new water maze testing regimen"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0040808:Regimen [Therapeutic or Preventive Procedure]
   804   C2945654:regimen [Intellectual Product]

Phrase: "(21, 25). In the most recent studies, an age-related deficit in learning capacity was detected in PDAPP mice using a new water maze testing regimen (56"

Phrase: "). In the most recent studies, an age-related deficit in learning capacity was detected in PDAPP mice using a new water maze testing regimen (56)."
Processing 00000000.tx.322: Nonetheless, from a practical point of view, the cognitive deficits in TgCRND8 mice have three important attributes as follows: they occur early in life; 

Phrase: "Nonetheless,"

Phrase: "from a practical point"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1552961:Point [Quantitative Concept]
   861   C2347617:point [Quantitative Concept]

Phrase: "of view,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "the cognitive deficits in TgCRND8 mice"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0679466:Cognitive deficits [Mental or Behavioral Dysfunction]
   753   C2987487:deficits [Qualitative Concept]
   719 E C0162429:Deficit, NOS [Disease or Syndrome]

Phrase: "have"

Phrase: "three important attributes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0449234:Attribute [Idea or Concept]
   793   C1704772:Attribute [Conceptual Entity]
   793   C1882133:Attribute [Qualitative Concept]

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "they"

Phrase: "occur"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "early in life"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0376558:Life [Idea or Concept]
   827   C1279919:Early [Temporal Concept]
   743 E C0595998:lives [Finding]

Phrase: ";"
Processing 00000000.tx.323: they are easily detected in the conventional spatial reference memory version of the water maze; 

Phrase: "they"

Phrase: "are"

Phrase: "easily"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332219:Easily [Qualitative Concept]

Phrase: "detected in the conventional spatial reference memory version of the water maze"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   751   C0814087:spatial memory [Mental Process]
   736   C0025260:Memory [Mental Process]
   736   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   736   C0083355:MAZE [Therapeutic or Preventive Procedure]
   736   C0333052:Version [Functional Concept]
   736   C0439858:Conventional [Qualitative Concept]
   736   C0442726:Detected [Finding]
   736   C0599638:WATER [Substance]
   736   C0700327:memory [Finding]
   736   C0870866:maze [Manufactured Object]
   736   C1428114:spatial [Gene or Genome]
   736   C1511790:Detected [Therapeutic or Preventive Procedure]
   736   C1514811:Reference [Idea or Concept]
   736   C1550678:Water [Inorganic Chemical]
   736   C1706377:Memory [Manufactured Object]
   736   C1706462:Reference [Conceptual Entity]
   736   C2607870:Version [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.324: and they are sufficiently robust to be detected without recourse to large sample sizes. 

Phrase: "and"

Phrase: "they"

Phrase: "are"

Phrase: "sufficiently robust to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2986815:Robust [Qualitative Concept]

Phrase: "be"

Phrase: "detected without recourse"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "to large sample sizes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0242618:Sizes, Sample [Quantitative Concept]
   827   C0456389:SIZES [Spatial Concept]
Processing 00000000.tx.325: Although overaccumulation of the A peptide is firmly implicated in AD pathogenesis, the mechanisms leading to cognitive decline are not clear. 

Phrase: "Although"

Phrase: "overaccumulation of the"

Phrase: "A peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "is"

Phrase: "firmly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880776:Firmly [Qualitative Concept]

Phrase: "implicated in AD pathogenesis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0543483:pathogenesis [Functional Concept]
   770   C0699748:Pathogenesis [Pathologic Function]

Phrase: "the mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "leading to cognitive decline"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   833   C0338656:Cognitive decline [Mental or Behavioral Dysfunction]
   770   C0332152:Leading [Temporal Concept]
   770   C1516691:Cognitive [Functional Concept]
   770   C1522538:Leading [Functional Concept]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "clear."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]
Processing 00000000.tx.326: As attempts to correlate plaque burdens and cognitive deterioration have produced mixed results (see Refs. 57-65 and also see Ref. 56), it is possible A affects the central nervous system by mechanisms other than (or in addition to) the toxicity of extracellular, aggregated forms. 

Phrase: "As"

Phrase: "attempts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516084:Attempt [Event]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "correlate"

Phrase: "plaque burdens"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828008:Burden [Idea or Concept]

Phrase: "and"

Phrase: "cognitive deterioration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0854193:Cognitive deterioration [Mental or Behavioral Dysfunction]
   861   C0868945:Deterioration [Phenomenon or Process]

Phrase: "have"

Phrase: "produced"

Phrase: "mixed results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Refs. 57-65"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0450385:65 [Intellectual Product]
   827   C1425988:REF [Gene or Genome]

Phrase: "and"

Phrase: "also"

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Ref. 56"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1425988:REF [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "it"

Phrase: "is"

Phrase: "possible A"

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the central nervous system by mechanisms"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   833   C0927232:Central Nervous System [Body System]
   833   C1269563:Central nervous system [Body System]
   790   C0027763:Nervous System [Body System]
   790   C0422837:NERVOUS SYSTEM [Finding]
   790   C1269560:Nervous system [Body System]
   753   C0027769:Nervous [Sign or Symptom]
   753   C0205099:Central [Spatial Concept]
   753   C0449913:System [Functional Concept]
   753   C0599851:Nervous [Functional Concept]
   753   C1553451:System [Manufactured Object]
   753   C1704459:System [Medical Device]
   753   C1879652:Central - [Laboratory Procedure]
   734 E C0205494:Neurologic [Qualitative Concept]

Phrase: "other than"

Phrase: "("

Phrase: "or was not reported (19). Impaired performance in other testing paradigms has been reported in PDAPP V717F mice, but here a subset of cognitive deficits was better correlated to confounding neuroanatomical abnormalities than to AD-related pathologies (21, 25). In the most recent studies, an age-related deficit in learning capacity was detected in PDAPP mice using a new water maze testing regimen (56). Nonetheless, from a practical point of view, the cognitive deficits in TgCRND8 mice have three important attributes as follows: they occur early in life; they are easily detected in the conventional spatial reference memory version of the water maze; and they are sufficiently robust to be detected without recourse to large sample sizes. Although overaccumulation of the A peptide is firmly implicated in AD pathogenesis, the mechanisms leading to cognitive decline are not clear. As attempts to correlate plaque burdens and cognitive deterioration have produced mixed results (see Refs. 57-65 and also see Ref. 56), it is possible A affects the central nervous system by mechanisms other than (or in addition to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1883712:Addition [Functional Concept]

Phrase: ")"

Phrase: "the toxicity of extracellular, aggregated forms."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0040539:toxicity [Qualitative Concept]
   753   C0600688:Toxicity [Injury or Poisoning]
Processing 00000000.tx.327: Indeed, recent studies emphasize soluble forms of A as crucial determinants of clinical outcome (50, 66, 67). 

Phrase: "Indeed,"

Phrase: "recent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "emphasize"

Phrase: "soluble forms of A as crucial determinants of clinical outcome"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   739   C0348078:forms [Qualitative Concept]
   739   C0376315:Forms [Manufactured Object]
   706 E C1522492:Form [Functional Concept]

Phrase: "(or in addition to) the toxicity of extracellular, aggregated forms. Indeed, recent studies emphasize soluble forms of A as crucial determinants of clinical outcome (50,"

Phrase: "66,"

Phrase: "67"

Phrase: ") the toxicity of extracellular, aggregated forms. Indeed, recent studies emphasize soluble forms of A as crucial determinants of clinical outcome (50, 66, 67)."
Processing 00000000.tx.328: Unfortunately, the molecular determinants for neurotoxicity (for example, free radical generating capacity of metal-bound A42 (68, 69) and perturbed signal transduction (70)) and the cellular consequences thereof (altered synaptic function, excitotoxicity, and induction of apoptosis (49, 66)) are undetermined. 

Phrase: "Unfortunately,"

Phrase: "the molecular determinants for neurotoxicity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1521761:Determinant [Functional Concept]

Phrase: "("

Phrase: "for example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "free radical generating capacity of metal-bound A42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1516240:Capacity [Quantitative Concept]

Phrase: "(for example, free radical generating capacity of metal-bound A42 (68,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]

Phrase: "69"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "perturbed signal transduction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0037083:Signal Transduction [Cell Function]
   827   C1160185:transduction [Organism Function]
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "(68, 69) and perturbed signal transduction (70"

Phrase: ")"

Phrase: ")"

Phrase: "and"

Phrase: "the cellular consequences thereof"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0686907:consequences [Functional Concept]

Phrase: "(70)) and the cellular consequences thereof (altered synaptic function,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0031843:function [Physiologic Function]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1705273:Function [Intellectual Product]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]

Phrase: "excitotoxicity,"

Phrase: "and"

Phrase: "induction of apoptosis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3266896:Induction of Apoptosis [Cell Function]
           Apoptosis Induction
   790   C0205263:Induction [Functional Concept]
   790   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "(altered synaptic function, excitotoxicity, and induction of apoptosis (49,"

Phrase: "66"

Phrase: ")"

Phrase: ")"

Phrase: "are"

Phrase: "undetermined."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205258:Undetermined [Idea or Concept]
  1000   C3536725:Undetermined [Qualitative Concept]
Processing 00000000.tx.329: We suggest TgCRND8 mice comprise a useful and validated system to address these issues. 

Phrase: "We"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "TgCRND8 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "comprise"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700400:Comprise [Activity]

Phrase: "a useful"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0042153:use [Functional Concept]
   928   C0457083:Use [Functional Concept]
   928   C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "validated system to"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "these issues."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0033213:Issue [Finding]
   966   C1706387:Issue [Intellectual Product]
Processing 00000000.tx.330: Amelioration of cognitive deficits by immunization against A42 peptide (1) provides compelling evidence for a strong pathogenic role for A peptide in the TgCRND8 model of AD and indeed for the amyloid cascade hypothesis. 

Phrase: "Amelioration of cognitive deficits"

Phrase: "by immunization"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020971:Immunisation [Therapeutic or Preventive Procedure]
  1000   C0042196:immunisation [Therapeutic or Preventive Procedure]
  1000   C3244291:immunization [Functional Concept]

Phrase: "against A42 peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "(49, 66)) are undetermined. We suggest TgCRND8 mice comprise a useful and validated system to address these issues. Amelioration of cognitive deficits by immunization against A42 peptide (1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "compelling evidence for a strong pathogenic role"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0332120:Evidence [Functional Concept]

Phrase: "for A peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "in the TgCRND8 model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]

Phrase: "of AD"

Phrase: "and"

Phrase: "indeed for the amyloid cascade hypothesis."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1512571:Hypothesis [Idea or Concept]
   753   C1707310:Cascade [Manufactured Object]
Processing 00000000.tx.331: Parenthetically, these data effectively exclude the proposition that cognitive deficits in TgCRND8 mice derive from an insertional mutation. 

Phrase: "Parenthetically,"

Phrase: "these data effectively"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "the proposition"

Phrase: "that cognitive deficits in TgCRND8 mice"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0679466:Cognitive deficits [Mental or Behavioral Dysfunction]
   753   C2987487:deficits [Qualitative Concept]
   719 E C0162429:Deficit, NOS [Disease or Syndrome]

Phrase: "derive from an insertional mutation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1512796:Insertion Mutation [Genetic Function]
   760   C0026882:Mutation [Genetic Function]
   760   C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.332: Furthermore, synthesis of antisera in A42-immunized mice that react strongly with the peptide presented in a -sheet conformation (1) suggests a potential to dissect the mechanism of A neuropathogenesis (for example, by passive immunization (71) with conformation-specific antibodies). 

Phrase: "Furthermore,"

Phrase: "synthesis of antisera"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0220781:synthesis [Biologic Function]
   790   C1883254:Synthesis [Activity]

Phrase: "in A42-immunized mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "that"

Phrase: "react"

Phrase: "strongly with the peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "presented in a -sheet conformation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0026377:Conformation [Spatial Concept]
   760   C0449450:Presented [Idea or Concept]
   760   C2349187:Sheet [Quantitative Concept]
   726 E C0150312:Present [Quantitative Concept]

Phrase: "(1) provides compelling evidence for a strong pathogenic role for A peptide in the TgCRND8 model of AD and indeed for the amyloid cascade hypothesis. Parenthetically, these data effectively exclude the proposition that cognitive deficits in TgCRND8 mice derive from an insertional mutation. Furthermore, synthesis of antisera in A42-immunized mice that react strongly with the peptide presented in a -sheet conformation (1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a potential to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3245505:Potential [Qualitative Concept]

Phrase: "dissect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205239:dissect [Functional Concept]

Phrase: "the mechanism of A neuropathogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441712:Mechanism [Functional Concept]
   760   C1706376:Mechanism [Manufactured Object]

Phrase: "("

Phrase: "for example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "by passive immunization"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0020974:Immunization, Passive [Therapeutic or Preventive Procedure]
   861   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   861   C0042196:immunisation [Therapeutic or Preventive Procedure]
   861   C3244291:immunization [Functional Concept]

Phrase: "(for example, by passive immunization (71"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450389:71 [Intellectual Product]

Phrase: ")"

Phrase: "with conformation-specific antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   884   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: ") with conformation-specific antibodies)."
Processing 00000000.tx.333: In short, the availability of a new AD model with robust cognitive deficits, levels of A peptide that equal those seen in AD cases, and AD-like pathology may allow both an improved understanding of causal relationships between these phenotypic traits and testing of candidate interventions.  

Phrase: "In short,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1282927:short [Qualitative Concept]
  1000   C1806781:Short [Quantitative Concept]
  1000   C2350002:Short [Quantitative Concept]

Phrase: "the availability of a new AD model"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0470187:Availability of [Functional Concept]
           Availability

Phrase: "with robust cognitive deficits,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C0679466:Cognitive deficits [Mental or Behavioral Dysfunction]
   827   C2987487:deficits [Qualitative Concept]
   793 E C0162429:Deficit, NOS [Disease or Syndrome]

Phrase: "levels of A peptide"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "that equal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205163:Equal [Qualitative Concept]
  1000   C1549782:Equal [Idea or Concept]

Phrase: "those"

Phrase: "seen in AD cases,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   770   C0205397:Seen [Qualitative Concept]
   770   C0868928:Cases [Functional Concept]
   770   C1533148:Cases [Quantitative Concept]
   737 E C0042789:see [Organism Function]
   737 E C1706255:CASE [Medical Device]
   737 E C1706256:Case [Conceptual Entity]
   737 E C1947903:See [Activity]

Phrase: "and"

Phrase: "AD-like pathology"

Phrase: "may"

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "both an improved understanding of causal relationships"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0162340:Understanding [Mental Process]

Phrase: "between these phenotypic traits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0599883:traits [Organism Attribute]
   861   C1427926:TRAITS [Gene or Genome]

Phrase: "and"

Phrase: "testing of candidate interventions."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0039593:Testing [Functional Concept]
   770   C0392366:testing [Intellectual Product]
Processing 00000000.tx.334: ACKNOWLEDGEMENTS We thank Richard Rubenstein for generously supplying the 4G8 antibody, Frdric Checler for the 3542antibody, Sam Gandy for the 369antibody, Julie Panakos for DNA microinjections, and Isabelle Aubert for discussions.  

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Richard Rubenstein for generously"

Phrase: "supplying"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0243163:supply [Idea or Concept]
   966   C0699914:supply [Quantitative Concept]
   966   C1314650:SUPPLY, NOT OTHERWISE SPECIFIED [Medical Device]
   966   C1561604:supply [Functional Concept]
   966   C1875802:SUPPLY [Medical Device]
   966   C1999230:Supply [Activity]

Phrase: "the 4G8 antibody,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "Frdric Checler for the 3542antibody,"

Phrase: "Sam Gandy for the 369antibody,"

Phrase: "Julie Panakos for DNA microinjections,"

Phrase: "and"

Phrase: "Isabelle Aubert for discussions."
Processing 00000000.tx.335: FOOTNOTES * This work was supported in part by the Canadian Institutes for Health Research, the Ontario Mental Health Foundation, The Howard Hughes Medical Institute, Natural Sciences and Engineering Research Council of Canada, The Scottish Rite Foundation, the Alzheimer Society of Ontario, the National Institute on Aging, and the Fraternal Order of Eagles.

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported in part"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0449719:Part [Spatial Concept]
   790   C1521721:Supported [Conceptual Entity]
   790   C1709471:Part [Quantitative Concept]
   756 E C0183683:Support [Medical Device]

Phrase: "by the Canadian Institutes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0021622:Institutes [Organization]
   827 E C1272753:Institute [Idea or Concept]

Phrase: "for Health Research,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]

Phrase: "the Ontario Mental Health Foundation,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   812   C0016617:Foundation [Organization]
   729 E C0002055:base [Inorganic Chemical]
   729 E C0178499:Base [Chemical Viewed Functionally]
   729 E C1626935:Bases [Quantitative Concept]
   729 E C1880279:Base [Biomedical or Dental Material]
   706 E C0205112:Basal [Spatial Concept]

Phrase: "The Howard Hughes Medical Institute,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0021622:institute [Organization]
   812   C0205476:Medical [Functional Concept]
   812   C1272753:Institute [Idea or Concept]
   812   C1551730:Hughes [Population Group]

Phrase: "Natural Sciences and Engineering Research Council of Canada,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0678530:Natural Sciences [Occupation or Discipline]
   744   C0014279:Engineering [Occupation or Discipline]
   744   C0035168:research [Research Activity]
   744   C0036397:Sciences [Occupation or Discipline]
   744   C0205296:Natural [Functional Concept]
   744   C0242481:Research [Research Activity]
   744   C1551807:Council [Population Group]
   711 E C0878517:Engineer [Professional or Occupational Group]

Phrase: "The Scottish Rite Foundation,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0016617:Foundation [Organization]
   743 E C0002055:base [Inorganic Chemical]
   743 E C0178499:Base [Chemical Viewed Functionally]
   743 E C1626935:Bases [Quantitative Concept]
   743 E C1880279:Base [Biomedical or Dental Material]
   721 E C0205112:Basal [Spatial Concept]

Phrase: "the Alzheimer Society of Ontario,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0037455:society [Organization]

Phrase: "the National Institute on Aging,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C1955974:National Institute on Aging [Health Care Related Organization]
   812   C0001811:Ageing [Organism Function]
   812   C0021622:institute [Organization]
   812   C1272753:Institute [Idea or Concept]
   812   C3245503:national [Intellectual Product]
   779 E C0001779:Age [Organism Attribute]

Phrase: "and"

Phrase: "the Fraternal Order of Eagles."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C1705175:Order [Intellectual Product]
   760   C1705176:Order [Qualitative Concept]
   760   C1705177:Order [Classification]
   760   C1705178:Order [Activity]
   760   C1882348:Order [Qualitative Concept]
Processing 00000000.tx.336: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.337: The article must therefore be hereby marked "advertisement" in accordance with 18U.S.C. 

Phrase: "The article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18U.S.C."
Processing 00000000.tx.338: Section 1734solely to indicate this fact. b Supported by Canadian Institutes for Health Research post-doctoral fellowship. f Supported by Natural Sciences and Engineering Research Council of Canada post-doctoral fellowships. k To whom correspondence should be addressed: University of Toronto, Center for Research in Neurodegenerative Diseases, Tanz Neuroscience Bldg., 6Queen's Park Crescent West, Toronto, Ontario M5S 3H2, Canada. 

Phrase: "Section 1734solely to"

Phrase: "indicate"

Phrase: "this fact. b"

Phrase: "Supported by Canadian Institutes"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0021622:Institutes [Organization]
   770   C0238884:CANADIAN [Finding]
   770   C1521721:Supported [Conceptual Entity]
   737 E C0183683:Support [Medical Device]
   737 E C1272753:Institute [Idea or Concept]

Phrase: "for Health Research post-doctoral fellowship. f"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   799   C0439133:(f) [Intellectual Product]
   799   C1553038:[f] [Quantitative Concept]

Phrase: "Supported by Natural Sciences and Engineering Research Council"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   770   C0678530:Natural Sciences [Occupation or Discipline]
   767   C0035176:research supported [Quantitative Concept]
   744   C0014279:Engineering [Occupation or Discipline]
   744   C0035168:research [Research Activity]
   744   C0036397:Sciences [Occupation or Discipline]
   744   C0205296:Natural [Functional Concept]
   744   C0242481:Research [Research Activity]
   744   C1521721:Supported [Conceptual Entity]
   744   C1551807:Council [Population Group]
   711 E C0183683:Support [Medical Device]
   711 E C0878517:Engineer [Professional or Occupational Group]

Phrase: "of Canada post-doctoral fellowships. k"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   804   C1708601:K' [Quantitative Concept]

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "University of Toronto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Center for Research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C0683939:center research [Manufactured Object,Organization]
   790   C0205099:Center [Spatial Concept]

Phrase: "in Neurodegenerative Diseases,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0524851:Neurodegenerative Diseases [Disease or Syndrome]
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]

Phrase: "Tanz Neuroscience Bldg.,"

Phrase: "6Queen's Park Crescent West,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1705493:West [Spatial Concept]

Phrase: "Toronto,"

Phrase: "Ontario M5S 3H2,"

Phrase: "Canada."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]
Processing 00000000.tx.339: Tel.: 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.340: 416-978-1556; 

Phrase: "416-978-1556"

Phrase: ";"
Processing 00000000.tx.341: Fax: 416-978-1878; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "416-978-1878"

Phrase: ";"
Processing 00000000.tx.342: E-mail: david.westaway@utoronto.ca. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "david.westaway@utoronto.ca."
Processing 00000000.tx.343: Published, JBC Papers in Press, March 15,2001,DOI 10.1074/jbc. 

Phrase: "Published"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034037:Published [Occupational Activity]
  1000   C1704324:Published [Intellectual Product]

Phrase: ","

Phrase: "JBC Papers in Press,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0030351:Papers [Manufactured Object]
   737 E C1547566:Paper [Idea or Concept]

Phrase: "March 15,"

Phrase: "2001,"

Phrase: "DOI 10.1074/jbc."
Processing 00000000.tx.344: M100710200  ABBREVIATIONS The abbreviations used are: A, amyloid -peptide; 

Phrase: "M100710200  ABBREVIATIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0000723:Abbreviations [Intellectual Product]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "A,"

Phrase: "amyloid -peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.345: FAD, familial Alzheimer's disease; 

Phrase: "FAD,"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   913   C0277558:Familial disease [Disease or Syndrome]
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   877 E C0344339:family disease [Finding]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0015576:familial [Family Group]
   827   C0241888:Familial [Functional Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   755 E C1704727:Family [Conceptual Entity]

Phrase: "familial Alzheimer's disease"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   913   C0277558:Familial disease [Disease or Syndrome]
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   877 E C0344339:family disease [Finding]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0015576:familial [Family Group]
   827   C0241888:Familial [Functional Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   755 E C1704727:Family [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.346: AD, Alzheimer's disease; 

Phrase: "AD,"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.347: ELISA, enzyme-linked immunosorbent assay; 

Phrase: "ELISA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014441:ELISA [Laboratory Procedure]

Phrase: "enzyme-linked immunosorbent assay"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0014441:Enzyme-Linked Immunosorbent Assay [Laboratory Procedure]
   902   C2717977:Enzyme Assay [Laboratory Procedure]
   812   C0005507:Assay [Laboratory Procedure]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021075:immunosorbent [Indicator, Reagent, or Diagnostic Aid]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]
   779   C1517892:Link [Intellectual Product]
   779   C1704666:Link [Intellectual Product]
   729 E C0014445:enzymes [Functional Concept]

Phrase: ";"
Processing 00000000.tx.348: APP, amyloid precursor protein; 

Phrase: "APP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "amyloid precursor protein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.349: NFTs, neurofibrillary tangles; 

Phrase: "NFTs,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "neurofibrillary tangles"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: ";"
Processing 00000000.tx.350: Tg, transgenic; 

Phrase: "Tg, transgenic"

Phrase: ";"
Processing 00000000.tx.351: PS1, presenilin 1; 

Phrase: "PS1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "presenilin 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: ";"
Processing 00000000.tx.352: mAb, monoclonal antibody; 

Phrase: "mAb,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "monoclonal antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0746619:monoclonal [Finding]

Phrase: ";"
Processing 00000000.tx.353: Tricine, N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]glycine; 

Phrase: "Tricine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0077068:tricine [Organic Chemical]

Phrase: "N-[2-hydroxy-1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441922:N+ [Intellectual Product]
   812   C0700307:Hydroxy [Inorganic Chemical]
   812   C1553036:[n] [Quantitative Concept]

Phrase: "1-bis("
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0556985:BIS [Temporal Concept]
   861   C2247301:BIS [Molecular Function]
   861   C3540495:BIS [Intellectual Product]

Phrase: "hydroxymethyl"

Phrase: ")"

Phrase: "ethyl"

Phrase: "]glycine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017890:Glycine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C0522461:Glycine [Plant]

Phrase: ";"
Processing 00000000.tx.354: wt, wild type; 

Phrase: "wt,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700323:WT [Fish]

Phrase: "wild type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.355: NSP, non-spatial pre-training; 

Phrase: "NSP,"

Phrase: "non-spatial"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1428114:spatial [Gene or Genome]
   861   C1518422:Non [Functional Concept]

Phrase: "pre-training"
Meta Candidates (Total=13; Excluded=6; Pruned=0; Remaining=7)
   964   C1709632:Pre-condition [Conceptual Entity]
   861   C0040607:Training [Educational Activity]
   861   C0220931:Training [Educational Activity]
   861   C0332152:Pre [Temporal Concept]
   861   C0740175:Pre [Qualitative Concept]
   861   C2257086:PRE [Genetic Function]
   861   C2673163:training [Qualitative Concept]
   827 E C0336809:Train [Manufactured Object]
   827 E C1552514:Train [Manufactured Object]
   789 E C0009647:Conditioned [Mental Process]
   789 E C0012634:condition [Disease or Syndrome]
   789 E C0348080:Condition [Qualitative Concept]
   789 E C1705253:Condition [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.356: PDAPP, APP transgenic mice constructed using the platelet derived growth factor beta promoter.  

Phrase: "PDAPP,"

Phrase: "APP transgenic mice"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   840   C0025936:Mice, Transgenic [Mammal]
   804   C0003069:Transgenic [Animal]
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "constructed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2827421:Construct [Classification]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the platelet derived growth factor beta promoter."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   780   C0072480:Platelet-Derived Growth Factor Beta [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.357: REFERENCES TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES 1. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.358: Janus, C., Pearson, J., McLaurin, J., Mathews, P. 

Phrase: "Janus,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0266700:Janus [Congenital Abnormality]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Pearson,"

Phrase: "J.,"

Phrase: "McLaurin,"

Phrase: "J.,"

Phrase: "Mathews,"

Phrase: "P."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]
Processing 00000000.tx.359: M., Jiang, Y., Schmidt, S. 

Phrase: "M."

Phrase: ","

Phrase: "Jiang,"

Phrase: "Y.,"

Phrase: "Schmidt,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.360: D., Chishti, M. 

Phrase: "D."

Phrase: ","

Phrase: "Chishti,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.361: A., Horne, P., Heslin, D., French, J., Mount, H. 

Phrase: "A.,"

Phrase: "Horne,"

Phrase: "P.,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]

Phrase: "Heslin,"

Phrase: "D."

Phrase: ","

Phrase: "French,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1556084:French [Population Group]

Phrase: "J.,"

Phrase: "Mount,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0181909:Mount [Medical Device]
  1000   C0449878:mount [Finding]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.362: T.J., Nixon, R. 

Phrase: "T.J.,"

Phrase: "Nixon,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.363: A., Mercken, M., Bergereon, C., Fraser, P. 

Phrase: "A.,"

Phrase: "Mercken,"

Phrase: "M."

Phrase: ","

Phrase: "Bergereon,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Fraser,"

Phrase: "P."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]
Processing 00000000.tx.364: E., St. 

Phrase: "E.,"

Phrase: "St."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3272372:ST [Intellectual Product]
Processing 00000000.tx.365: George-Hyslop, P., and Westaway, D. 

Phrase: "George-Hyslop,"

Phrase: "P.,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]

Phrase: "and"

Phrase: "Westaway,"

Phrase: "D."
Processing 00000000.tx.366: (2000) Nature 408, 979-982[CrossRef][Medline] [OrderarticleviaInfotrieve] 2. 

Phrase: "(71) with conformation-specific antibodies). In short, the availability of a new AD model with robust cognitive deficits, levels of A peptide that equal those seen in AD cases, and AD-like pathology may allow both an improved understanding of causal relationships between these phenotypic traits and testing of candidate interventions.  ACKNOWLEDGEMENTS We thank Richard Rubenstein for generously supplying the 4G8 antibody, Frdric Checler for the 3542antibody, Sam Gandy for the 369antibody, Julie Panakos for DNA microinjections, and Isabelle Aubert for discussions.  FOOTNOTES * This work was supported in part by the Canadian Institutes for Health Research, the Ontario Mental Health Foundation, The Howard Hughes Medical Institute, Natural Sciences and Engineering Research Council of Canada, The Scottish Rite Foundation, the Alzheimer Society of Ontario, the National Institute on Aging, and the Fraternal Order of Eagles.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked ""advertisement"" in accordance with 18U.S.C. Section 1734solely to indicate this fact. b Supported by Canadian Institutes for Health Research post-doctoral fellowship. f Supported by Natural Sciences and Engineering Research Council of Canada post-doctoral fellowships. k To whom correspondence should be addressed: University of Toronto, Center for Research in Neurodegenerative Diseases, Tanz Neuroscience Bldg., 6Queen's Park Crescent West, Toronto, Ontario M5S 3H2, Canada. Tel.: 416-978-1556; Fax: 416-978-1878; E-mail: david.westaway@utoronto.ca. Published, JBC Papers in Press, March 15,2001,DOI 10.1074/jbc. M100710200  ABBREVIATIONS The abbreviations used are: A, amyloid -peptide; FAD, familial Alzheimer's disease; AD, Alzheimer's disease; ELISA, enzyme-linked immunosorbent assay; APP, amyloid precursor protein; NFTs, neurofibrillary tangles; Tg, transgenic; PS1, presenilin 1; mAb, monoclonal antibody; Tricine, N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]glycine; wt, wild type; NSP, non-spatial pre-training; PDAPP, APP transgenic mice constructed using the platelet derived growth factor beta promoter.  REFERENCES TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES 1. Janus, C., Pearson, J., McLaurin, J., Mathews, P. M., Jiang, Y., Schmidt, S. D., Chishti, M. A., Horne, P., Heslin, D., French, J., Mount, H. T.J., Nixon, R. A., Mercken, M., Bergereon, C., Fraser, P. E., St. George-Hyslop, P., and Westaway, D. (2000"

Phrase: ")"

Phrase: "Nature 408,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "979-982"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.367: Citron, M., Oltersdorf, T., Haass, C., McConlogue, C., Hung, A. 

Phrase: "Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M."

Phrase: ","

Phrase: "Oltersdorf,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Haass,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "McConlogue,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Hung,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0544691:hang [Injury or Poisoning]
   966   C1823998:HANG [Gene or Genome]

Phrase: "A."
Processing 00000000.tx.368: Y., Seubert, P., Vigo-Pelfrey, C., Lieberburg, I., and Selkoe, D. 

Phrase: "Y.,"

Phrase: "Seubert,"

Phrase: "P.,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]

Phrase: "Vigo-Pelfrey,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Lieberburg,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.369: J. 

Phrase: "J."
Processing 00000000.tx.370: (1992) Nature 360, 672-674[CrossRef][Medline] [OrderarticleviaInfotrieve] 3. 

Phrase: "(2000) Nature 408, 979-982[CrossRef][Medline] [OrderarticleviaInfotrieve] 2. Citron, M., Oltersdorf, T., Haass, C., McConlogue, C., Hung, A. Y., Seubert, P., Vigo-Pelfrey, C., Lieberburg, I., and Selkoe, D. J. (1992"

Phrase: ")"

Phrase: "Nature 360,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "672-674"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.371: Roher, A. 

Phrase: "Roher,"

Phrase: "A."
Processing 00000000.tx.372: E., Lowenson, J. 

Phrase: "E.,"

Phrase: "Lowenson,"

Phrase: "J."
Processing 00000000.tx.373: D., Clarke, S., Wolkow, C., Wang, R., Cotter, R. 

Phrase: "D."

Phrase: ","

Phrase: "Clarke,"

Phrase: "S."

Phrase: ","

Phrase: "Wolkow,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Wang,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Cotter,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.374: J., Reardon, I. 

Phrase: "J.,"

Phrase: "Reardon,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.375: L., Zurcher-Neely, H. 

Phrase: "L., Zurcher-Neely,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.376: A., Heinrikson, R. 

Phrase: "A.,"

Phrase: "Heinrikson,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.377: L., Ball, M. 

Phrase: "L., Ball,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1706910:Ball [Manufactured Object]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.378: J., and Greenberg, B. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Greenberg,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.379: D. 

Phrase: "D."
Processing 00000000.tx.380: (1993) J. 

Phrase: "(1992) Nature 360, 672-674[CrossRef][Medline] [OrderarticleviaInfotrieve] 3. Roher, A. E., Lowenson, J. D., Clarke, S., Wolkow, C., Wang, R., Cotter, R. J., Reardon, I. L., Zurcher-Neely, H. A., Heinrikson, R. L., Ball, M. J., and Greenberg, B. D. (1993"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.381: Biol. 

Phrase: "Biol."
Processing 00000000.tx.382: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.383: 268, 3072-3083[Abstract/Free FullText] 4. 

Phrase: "268,"

Phrase: "3072-3083"

Phrase: "[Abstract/Free FullText"

Phrase: "] 4."
Processing 00000000.tx.384: Johnston, J. 

Phrase: "Johnston,"

Phrase: "J."
Processing 00000000.tx.385: A., Cowburn, R. 

Phrase: "A.,"

Phrase: "Cowburn,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.386: F., Norgren, S., Wiehager, B., Venizelos, N., Winblad, B., Vigo-Pelfrey, C., Schenk, D., Lannfelt, L., and O'Neill, C. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Norgren,"

Phrase: "S."

Phrase: ","

Phrase: "Wiehager,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Venizelos,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Winblad,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Vigo-Pelfrey,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Schenk,"

Phrase: "D."

Phrase: ","

Phrase: "Lannfelt,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "O'Neill,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439114:O NOS [Intellectual Product]

Phrase: "C."
Processing 00000000.tx.387: (1994) FEBS Lett. 

Phrase: "(1993) J. Biol. Chem. 268, 3072-3083[Abstract/Free FullText] 4. Johnston, J. A., Cowburn, R. F., Norgren, S., Wiehager, B., Venizelos, N., Winblad, B., Vigo-Pelfrey, C., Schenk, D., Lannfelt, L., and O'Neill, C. (1994"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.388: 354, 274-278[CrossRef][Medline] [OrderarticleviaInfotrieve] 5. 

Phrase: "354,"

Phrase: "274-278"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.389: Suzuki, N., Cheung, T. 

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Cheung,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.390: T., Cai, X.-D., Odaka, A., Otvos, L., Eckman, C., Golde, T., and Younkin, S. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Cai,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0064494:CAI [Organic Chemical,Pharmacologic Substance]

Phrase: "X.-"

Phrase: "D."

Phrase: ","

Phrase: "Odaka,"

Phrase: "A.,"

Phrase: "Otvos,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Eckman,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Golde,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Younkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.391: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.392: (1994) Science 264, 1336-1340[Medline] [OrderarticleviaInfotrieve] 6. 

Phrase: "(1994) FEBS Lett. 354, 274-278[CrossRef][Medline] [OrderarticleviaInfotrieve] 5. Suzuki, N., Cheung, T. T., Cai, X.-D., Odaka, A., Otvos, L., Eckman, C., Golde, T., and Younkin, S. G. (1994"

Phrase: ")"

Phrase: "Science 264,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "1336-1340"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 6."
Processing 00000000.tx.393: Thinakaran, G., Teplow, D. 

Phrase: "Thinakaran,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Teplow,"

Phrase: "D."
Processing 00000000.tx.394: B., Siman, R., Greenberg, B., and Sisodia, S. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Siman,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Greenberg,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.395: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.396: (1996) J. 

Phrase: "(1994) Science 264, 1336-1340[Medline] [OrderarticleviaInfotrieve] 6. Thinakaran, G., Teplow, D. B., Siman, R., Greenberg, B., and Sisodia, S. S. (1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.397: Biol. 

Phrase: "Biol."
Processing 00000000.tx.398: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.399: 271, 9390-9397[Abstract/Free FullText] 7. 

Phrase: "271,"

Phrase: "9390-9397"

Phrase: "[Abstract/Free FullText"

Phrase: "] 7."
Processing 00000000.tx.400: Duff, K., Eckman, C., Zehr, C., Yu, X., Prada, C.-M., Perez-tur, J., Hutton, M., Buee, L., Harigaya, Y., Yager, D., Morgan, D., Gordon, M., Holcomb, L., Refolo, L., Zenk, B., Hardy, J., and Younkin, S. 

Phrase: "Duff,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Eckman,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Zehr,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "X.,"

Phrase: "Prada,"

Phrase: "C.-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "M."

Phrase: ","

Phrase: "Perez-tur,"

Phrase: "J.,"

Phrase: "Hutton,"

Phrase: "M."

Phrase: ","

Phrase: "Buee,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Harigaya,"

Phrase: "Y.,"

Phrase: "Yager,"

Phrase: "D."

Phrase: ","

Phrase: "Morgan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0582521:morgan [Quantitative Concept]

Phrase: "D."

Phrase: ","

Phrase: "Gordon,"

Phrase: "M."

Phrase: ","

Phrase: "Holcomb,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Refolo,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Zenk,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Younkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.401: (1996) Nature 383, 710-713[CrossRef][Medline] [OrderarticleviaInfotrieve] 8. 

Phrase: "(1996) J. Biol. Chem. 271, 9390-9397[Abstract/Free FullText] 7. Duff, K., Eckman, C., Zehr, C., Yu, X., Prada, C.-M., Perez-tur, J., Hutton, M., Buee, L., Harigaya, Y., Yager, D., Morgan, D., Gordon, M., Holcomb, L., Refolo, L., Zenk, B., Hardy, J., and Younkin, S. (1996"

Phrase: ")"

Phrase: "Nature 383,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "710-713"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 8."
Processing 00000000.tx.402: Borchelt, D. 

Phrase: "Borchelt,"

Phrase: "D."
Processing 00000000.tx.403: R., Thinakaran, G., Eckman, C. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Thinakaran,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Eckman,"

Phrase: "C."
Processing 00000000.tx.404: B., Lee, M. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Lee,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.405: K., Davenport, F., Ratovitsky, T., Prada, C.-M., Kim, G., Seekins, S., Yager, D., Slunt, H. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Davenport,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Ratovitsky,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Prada,"

Phrase: "C.-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "M."

Phrase: ","

Phrase: "Kim,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Seekins,"

Phrase: "S."

Phrase: ","

Phrase: "Yager,"

Phrase: "D."

Phrase: ","

Phrase: "Slunt,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.406: H., Wang, R., Seeger, M., Levey, A. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Wang,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Seeger,"

Phrase: "M."

Phrase: ","

Phrase: "Levey,"

Phrase: "A."
Processing 00000000.tx.407: I., Gandy, S. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Gandy,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.408: E., Copeland, N. 

Phrase: "E.,"

Phrase: "Copeland,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.409: G., Jenkins, N. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Jenkins,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.410: A., Price, D. 

Phrase: "A.,"

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."
Processing 00000000.tx.411: L., Younkin, S. 

Phrase: "L., Younkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.412: G., and Sisodia, S. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.413: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.414: (1996) Neuron 17, 1005-1013[Medline] [OrderarticleviaInfotrieve] 9. 

Phrase: "(1996) Nature 383, 710-713[CrossRef][Medline] [OrderarticleviaInfotrieve] 8. Borchelt, D. R., Thinakaran, G., Eckman, C. B., Lee, M. K., Davenport, F., Ratovitsky, T., Prada, C.-M., Kim, G., Seekins, S., Yager, D., Slunt, H. H., Wang, R., Seeger, M., Levey, A. I., Gandy, S. E., Copeland, N. G., Jenkins, N. A., Price, D. L., Younkin, S. G., and Sisodia, S. S. (1996"

Phrase: ")"

Phrase: "Neuron 17,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "1005-1013"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 9."
Processing 00000000.tx.415: Citron, M., Westaway, D., Xia, W., Carlson, G. 

Phrase: "Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M."

Phrase: ","

Phrase: "Westaway,"

Phrase: "D."

Phrase: ","

Phrase: "Xia,"

Phrase: "W.,"

Phrase: "Carlson,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.416: A., Diehl, T., Levesque, G., Johnson-Wood, K., Lee, M., Seubert, P., Davis, A., Kholodenko, D., Motter, R., Sherrington, R., Perry, B., Yao, H., Strome, R., Lieberburg, I., Rommens, J., Kim, S., Schenk, D., Fraser, P., St. 

Phrase: "A.,"

Phrase: "Diehl,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Levesque,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Johnson-Wood,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0043217:Wood [Substance]
   805 E C0144237:Sylvan [Organic Chemical]
   777 E C0442548:Woods [Geographic Area]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Lee,"

Phrase: "M."

Phrase: ","

Phrase: "Seubert,"

Phrase: "P.,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]

Phrase: "Davis,"

Phrase: "A.,"

Phrase: "Kholodenko,"

Phrase: "D."

Phrase: ","

Phrase: "Motter,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Sherrington,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Perry,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Yao,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Strome,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Lieberburg,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Rommens,"

Phrase: "J.,"

Phrase: "Kim,"

Phrase: "S."

Phrase: ","

Phrase: "Schenk,"

Phrase: "D."

Phrase: ","

Phrase: "Fraser,"

Phrase: "P.,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]

Phrase: "St."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3272372:ST [Intellectual Product]
Processing 00000000.tx.417: George-Hyslop, and Selkoe, D. 

Phrase: "George-Hyslop,"

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.418: (1997) Nat. 

Phrase: "(1996) Neuron 17, 1005-1013[Medline] [OrderarticleviaInfotrieve] 9. Citron, M., Westaway, D., Xia, W., Carlson, G. A., Diehl, T., Levesque, G., Johnson-Wood, K., Lee, M., Seubert, P., Davis, A., Kholodenko, D., Motter, R., Sherrington, R., Perry, B., Yao, H., Strome, R., Lieberburg, I., Rommens, J., Kim, S., Schenk, D., Fraser, P., St. George-Hyslop, and Selkoe, D. (1997"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.419: Med. 

Phrase: "Med."
Processing 00000000.tx.420: 3, 67-72[Medline] [OrderarticleviaInfotrieve] 10. 

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "67-72"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 10."
Processing 00000000.tx.421: Corder, E. 

Phrase: "Corder,"

Phrase: "E."
Processing 00000000.tx.422: H., Saunders, A. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Saunders,"

Phrase: "A."
Processing 00000000.tx.423: M., Srittmatter, W. 

Phrase: "M."

Phrase: ","

Phrase: "Srittmatter,"

Phrase: "W."
Processing 00000000.tx.424: J., Schmechel, D. 

Phrase: "J.,"

Phrase: "Schmechel,"

Phrase: "D."
Processing 00000000.tx.425: E., Gaskell, P. 

Phrase: "E.,"

Phrase: "Gaskell,"

Phrase: "P."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]
Processing 00000000.tx.426: C., Small, G. 

Phrase: "C., Small, G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.427: W., Roses, A. 

Phrase: "W., Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0035853:Roses [Plant]
   827 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A."
Processing 00000000.tx.428: D., Haines, J. 

Phrase: "D."

Phrase: ","

Phrase: "Haines,"

Phrase: "J."
Processing 00000000.tx.429: L., and Pericak-Vance, M. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Pericak-Vance,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.430: A. 

Phrase: "A."
Processing 00000000.tx.431: (1993) Science 261, 921-923[Medline] [OrderarticleviaInfotrieve] 11. 

Phrase: "(1997) Nat. Med. 3, 67-72[Medline] [OrderarticleviaInfotrieve] 10. Corder, E. H., Saunders, A. M., Srittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., and Pericak-Vance, M. A. (1993"

Phrase: ")"

Phrase: "Science 261,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "921-923"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 11."
Processing 00000000.tx.432: Holtzman, D. 

Phrase: "Holtzman,"

Phrase: "D."
Processing 00000000.tx.433: M., Bales, K. 

Phrase: "M."

Phrase: ","

Phrase: "Bales,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2826220:BALE [Quantitative Concept]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.434: R., Tenkova, T., Fagan, A. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Tenkova,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Fagan,"

Phrase: "A."
Processing 00000000.tx.435: M., Parsadanian, M., Sartorius, L. 

Phrase: "M."

Phrase: ","

Phrase: "Parsadanian,"

Phrase: "M."

Phrase: ","

Phrase: "Sartorius,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0224434:Sartorius [Body Part, Organ, or Organ Component]
  1000   C1305055:Sartorius [Body Part, Organ, or Organ Component]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.436: J., Mackey, B., Olney, J., McKeel, D., Wozniak, D., and Paul, S. 

Phrase: "J.,"

Phrase: "Mackey,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Olney,"

Phrase: "J.,"

Phrase: "McKeel,"

Phrase: "D."

Phrase: ","

Phrase: "Wozniak,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Paul,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.437: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.438: (2000) Proc. 

Phrase: "(1993) Science 261, 921-923[Medline] [OrderarticleviaInfotrieve] 11. Holtzman, D. M., Bales, K. R., Tenkova, T., Fagan, A. M., Parsadanian, M., Sartorius, L. J., Mackey, B., Olney, J., McKeel, D., Wozniak, D., and Paul, S. M. (2000"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.439: Natl. 

Phrase: "Natl."
Processing 00000000.tx.440: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.441: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.442: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.443: 97, 2892-2897[Abstract/Free FullText] 12. 

Phrase: "97,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439073:97 [Intellectual Product]
  1000   C0439082:>97 [Quantitative Concept]

Phrase: "2892-2897"

Phrase: "[Abstract/Free FullText"

Phrase: "] 12."
Processing 00000000.tx.444: Yankner, B. 

Phrase: "Yankner,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.445: A., Duffy, L. 

Phrase: "A.,"

Phrase: "Duffy,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.446: K., and Kirschner, D. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Kirschner,"

Phrase: "D."
Processing 00000000.tx.447: A. 

Phrase: "A."
Processing 00000000.tx.448: (1990) Science 250, 279-282[Medline] [OrderarticleviaInfotrieve] 13. 

Phrase: "(2000) Proc. Natl. Acad. Sci. U.S.A. 97, 2892-2897[Abstract/Free FullText] 12. Yankner, B. A., Duffy, L. K., and Kirschner, D. A. (1990"

Phrase: ")"

Phrase: "Science 250,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "279-282"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 13."
Processing 00000000.tx.449: Lorenzo, A., and Yankner, B. 

Phrase: "Lorenzo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1875453:LORENZO'S [Lipid,Pharmacologic Substance]

Phrase: "A.,"

Phrase: "and"

Phrase: "Yankner,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.450: A. 

Phrase: "A."
Processing 00000000.tx.451: (1994) Proc. 

Phrase: "(1990) Science 250, 279-282[Medline] [OrderarticleviaInfotrieve] 13. Lorenzo, A., and Yankner, B. A. (1994"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.452: Natl. 

Phrase: "Natl."
Processing 00000000.tx.453: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.454: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.455: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.456: 91, 12243-12247[Abstract/Free FullText] 14. 

Phrase: "91,"

Phrase: "12243-12247"

Phrase: "[Abstract/Free FullText"

Phrase: "] 14."
Processing 00000000.tx.457: Geula, C., Wu, C. 

Phrase: "Geula,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "C."
Processing 00000000.tx.458: K., Saroff, D., Lorenzo, A., Yuan, M., and Yankner, B. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Saroff,"

Phrase: "D."

Phrase: ","

Phrase: "Lorenzo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1875453:LORENZO'S [Lipid,Pharmacologic Substance]

Phrase: "A.,"

Phrase: "Yuan,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Yankner,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.459: A. 

Phrase: "A."
Processing 00000000.tx.460: (1998) Nat. 

Phrase: "(1994) Proc. Natl. Acad. Sci. U.S.A. 91, 12243-12247[Abstract/Free FullText] 14. Geula, C., Wu, C. K., Saroff, D., Lorenzo, A., Yuan, M., and Yankner, B. A. (1998"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.461: Med. 

Phrase: "Med."
Processing 00000000.tx.462: 4, 827-831[Medline] [OrderarticleviaInfotrieve] 15. 

Phrase: "4,"

Phrase: "827-831"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 15."
Processing 00000000.tx.463: Hsiao, K. 

Phrase: "Hsiao,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.464: (1998) Exp. 

Phrase: "(1998) Nat. Med. 4, 827-831[Medline] [OrderarticleviaInfotrieve] 15. Hsiao, K. (1998"

Phrase: ")"

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.465: Gerontol. 

Phrase: "Gerontol."
Processing 00000000.tx.466: 33, 883-889[CrossRef][Medline] [OrderarticleviaInfotrieve] 16. 

Phrase: "33,"

Phrase: "883-889"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 16."
Processing 00000000.tx.467: Janus, C., Chishti, M. 

Phrase: "Janus,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0266700:Janus [Congenital Abnormality]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Chishti,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.468: A., and Westaway, D. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Westaway,"

Phrase: "D."
Processing 00000000.tx.469: (2000) Biochim. 

Phrase: "(1998) Exp. Gerontol. 33, 883-889[CrossRef][Medline] [OrderarticleviaInfotrieve] 16. Janus, C., Chishti, M. A., and Westaway, D. (2000"

Phrase: ")"

Phrase: "Biochim."
Processing 00000000.tx.470: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.471: Acta 1502, 63-75[Medline] [OrderarticleviaInfotrieve] 17. 

Phrase: "Acta 1502,"

Phrase: "63-75"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 17."
Processing 00000000.tx.472: Games, D., et al.. 

Phrase: "Games,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0150593:games [Daily or Recreational Activity]

Phrase: "D."

Phrase: ","

Phrase: "et al.."
Processing 00000000.tx.473: (1995) Nature 373, 523-527[CrossRef][Medline] [OrderarticleviaInfotrieve] 18. 

Phrase: "(2000) Biochim. Biophys. Acta 1502, 63-75[Medline] [OrderarticleviaInfotrieve] 17. Games, D., et al.. (1995"

Phrase: ")"

Phrase: "Nature 373,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "523-527"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 18."
Processing 00000000.tx.474: Hsiao, K. 

Phrase: "Hsiao,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.475: H., Chapman, P., Nilsen, S., Eckman, C., Harigawa, Y., Younkin, S., Yang, F. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Chapman,"

Phrase: "P.,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]

Phrase: "Nilsen,"

Phrase: "S."

Phrase: ","

Phrase: "Eckman,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Harigawa,"

Phrase: "Y.,"

Phrase: "Younkin,"

Phrase: "S."

Phrase: ","

Phrase: "Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.476: S., and Cole, G. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Cole,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.477: (1996) Science 274, 99-102[Abstract/Free FullText] 19. 

Phrase: "(1995) Nature 373, 523-527[CrossRef][Medline] [OrderarticleviaInfotrieve] 18. Hsiao, K. H., Chapman, P., Nilsen, S., Eckman, C., Harigawa, Y., Younkin, S., Yang, F. S., and Cole, G. (1996"

Phrase: ")"

Phrase: "Science 274,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "99-102"

Phrase: "[Abstract/Free FullText"

Phrase: "] 19."
Processing 00000000.tx.478: Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K. 

Phrase: "Sturchler-Pierrat,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Abramowski,"

Phrase: "D."

Phrase: ","

Phrase: "Duke,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1446468:Duke [Laboratory Procedure]

Phrase: "M."

Phrase: ","

Phrase: "Wiederhold,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.479: H., Mistl, C., Rothacher, S., Ledermann, B., Burki, K., Frey, P., Paganetti, P. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Mistl,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Rothacher,"

Phrase: "S."

Phrase: ","

Phrase: "Ledermann,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Burki,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Frey,"

Phrase: "P.,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]

Phrase: "Paganetti,"

Phrase: "P."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]
Processing 00000000.tx.480: A., Waridel, C., Calhoun, M. 

Phrase: "A.,"

Phrase: "Waridel,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Calhoun,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.481: E., Jucker, M., Probst, A., Staufenbiel, M., and Sommer, B. 

Phrase: "E.,"

Phrase: "Jucker,"

Phrase: "M."

Phrase: ","

Phrase: "Probst,"

Phrase: "A.,"

Phrase: "Staufenbiel,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Sommer,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.482: (1997) Proc. 

Phrase: "(1996) Science 274, 99-102[Abstract/Free FullText] 19. Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K. H., Mistl, C., Rothacher, S., Ledermann, B., Burki, K., Frey, P., Paganetti, P. A., Waridel, C., Calhoun, M. E., Jucker, M., Probst, A., Staufenbiel, M., and Sommer, B. (1997"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.483: Natl. 

Phrase: "Natl."
Processing 00000000.tx.484: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.485: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.486: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.487: 94, 13287-13292[Abstract/Free FullText] 20. 

Phrase: "94,"

Phrase: "13287-13292"

Phrase: "[Abstract/Free FullText"

Phrase: "] 20."
Processing 00000000.tx.488: Calhoun, M. 

Phrase: "Calhoun,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.489: E., Wederhold, K.-H., Abramowski, D., Phinney, A. 

Phrase: "E.,"

Phrase: "Wederhold,"

Phrase: "K.-H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Abramowski,"

Phrase: "D."

Phrase: ","

Phrase: "Phinney,"

Phrase: "A."
Processing 00000000.tx.490: L., Probst, A., Sturchler-Pierrat, C., Staufenbiel, M., Sommer, B., and Jucker, M. 

Phrase: "L., Probst,"

Phrase: "A.,"

Phrase: "Sturchler-Pierrat,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Staufenbiel,"

Phrase: "M."

Phrase: ","

Phrase: "Sommer,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Jucker,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.491: (1998) Nature 395, 755-756[CrossRef][Medline] [OrderarticleviaInfotrieve] 21. 

Phrase: "(1997) Proc. Natl. Acad. Sci. U.S.A. 94, 13287-13292[Abstract/Free FullText] 20. Calhoun, M. E., Wederhold, K.-H., Abramowski, D., Phinney, A. L., Probst, A., Sturchler-Pierrat, C., Staufenbiel, M., Sommer, B., and Jucker, M. (1998"

Phrase: ")"

Phrase: "Nature 395,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "755-756"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 21."
Processing 00000000.tx.492: Dodart, J. 

Phrase: "Dodart,"

Phrase: "J."
Processing 00000000.tx.493: C., Mathis, C., Saura, J., Bales, K. 

Phrase: "C., Mathis,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Saura,"

Phrase: "J.,"

Phrase: "Bales,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2826220:BALE [Quantitative Concept]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.494: R., Paul, S. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Paul,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.495: M., and Ungerer, A. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Ungerer,"

Phrase: "A."
Processing 00000000.tx.496: (2000) Neurobiol. 

Phrase: "(1998) Nature 395, 755-756[CrossRef][Medline] [OrderarticleviaInfotrieve] 21. Dodart, J. C., Mathis, C., Saura, J., Bales, K. R., Paul, S. M., and Ungerer, A. (2000"

Phrase: ")"

Phrase: "Neurobiol."
Processing 00000000.tx.497: Dis. 

Phrase: "Dis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0451119:DIS [Intellectual Product]
  1000   C1444662:DIS [Finding]
Processing 00000000.tx.498: 7, 71-85[CrossRef][Medline] [OrderarticleviaInfotrieve] 22. 

Phrase: "7,"

Phrase: "71-85"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450389:71 [Intellectual Product]

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 22."
Processing 00000000.tx.499: Hsiao, K. 

Phrase: "Hsiao,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.500: K., Borchelt, D. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Borchelt,"

Phrase: "D."
Processing 00000000.tx.501: R., Olson, K., Johannsdottir, R., Kitt, C., Yunis, W., Xu, S., Eckman, C., Younkin, S., Price, D., Iadecola, C., Clark, H. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Olson,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Johannsdottir,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Kitt,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Yunis,"

Phrase: "W.,"

Phrase: "Xu,"

Phrase: "S."

Phrase: ","

Phrase: "Eckman,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Younkin,"

Phrase: "S."

Phrase: ","

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."

Phrase: ","

Phrase: "Iadecola,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Clark,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.502: B., and Carlson, G. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Carlson,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.503: A. 

Phrase: "A."
Processing 00000000.tx.504: (1995) Neuron 15, 1203-1218[Medline] [OrderarticleviaInfotrieve] 23. 

Phrase: "(2000) Neurobiol. Dis. 7, 71-85[CrossRef][Medline] [OrderarticleviaInfotrieve] 22. Hsiao, K. K., Borchelt, D. R., Olson, K., Johannsdottir, R., Kitt, C., Yunis, W., Xu, S., Eckman, C., Younkin, S., Price, D., Iadecola, C., Clark, H. B., and Carlson, G. A. (1995"

Phrase: ")"

Phrase: "Neuron 15,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "1203-1218"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 23."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]
Processing 00000000.tx.505: Moechars, D., Dewachter, I., Lorent, K., Reverse, D., Baekelandt, V., Naidu, A., Tesseur, I., Spittaels, K., Haute, C. 

Phrase: "Moechars,"

Phrase: "D."

Phrase: ","

Phrase: "Dewachter,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Lorent,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Reverse,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: "D."

Phrase: ","

Phrase: "Baekelandt,"

Phrase: "V.,"

Phrase: "Naidu,"

Phrase: "A.,"

Phrase: "Tesseur,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Spittaels,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Haute,"

Phrase: "C."
Processing 00000000.tx.506: V., Checler, F., Godaux, E., Cordell, B., and Van Leuven, F. 

Phrase: "V., Checler,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Godaux,"

Phrase: "E.,"

Phrase: "Cordell,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Van Leuven,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.507: (1999) J. 

Phrase: "(1995) Neuron 15, 1203-1218[Medline] [OrderarticleviaInfotrieve] 23. Moechars, D., Dewachter, I., Lorent, K., Reverse, D., Baekelandt, V., Naidu, A., Tesseur, I., Spittaels, K., Haute, C. V., Checler, F., Godaux, E., Cordell, B., and Van Leuven, F. (1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.508: Biol. 

Phrase: "Biol."
Processing 00000000.tx.509: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.510: 274, 6483-6492[Abstract/Free FullText] 24. 

Phrase: "274,"

Phrase: "6483-6492"

Phrase: "[Abstract/Free FullText"

Phrase: "] 24."
Processing 00000000.tx.511: Chapman, P. 

Phrase: "Chapman,"

Phrase: "P."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]
Processing 00000000.tx.512: F., White, G. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "White,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007457:White [Population Group]
  1000   C0043157:White [Population Group]
  1000   C0220938:White [Qualitative Concept]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.513: L., Jones, M. 

Phrase: "L., Jones,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0443013:Jones [Intellectual Product]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.514: W., Cooper-Blacketer, D., Marshall, V. 

Phrase: "W., Cooper-Blacketer,"

Phrase: "D."

Phrase: ","

Phrase: "Marshall,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551881:Marshall [Population Group]

Phrase: "V."
Processing 00000000.tx.515: J., Irizarry, M., Younkin, L., Good, M. 

Phrase: "J.,"

Phrase: "Irizarry,"

Phrase: "M."

Phrase: ","

Phrase: "Younkin,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Good,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205170:Good [Qualitative Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.516: A., Bliss, T. 

Phrase: "A.,"

Phrase: "Bliss,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.517: V., Hyman, B. 

Phrase: "V., Hyman,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.518: T., Younkin, S. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Younkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.519: G., and Hsiao, K. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Hsiao,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.520: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.521: (1999) Nat. 

Phrase: "(1999) J. Biol. Chem. 274, 6483-6492[Abstract/Free FullText] 24. Chapman, P. F., White, G. L., Jones, M. W., Cooper-Blacketer, D., Marshall, V. J., Irizarry, M., Younkin, L., Good, M. A., Bliss, T. V., Hyman, B. T., Younkin, S. G., and Hsiao, K. K. (1999"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.522: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.523: 2, 271-276[CrossRef][Medline] [OrderarticleviaInfotrieve] 25. 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "271-276"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 25."
Processing 00000000.tx.524: Dodart, J. 

Phrase: "Dodart,"

Phrase: "J."
Processing 00000000.tx.525: C., Meziane, H., Mathis, C., Bales, K. 

Phrase: "C., Meziane,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Mathis,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Bales,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2826220:BALE [Quantitative Concept]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.526: R., Paul, S. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Paul,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.527: M., and Ungerer, A. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Ungerer,"

Phrase: "A."
Processing 00000000.tx.528: (1999) Behav. 

Phrase: "(1999) Nat. Neurosci. 2, 271-276[CrossRef][Medline] [OrderarticleviaInfotrieve] 25. Dodart, J. C., Meziane, H., Mathis, C., Bales, K. R., Paul, S. M., and Ungerer, A. (1999"

Phrase: ")"

Phrase: "Behav."
Processing 00000000.tx.529: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.530: 113, 982-990[CrossRef][Medline] [OrderarticleviaInfotrieve] 26. 

Phrase: "113,"

Phrase: "982-990"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 26."
Processing 00000000.tx.531: Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. 

Phrase: "Kang,"

Phrase: "J.,"

Phrase: "Lemaire,"

Phrase: "H.-G.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0560020:h g [Quantitative Concept]
   861   C0439267:g% [Quantitative Concept]

Phrase: "Unterbeck,"

Phrase: "A.,"

Phrase: "Salbaum,"

Phrase: "J."
Processing 00000000.tx.532: M., Masters, C. 

Phrase: "M."

Phrase: ","

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.533: L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., and Muller-Hill, B. 

Phrase: "L., Grzeschik,"

Phrase: "K.-H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Multhaup,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Beyreuther,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Muller-Hill,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442532:Hill [Spatial Concept]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.534: (1987) Nature 325, 733-736[CrossRef][Medline] [OrderarticleviaInfotrieve] 27. 

Phrase: "(1999) Behav. Neurosci. 113, 982-990[CrossRef][Medline] [OrderarticleviaInfotrieve] 26. Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., and Muller-Hill, B. (1987"

Phrase: ")"

Phrase: "Nature 325,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "733-736"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 27."
Processing 00000000.tx.535: Vieira, J., and Messing, J. 

Phrase: "Vieira,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Messing,"

Phrase: "J."
Processing 00000000.tx.536: (1982) Gene (Amst.) 

Phrase: "(1987) Nature 325, 733-736[CrossRef][Medline] [OrderarticleviaInfotrieve] 27. Vieira, J., and Messing, J. (1982"

Phrase: ")"

Phrase: "Gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "(1982) Gene (Amst."

Phrase: ")"
Processing 00000000.tx.537: 19, 259-268[CrossRef][Medline] [OrderarticleviaInfotrieve] 28. 

Phrase: "19,"

Phrase: "259-268"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 28."
Processing 00000000.tx.538: Bolivar, F., Rodriguez, R. 

Phrase: "Bolivar,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Rodriguez,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.539: L., Greene, P. 

Phrase: "L., Greene,"

Phrase: "P."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]
Processing 00000000.tx.540: J., Betlach, M. 

Phrase: "J.,"

Phrase: "Betlach,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.541: C., Heyneker, H. 

Phrase: "C., Heyneker,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.542: L., and Boyer, H. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Boyer,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.543: W. 

Phrase: "W."
Processing 00000000.tx.544: (1977) Gene (Amst.) 

Phrase: "(Amst.) 19, 259-268[CrossRef][Medline] [OrderarticleviaInfotrieve] 28. Bolivar, F., Rodriguez, R. L., Greene, P. J., Betlach, M. C., Heyneker, H. L., and Boyer, H. W. (1977"

Phrase: ")"

Phrase: "Gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "(1977) Gene (Amst."

Phrase: ")"
Processing 00000000.tx.545: 2, 95-113[Medline] [OrderarticleviaInfotrieve] 29. 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "95-113"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 29."
Processing 00000000.tx.546: Scott, M. 

Phrase: "Scott,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.547: R., Khler, R., Foster, D., and Prusiner, S. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Khler,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Foster,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242298:foster [Daily or Recreational Activity]
  1000   C0344349:foster [Family Group]

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Prusiner,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.548: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.549: (1992) Protein Sci. 

Phrase: "(Amst.) 2, 95-113[Medline] [OrderarticleviaInfotrieve] 29. Scott, M. R., Khler, R., Foster, D., and Prusiner, S. B. (1992"

Phrase: ")"

Phrase: "Protein Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.550: 1, 986-997[Abstract/Free FullText] 30. 

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "986-997"

Phrase: "[Abstract/Free FullText"

Phrase: "] 30."
Processing 00000000.tx.551: Scott, M., Foster, D., Mirenda, C., Serban, D., Coufal, F., Wlchli, M., Torchia, M., Groth, D., Carlson, G., DeArmond, S. 

Phrase: "Scott,"

Phrase: "M."

Phrase: ","

Phrase: "Foster,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242298:foster [Daily or Recreational Activity]
  1000   C0344349:foster [Family Group]

Phrase: "D."

Phrase: ","

Phrase: "Mirenda,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Serban,"

Phrase: "D."

Phrase: ","

Phrase: "Coufal,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Wlchli,"

Phrase: "M."

Phrase: ","

Phrase: "Torchia,"

Phrase: "M."

Phrase: ","

Phrase: "Groth,"

Phrase: "D."

Phrase: ","

Phrase: "Carlson,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "DeArmond,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.552: J., Westaway, D., and Prusiner, S. 

Phrase: "J.,"

Phrase: "Westaway,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Prusiner,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.553: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.554: (1989) Cell 59, 847-857[Medline] [OrderarticleviaInfotrieve] 31. 

Phrase: "(1992) Protein Sci. 1, 986-997[Abstract/Free FullText] 30. Scott, M., Foster, D., Mirenda, C., Serban, D., Coufal, F., Wlchli, M., Torchia, M., Groth, D., Carlson, G., DeArmond, S. J., Westaway, D., and Prusiner, S. B. (1989"

Phrase: ")"

Phrase: "Cell 59,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "847-857"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 31."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]
Processing 00000000.tx.555: Johnson-Wood, K., Lee, M., Motter, R., Hu, K., Gordon, G., Barbour, R., Khan, K., Gordon, M., Tan, H., Games, D., Lieberburg, I., Schenk, D., Seubert, P., and McConlogue, L. 

Phrase: "Johnson-Wood,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0043217:Wood [Substance]
   805 E C0144237:Sylvan [Organic Chemical]
   777 E C0442548:Woods [Geographic Area]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Lee,"

Phrase: "M."

Phrase: ","

Phrase: "Motter,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Hu,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Gordon,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Barbour,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Khan,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Gordon,"

Phrase: "M."

Phrase: ","

Phrase: "Tan,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302595:tan [Individual Behavior]
  1000   C1537110:Tan [Clinical Attribute]
  1000   C3275241:Tan [Qualitative Concept]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Games,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0150593:games [Daily or Recreational Activity]

Phrase: "D."

Phrase: ","

Phrase: "Lieberburg,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Schenk,"

Phrase: "D."

Phrase: ","

Phrase: "Seubert,"

Phrase: "P.,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]

Phrase: "and"

Phrase: "McConlogue,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.556: (1997) Proc. 

Phrase: "(1989) Cell 59, 847-857[Medline] [OrderarticleviaInfotrieve] 31. Johnson-Wood, K., Lee, M., Motter, R., Hu, K., Gordon, G., Barbour, R., Khan, K., Gordon, M., Tan, H., Games, D., Lieberburg, I., Schenk, D., Seubert, P., and McConlogue, L. (1997"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.557: Natl. 

Phrase: "Natl."
Processing 00000000.tx.558: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.559: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.560: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.561: 94, 1550-1555[Abstract/Free FullText] 32. 

Phrase: "94,"

Phrase: "1550-1555"

Phrase: "[Abstract/Free FullText"

Phrase: "] 32."
Processing 00000000.tx.562: Haccou, P., and Meelis, E. 

Phrase: "Haccou,"

Phrase: "P.,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]

Phrase: "and"

Phrase: "Meelis,"

Phrase: "E."
Processing 00000000.tx.563: (1995) Statistical Analysis of Behavioural Data , pp. 

Phrase: "(1997) Proc. Natl. Acad. Sci. U.S.A. 94, 1550-1555[Abstract/Free FullText] 32. Haccou, P., and Meelis, E. (1995"

Phrase: ")"

Phrase: "Statistical Analysis of Behavioural Data ,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   835   C0010998:Data Analysis, Statistical [Quantitative Concept]
   806   C0871424:statistical analysis [Research Activity]
   797   C0010992:Data Analysis [Occupational Activity]
   797   C1160858:Behavioral analysis [Health Care Activity]
   762 E C0935545:analysis behavior [Research Activity]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "pp."
Processing 00000000.tx.564: 120-186, Oxford University Press, Oxford 33. 

Phrase: "120-186,"

Phrase: "Oxford University Press,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Oxford 33."
Processing 00000000.tx.565: Janus, C., D'Amelio, S., Amitay, O., Chishti, M. 

Phrase: "Janus,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0266700:Janus [Congenital Abnormality]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "D'"

Phrase: "Amelio,"

Phrase: "S."

Phrase: ","

Phrase: "Amitay,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Chishti,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.566: A., Strome, R., Fraser, P. 

Phrase: "A.,"

Phrase: "Strome,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Fraser,"

Phrase: "P."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]
Processing 00000000.tx.567: E., Carlson, G. 

Phrase: "E.,"

Phrase: "Carlson,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.568: A., Roder, J., St. 

Phrase: "A.,"

Phrase: "Roder,"

Phrase: "J.,"

Phrase: "St."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3272372:ST [Intellectual Product]
Processing 00000000.tx.569: George-Hyslop, P., and Westaway, D. 

Phrase: "George-Hyslop,"

Phrase: "P.,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]

Phrase: "and"

Phrase: "Westaway,"

Phrase: "D."
Processing 00000000.tx.570: (2000) Neurobiol. 

Phrase: "(1995) Statistical Analysis of Behavioural Data , pp. 120-186, Oxford University Press, Oxford 33. Janus, C., D'Amelio, S., Amitay, O., Chishti, M. A., Strome, R., Fraser, P. E., Carlson, G. A., Roder, J., St. George-Hyslop, P., and Westaway, D. (2000"

Phrase: ")"

Phrase: "Neurobiol."
Processing 00000000.tx.571: Dis. 

Phrase: "Dis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0451119:DIS [Intellectual Product]
  1000   C1444662:DIS [Finding]
Processing 00000000.tx.572: 21, 541-549 34. 

Phrase: "21,"

Phrase: "541-549 34."
Processing 00000000.tx.573: Gass, P., Wolfer, D. 

Phrase: "Gass,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0017110:Gas [Chemical Viewed Structurally]
   966   C0596601:Gas [Sign or Symptom]

Phrase: "P.,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]

Phrase: "Wolfer,"

Phrase: "D."
Processing 00000000.tx.574: P., Balschun, D., Rudolph, D., Frey, U., Lipp, H. 

Phrase: "P.,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]

Phrase: "Balschun,"

Phrase: "D."

Phrase: ","

Phrase: "Rudolph,"

Phrase: "D."

Phrase: ","

Phrase: "Frey,"

Phrase: "U.,"

Phrase: "Lipp,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.575: P., and Schutz, G. 

Phrase: "P.,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]

Phrase: "and"

Phrase: "Schutz,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.576: (1998) Learn. 

Phrase: "(2000) Neurobiol. Dis. 21, 541-549 34. Gass, P., Wolfer, D. P., Balschun, D., Rudolph, D., Frey, U., Lipp, H. P., and Schutz, G. (1998"

Phrase: ")"

Phrase: "Learn."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023185:learn [Mental Process]
Processing 00000000.tx.577: Mem. 

Phrase: "Mem."
Processing 00000000.tx.578: 5, 274-88[Abstract/Free FullText] 35. 

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "274-88"

Phrase: "[Abstract/Free FullText"

Phrase: "] 35."
Processing 00000000.tx.579: Wehner, J. 

Phrase: "Wehner,"

Phrase: "J."
Processing 00000000.tx.580: M., Sleight, S., and Upchurch, M. 

Phrase: "M."

Phrase: ","

Phrase: "Sleight,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Upchurch,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.581: (1990) Brain Res. 

Phrase: "(1998) Learn. Mem. 5, 274-88[Abstract/Free FullText] 35. Wehner, J. M., Sleight, S., and Upchurch, M. (1990"

Phrase: ")"

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.582: 523, 181-187[CrossRef][Medline] [OrderarticleviaInfotrieve] 36. 

Phrase: "523,"

Phrase: "181-187"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 36."
Processing 00000000.tx.583: Carlson, G. 

Phrase: "Carlson,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.584: A., Borchelt, D. 

Phrase: "A.,"

Phrase: "Borchelt,"

Phrase: "D."
Processing 00000000.tx.585: R., Dake, A., Turner, S., Danielson, V., Coffin, J. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Dake,"

Phrase: "A.,"

Phrase: "Turner,"

Phrase: "S."

Phrase: ","

Phrase: "Danielson,"

Phrase: "V.,"

Phrase: "Coffin,"

Phrase: "J."
Processing 00000000.tx.586: D., Eckman, C., Meiners, J., Nilsen, S. 

Phrase: "D."

Phrase: ","

Phrase: "Eckman,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Meiners,"

Phrase: "J.,"

Phrase: "Nilsen,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.587: P., Younkin, S. 

Phrase: "P.,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]

Phrase: "Younkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.588: G., and Hsiao, K. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Hsiao,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.589: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.590: (1997) Hum. 

Phrase: "(1990) Brain Res. 523, 181-187[CrossRef][Medline] [OrderarticleviaInfotrieve] 36. Carlson, G. A., Borchelt, D. R., Dake, A., Turner, S., Danielson, V., Coffin, J. D., Eckman, C., Meiners, J., Nilsen, S. P., Younkin, S. G., and Hsiao, K. K. (1997"

Phrase: ")"

Phrase: "Hum."
Processing 00000000.tx.591: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.592: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.593: 6, 1951-1959[Abstract/Free FullText] 37. 

Phrase: "6,"

Phrase: "1951-1959"

Phrase: "[Abstract/Free FullText"

Phrase: "] 37."
Processing 00000000.tx.594: Iadecola, C., Zhang, F., Niwa, K., Eckman, C., Turner, S. 

Phrase: "Iadecola,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Zhang,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Niwa,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Eckman,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Turner,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.595: K., Fischer, E., Younkin, S., Borchelt, D. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Fischer,"

Phrase: "E.,"

Phrase: "Younkin,"

Phrase: "S."

Phrase: ","

Phrase: "Borchelt,"

Phrase: "D."
Processing 00000000.tx.596: R., Hsiao, K. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Hsiao,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.597: K., and Carlson, G. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Carlson,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.598: A. 

Phrase: "A."
Processing 00000000.tx.599: (1999) Nat. 

Phrase: "(1997) Hum. Mol. Genet. 6, 1951-1959[Abstract/Free FullText] 37. Iadecola, C., Zhang, F., Niwa, K., Eckman, C., Turner, S. K., Fischer, E., Younkin, S., Borchelt, D. R., Hsiao, K. K., and Carlson, G. A. (1999"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.600: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.601: 2, 157-161[CrossRef][Medline] [OrderarticleviaInfotrieve] 38. 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "157-161"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 38."
Processing 00000000.tx.602: Telling, G. 

Phrase: "Telling,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.603: C., Scott, M., Mastrianni, J., Gabizon, R., Torchia, M., Cohen, F. 

Phrase: "C., Scott,"

Phrase: "M."

Phrase: ","

Phrase: "Mastrianni,"

Phrase: "J.,"

Phrase: "Gabizon,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Torchia,"

Phrase: "M."

Phrase: ","

Phrase: "Cohen,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.604: E., DeArmond, S. 

Phrase: "E.,"

Phrase: "DeArmond,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.605: J., and Prusiner, S. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Prusiner,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.606: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.607: (1995) Cell 83, 79-90[Medline] [OrderarticleviaInfotrieve] 39. 

Phrase: "(1999) Nat. Neurosci. 2, 157-161[CrossRef][Medline] [OrderarticleviaInfotrieve] 38. Telling, G. C., Scott, M., Mastrianni, J., Gabizon, R., Torchia, M., Cohen, F. E., DeArmond, S. J., and Prusiner, S. B. (1995"

Phrase: ")"

Phrase: "Cell 83,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "79-90"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439083:>90 [Quantitative Concept]
   861   C0439087:<90 [Quantitative Concept]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 39."
Processing 00000000.tx.608: Moser, M., Colello, R. 

Phrase: "Moser,"

Phrase: "M."

Phrase: ","

Phrase: "Colello,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.609: J., Pott, U., and Oesch, B. 

Phrase: "J.,"

Phrase: "Pott,"

Phrase: "U.,"

Phrase: "and"

Phrase: "Oesch,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.610: (1995) Neuron 14, 509-517[Medline] [OrderarticleviaInfotrieve] 40. 

Phrase: "(1995) Cell 83, 79-90[Medline] [OrderarticleviaInfotrieve] 39. Moser, M., Colello, R. J., Pott, U., and Oesch, B. (1995"

Phrase: ")"

Phrase: "Neuron 14,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "509-517"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 40."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]
Processing 00000000.tx.611: DeArmond, S. 

Phrase: "DeArmond,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.612: J., Sanchez, H., Yehiely, F., Qiu, Y., Ninchak-Casey, A., Daggett, V., Camerino, A. 

Phrase: "J.,"

Phrase: "Sanchez,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Yehiely,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Qiu,"

Phrase: "Y.,"

Phrase: "Ninchak-Casey,"

Phrase: "A.,"

Phrase: "Daggett,"

Phrase: "V.,"

Phrase: "Camerino,"

Phrase: "A."
Processing 00000000.tx.613: P., Cayetano, J., Rogers, M., Groth, D., Torchia, M., Tremblay, P., Scott, M. 

Phrase: "P.,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]

Phrase: "Cayetano,"

Phrase: "J.,"

Phrase: "Rogers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3463939:Roger [Eukaryote]

Phrase: "M."

Phrase: ","

Phrase: "Groth,"

Phrase: "D."

Phrase: ","

Phrase: "Torchia,"

Phrase: "M."

Phrase: ","

Phrase: "Tremblay,"

Phrase: "P.,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]

Phrase: "Scott,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.614: R., Cohen, F. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Cohen,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.615: E., and Prusiner, S. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Prusiner,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.616: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.617: (1997) Neuron 19, 1337-1348[Medline] [OrderarticleviaInfotrieve] 41. 

Phrase: "(1995) Neuron 14, 509-517[Medline] [OrderarticleviaInfotrieve] 40. DeArmond, S. J., Sanchez, H., Yehiely, F., Qiu, Y., Ninchak-Casey, A., Daggett, V., Camerino, A. P., Cayetano, J., Rogers, M., Groth, D., Torchia, M., Tremblay, P., Scott, M. R., Cohen, F. E., and Prusiner, S. B. (1997"

Phrase: ")"

Phrase: "Neuron 19,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "1337-1348"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 41."
Processing 00000000.tx.618: Irizarry, M. 

Phrase: "Irizarry,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.619: C., McNamara, M., Fedorchak, K., Hsiao, K., and Hyman, B. 

Phrase: "C., McNamara,"

Phrase: "M."

Phrase: ","

Phrase: "Fedorchak,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Hsiao,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Hyman,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.620: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.621: (1997) J. 

Phrase: "(1997) Neuron 19, 1337-1348[Medline] [OrderarticleviaInfotrieve] 41. Irizarry, M. C., McNamara, M., Fedorchak, K., Hsiao, K., and Hyman, B. T. (1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.622: Neuropathol. 

Phrase: "Neuropathol."
Processing 00000000.tx.623: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.624: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.625: 56, 965-973[Medline] [OrderarticleviaInfotrieve] 42. 

Phrase: "56,"

Phrase: "965-973"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 42."
Processing 00000000.tx.626: Kim, K. 

Phrase: "Kim,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.627: W., Miller, D. 

Phrase: "W., Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0402830:Miller [Professional or Occupational Group]

Phrase: "D."
Processing 00000000.tx.628: L., Sapienza, V. 

Phrase: "L., Sapienza,"

Phrase: "V."
Processing 00000000.tx.629: J., Chen, C. 

Phrase: "J.,"

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "C."
Processing 00000000.tx.630: M.J., Bai, C., Grundke-Iqbal, I., Currie, J. 

Phrase: "M."

Phrase: "J.,"

Phrase: "Bai,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234880:bai [Individual Behavior]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Grundke-Iqbal,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Currie,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1440524:Curry [Immunologic Factor]

Phrase: "J."
Processing 00000000.tx.631: R., and Wisnieski, H. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Wisnieski,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.632: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.633: (1988) Neurosci. 

Phrase: "(1997) J. Neuropathol. Exp. Neurol. 56, 965-973[Medline] [OrderarticleviaInfotrieve] 42. Kim, K. W., Miller, D. L., Sapienza, V. J., Chen, C. M.J., Bai, C., Grundke-Iqbal, I., Currie, J. R., and Wisnieski, H. M. (1988"

Phrase: ")"

Phrase: "Neurosci."
Processing 00000000.tx.634: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.635: Commun 2, 121-130 43. 

Phrase: "Commun 2,"

Phrase: "121-130 43."
Processing 00000000.tx.636: Spillantini, M. 

Phrase: "Spillantini,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.637: G., Goedert, M., Jakes, R., and Klug, A. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Goedert,"

Phrase: "M."

Phrase: ","

Phrase: "Jakes,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Klug,"

Phrase: "A."
Processing 00000000.tx.638: (1990) Proc. 

Phrase: "(1988) Neurosci. Res. Commun 2, 121-130 43. Spillantini, M. G., Goedert, M., Jakes, R., and Klug, A. (1990"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.639: Natl. 

Phrase: "Natl."
Processing 00000000.tx.640: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.641: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.642: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.643: 87, 3947-3951[Abstract] 44. 

Phrase: "87,"

Phrase: "3947-3951"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 44."
Processing 00000000.tx.644: Oesch, B., Westaway, D., Wlchli, M., McKinley, M. 

Phrase: "Oesch,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Westaway,"

Phrase: "D."

Phrase: ","

Phrase: "Wlchli,"

Phrase: "M."

Phrase: ","

Phrase: "McKinley,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.645: P., Kent, S. 

Phrase: "P.,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]

Phrase: "Kent,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454861:Kent [Geographic Area]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.646: B.H., Aebersold, R., Barry, R. 

Phrase: "B.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Aebersold,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Barry,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.647: A., Tempst, P., Teplow, D. 

Phrase: "A.,"

Phrase: "Tempst,"

Phrase: "P.,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]

Phrase: "Teplow,"

Phrase: "D."
Processing 00000000.tx.648: B., Hood, L. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Hood,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2720748:hood [Medical Device]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.649: E., Prusiner, S. 

Phrase: "E.,"

Phrase: "Prusiner,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.650: B., and Weissmann, C. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Weissmann,"

Phrase: "C."
Processing 00000000.tx.651: (1985) Cell 40, 735-746[Medline] [OrderarticleviaInfotrieve] 45. 

Phrase: "(1990) Proc. Natl. Acad. Sci. U.S.A. 87, 3947-3951[Abstract] 44. Oesch, B., Westaway, D., Wlchli, M., McKinley, M. P., Kent, S. B.H., Aebersold, R., Barry, R. A., Tempst, P., Teplow, D. B., Hood, L. E., Prusiner, S. B., and Weissmann, C. (1985"

Phrase: ")"

Phrase: "Cell 40,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0007634:Cell [Cell]
   861   C0439509:/40 [Temporal Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "735-746"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 45."
Processing 00000000.tx.652: Braak, H., and Braak, E. 

Phrase: "Braak,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Braak,"

Phrase: "E."
Processing 00000000.tx.653: (1991) Acta Neuropathol. 

Phrase: "(1985) Cell 40, 735-746[Medline] [OrderarticleviaInfotrieve] 45. Braak, H., and Braak, E. (1991"

Phrase: ")"

Phrase: "Acta Neuropathol."
Processing 00000000.tx.654: 82, 239-259[Medline] [OrderarticleviaInfotrieve] 46. 

Phrase: "82,"

Phrase: "239-259"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 46."
Processing 00000000.tx.655: Citron, M., Eckman, C. 

Phrase: "Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M."

Phrase: ","

Phrase: "Eckman,"

Phrase: "C."
Processing 00000000.tx.656: B., Diehl, T. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Diehl,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.657: S., Corcoran, C., Ostaszewski, B. 

Phrase: "S."

Phrase: ","

Phrase: "Corcoran,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Ostaszewski,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.658: L., Xia, W., Levesque, G., St. 

Phrase: "L., Xia,"

Phrase: "W.,"

Phrase: "Levesque,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "St."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3272372:ST [Intellectual Product]
Processing 00000000.tx.659: George-Hyslop, P., Younkin, S. 

Phrase: "George-Hyslop,"

Phrase: "P.,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]

Phrase: "Younkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.660: G., and Selkoe, D. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.661: J. 

Phrase: "J."
Processing 00000000.tx.662: (1998) Neurobiol. 

Phrase: "(1991) Acta Neuropathol. 82, 239-259[Medline] [OrderarticleviaInfotrieve] 46. Citron, M., Eckman, C. B., Diehl, T. S., Corcoran, C., Ostaszewski, B. L., Xia, W., Levesque, G., St. George-Hyslop, P., Younkin, S. G., and Selkoe, D. J. (1998"

Phrase: ")"

Phrase: "Neurobiol."
Processing 00000000.tx.663: Dis. 

Phrase: "Dis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0451119:DIS [Intellectual Product]
  1000   C1444662:DIS [Finding]
Processing 00000000.tx.664: 5, 107-116[CrossRef][Medline] [OrderarticleviaInfotrieve] 47. 

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "107-116"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 47."
Processing 00000000.tx.665: Storey, E., and Cappai, R. 

Phrase: "Storey,"

Phrase: "E.,"

Phrase: "and"

Phrase: "Cappai,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.666: (1999) Neuropathol. 

Phrase: "(1998) Neurobiol. Dis. 5, 107-116[CrossRef][Medline] [OrderarticleviaInfotrieve] 47. Storey, E., and Cappai, R. (1999"

Phrase: ")"

Phrase: "Neuropathol."
Processing 00000000.tx.667: Appl. 

Phrase: "Appl."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1858559:APPL [Gene or Genome]
Processing 00000000.tx.668: Neurobiol. 

Phrase: "Neurobiol."
Processing 00000000.tx.669: 25, 81-97[CrossRef][Medline] [OrderarticleviaInfotrieve] 48. 

Phrase: "25,"

Phrase: "81-97"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439073:97 [Intellectual Product]
   861   C0439082:>97 [Quantitative Concept]

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 48."
Processing 00000000.tx.670: Sherrington, R., Rogaev, E., Liang, Y., Rogaeva, E., Levesque, G., Ikeda, M., Chi, H., Lin, C., Holman, K., Tsuda, T., Mar, L., Fraser, P., Rommens, J. 

Phrase: "Sherrington,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Rogaev,"

Phrase: "E.,"

Phrase: "Liang,"

Phrase: "Y.,"

Phrase: "Rogaeva,"

Phrase: "E.,"

Phrase: "Levesque,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Ikeda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3613423:Ikeda [Eukaryote]

Phrase: "M."

Phrase: ","

Phrase: "Chi,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1720589:Chi [Intellectual Product]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0861352:LIN [Neoplastic Process]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Holman,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Tsuda,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Mar"

Phrase: ","

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Fraser,"

Phrase: "P.,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]

Phrase: "Rommens,"

Phrase: "J."
Processing 00000000.tx.671: M., and St. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "St."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3272372:ST [Intellectual Product]
Processing 00000000.tx.672: George-Hyslop, P. 

Phrase: "George-Hyslop,"

Phrase: "P."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]
Processing 00000000.tx.673: (1995) Nature 375, 754-760[CrossRef][Medline] [OrderarticleviaInfotrieve] 49. 

Phrase: "(1999) Neuropathol. Appl. Neurobiol. 25, 81-97[CrossRef][Medline] [OrderarticleviaInfotrieve] 48. Sherrington, R., Rogaev, E., Liang, Y., Rogaeva, E., Levesque, G., Ikeda, M., Chi, H., Lin, C., Holman, K., Tsuda, T., Mar, L., Fraser, P., Rommens, J. M., and St. George-Hyslop, P. (1995"

Phrase: ")"

Phrase: "Nature 375,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "754-760"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 49."
Processing 00000000.tx.674: Hsia, A. 

Phrase: "Hsia,"

Phrase: "A."
Processing 00000000.tx.675: Y., Masliah, E., McConlogue, L., Yu, G.Q., Tatsuno, G., Hu, K., Kholodenko, D., Malenka, R. 

Phrase: "Y.,"

Phrase: "Masliah,"

Phrase: "E.,"

Phrase: "McConlogue,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "G.Q., Tatsuno,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Hu,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kholodenko,"

Phrase: "D."

Phrase: ","

Phrase: "Malenka,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1069595:Malenka [Eukaryote]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.676: C., Nicoll, R. 

Phrase: "C., Nicoll,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.677: A., and Mucke, L. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Mucke,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.678: (1999) Proc. 

Phrase: "(1995) Nature 375, 754-760[CrossRef][Medline] [OrderarticleviaInfotrieve] 49. Hsia, A. Y., Masliah, E., McConlogue, L., Yu, G.Q., Tatsuno, G., Hu, K., Kholodenko, D., Malenka, R. C., Nicoll, R. A., and Mucke, L. (1999"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.679: Natl. 

Phrase: "Natl."
Processing 00000000.tx.680: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.681: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.682: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.683: 96, 3228-3233[Abstract/Free FullText] 50. 

Phrase: "96,"

Phrase: "3228-3233"

Phrase: "[Abstract/Free FullText"

Phrase: "] 50."
Processing 00000000.tx.684: Wang, J., Dickson, D. 

Phrase: "Wang,"

Phrase: "J.,"

Phrase: "Dickson,"

Phrase: "D."
Processing 00000000.tx.685: W., Trojanowski, J. 

Phrase: "W., Trojanowski,"

Phrase: "J."
Processing 00000000.tx.686: Q., and Lee, V. 

Phrase: "Q.,"

Phrase: "and"

Phrase: "Lee,"

Phrase: "V."
Processing 00000000.tx.687: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.688: (1999) Exp. 

Phrase: "(1999) Proc. Natl. Acad. Sci. U.S.A. 96, 3228-3233[Abstract/Free FullText] 50. Wang, J., Dickson, D. W., Trojanowski, J. Q., and Lee, V. M. (1999"

Phrase: ")"

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.689: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.690: 158, 328-337[CrossRef][Medline] [OrderarticleviaInfotrieve] 51. 

Phrase: "158,"

Phrase: "328-337"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 51."
Processing 00000000.tx.691: Mucke, L., Masliah, E., Yu, G.Q., Mallory, M., Rockenstein, E. 

Phrase: "Mucke,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Masliah,"

Phrase: "E.,"

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "G.Q., Mallory,"

Phrase: "M."

Phrase: ","

Phrase: "Rockenstein,"

Phrase: "E."
Processing 00000000.tx.692: M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., and McConlogue, L. 

Phrase: "M."

Phrase: ","

Phrase: "Tatsuno,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Hu,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kholodenko,"

Phrase: "D."

Phrase: ","

Phrase: "Johnson-Wood,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0043217:Wood [Substance]
   805 E C0144237:Sylvan [Organic Chemical]
   777 E C0442548:Woods [Geographic Area]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "McConlogue,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.693: (2000) J. 

Phrase: "(1999) Exp. Neurol. 158, 328-337[CrossRef][Medline] [OrderarticleviaInfotrieve] 51. Mucke, L., Masliah, E., Yu, G.Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., and McConlogue, L. (2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.694: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.695: 20, 4050-4058[Abstract/Free FullText] 52. 

Phrase: "20,"

Phrase: "4050-4058"

Phrase: "[Abstract/Free FullText"

Phrase: "] 52."
Processing 00000000.tx.696: Masliah, E., Sisk, A., Mallory, M., Mucke, L., Schenk, D., and Games, D. 

Phrase: "Masliah,"

Phrase: "E.,"

Phrase: "Sisk,"

Phrase: "A.,"

Phrase: "Mallory,"

Phrase: "M."

Phrase: ","

Phrase: "Mucke,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Schenk,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Games,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0150593:games [Daily or Recreational Activity]

Phrase: "D."
Processing 00000000.tx.697: (1996) J. 

Phrase: "(2000) J. Neurosci. 20, 4050-4058[Abstract/Free FullText] 52. Masliah, E., Sisk, A., Mallory, M., Mucke, L., Schenk, D., and Games, D. (1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.698: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.699: 16, 5795-5811[Abstract/Free FullText] 53. 

Phrase: "16,"

Phrase: "5795-5811"

Phrase: "[Abstract/Free FullText"

Phrase: "] 53."
Processing 00000000.tx.700: Irizarry, M. 

Phrase: "Irizarry,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.701: C., McNamara, M., Page, K. 

Phrase: "C., McNamara,"

Phrase: "M."

Phrase: ","

Phrase: "Page,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704732:Page [Intellectual Product]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.702: J., Schenk, D., Games, D., and Hyman, B. 

Phrase: "J.,"

Phrase: "Schenk,"

Phrase: "D."

Phrase: ","

Phrase: "Games,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0150593:games [Daily or Recreational Activity]

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Hyman,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.703: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.704: (1997) J. 

Phrase: "(1996) J. Neurosci. 16, 5795-5811[Abstract/Free FullText] 53. Irizarry, M. C., McNamara, M., Page, K. J., Schenk, D., Games, D., and Hyman, B. T. (1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.705: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.706: 17, 7053-7059[Abstract/Free FullText] 54. 

Phrase: "17,"

Phrase: "7053-7059"

Phrase: "[Abstract/Free FullText"

Phrase: "] 54."
Processing 00000000.tx.707: Patrick, G. 

Phrase: "Patrick,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.708: N., Zukerberg, L., Nikolic, M., de la Monte, S., Dikkes, P., and Tsai, L. 

Phrase: "N., Zukerberg,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Nikolic,"

Phrase: "M."

Phrase: ","

Phrase: "de la Monte,"

Phrase: "S."

Phrase: ","

Phrase: "Dikkes,"

Phrase: "P.,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]

Phrase: "and"

Phrase: "Tsai,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.709: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.710: (1999) Nature 402, 615-622[CrossRef][Medline] [OrderarticleviaInfotrieve] 55. 

Phrase: "(1997) J. Neurosci. 17, 7053-7059[Abstract/Free FullText] 54. Patrick, G. N., Zukerberg, L., Nikolic, M., de la Monte, S., Dikkes, P., and Tsai, L. H. (1999"

Phrase: ")"

Phrase: "Nature 402,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "615-622"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 55."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]
Processing 00000000.tx.711: Ahlijanian, M. 

Phrase: "Ahlijanian,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.712: K., Barrezueta, N. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Barrezueta,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.713: X., Williams, R. 

Phrase: "X.,"

Phrase: "Williams,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.714: D., Jakowski, A., Kowsz, K. 

Phrase: "D."

Phrase: ","

Phrase: "Jakowski,"

Phrase: "A.,"

Phrase: "Kowsz,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.715: P., McCarthy, S., Coskran, T., Carlo, A., Seymour, P. 

Phrase: "P.,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]

Phrase: "McCarthy,"

Phrase: "S."

Phrase: ","

Phrase: "Coskran,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Carlo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0445462:carlo [Intellectual Product]

Phrase: "A.,"

Phrase: "Seymour,"

Phrase: "P."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]
Processing 00000000.tx.716: A., Burkhardt, J. 

Phrase: "A.,"

Phrase: "Burkhardt,"

Phrase: "J."
Processing 00000000.tx.717: E., Nelson, R. 

Phrase: "E.,"

Phrase: "Nelson,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.718: B., and McNeish, J. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "McNeish,"

Phrase: "J."
Processing 00000000.tx.719: D. 

Phrase: "D."
Processing 00000000.tx.720: (2000) Proc. 

Phrase: "(1999) Nature 402, 615-622[CrossRef][Medline] [OrderarticleviaInfotrieve] 55. Ahlijanian, M. K., Barrezueta, N. X., Williams, R. D., Jakowski, A., Kowsz, K. P., McCarthy, S., Coskran, T., Carlo, A., Seymour, P. A., Burkhardt, J. E., Nelson, R. B., and McNeish, J. D. (2000"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.721: Natl. 

Phrase: "Natl."
Processing 00000000.tx.722: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.723: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.724: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.725: 97, 2910-2915[Abstract/Free FullText] 56. 

Phrase: "97,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439073:97 [Intellectual Product]
  1000   C0439082:>97 [Quantitative Concept]

Phrase: "2910-2915"

Phrase: "[Abstract/Free FullText"

Phrase: "] 56."
Processing 00000000.tx.726: Chen, G., Chen, K. 

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.727: S., Knox, J., Inglis, J., Bernard, A., Martin, S. 

Phrase: "S."

Phrase: ","

Phrase: "Knox,"

Phrase: "J.,"

Phrase: "Inglis,"

Phrase: "J.,"

Phrase: "Bernard,"

Phrase: "A.,"

Phrase: "Martin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.728: J., Justice, A., McConlogue, L., Games, D., Freedman, S. 

Phrase: "J.,"

Phrase: "Justice,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022437:Justice [Qualitative Concept]

Phrase: "A.,"

Phrase: "McConlogue,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Games,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0150593:games [Daily or Recreational Activity]

Phrase: "D."

Phrase: ","

Phrase: "Freedman,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.729: B., and Morris, R. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Morris,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.730: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.731: (2000) Nature 408, 975-979[CrossRef][Medline] [OrderarticleviaInfotrieve] 57. 

Phrase: "(2000) Proc. Natl. Acad. Sci. U.S.A. 97, 2910-2915[Abstract/Free FullText] 56. Chen, G., Chen, K. S., Knox, J., Inglis, J., Bernard, A., Martin, S. J., Justice, A., McConlogue, L., Games, D., Freedman, S. B., and Morris, R. G. (2000"

Phrase: ")"

Phrase: "Nature 408,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "975-979"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 57."
Processing 00000000.tx.732: Masliah, E., Terry, R. 

Phrase: "Masliah,"

Phrase: "E.,"

Phrase: "Terry,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.733: D., Alford, M., DeTeresa, R. 

Phrase: "D."

Phrase: ","

Phrase: "Alford,"

Phrase: "M."

Phrase: ","

Phrase: "DeTeresa,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.734: M., and Hansen, L. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Hansen,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.735: A. 

Phrase: "A."
Processing 00000000.tx.736: (1991) Am. 

Phrase: "(2000) Nature 408, 975-979[CrossRef][Medline] [OrderarticleviaInfotrieve] 57. Masliah, E., Terry, R. D., Alford, M., DeTeresa, R. M., and Hansen, L. A. (1991"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.737: J.Pathol. 

Phrase: "J.Pathol."
Processing 00000000.tx.738: 138, 235-246[Abstract] 58. 

Phrase: "138,"

Phrase: "235-246"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 58."
Processing 00000000.tx.739: Terry, R. 

Phrase: "Terry,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.740: D., Masliah, E., Salmon, D. 

Phrase: "D."

Phrase: ","

Phrase: "Masliah,"

Phrase: "E.,"

Phrase: "Salmon,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036110:Salmon [Fish]
  1000   C0327949:salmon [Fish]
  1000   C0459210:Salmon [Food]

Phrase: "D."
Processing 00000000.tx.741: P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. 

Phrase: "P.,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]

Phrase: "Butters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006494:Butter [Food,Lipid]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "DeTeresa,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Hill,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442532:Hill [Spatial Concept]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Hansen,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.742: A., and Katzman, R. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Katzman,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.743: (1991) Ann. 

Phrase: "(1991) Am. J.Pathol. 138, 235-246[Abstract] 58. Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., and Katzman, R. (1991"

Phrase: ")"

Phrase: "Ann."
Processing 00000000.tx.744: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.745: 30, 572-580[Medline] [OrderarticleviaInfotrieve] 59. 

Phrase: "30,"

Phrase: "572-580"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 59."
Processing 00000000.tx.746: Arriagada, P. 

Phrase: "Arriagada,"

Phrase: "P."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]
Processing 00000000.tx.747: V., Growdon, J. 

Phrase: "V., Growdon,"

Phrase: "J."
Processing 00000000.tx.748: H., Hedley-Whyte, E. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hedley-Whyte,"

Phrase: "E."
Processing 00000000.tx.749: T., and Hyman, B. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Hyman,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.750: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.751: (1992) Neurology 42, 631-639[Abstract] 60. 

Phrase: "(1991) Ann. Neurol. 30, 572-580[Medline] [OrderarticleviaInfotrieve] 59. Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., and Hyman, B. T. (1992"

Phrase: ")"

Phrase: "Neurology 42,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: "631-639"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 60."
Processing 00000000.tx.752: Terry, R. 

Phrase: "Terry,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.753: D. 

Phrase: "D."
Processing 00000000.tx.754: (1996) J. 

Phrase: "(1992) Neurology 42, 631-639[Abstract] 60. Terry, R. D. (1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.755: Neuropathol. 

Phrase: "Neuropathol."
Processing 00000000.tx.756: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.757: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.758: 55, 1023-1025[Medline] [OrderarticleviaInfotrieve] 61. 

Phrase: "55,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "1023-1025"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 61."
Processing 00000000.tx.759: Cummings, B. 

Phrase: "Cummings,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.760: J., Pike, C. 

Phrase: "J.,"

Phrase: "Pike,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014878:Pike [Fish]
  1000   C0522667:Pike [Manufactured Object]
  1000   C0730321:PIC [Disease or Syndrome]

Phrase: "C."
Processing 00000000.tx.761: J., Shankle, R., and Cotman, C. 

Phrase: "J.,"

Phrase: "Shankle,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Cotman,"

Phrase: "C."
Processing 00000000.tx.762: W. 

Phrase: "W."
Processing 00000000.tx.763: (1996) Neurobiol. 

Phrase: "(1996) J. Neuropathol. Exp. Neurol. 55, 1023-1025[Medline] [OrderarticleviaInfotrieve] 61. Cummings, B. J., Pike, C. J., Shankle, R., and Cotman, C. W. (1996"

Phrase: ")"

Phrase: "Neurobiol."
Processing 00000000.tx.764: Aging 17, 921-933[CrossRef][Medline] [OrderarticleviaInfotrieve] 62. 

Phrase: "Aging"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001811:Aging [Organism Function]
   966 E C0001779:Age [Organism Attribute]

Phrase: "17,"

Phrase: "921-933"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 62."
Processing 00000000.tx.765: Gomez-Isla, T., Hollister, R., West, H., Mui, S., Growdon, J. 

Phrase: "Gomez-Isla,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Hollister,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "West,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705493:West [Spatial Concept]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Mui,"

Phrase: "S."

Phrase: ","

Phrase: "Growdon,"

Phrase: "J."
Processing 00000000.tx.766: H., Petersen, R. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Petersen,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.767: C., Parisi, J. 

Phrase: "C., Parisi,"

Phrase: "J."
Processing 00000000.tx.768: E., and Hyman, B. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Hyman,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.769: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.770: (1997) Ann. 

Phrase: "(1996) Neurobiol. Aging 17, 921-933[CrossRef][Medline] [OrderarticleviaInfotrieve] 62. Gomez-Isla, T., Hollister, R., West, H., Mui, S., Growdon, J. H., Petersen, R. C., Parisi, J. E., and Hyman, B. T. (1997"

Phrase: ")"

Phrase: "Ann."
Processing 00000000.tx.771: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.772: 41, 17-24[Medline] [OrderarticleviaInfotrieve] 63. 

Phrase: "41,"

Phrase: "17-24"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 63."
Processing 00000000.tx.773: Bartoo, G. 

Phrase: "Bartoo,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.774: T., Nochlin, D., Chang, D., Kim, Y., and Sumi, S. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Nochlin,"

Phrase: "D."

Phrase: ","

Phrase: "Chang,"

Phrase: "D."

Phrase: ","

Phrase: "Kim,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Sumi,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.775: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.776: (1997) J. 

Phrase: "(1997) Ann. Neurol. 41, 17-24[Medline] [OrderarticleviaInfotrieve] 63. Bartoo, G. T., Nochlin, D., Chang, D., Kim, Y., and Sumi, S. M. (1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.777: Neuropathol. 

Phrase: "Neuropathol."
Processing 00000000.tx.778: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.779: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.780: 56, 531-540[Medline] [OrderarticleviaInfotrieve] 64. 

Phrase: "56,"

Phrase: "531-540"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 64."
Processing 00000000.tx.781: Crook, R., Verkkoneimi, A., Perez-Tur, J., Mehta, N., Baker, M., Houlden, H., Farrer, M., Hutton, M., Lincoln, S., Hardy, J., Gwinn, K., Somer, M., Paetau, A., Kalimo, H., Ylikoski, R., Poyhonen, M., Kucera, S., and Haltia, M. 

Phrase: "Crook,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Verkkoneimi,"

Phrase: "A.,"

Phrase: "Perez-Tur,"

Phrase: "J.,"

Phrase: "Mehta,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Baker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0238749:Baker [Professional or Occupational Group]

Phrase: "M."

Phrase: ","

Phrase: "Houlden,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Farrer,"

Phrase: "M."

Phrase: ","

Phrase: "Hutton,"

Phrase: "M."

Phrase: ","

Phrase: "Lincoln,"

Phrase: "S."

Phrase: ","

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "Gwinn,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Somer,"

Phrase: "M."

Phrase: ","

Phrase: "Paetau,"

Phrase: "A.,"

Phrase: "Kalimo,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Ylikoski,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Poyhonen,"

Phrase: "M."

Phrase: ","

Phrase: "Kucera,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Haltia,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.782: (1998) Nat. 

Phrase: "(1997) J. Neuropathol. Exp. Neurol. 56, 531-540[Medline] [OrderarticleviaInfotrieve] 64. Crook, R., Verkkoneimi, A., Perez-Tur, J., Mehta, N., Baker, M., Houlden, H., Farrer, M., Hutton, M., Lincoln, S., Hardy, J., Gwinn, K., Somer, M., Paetau, A., Kalimo, H., Ylikoski, R., Poyhonen, M., Kucera, S., and Haltia, M. (1998"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.783: Med. 

Phrase: "Med."
Processing 00000000.tx.784: 4, 452-455[Medline] [OrderarticleviaInfotrieve] 65. 

Phrase: "4,"

Phrase: "452-455"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 65."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]
Processing 00000000.tx.785: Beach, T. 

Phrase: "Beach,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331781:Beach [Geographic Area]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.786: G., Kuo, Y. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Kuo,"

Phrase: "Y."
Processing 00000000.tx.787: M., Spiegel, K., Emmerling, M. 

Phrase: "M."

Phrase: ","

Phrase: "Spiegel,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Emmerling,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.788: R., Sue, L. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Sue"

Phrase: ","

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.789: I., Kokjohn, K., and Roher, A. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Kokjohn,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Roher,"

Phrase: "A."
Processing 00000000.tx.790: E. 

Phrase: "E."
Processing 00000000.tx.791: (2000) J. 

Phrase: "(1998) Nat. Med. 4, 452-455[Medline] [OrderarticleviaInfotrieve] 65. Beach, T. G., Kuo, Y. M., Spiegel, K., Emmerling, M. R., Sue, L. I., Kokjohn, K., and Roher, A. E. (2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.792: Neuropathol. 

Phrase: "Neuropathol."
Processing 00000000.tx.793: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.794: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.795: 59, 308-313[Medline] [OrderarticleviaInfotrieve] 66. 

Phrase: "59,"

Phrase: "308-313"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 66."
Processing 00000000.tx.796: Lue, L. 

Phrase: "Lue,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.797: F., Kuo, Y. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Kuo,"

Phrase: "Y."
Processing 00000000.tx.798: M., Roher, A. 

Phrase: "M."

Phrase: ","

Phrase: "Roher,"

Phrase: "A."
Processing 00000000.tx.799: E., Brachova, L., Shen, Y., Sue, L., Beach, T., Kurth, J. 

Phrase: "E.,"

Phrase: "Brachova,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Shen,"

Phrase: "Y.,"

Phrase: "Sue"

Phrase: ","

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Beach,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331781:Beach [Geographic Area]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Kurth,"

Phrase: "J."
Processing 00000000.tx.800: H., Rydel, R. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Rydel,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.801: E., and Rogers, J. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Rogers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3463939:Roger [Eukaryote]

Phrase: "J."
Processing 00000000.tx.802: (1999) Am. 

Phrase: "(2000) J. Neuropathol. Exp. Neurol. 59, 308-313[Medline] [OrderarticleviaInfotrieve] 66. Lue, L. F., Kuo, Y. M., Roher, A. E., Brachova, L., Shen, Y., Sue, L., Beach, T., Kurth, J. H., Rydel, R. E., and Rogers, J. (1999"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.803: J.Pathol. 

Phrase: "J.Pathol."
Processing 00000000.tx.804: 155, 853-862[Abstract/Free FullText] 67. 

Phrase: "155,"

Phrase: "853-862"

Phrase: "[Abstract/Free FullText"

Phrase: "] 67."
Processing 00000000.tx.805: McLean, C. 

Phrase: "McLean,"

Phrase: "C."
Processing 00000000.tx.806: A., Cherny, R. 

Phrase: "A.,"

Phrase: "Cherny,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.807: A., Fraser, F. 

Phrase: "A.,"

Phrase: "Fraser,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.808: W., Fuller, S. 

Phrase: "W., Fuller,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.809: J., Smith, M. 

Phrase: "J.,"

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.810: J., Beyreuther, K., Bush, A. 

Phrase: "J.,"

Phrase: "Beyreuther,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Bush,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0330099:Bush [Plant]

Phrase: "A."
Processing 00000000.tx.811: I., and Masters, C. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.812: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.813: (1999) Ann. 

Phrase: "(1999) Am. J.Pathol. 155, 853-862[Abstract/Free FullText] 67. McLean, C. A., Cherny, R. A., Fraser, F. W., Fuller, S. J., Smith, M. J., Beyreuther, K., Bush, A. I., and Masters, C. L. (1999"

Phrase: ")"

Phrase: "Ann."
Processing 00000000.tx.814: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.815: 46, 860-866[CrossRef][Medline] [OrderarticleviaInfotrieve] 68. 

Phrase: "46,"

Phrase: "860-866"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 68."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]
Processing 00000000.tx.816: Huang, X., Atwood, C. 

Phrase: "Huang,"

Phrase: "X.,"

Phrase: "Atwood,"

Phrase: "C."
Processing 00000000.tx.817: S., Hartshorn, M. 

Phrase: "S."

Phrase: ","

Phrase: "Hartshorn,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.818: A., Multhaup, G., Goldstein, L. 

Phrase: "A.,"

Phrase: "Multhaup,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Goldstein,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.819: E., Scarpa, R. 

Phrase: "E.,"

Phrase: "Scarpa,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.820: C., Cuajungco, M. 

Phrase: "C., Cuajungco,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.821: P., Gray, D. 

Phrase: "P.,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]

Phrase: "Gray,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0556636:gray [Quantitative Concept]
  1000   C1269776:Gray [Qualitative Concept]

Phrase: "D."
Processing 00000000.tx.822: N., Lim, J., Moir, R. 

Phrase: "N., Lim,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0449205:LIM [Body Location or Region]
   861   C1538613:LIM [Gene or Genome]

Phrase: "J.,"

Phrase: "Moir,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.823: D., Tanzi, R. 

Phrase: "D."

Phrase: ","

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.824: E., and Bush, A. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Bush,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0330099:Bush [Plant]

Phrase: "A."
Processing 00000000.tx.825: I. 

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.826: (1999) Biochemistry 38, 7609-7616[CrossRef][Medline] [OrderarticleviaInfotrieve] 69. 

Phrase: "(1999) Ann. Neurol. 46, 860-866[CrossRef][Medline] [OrderarticleviaInfotrieve] 68. Huang, X., Atwood, C. S., Hartshorn, M. A., Multhaup, G., Goldstein, L. E., Scarpa, R. C., Cuajungco, M. P., Gray, D. N., Lim, J., Moir, R. D., Tanzi, R. E., and Bush, A. I. (1999"

Phrase: ")"

Phrase: "Biochemistry 38,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "7609-7616"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 69."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]
Processing 00000000.tx.827: Huang, X., Cuajungco, M. 

Phrase: "Huang,"

Phrase: "X.,"

Phrase: "Cuajungco,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.828: P., Atwood, C. 

Phrase: "P.,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]

Phrase: "Atwood,"

Phrase: "C."
Processing 00000000.tx.829: S., Hartshorn, M. 

Phrase: "S."

Phrase: ","

Phrase: "Hartshorn,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.830: A., Tyndall, J. 

Phrase: "A.,"

Phrase: "Tyndall,"

Phrase: "J."
Processing 00000000.tx.831: D., Hanson, G. 

Phrase: "D."

Phrase: ","

Phrase: "Hanson,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.832: R., Stokes, K. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Stokes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551086:Stokes [Quantitative Concept]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.833: C., Leopold, M., Multhaup, G., Goldstein, L. 

Phrase: "C., Leopold,"

Phrase: "M."

Phrase: ","

Phrase: "Multhaup,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Goldstein,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.834: E., Scarpa, R. 

Phrase: "E.,"

Phrase: "Scarpa,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.835: C., Saunders, A. 

Phrase: "C., Saunders,"

Phrase: "A."
Processing 00000000.tx.836: J., Lim, J., Moir, R. 

Phrase: "J.,"

Phrase: "Lim,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449205:LIM [Body Location or Region]
  1000   C1538613:LIM [Gene or Genome]

Phrase: "J.,"

Phrase: "Moir,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.837: D., Glabe, C., Bowden, E. 

Phrase: "D."

Phrase: ","

Phrase: "Glabe,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Bowden,"

Phrase: "E."
Processing 00000000.tx.838: F., Masters, C. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.839: L., Fairlie, D. 

Phrase: "L., Fairlie,"

Phrase: "D."
Processing 00000000.tx.840: P., Tanzi, R. 

Phrase: "P.,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.841: E., and Bush, A. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Bush,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0330099:Bush [Plant]

Phrase: "A."
Processing 00000000.tx.842: I. 

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.843: (1999) J. 

Phrase: "(1999) Biochemistry 38, 7609-7616[CrossRef][Medline] [OrderarticleviaInfotrieve] 69. Huang, X., Cuajungco, M. P., Atwood, C. S., Hartshorn, M. A., Tyndall, J. D., Hanson, G. R., Stokes, K. C., Leopold, M., Multhaup, G., Goldstein, L. E., Scarpa, R. C., Saunders, A. J., Lim, J., Moir, R. D., Glabe, C., Bowden, E. F., Masters, C. L., Fairlie, D. P., Tanzi, R. E., and Bush, A. I. (1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.844: Biol. 

Phrase: "Biol."
Processing 00000000.tx.845: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.846: 274, 37111-37116[Abstract/Free FullText] 70. 

Phrase: "274,"

Phrase: "37111-37116"

Phrase: "[Abstract/Free FullText"

Phrase: "] 70."
Processing 00000000.tx.847: Harkany, T., Abraham, I., Konya, C., Nyakas, C., Zarandi, M., Penke, B., and Luiten, P. 

Phrase: "Harkany,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Abraham,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442982:Abraham [Intellectual Product]

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Konya,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Nyakas,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Zarandi,"

Phrase: "M."

Phrase: ","

Phrase: "Penke,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Luiten,"

Phrase: "P."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]
Processing 00000000.tx.848: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.849: (2000) Rev. 

Phrase: "(1999) J. Biol. Chem. 274, 37111-37116[Abstract/Free FullText] 70. Harkany, T., Abraham, I., Konya, C., Nyakas, C., Zarandi, M., Penke, B., and Luiten, P. G. (2000"

Phrase: ")"

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.850: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.851: 11, 329-382[Medline] [OrderarticleviaInfotrieve] 71. 

Phrase: "11,"

Phrase: "329-382"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 71."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450389:71 [Intellectual Product]
Processing 00000000.tx.852: Bard, F., Cannon, C., Barbour, R., Burke, R.-L., Games, D., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., Kholodenko, D., Lee, M., Lieberburg, I., Motter, R., Nguyen, M., Soriano, F., Vasquez, N., Weiss, K., Welch, B., Seubert, P., Schenk, D., and Yednock, T. 

Phrase: "Bard,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Cannon,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Barbour,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Burke"

Phrase: ","

Phrase: "R.-L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Games,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0150593:games [Daily or Recreational Activity]

Phrase: "D."

Phrase: ","

Phrase: "Grajeda,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Guido,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Hu,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Huang,"

Phrase: "J.,"

Phrase: "Johnson-Wood,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0043217:Wood [Substance]
   805 E C0144237:Sylvan [Organic Chemical]
   777 E C0442548:Woods [Geographic Area]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Khan,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kholodenko,"

Phrase: "D."

Phrase: ","

Phrase: "Lee,"

Phrase: "M."

Phrase: ","

Phrase: "Lieberburg,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Motter,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Nguyen,"

Phrase: "M."

Phrase: ","

Phrase: "Soriano,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Vasquez,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Weiss,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Welch"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043114:Welsh [Population Group]

Phrase: ","

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Seubert,"

Phrase: "P.,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]

Phrase: "Schenk,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Yednock,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.853: (2000) Nat. 

Phrase: "(2000) Rev. Neurosci. 11, 329-382[Medline] [OrderarticleviaInfotrieve] 71. Bard, F., Cannon, C., Barbour, R., Burke, R.-L., Games, D., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., Kholodenko, D., Lee, M., Lieberburg, I., Motter, R., Nguyen, M., Soriano, F., Vasquez, N., Weiss, K., Welch, B., Seubert, P., Schenk, D., and Yednock, T. (2000"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.854: Med. 

Phrase: "Med."
Processing 00000000.tx.855: 6, 916-919[CrossRef][Medline] [OrderarticleviaInfotrieve] 72. 

Phrase: "6,"

Phrase: "916-919"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 72."
Processing 00000000.tx.856: Capell, A., Saffrich, R., Olivo, J.-C., Meyn, L., Walter, J., Grunberg, J., Dotti, C., and Haass, C. 

Phrase: "Capell,"

Phrase: "A.,"

Phrase: "Saffrich,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Olivo,"

Phrase: "J.-C., Meyn,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Walter,"

Phrase: "J.,"

Phrase: "Grunberg,"

Phrase: "J.,"

Phrase: "Dotti,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Haass,"

Phrase: "C."
Processing 00000000.tx.857: (1997) J. 

Phrase: "(2000) Nat. Med. 6, 916-919[CrossRef][Medline] [OrderarticleviaInfotrieve] 72. Capell, A., Saffrich, R., Olivo, J.-C., Meyn, L., Walter, J., Grunberg, J., Dotti, C., and Haass, C. (1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.858: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.859: 69, 2432-2340[Medline] [OrderarticleviaInfotrieve] 73. 

Phrase: "69,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]

Phrase: "2432-2340"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 73."
Processing 00000000.tx.860: Dewachter, I., Van Dorpe, J., Smeijers, L., Gilis, M., Kuiperi, C., Laenen, I., Caluwaerts, N., Moechars, D., Checler, F., Vanderstichele, H., and Van Leuven, F. 

Phrase: "Dewachter,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Van Dorpe,"

Phrase: "J.,"

Phrase: "Smeijers,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Gilis,"

Phrase: "M."

Phrase: ","

Phrase: "Kuiperi,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Laenen,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Caluwaerts,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Moechars,"

Phrase: "D."

Phrase: ","

Phrase: "Checler,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Vanderstichele,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Van Leuven,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.861: (2000) J. 

Phrase: "(1997) J. Neurochem. 69, 2432-2340[Medline] [OrderarticleviaInfotrieve] 73. Dewachter, I., Van Dorpe, J., Smeijers, L., Gilis, M., Kuiperi, C., Laenen, I., Caluwaerts, N., Moechars, D., Checler, F., Vanderstichele, H., and Van Leuven, F. (2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.862: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.863: 20, 6452-6458[Abstract/Free FullText] Copyright  2001 by The American Society for Biochemistry and Molecular Biology, Inc.

Phrase: "20,"

Phrase: "6452-6458"

Phrase: "[Abstract/Free FullText"

Phrase: "] Copyright  2001 by The American Society"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0009993:Copyright [Intellectual Product]
   753   C0037455:society [Organization]
   753   C0596070:American [Population Group]
   753   C1552856:copyright [Idea or Concept]

Phrase: "for Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Inc."

